<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta name="author" content="Tim Woelfle" />

<meta name="date" content="2023-08-07" />


<title>PRISMA 2009 Scores in Cullis 2017: Human Consensus vs LLM (GPT 3.5) - 2nd run</title>

<meta property="og:title" content="PRISMA 2009 Scores in Cullis 2017: Human Consensus vs LLM (GPT 3.5) - 2nd run" />

<meta name='viewport' content='width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no' />

<link rel="icon" href="data:image/x-icon;" type="image/x-icon">


<script type="text/javascript">
window.FlexDashboardComponents = [];
</script>

<script id="flexdashboard-navbar" type="application/json">
[{"title":"Source Code","icon":"fa-code","href":"","align":"right"}]
</script>
<script src="lib/header-attrs-2.21/header-attrs.js"></script>
<script src="lib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="lib/bootstrap-3.3.5/css/cosmo.min.css" rel="stylesheet" />
<script src="lib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="lib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="lib/stickytableheaders-0.1.19/jquery.stickytableheaders.min.js"></script>
<link href="lib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="lib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<link href="lib/value-box-accent-static-0.6.1/theme-cosmo-value-box.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/flexdashboard.min.css" rel="stylesheet" />
<link href="lib/flexdashboard-css-0.6.1/theme-cosmo.css" rel="stylesheet" />
<script src="lib/htmlwidgets-1.6.2/htmlwidgets.js"></script>
<link href="lib/datatables-css-0.0.0/datatables-crosstalk.css" rel="stylesheet" />
<script src="lib/datatables-binding-0.28/datatables.js"></script>
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.min.css" rel="stylesheet" />
<link href="lib/dt-core-1.13.4/css/jquery.dataTables.extra.css" rel="stylesheet" />
<script src="lib/dt-core-1.13.4/js/jquery.dataTables.min.js"></script>
<link href="lib/crosstalk-1.2.0/css/crosstalk.min.css" rel="stylesheet" />
<script src="lib/crosstalk-1.2.0/js/crosstalk.min.js"></script>
<style type="text/css">
/*
  CSS for flexdashboard.js' use of Sly(). The sizing/position of this CSS needs to be
  applied _before_ flexdashboard.js initializes, which is why this CSS has been pulled
  out from flexdashboard.scss and inlined in the document's head.
*/

.storyboard-nav button {
  background: transparent;
  border: 0;
  opacity: .3;
  outline: none;
  padding: 0;
}

.storyboard-nav button:hover,
.storyboard-nav button:hover {
  opacity: .5;
}

.storyboard-nav button:disabled,
.storyboard-nav button:disabled {
  opacity: .1;
}

.storyboard-nav .sbnext,
.storyboard-nav .sbprev {
  float: left;
  width: 2%;
  height: 120px;
}

.storyboard-nav .sbprev {
  text-align: left;
  width: 2%;
}

.storyboard-nav .sbnext {
  float: right;
  text-align: right;
  margin-right: 8px;
}

.storyboard-nav .sbframelist {
  margin: 0 auto;
  width: 94%;
  height: 120px;
  overflow: hidden;
  text-shadow: none;
  margin-bottom: 8px;
}

.storyboard-nav .sbframelist ul {
  list-style: none;
  margin: 0;
  padding: 0;
  height: 100%;
}

.storyboard-nav .sbframelist ul li {
  float: left;
  width: 270px;
  height: 100%;
  padding: 10px 10px 10px 10px;
  margin-right: 8px;
  text-align: left;
  cursor: pointer;
}

.storyboard-nav .sbframelist ul li:last-child {
  margin-right: 0px;
}

.sbframe-commentary {
  width: 300px;
}

.sbframe-commentary ul {
  padding-left: 22px;
}

.sbframe.active {
  display: flex;
}

.sbframe:not(.active) {
  display: none;
}
@media only screen and (min-width: 768px) {
html, body {
  height: 100%;
}

#dashboard-container {
  height: 100%;
}
}
</style>



</head>

<body>

<div class="navbar navbar-inverse navbar-fixed-top" role="navigation">
<div class="container-fluid">
<div class="navbar-header">

<span class="navbar-logo pull-left">
  
</span>
<span class="navbar-brand">
  PRISMA 2009 Scores in Cullis 2017: Human Consensus vs LLM (GPT 3.5) - 2nd run
  <span class="navbar-author">
    Tim Woelfle &mdash; 2023-08-07
    </span>
</span>

<button id="navbar-button" type="button" class="navbar-toggle collapsed pull-right" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
<span class="icon-bar"></span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
</button>

</div>
<div id="navbar" class="navbar-collapse collapse">
<ul class="nav navbar-nav navbar-left">
</ul>
<ul class="nav navbar-nav navbar-right">
</ul>
</div><!--/.nav-collapse-->
</div><!--/.container-->
</div><!--/.navbar-->

<script type="text/javascript">


var FlexDashboard = (function () {

  // initialize options
  var _options = {};

  var FlexDashboard = function() {

    // default options
    _options = $.extend(_options, {
      theme: "cosmo",
      fillPage: false,
      orientation: 'columns',
      storyboard: false,
      defaultFigWidth: 576,
      defaultFigHeight: 461,
      defaultFigWidthMobile: 360,
      defaultFigHeightMobile: 461,
      isMobile: false,
      isPortrait: false,
      resize_reload: true
    });
  };

  function init(options) {

    // extend default options
    $.extend(true, _options, options);

    // add ids to sections that don't have them (pandoc won't assign ids
    // to e.g. sections with titles consisting of only chinese characters)
    var nextId = 1;
    $('.level1:not([id]),.level2:not([id]),.level3:not([id])').each(function() {
      $(this).attr('id', 'dashboard-' + nextId++);
    });

    // find navbar items
    var navbarItems = $('#flexdashboard-navbar');
    if (navbarItems.length)
      navbarItems = JSON.parse(navbarItems.html());
    addNavbarItems(navbarItems);

    // find the main dashboard container
    var dashboardContainer = $('#dashboard-container');

    // resolve mobile classes
    resolveMobileClasses(dashboardContainer);

    // one time global initialization for components
    componentsInit(dashboardContainer);

    // look for a global sidebar
    var globalSidebar = dashboardContainer.find(".section.level1.sidebar");
    if (globalSidebar.length > 0) {

      // global layout for fullscreen displays
      if (!isMobilePhone()) {

         // hoist it up to the top level
         globalSidebar.insertBefore(dashboardContainer);

         // lay it out (set width/positions)
         layoutSidebar(globalSidebar, dashboardContainer);

      // tuck sidebar into first page for mobile phones
      } else {

        // convert it into a level3 section
        globalSidebar.removeClass('sidebar');
        globalSidebar.removeClass('level1');
        globalSidebar.addClass('level3');
        var h1 = globalSidebar.children('h1');
        var h3 = $('<h3></h3>');
        h3.append(h1.contents());
        h3.insertBefore(h1);
        h1.detach();

        // move it into the first page
        var page = dashboardContainer.find('.section.level1').first();
        if (page.length > 0)
          page.prepend(globalSidebar);
      }
    }

    // look for pages to layout
    var pages = $('div.section.level1');
    if (pages.length > 0) {

        // find the navbar and collapse on clicked
        var navbar = $('#navbar');
        navbar.on("click", "a[data-toggle!=dropdown]", null, function () {
           navbar.collapse('hide');
        });

        // envelop the dashboard container in a tab content div
        dashboardContainer.wrapInner('<div class="tab-content"></div>');

        pages.each(function(index) {

          // lay it out
          layoutDashboardPage($(this));

          // add it to the navbar
          addToNavbar($(this), index === 0);

        });

    } else {

      // remove the navbar and navbar button if we don't
      // have any navbuttons
      if (navbarItems.length === 0) {
        $('#navbar').remove();
        $('#navbar-button').remove();
      }

      // add the storyboard class if requested
      if (_options.storyboard)
        dashboardContainer.addClass('storyboard');

      // layout the entire page
      layoutDashboardPage(dashboardContainer);
    }

    // if we are in shiny we need to trigger a window resize event to
    // force correct layout of shiny-bound-output elements
    if (isShinyDoc())
      $(window).trigger('resize');

    // make main components visible
    $('.section.sidebar').css('visibility', 'visible');
    dashboardContainer.css('visibility', 'visible');

    // handle location hash
    handleLocationHash();

    // intialize prism highlighting
    initPrismHighlighting();

    // record mobile and orientation state then register a handler
    // to refresh if resize_reload is set to true and it changes
    _options.isMobile = isMobilePhone();
    _options.isPortrait = isPortrait();
    if (_options.resize_reload) {
      $(window).on('resize', function() {
        if (_options.isMobile !== isMobilePhone() ||
            _options.isPortrait !== isPortrait()) {
          window.location.reload();
        }
      });
    } else {
      // if in desktop mode and resizing to mobile, make sure the heights are 100%
      // This enforces what `fillpage.css` does for "wider" pages.
      // Since we are not reloading once the page becomes small, we need to force the height to 100%
      // This is a new situation introduced when `_options.resize_reload` is `false`
      if (! _options.isMobile) {
        // only add if `fillpage.css` was added in the first place
        if (_options.fillPage) {
          // fillpage.css
          $("html,body,#dashboard").css("height", "100%");
        }
      }
    }
    // trigger layoutcomplete event
    dashboardContainer.trigger('flexdashboard:layoutcomplete');
  }

  function resolveMobileClasses(dashboardContainer) {
     // add top level layout class
    dashboardContainer.addClass(isMobilePhone() ? 'mobile-layout' :
                                                  'desktop-layout');

    // look for .mobile sections and add .no-mobile to their peers
    var mobileSections = $('.section.mobile');
    mobileSections.each(function() {
       var id = $(this).attr('id');
       var nomobileId = id.replace(/-\d+$/, '');
       $('#' + nomobileId).addClass('no-mobile');
    });
  }

  function addNavbarItems(navbarItems) {

    var navbarLeft = $('ul.navbar-left');
    var navbarRight = $('ul.navbar-right');

    for (var i = 0; i<navbarItems.length; i++) {

      // get the item
      var item = navbarItems[i];

      // determine the container
      var container = null;
      if (item.align === "left")
        container = navbarLeft;
      else
        container = navbarRight;

      // navbar menu if we have multiple items
      if (item.items) {
        var menu = navbarMenu(null, item.icon, item.title, container);
        for (var j = 0; j<item.items.length; j++) {
          var subItem = item.items[j];
          var li = $('<li></li>');
          var a = navbarLink(subItem.icon, subItem.title, subItem.href, subItem.target);
          a.removeClass("nav-link").addClass("dropdown-item");
          li.append(a);
          menu.append(li);
        }
      } else {
        var li = $('<li class="nav-item"></li>');
        li.append(navbarLink(item.icon, item.title, item.href, item.target));
        container.append(li);
      }
    }
  }

  // create or get a reference to an existing dropdown menu
  function navbarMenu(id, icon, title, container) {
    var existingMenu = [];
    if (id)
      existingMenu = container.children('#' + id);
    if (existingMenu.length > 0) {
      return existingMenu.children('ul');
    } else {
      var li = $('<li class="nav-item"></li>');
      if (id)
        li.attr('id', id);
      li.addClass('dropdown');
      // auto add "Share" title on mobile if necessary
      if (!title && icon && (icon === "fa-share-alt") && isMobilePhone())
        title = "Share";
      if (title) {
        title = title + ' <span class="caret"></span>';
      }
      var a = navbarLink(icon, title, "#");
      a.addClass('dropdown-toggle');
      a.attr('data-toggle', 'dropdown');
      a.attr('data-bs-toggle', 'dropdown');
      a.attr('role', 'button');
      a.attr('aria-expanded', 'false');
      li.append(a);
      var ul = $('<ul class="dropdown-menu"></ul>');
      ul.attr('role', 'menu');
      li.append(ul);
      container.append(li);
      return ul;
    }
  }

  function addToNavbar(page, active) {

    // capture the id and data-icon attribute (if any)
    var id = page.attr('id');
    var icon = page.attr('data-icon');
    var navmenu = page.attr('data-navmenu');

    // get hidden state (transfer this to navbar)
    var hidden = page.hasClass('hidden');
    page.removeClass('hidden');

    // sanitize the id for use with bootstrap tabs
    id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
    page.attr('id', id);

    // get the wrapper
    var wrapper = page.closest('.dashboard-page-wrapper');

    // move the id to the wrapper
    page.removeAttr('id');
    wrapper.attr('id', id);

    // add the tab-pane class to the wrapper
    wrapper.addClass('tab-pane');
    if (active)
      wrapper.addClass('active');

    // get a reference to the h1, discover its inner contens, then detach it
    var h1 = wrapper.find('h1').first();
    var title = h1.contents();
    h1.detach();

    // create a navbar item
    var li = $('<li></li>');
    var a = navbarLink(icon, title, '#' + id);
    a.attr('data-toggle', 'tab');
    li.append(a);

    // add it to the navbar (or navbar menu if specified)
    var container = $('ul.navbar-left');
    if (navmenu) {
      var menuId = navmenu.replace(/\s+/g, '');
      var menu = navbarMenu(menuId, null, navmenu, container);
      li.find("> a").removeClass("nav-link").addClass("dropdown-item");
      menu.append(li);
    } else {
      li.addClass("nav-item")
      container.append(li);
    }

    // hide it if requested
    if (hidden)
      li.addClass('hidden');
  }

  function navbarLink(icon, title, href, target) {

    var a = $('<a class="nav-link"></a>');
    if (icon) {

      // get the name of the icon set and icon
      var dashPos = icon.indexOf("-");
      var iconSet = null;
      var iconSplit = icon.split(" ");
      if (iconSplit.length > 1) {
        iconSet = iconSplit[0];
        icon = iconSplit.slice(1).join(" ");
      } else {
        iconSet = icon.substring(0, dashPos);
      }
      var iconName = icon.substring(dashPos + 1);

      // create the icon
      var iconElement = $('<span class="' + iconSet + ' ' + icon + '"></span>');
      if (title)
        iconElement.css('margin-right', '7px');
      a.append(iconElement);
      // if href is null see if we can auto-generate based on icon (e.g. social)
      if (!href)
        maybeGenerateLinkFromIcon(iconName, a);
    }
    if (title)
      a.append(title);

    // add the href.
    if (href) {
      if (href === "source_embed") {
        a.attr('href', '#');
        a.attr('data-featherlight', "#flexdashboard-source-code");
        a.featherlight({
            beforeOpen: function(event){
              $('body').addClass('unselectable');
            },
            afterClose: function(event){
              $('body').removeClass('unselectable');
            }
        });
      } else {
        a.attr('href', href);
      }
    }

    // add the arget
    if (target)
      a.attr('target', target);

    return a;
  }

  // auto generate a link from an icon name (e.g. twitter) when possible
  function maybeGenerateLinkFromIcon(iconName, a) {

     var serviceLinks = {
      "twitter": "https://twitter.com/share?text=" + encodeURIComponent(document.title) + "&url="+encodeURIComponent(location.href),
      "facebook": "https://www.facebook.com/sharer/sharer.php?s=100&p[url]="+encodeURIComponent(location.href),
      "linkedin": "https://www.linkedin.com/shareArticle?mini=true&url="+encodeURIComponent(location.href) + "&title=" + encodeURIComponent(document.title),
      "pinterest": "https://pinterest.com/pin/create/link/?url="+encodeURIComponent(location.href) + "&description=" + encodeURIComponent(document.title)
    };

    var makeSocialLink = function(a, href) {
      a.attr('href', '#');
      a.on('click', function(e) {
        e.preventDefault();
        window.open(href);
      });
    };

    $.each(serviceLinks, function(key, value) {
      if (iconName.indexOf(key) !== -1)
        makeSocialLink(a, value);
    });
  }

  // layout a dashboard page
  function layoutDashboardPage(page) {

    // use a page wrapper so that free form content above the
    // dashboard appears at the top rather than the side (as it
    // would without the wrapper in a column orientation)
    var wrapper = $('<div class="dashboard-page-wrapper"></div>');
    page.wrap(wrapper);

    // if there are no level2 or level3 headers synthesize a level3
    // header to contain the (e.g. frame it, scroll container, etc.)
    var headers = page.find('h2,h3');
    if (headers.length === 0)
      page.wrapInner('<div class="section level3"></div>');

    // hoist up any content before level 2 or level 3 headers
    var children = page.children();
    children.each(function(index) {
      if ($(this).hasClass('level2') || $(this).hasClass('level3'))
        return false;
      $(this).insertBefore(page);
    });

    // determine orientation and fillPage behavior for distinct media
    var orientation, fillPage, storyboard;

    // media: mobile phone
    if (isMobilePhone()) {

      // if there is a sidebar we need to ensure it's content
      // is properly framed as an h3
      var sidebar = page.find('.section.sidebar');
      sidebar.removeClass('sidebar');
      sidebar.wrapInner('<div class="section level3"></div>');
      var h2 = sidebar.find('h2');
      var h3 = $('<h3></h3>');
      h3.append(h2.contents());
      h3.insertBefore(h2);
      h2.detach();

      // wipeout h2 elements then enclose them in a single h2
      var level2 = page.find('div.section.level2');
      level2.each(function() {
        level2.children('h2').remove();
        level2.children().unwrap();
      });
      page.wrapInner('<div class="section level2"></div>');

      // substitute mobile images
      if (isPortrait()) {
        var mobileFigures = $('img.mobile-figure');
        mobileFigures.each(function() {
          // get the src (might be base64 encoded)
          var src = $(this).attr('src');

          // find it's peer
          var id = $(this).attr('data-mobile-figure-id');
          var img = $('img[data-figure-id=' + id + "]");
          img.attr('src', src)
             .attr('width', _options.defaultFigWidthMobile)
             .attr('height', _options.defaultFigHeightMobile);
        });
      }

      // hoist storyboard commentary into it's own section
      if (page.hasClass('storyboard')) {
        var commentaryHR = page.find('div.section.level3 hr');
        commentaryHR.each(function() {
          var commentary = $(this).nextAll().detach();
          var commentarySection = $('<div class="section level3"></div>');
          commentarySection.append(commentary);
          commentarySection.insertAfter($(this).closest('div.section.level3'));
          $(this).remove();
        });
      }

      // force a non full screen layout by columns
      orientation = _options.orientation = 'columns';
      fillPage = _options.fillPage = false;
      storyboard = _options.storyboard = false;

    // media: desktop
    } else {

      // determine orientation
      orientation = page.attr('data-orientation');
      if (orientation !== 'rows' && orientation != 'columns')
        orientation = _options.orientation;

      // determine storyboard mode
      storyboard = page.hasClass('storyboard');

      // fillPage based on options (force for storyboard)
      fillPage = _options.fillPage || storyboard;

      // handle sidebar
      var sidebar = page.find('.section.level2.sidebar');
      if (sidebar.length > 0)
        layoutSidebar(sidebar, page);
    }

    // give it and it's parent divs height: 100% if we are in fillPage mode
    if (fillPage) {
      page.addClass('vertical-layout-fill');
      page.css('height', '100%');
      page.parents('div').css('height', '100%');
    } else {
      page.addClass('vertical-layout-scroll');
    }

    // perform the layout
    if (storyboard)
      layoutPageAsStoryboard(page);
    else if (orientation === 'rows')
      layoutPageByRows(page, fillPage);
    else if (orientation === 'columns')
      layoutPageByColumns(page, fillPage);
  }

  function layoutSidebar(sidebar, content) {

    // get it out of the header hierarchy
    sidebar = sidebar.first();
    if (sidebar.hasClass('level1')) {
      sidebar.removeClass('level1');
      sidebar.children('h1').remove();
    } else if (sidebar.hasClass('level2')) {
      sidebar.removeClass('level2');
      sidebar.children('h2').remove();
    }

    // determine width
    var sidebarWidth = isTablet() ? 220 : 250;
    var dataWidth = parseInt(sidebar.attr('data-width'));
    if (dataWidth)
      sidebarWidth = dataWidth;

    // set the width and shift the page right to accomodate the sidebar
    sidebar.css('width', sidebarWidth + 'px');
    content.css('padding-left', sidebarWidth + 'px');

    // wrap it's contents in a form
    sidebar.wrapInner($('<form></form>'));
  }

  function layoutPageAsStoryboard(page) {

    // create storyboard navigation
    var nav = $('<div class="storyboard-nav"></div>');

    // add navigation buttons
    var prev = $('<button class="sbprev"><i class="fa fa-angle-left"></i></button>');
    nav.append(prev);
    var next= $('<button class="sbnext"><i class="fa fa-angle-right"></i></button>');
    nav.append(next);

    // add navigation frame
    var frameList = $('<div class="sbframelist"></div>');
    nav.append(frameList);
    var ul = $('<ul></ul>');
    frameList.append(ul);

     // find all the level3 sections (those are the storyboard frames)
    var frames = page.find('div.section.level3');
    frames.each(function() {

      // mark it
      $(this).addClass('sbframe');

      // divide it into chart content and (optional) commentary
      $(this).addClass('dashboard-column-orientation');

      // stuff the chart into it's own div w/ flex
      $(this).wrapInner('<div class="sbframe-component"></div>');
      setFlex($(this), 1);
      var frame = $(this).children('.sbframe-component');

      // extract the title from the h3
      var li = $('<li></li>');
      var h3 = frame.children('h3');
      li.append(h3.contents());
      h3.detach();
      ul.append(li);

      // extract commentary
      var hr = frame.children('hr');
      if (hr.length) {
        var commentary = hr.nextAll().detach();
        hr.remove();
        var commentaryFrame = $('<div class="sbframe-commentary"></div>');
        commentaryFrame.addClass('flowing-content-shim');
        commentaryFrame.addClass('flowing-content-container');
        commentaryFrame.append(commentary);
        $(this).append(commentaryFrame);

        // look for a data-commentary-width attribute
        var commentaryWidth = $(this).attr('data-commentary-width');
        if (commentaryWidth)
          commentaryFrame.css('width', commentaryWidth + 'px');
      }

      // layout the chart (force flex)
      var result = layoutChart(frame, true);

      // ice the notes if there are none
      if (!result.notes)
        frame.find('.chart-notes').remove();

      // set flex on chart
      setFlex(frame, 1);
    });

    // create a div to hold all the frames
    var frameContent = $('<div class="sbframe-content"></div>');
    frameContent.addClass('dashboard-row-orientation');
    frameContent.append(frames.detach());

    // row orientation to stack nav and frame content
    page.addClass('dashboard-row-orientation');
    page.append(nav);
    page.append(frameContent);
    setFlex(frameContent, 1);

    // initialize sly
    var sly = new Sly(frameList, {
    		horizontal: true,
    		itemNav: 'basic',
    		smart: true,
    		activateOn: 'click',
    		startAt: 0,
    		scrollBy: 1,
    		activatePageOn: 'click',
    		speed: 200,
    		moveBy: 600,
    		dragHandle: true,
    		dynamicHandle: true,
    		clickBar: true,
    		keyboardNavBy: 'items',
    		next: next,
    		prev: prev
    	}).init();

    // make first frame active
    frames.removeClass('active');
    frames.first().addClass('active');

    // subscribe to frame changed events
    sly.on('active', function (eventName, itemIndex) {
      frames.removeClass('active');
      frames.eq(itemIndex).addClass('active')
                          .trigger('shown');
    });
  }

  function layoutPageByRows(page, fillPage) {

    // row orientation
    page.addClass('dashboard-row-orientation');

    // find all the level2 sections (those are the rows)
    var rows = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (rows.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      rows = page.find('div.section.level2');
    }

    rows.each(function () {

      // flags
      var haveNotes = false;
      var haveFlexHeight = true;

      // remove the h2
      $(this).children('h2').remove();

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // give it row layout semantics if it's not a tabset
      if (!isTabset)
        $(this).addClass('dashboard-row');

      // find all of the level 3 subheads
      var columns = $(this).find('div.section.level3');

      // determine figureSizes sizes
      var figureSizes = chartFigureSizes(columns);

      // fixup the columns
      columns.each(function(index) {

        // layout the chart (force flex if we are in a tabset)
        var result = layoutChart($(this), isTabset);

        // update flexHeight state
        if (!result.flex)
          haveFlexHeight = false;

        // update state
        if (result.notes)
          haveNotes = true;

        // set the column flex based on the figure width
        // (value boxes will just get the default figure width)
        var chartWidth = figureSizes[index].width;
        setFlex($(this), chartWidth + ' ' + chartWidth + ' 0px');

      });

      // remove empty chart note divs
      if (isTabset)
        $(this).find('.chart-notes').filter(function() {
            return $(this).html() === "&nbsp;";
        }).remove();
      if (!haveNotes)
        $(this).find('.chart-notes').remove();

       // make it a flexbox row
      if (haveFlexHeight)
        $(this).addClass('dashboard-row-flex');

      // now we can set the height on all the wrappers (based on maximum
      // figure height + room for title and notes, or data-height on the
      // container if specified). However, don't do this if there is
      // no flex on any of the constituent columns
      var flexHeight = null;
      var dataHeight = parseInt($(this).attr('data-height'));
      if (dataHeight)
        flexHeight = adjustedHeight(dataHeight, columns.first());
      else if (haveFlexHeight)
        flexHeight = maxChartHeight(figureSizes, columns);
      if (flexHeight) {
        if (fillPage)
          setFlex($(this), flexHeight + ' ' + flexHeight + ' 0px');
        else {
          $(this).css('height', flexHeight + 'px');
          setFlex($(this), '0 0 ' + flexHeight + 'px');
        }
      }

    });
  }

  function layoutPageByColumns(page, fillPage) {

    // column orientation
    page.addClass('dashboard-column-orientation');

    // find all the level2 sections (those are the columns)
    var columns = page.find('div.section.level2');

    // if there are no level2 sections then treat the
    // entire page as if it's a level 2 section
    if (columns.length === 0) {
      page.wrapInner('<div class="section level2"></div>');
      columns = page.find('div.section.level2');
    }

    // layout each column
    columns.each(function (index) {

      // remove the h2
      $(this).children('h2').remove();

      // make it a flexbox column
      $(this).addClass('dashboard-column');

      // check for a tabset
      var isTabset = $(this).hasClass('tabset');
      if (isTabset)
        layoutTabset($(this));

      // find all the h3 elements
      var rows = $(this).find('div.section.level3');

      // get the figure sizes for the rows
      var figureSizes = chartFigureSizes(rows);

      // column flex is the max row width (or data-width if specified)
      var flexWidth;
      var dataWidth = parseInt($(this).attr('data-width'));
      if (dataWidth)
        flexWidth = dataWidth;
      else
        flexWidth = maxChartWidth(figureSizes);
      setFlex($(this), flexWidth + ' ' + flexWidth + ' 0px');

      // layout each chart
      rows.each(function(index) {

        // perform the layout
        var result = layoutChart($(this), false);

        // ice the notes if there are none
        if (!result.notes)
          $(this).find('.chart-notes').remove();

        // set flex height based on figHeight, then adjust
        if (result.flex) {
          var chartHeight = figureSizes[index].height;
          chartHeight = adjustedHeight(chartHeight, $(this));
          if (fillPage)
            setFlex($(this), chartHeight + ' ' + chartHeight + ' 0px');
          else {
            $(this).css('height', chartHeight + 'px');
            setFlex($(this), chartHeight + ' ' + chartHeight + ' ' + chartHeight + 'px');
          }
        }
      });
    });
  }

  function chartFigureSizes(charts) {

    // sizes
    var figureSizes = new Array(charts.length);

    // check each chart
    charts.each(function(index) {

      // start with default
      figureSizes[index] = {
        width: _options.defaultFigWidth,
        height: _options.defaultFigHeight
      };

      // look for data-height or data-width then knit options
      var dataWidth = parseInt($(this).attr('data-width'));
      var dataHeight = parseInt($(this).attr('data-height'));
      var knitrOptions = $(this).find('.knitr-options:first');
      var knitrWidth, knitrHeight;
      if (knitrOptions) {
        knitrWidth = parseInt(knitrOptions.attr('data-fig-width'));
        knitrHeight =  parseInt(knitrOptions.attr('data-fig-height'));
      }

      // width
      if (dataWidth)
        figureSizes[index].width = dataWidth;
      else if (knitrWidth)
        figureSizes[index].width = knitrWidth;

      // height
      if (dataHeight)
        figureSizes[index].height = dataHeight;
      else if (knitrHeight)
        figureSizes[index].height = knitrHeight;
    });

    // return sizes
    return figureSizes;
  }

  function maxChartHeight(figureSizes, charts) {

    // first compute the maximum height
    var maxHeight = _options.defaultFigHeight;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].height > maxHeight)
        maxHeight = figureSizes[i].height;

    // now add offests for chart title and chart notes
    if (charts.length)
      maxHeight = adjustedHeight(maxHeight, charts.first());

    return maxHeight;
  }

  function adjustedHeight(height, chart) {
    if (chart.length > 0) {
      var chartTitle = chart.find('.chart-title');
      if (chartTitle.length)
        height += chartTitle.first().outerHeight();
      var chartNotes = chart.find('.chart-notes');
      if (chartNotes.length)
        height += chartNotes.first().outerHeight();
    }
    return height;
  }

  function maxChartWidth(figureSizes) {
    var maxWidth = _options.defaultFigWidth;
    for (var i = 0; i<figureSizes.length; i++)
      if (figureSizes[i].width > maxWidth)
        maxWidth = figureSizes[i].width;
    return maxWidth;
  }

  // layout a chart
  function layoutChart(chart, forceFlex) {

    // state to return
    var result = {
      notes: false,
      flex: false
    };

    // extract the title
    var title = extractTitle(chart);

    // find components that apply to this container
    var components = componentsFind(chart);

    // if it's a custom component then call it and return
    var customComponents = componentsCustom(components);
    if (customComponents.length) {
      componentsLayout(customComponents, title, chart);
      result.notes = false;
      result.flex = forceFlex || componentsFlex(customComponents);
      return result;
    }

    // put all the content in a chart wrapper div
    chart.addClass('chart-wrapper');
    chart.wrapInner('<div class="chart-stage"></div>');
    var chartContent = chart.children('.chart-stage');

    // flex the content if appropriate
    result.flex = forceFlex || componentsFlex(components);
    if (result.flex) {
      // add flex classes
      chart.addClass('chart-wrapper-flex');
      chartContent.addClass('chart-stage-flex');

      // additional shim to break out of flexbox sizing
      chartContent.wrapInner('<div class="chart-shim"></div>');
      chartContent = chartContent.children('.chart-shim');
    }

    // set custom data-padding attribute
    var pad = chart.attr('data-padding');
    if (pad) {
      if (pad === "0")
        chart.addClass('no-padding');
      else {
        pad = pad + 'px';
        chartContent.css('left', pad)
                    .css('top', pad)
                    .css('right', pad)
                    .css('bottom', pad)
      }
    }

    // call compoents
    componentsLayout(components, title, chartContent);

    // also activate components on shiny output
    findShinyOutput(chartContent).on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {

          // see if we opted out of flex based on our output (for shiny
          // we can't tell what type of output we have until after the
          // value is bound)
          var components = componentsFind(element);
          var flex = forceFlex || componentsFlex(components);
          if (!flex) {
            chart.css('height', "");
            setFlex(chart, "");
            chart.removeClass('chart-wrapper-flex');
            chartContent.removeClass('chart-stage-flex');
            chartContent.children().unwrap();
          }

          // perform layout
          componentsLayout(components, title, element.parent());
        }, 10);
      });

    // add the title
    var chartTitle = $('<div class="chart-title"></div>');
    chartTitle.append(title);
    chart.prepend(chartTitle);

    // add the notes section
    var chartNotes = $('<div class="chart-notes"></div>');
    chartNotes.html('&nbsp;');
    chart.append(chartNotes);

    // attempt to extract notes if we have a component
    if (components.length)
      result.notes = extractChartNotes(chartContent, chartNotes);

    // return result
    return result;
  }

  // build a tabset from a section div with the .tabset class
  function layoutTabset(tabset) {

    // check for fade option
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it and grab it's text
      var heading = tab.find('h' + tabLevel + ':first');
      var headingDom = heading.contents();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab" class="nav-link"></a>');
      a.append(headingDom);
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation" class="nav-item"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      tab.addClass('no-title');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children()[activeTab]).tab("show");
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    // add nav-tabs-custom
    tabset.addClass('nav-tabs-custom');

    // internal layout is dashboard-column with tab-content flexing
    tabset.addClass('dashboard-column');
    setFlex(tabContent, 1);
  }

  // one time global initialization for components
  function componentsInit(dashboardContainer) {
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.init)
        component.init(dashboardContainer);
    }
  }

  // find components that apply within a container
  function componentsFind(container) {

    // look for components
    var components = [];
    for (var i=0; i<window.FlexDashboardComponents.length; i++) {
      var component = window.FlexDashboardComponents[i];
      if (component.find(container).length)
        components.push(component);
    }

    // if there were none then use a special flowing content component
    // that just adds a scrollbar in fillPage mode
    if (components.length == 0) {
      components.push({
        find: function(container) {
          return container;
        },

        flex: function(fillPage) {
          return fillPage;
        },

        layout: function(title, container, element, fillPage) {
          if (fillPage) {
            container.addClass('flowing-content-shim');
            container.addClass('flowing-content-container');
          }
        }
      });
    }

    return components;
  }

  // if there is a custom component then pick it out
  function componentsCustom(components) {
    var customComponent = [];
    for (var i=0; i<components.length; i++)
      if (components[i].type === "custom") {
        customComponent.push(components[i]);
        break;
      }
    return customComponent;
  }

  // query all components for flex
  function componentsFlex(components) {

    // no components at all means no flex
    if (components.length === 0)
      return false;

    // otherwise query components (assume true unless we see false)
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++)
      if (components[i].flex && !components[i].flex(_options.fillPage))
        return false;
    return true;
  }

  // layout all components
  function componentsLayout(components, title, container) {
    var isMobile = isMobilePhone();
    for (var i=0; i<components.length; i++) {
      var element = components[i].find(container);
      if (components[i].layout) {
        // call layout (don't call other components if it returns false)
        var result = components[i].layout(title, container, element, _options.fillPage);
        if (result === false)
          return;
      }
    }
  }

  // get a reference to the h3, discover it's inner html, and remove it
  function extractTitle(container) {
    var h3 = container.children('h3').first();
    var title = '';
    if (!container.hasClass('no-title'))
      title = h3.contents();
    h3.detach();
    return title;
  }

  // extract chart notes
  function extractChartNotes(chartContent, chartNotes) {
    // look for a terminating blockquote or image caption
    var blockquote = chartContent.children('blockquote:last-child');
    var caption = chartContent.children('div.image-container')
                              .children('p.caption');
    if (blockquote.length) {
      chartNotes.empty().append(blockquote.children('p:first-child').contents());
      blockquote.remove();
      return true;
    } else if (caption.length) {
      chartNotes.empty().append(caption.contents());
      caption.remove();
      return true;
    } else {
      return false;
    }
  }

  function findShinyOutput(chartContent) {
    return chartContent.find('.shiny-text-output, .shiny-html-output');
  }

  // safely detect rendering on a mobile phone
  function isMobilePhone() {
    try
    {
      return ! window.matchMedia("only screen and (min-width: 768px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  function isFillPage() {
    return _options.fillPage;
  }

  // detect portrait mode
  function isPortrait() {
    return ($(window).width() < $(window).height());
  }

  // safely detect rendering on a tablet
  function isTablet() {
    try
    {
      return window.matchMedia("only screen and (min-width: 769px) and (max-width: 992px)").matches;
    }
    catch(e) {
      return false;
    }
  }

  // test whether this is a shiny doc
  function isShinyDoc() {
    return (typeof(window.Shiny) !== "undefined" && !!window.Shiny.outputBindings);
  }

  // set flex using vendor specific prefixes
  function setFlex(el, flex) {
    el.css('-webkit-box-flex', flex)
      .css('-webkit-flex', flex)
      .css('-ms-flex', flex)
      .css('flex', flex);
  }

  // support bookmarking of pages
  function handleLocationHash() {

    // restore tab/page from bookmark
    var hash = window.decodeURIComponent(window.location.hash);
    if (hash.length > 0)
      $('ul.nav a[href="' + hash + '"]').tab('show');
    FlexDashboardUtils.manageActiveNavbarMenu();

    // navigate to a tab when the history changes
    window.addEventListener("popstate", function(e) {
      var hash = window.decodeURIComponent(window.location.hash);
      var activeTab = $('ul.nav a[href="' + hash + '"]');
      if (activeTab.length) {
        activeTab.tab('show');
      } else {
        $('ul.nav a:first').tab('show');
      }
      FlexDashboardUtils.manageActiveNavbarMenu();
    });

    // add a hash to the URL when the user clicks on a tab/page
    $('.navbar-nav a[data-toggle="tab"]').on('click', function(e) {
      var baseUrl = FlexDashboardUtils.urlWithoutHash(window.location.href);
      var hash = FlexDashboardUtils.urlHash($(this).attr('href'));
      var href = baseUrl + hash;
      FlexDashboardUtils.setLocation(href);
    });

    // handle clicks of other links that should activate pages
    var navPages = $('ul.navbar-nav li a[data-toggle=tab]');
    navPages.each(function() {
      var href =  $(this).attr('href');
      var links = $('a[href="' + href + '"][data-toggle!=tab]');
      links.each(function() {
        $(this).on('click', function(e) {
          window.FlexDashboardUtils.showPage(href);
        });
      });
    });
  }

  // tweak Prism highlighting
  function initPrismHighlighting() {

    if (window.Prism) {
      Prism.languages.insertBefore('r', 'comment', {
        'heading': [
          {
            // title 1
        	  // =======

        	  // title 2
        	  // -------
        	  pattern: /\w+.*(?:\r?\n|\r)(?:====+|----+)/,
            alias: 'operator'
          },
          {
            // ### title 3
            pattern: /(^\s*)###[^#].+/m,
            lookbehind: true,
            alias: 'operator'
          }
        ]
      });

      // prism highlight
      Prism.highlightAll();
    }
  }

  FlexDashboard.prototype = {
    constructor: FlexDashboard,
    init: init,
    isMobilePhone: isMobilePhone,
    isFillPage: isFillPage
  };

  return FlexDashboard;

})();

// utils
window.FlexDashboardUtils = {
  resizableImage: function(img) {
    var src = img.attr('src');
    var url = 'url("' + src + '")';
    img.parent().css('background', url)
                .css('background-size', 'contain')
                .css('background-repeat', 'no-repeat')
                .css('background-position', 'center')
                .addClass('image-container');
  },
  setLocation: function(href) {
    if (history && history.pushState) {
      history.pushState(null, null, href);
    } else {
      window.location.replace(href);
    }
    setTimeout(function() {
        window.scrollTo(0, 0);
    }, 10);
    this.manageActiveNavbarMenu();
  },
  showPage: function(href) {
    $('ul.navbar-nav li a[href="' + href + '"]').tab('show');
    var baseUrl = this.urlWithoutHash(window.location.href);
    var loc = baseUrl + href;
    this.setLocation(loc);
  },
  showLinkedValue: function(href) {
    // check for a page link
    if ($('ul.navbar-nav li a[data-toggle=tab][href="' + href + '"]').length > 0)
      this.showPage(href);
    else
      window.open(href);
  },
  urlWithoutHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(0, hashLoc);
    else
      return url;
  },
  urlHash: function(url) {
    var hashLoc = url.indexOf('#');
    if (hashLoc != -1)
      return url.substring(hashLoc);
    else
      return "";
  },
  manageActiveNavbarMenu: function () {
    // remove active from currently active tabs
    $('.navbar ul.nav .active').removeClass('active');
    // find the active tab
    var activeTab = $('.dashboard-page-wrapper.tab-pane.active');
    if (activeTab.length > 0) {
      var tabId = activeTab.attr('id');
      if (tabId)
        $(".navbar ul.nav a[href='#" + tabId + "']").tab("show");
    }
  }
};

window.FlexDashboard = new FlexDashboard();

// empty content
window.FlexDashboardComponents.push({
  find: function(container) {
    if (container.find('p').length == 0)
      return container;
    else
      return $();
  }
})

// plot image
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('p')
                    .children('img:only-child');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// plot image (figure style)
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.figure').children('img');
  },

  layout: function(title, container, element, fillPage) {
    FlexDashboardUtils.resizableImage(element);
  }
});

// htmlwidget
window.FlexDashboardComponents.push({

  init: function(dashboardContainer) {
    // trigger "shown" after initial layout to force static htmlwidgets
    // in runtime: shiny to be resized after the dom has been transformed
    dashboardContainer.on('flexdashboard:layoutcomplete', function(event) {
      setTimeout(function() {
        dashboardContainer.trigger('shown');
      }, 200);
    });
  },

  find: function(container) {
    return container.children('div[id^="htmlwidget-"],div.html-widget');
  }
});

// gauge
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.children('div.html-widget.gauge');
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {


  }

});

// shiny output
window.FlexDashboardComponents.push({
  find: function(container) {
    return container.children('div[class^="shiny-"]');
  }
});

// bootstrap table
window.FlexDashboardComponents.push({

  find: function(container) {
    var bsTable = container.find('table.table');
    if (bsTable.length !== 0)
      return bsTable;
    else
      return container.find('tr.header').parent('thead').parent('table');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var bsTable = element;

    // fixup xtable generated tables with a proper thead
    var headerRow = bsTable.find('tbody > tr:first-child > th').parent();
    if (headerRow.length > 0) {
      var thead = $('<thead></thead>');
      bsTable.prepend(thead);
      headerRow.detach().appendTo(thead);
    }

    // improve appearance
    container.addClass('bootstrap-table');

    // for fill page provide scrolling w/ sticky headers
    if (fillPage) {
      // force scrollbar on overflow
      container.addClass('flowing-content-shim');

      // stable table headers when scrolling
      bsTable.stickyTableHeaders({
        scrollableArea: container
      });
    }
  }
});

// embedded shiny app
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('iframe.shiny-frame');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage) {
      element.attr('height', '100%');
    } else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (!height)
        height = element.attr('height');
      if (!height)
        element.attr('height', 500);
    }
  }
});

// shiny fillRow or fillCol
window.FlexDashboardComponents.push({

  find: function(container) {
    return container.find('.flexfill-container');
  },

  flex: function(fillPage) {
    return fillPage;
  },

  layout: function(title, container, element, fillPage) {
    if (fillPage)
      element.css('height', '100%');
    else {
      // provide default height if necessary
      var height = element.get(0).style.height;
      if (height === "100%" || height === "auto" || height === "initial" ||
          height === "inherit" || !height) {
        element.css('height', 500);
      }
    }
  }
});

// valueBox
window.FlexDashboardComponents.push({

  type: "custom",

  find: function(container) {
    if (container.find('span.value-output, .shiny-valuebox-output').length)
      return container;
    else
      return $();
  },

  flex: function(fillPage) {
    return false;
  },

  layout: function(title, container, element, fillPage) {

    // alias variables
    var chartTitle = title;
    var valueBox = element;

    // add value-box class to container
    container.addClass('value-box');

    // value paragraph
    var value = $('<p class="value"></p>');

    // if we have shiny-text-output then just move it in
    var valueOutputSpan = [];
    var shinyOutput = valueBox.find('.shiny-valuebox-output').detach();
    if (shinyOutput.length) {
      valueBox.children().remove();
      shinyOutput.html("&mdash;");
      value.append(shinyOutput);
    } else {
      // extract the value (remove leading vector index)
      var chartValue = valueBox.text().trim();
      chartValue = chartValue.replace("[1] ", "");
      valueOutputSpan = valueBox.find('span.value-output').detach();
      valueBox.children().remove();
      value.text(chartValue);
    }

    // caption
    var caption = $('<p class="caption"></p>');
    caption.append(chartTitle);

    // build inner div for value box and add it
    var inner = $('<div class="inner"></div>');
    inner.append(value);
    inner.append(caption);
    valueBox.append(inner);

    // add icon if specified
    var icon = $('<div class="icon"><i></i></div>');
    valueBox.append(icon);
    function setIcon(chartIcon) {
      var iconLib = "";
      var iconSplit = chartIcon.split(" ");
      if (iconSplit.length > 1) {
        iconLib = iconSplit[0];
        chartIcon = iconSplit.slice(1).join(" ");
      } else {
        var components = chartIcon.split("-");
        if (components.length > 1)
          iconLib = components[0];
      }
      icon.children('i').attr('class', iconLib + ' ' + chartIcon);
    }
    var chartIcon = valueBox.attr('data-icon');
    if (chartIcon)
      setIcon(chartIcon);

    // handle data attributes in valueOutputSpan
    function handleValueOutput(valueOutput) {

      // caption
      var dataCaption = valueOutput.attr('data-caption');
      if (dataCaption)
        caption.html(dataCaption);

      // icon
      var dataIcon = valueOutput.attr('data-icon');
      if (dataIcon)
        setIcon(dataIcon);

      // If valueBox(color=) was an accent color, this attr should
      // be populated with the accent color and the relevant CSS comes
      // in through HTML dependencies
      var dataColorAccent = valueOutput.attr('data-color-accent');
      var valueBoxClasses = "value-box-" + (["primary", "info", "danger", "warning", "success"].join(" value-box-"));
      if (dataColorAccent) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.addClass('value-box-' + dataColorAccent);
      }

      // If valueBox(color=) was a CSS color, these other data-color-*
      // attrs will be populated
      var dataColor = valueOutput.attr('data-color');
      if (dataColor) {
        valueBox.removeClass(valueBoxClasses);
        valueBox.css('background-color', dataColor);
      }
      var dataColorText = valueOutput.attr('data-color-text');
      if (dataColorText) {
        valueBox.find(".inner").css('color', dataColorText);
      }
      var dataColorIcon = valueOutput.attr('data-color-icon');
      if (dataColorIcon) {
        valueBox.find(".icon").css('color', dataColorIcon);
      }

      // url
      var dataHref = valueOutput.attr('data-href');
      if (dataHref) {
        valueBox.addClass('linked-value');
        valueBox.off('click.value-box');
        valueBox.on('click.value-box', function(e) {
          window.FlexDashboardUtils.showLinkedValue(dataHref);
        });
      }
    }

    // check for a valueOutputSpan
    if (valueOutputSpan.length > 0) {
      handleValueOutput(valueOutputSpan);
    }

    // if we have a shinyOutput then bind a listener to handle
    // new valueOutputSpan values
    shinyOutput.on('shiny:value',
      function(event) {
        var element = $(event.target);
        setTimeout(function() {
          var valueOutputSpan = element.find('span.value-output');
          if (valueOutputSpan.length > 0)
            handleValueOutput(valueOutputSpan);
        }, 10);
      }
    );
  }
});
</script>

<div id="dashboard-container">

<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<style type="text/css">
table {
  margin: auto;
  border-top: 1px solid #666;
  border-bottom: 1px solid #666;
}
table thead th { border-bottom: 1px solid #ddd; }
th, td { padding: 5px; }

pre {
  white-space: pre-wrap;
  word-break: keep-all;
}

/* Hack to make prompt-tab scrollable again */
div.level3.tab-pane .chart-stage {
  overflow: scroll;
}
</style>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div id="column" class="section level2" data-width="55">
<h2>Column</h2>
<div id="score-comparisons-of-108-publications" class="section level3">
<h3>Score comparisons of 108 publications</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-a0eed13e8b1b237f46a0" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-a0eed13e8b1b237f46a0">{"x":{"filter":"none","vertical":false,"fillContainer":true,"data":[["61","62","63","64","65","66","67","68","69","70","71","72","73","74","75","76","77","78","79","80","81","82","83","84","85","86","87","88","89","90","91","92","93","94","95","96","97","98","99","100","101","102","103","104","105","106","107","108","110","111","112","113","114","115","116","117","118","119","120","121","123","124","125","126","127","128","129","130","131","132","133","134","136","137","138","139","140","141","142","143","144","145","146","147","148","149","150","151","152","153","154","155","156","157","158","159","160","161","162","163","164","165","166","167","168","169","171","172"],["<a href='#61' title='Jump to individual results on the right'>Aikenhead 2011<\/a>","<a href='#62' title='Jump to individual results on the right'>Al-Hozaim 2010<\/a>","<a href='#63' title='Jump to individual results on the right'>Allen 2015<\/a>","<a href='#64' title='Jump to individual results on the right'>Allin 2015<\/a>","<a href='#65' title='Jump to individual results on the right'>Alzahem 2011<\/a>","<a href='#66' title='Jump to individual results on the right'>Apelt 2013<\/a>","<a href='#67' title='Jump to individual results on the right'>Aworanti 2014<\/a>","<a href='#68' title='Jump to individual results on the right'>Baker 2015<\/a>","<a href='#69' title='Jump to individual results on the right'>Berger 2012<\/a>","<a href='#70' title='Jump to individual results on the right'>Billingham 2010<\/a>","<a href='#71' title='Jump to individual results on the right'>Black 2013<\/a>","<a href='#72' title='Jump to individual results on the right'>Borruto 2010<\/a>","<a href='#73' title='Jump to individual results on the right'>Castagnetti 2010<\/a>","<a href='#74' title='Jump to individual results on the right'>Castagnetti 2016<\/a>","<a href='#75' title='Jump to individual results on the right'>Chan 2014 (Pediatr Surg Int)<\/a>","<a href='#76' title='Jump to individual results on the right'>Chan 2014 (J Pediatr Surg)<\/a>","<a href='#77' title='Jump to individual results on the right'>Chang 2015<\/a>","<a href='#78' title='Jump to individual results on the right'>Chen 2013<\/a>","<a href='#79' title='Jump to individual results on the right'>Corbett 2015<\/a>","<a href='#80' title='Jump to individual results on the right'>Cullis 2016<\/a>","<a href='#81' title='Jump to individual results on the right'>Cundy 2014 (BJU Int)<\/a>","<a href='#82' title='Jump to individual results on the right'>Cundy 2014 (J Pediatr Surg)<\/a>","<a href='#83' title='Jump to individual results on the right'>Cundy 2014 (Eur J Pediatr Surg)<\/a>","<a href='#84' title='Jump to individual results on the right'>Ding 2013<\/a>","<a href='#85' title='Jump to individual results on the right'>Dingemann 2014<\/a>","<a href='#86' title='Jump to individual results on the right'>Dingemann 2013<\/a>","<a href='#87' title='Jump to individual results on the right'>Ells 2015<\/a>","<a href='#88' title='Jump to individual results on the right'>Elyas 2010<\/a>","<a href='#89' title='Jump to individual results on the right'>Esposito 2014<\/a>","<a href='#90' title='Jump to individual results on the right'>Feng 2016<\/a>","<a href='#91' title='Jump to individual results on the right'>Feng 2015<\/a>","<a href='#92' title='Jump to individual results on the right'>Friedmacher 2011<\/a>","<a href='#93' title='Jump to individual results on the right'>Friedmacher 2012<\/a>","<a href='#94' title='Jump to individual results on the right'>Frongia 2013<\/a>","<a href='#95' title='Jump to individual results on the right'>Gallo 2012<\/a>","<a href='#96' title='Jump to individual results on the right'>Gosemann 2013<\/a>","<a href='#97' title='Jump to individual results on the right'>Graziano 2015<\/a>","<a href='#98' title='Jump to individual results on the right'>Guo 2011<\/a>","<a href='#99' title='Jump to individual results on the right'>Hall 2011<\/a>","<a href='#100' title='Jump to individual results on the right'>Healy 2015<\/a>","<a href='#101' title='Jump to individual results on the right'>Healy 2016<\/a>","<a href='#102' title='Jump to individual results on the right'>Heloury 2012<\/a>","<a href='#103' title='Jump to individual results on the right'>Huang 2015<\/a>","<a href='#104' title='Jump to individual results on the right'>Ishii 2014<\/a>","<a href='#105' title='Jump to individual results on the right'>Ishii 2015<\/a>","<a href='#106' title='Jump to individual results on the right'>Ito 2014<\/a>","<a href='#107' title='Jump to individual results on the right'>Jia 2011<\/a>","<a href='#108' title='Jump to individual results on the right'>Kapralik 2016<\/a>","<a href='#110' title='Jump to individual results on the right'>Landisch 2015<\/a>","<a href='#111' title='Jump to individual results on the right'>Lane 2010<\/a>","<a href='#112' title='Jump to individual results on the right'>Lansdale 2010<\/a>","<a href='#113' title='Jump to individual results on the right'>Lee 2010<\/a>","<a href='#114' title='Jump to individual results on the right'>LeeVan 2016<\/a>","<a href='#115' title='Jump to individual results on the right'>Liang 2011<\/a>","<a href='#116' title='Jump to individual results on the right'>Lishuang 2015<\/a>","<a href='#117' title='Jump to individual results on the right'>Livingston 2015<\/a>","<a href='#118' title='Jump to individual results on the right'>Mauritz 2013<\/a>","<a href='#119' title='Jump to individual results on the right'>Mauritz 2011<\/a>","<a href='#120' title='Jump to individual results on the right'>Mei 2011<\/a>","<a href='#121' title='Jump to individual results on the right'>Mullassery 2014<\/a>","<a href='#123' title='Jump to individual results on the right'>Narayanan 2013<\/a>","<a href='#124' title='Jump to individual results on the right'>Nasr 2010<\/a>","<a href='#125' title='Jump to individual results on the right'>Nasr 2013<\/a>","<a href='#126' title='Jump to individual results on the right'>Nataraja 2013<\/a>","<a href='#127' title='Jump to individual results on the right'>Nicolau 2011<\/a>","<a href='#128' title='Jump to individual results on the right'>Oliveira 2016<\/a>","<a href='#129' title='Jump to individual results on the right'>Oomen 2012<\/a>","<a href='#130' title='Jump to individual results on the right'>Parolini 2016<\/a>","<a href='#131' title='Jump to individual results on the right'>Parolini 2014<\/a>","<a href='#132' title='Jump to individual results on the right'>Peters 2013<\/a>","<a href='#133' title='Jump to individual results on the right'>Peycelon 2014<\/a>","<a href='#134' title='Jump to individual results on the right'>Pfistermuller 2015<\/a>","<a href='#136' title='Jump to individual results on the right'>Reddy 2010<\/a>","<a href='#137' title='Jump to individual results on the right'>Romao 2012<\/a>","<a href='#138' title='Jump to individual results on the right'>Ross 2015<\/a>","<a href='#139' title='Jump to individual results on the right'>Ruttenstock 2010<\/a>","<a href='#140' title='Jump to individual results on the right'>Rynja 2011<\/a>","<a href='#141' title='Jump to individual results on the right'>Saldaña 2013<\/a>","<a href='#142' title='Jump to individual results on the right'>Sauerland 2010<\/a>","<a href='#143' title='Jump to individual results on the right'>Scholfield 2016<\/a>","<a href='#144' title='Jump to individual results on the right'>Sharp 2015<\/a>","<a href='#145' title='Jump to individual results on the right'>Shawyer 2014<\/a>","<a href='#146' title='Jump to individual results on the right'>Shawyer 2015<\/a>","<a href='#147' title='Jump to individual results on the right'>Shen 2015<\/a>","<a href='#148' title='Jump to individual results on the right'>Siddiqui 2011<\/a>","<a href='#149' title='Jump to individual results on the right'>Siminas 2015<\/a>","<a href='#150' title='Jump to individual results on the right'>Sklar 2014<\/a>","<a href='#151' title='Jump to individual results on the right'>Sola 2010<\/a>","<a href='#152' title='Jump to individual results on the right'>Symeonidis 2016<\/a>","<a href='#153' title='Jump to individual results on the right'>Tan 2016<\/a>","<a href='#154' title='Jump to individual results on the right'>Terui 2015<\/a>","<a href='#155' title='Jump to individual results on the right'>Thomson 2015<\/a>","<a href='#156' title='Jump to individual results on the right'>Thyoka 2013<\/a>","<a href='#157' title='Jump to individual results on the right'>van Dalen 2015<\/a>","<a href='#158' title='Jump to individual results on the right'>Vanden Berg 2016<\/a>","<a href='#159' title='Jump to individual results on the right'>van den Hondel 2014<\/a>","<a href='#160' title='Jump to individual results on the right'>Vernon-Roberts 2013<\/a>","<a href='#161' title='Jump to individual results on the right'>Wang 2013<\/a>","<a href='#162' title='Jump to individual results on the right'>Wayne 2015<\/a>","<a href='#163' title='Jump to individual results on the right'>Weih 2012<\/a>","<a href='#164' title='Jump to individual results on the right'>Wenk 2015<\/a>","<a href='#165' title='Jump to individual results on the right'>Wilkinson 2012<\/a>","<a href='#166' title='Jump to individual results on the right'>Wright 2013<\/a>","<a href='#167' title='Jump to individual results on the right'>Yang 2011<\/a>","<a href='#168' title='Jump to individual results on the right'>Yang 2013<\/a>","<a href='#169' title='Jump to individual results on the right'>Youssef 2016<\/a>","<a href='#171' title='Jump to individual results on the right'>Zhao 2015<\/a>","<a href='#172' title='Jump to individual results on the right'>Zhu 2016<\/a>"],[0.585526315789474,0.611909650924025,0.549060542797495,0.287769784172662,0.511627906976744,0.718162839248434,0.624254473161034,0.539249146757679,0.376923076923077,0.370762711864407,0.230403800475059,0.402654867256637,0.447852760736196,0.207823960880196,0.55,0.372093023255814,0.2,0.537897310513447,0.4,0.496503496503496,0.0181818181818181,0.354948805460751,0.446469248291572,0.0496894409937889,0.464285714285714,0.522593320235756,0.129032258064516,0.152466367713004,0.548117154811715,0.497674418604651,0.557377049180328,0.377358490566038,0.246781115879828,0.609504132231405,0.233624454148472,0.498969072164948,0.650862068965517,0.319327731092437,0.333965844402277,0.379310344827586,0.722792607802875,0.608695652173913,-0.024390243902439,0.717573221757322,0.454545454545454,0.248101265822785,0.419354838709677,0.307692307692308,0.393258426966292,0.5,0.423780487804878,0.586433260393873,0.32887189292543,0.194029850746269,0.0847457627118643,0.303225806451613,0.382857142857143,0.721649484536082,0.265861027190332,0.326869806094183,0.590909090909091,0.361702127659574,0.377358490566038,0.401662049861496,0.558282208588957,0.457831325301205,0.360189573459716,0.419354838709677,0.451219512195122,0.7,0.420600858369099,0.31063829787234,0.204419889502762,0.20945945945946,0.402948402948403,0.4375,0.546218487394958,0.46119733924612,0.0689655172413793,0.223819301848049,0.587786259541985,0.553191489361702,0.287390029325513,0.433566433566434,0.0277008310249307,0.5625,0.0979955456570154,0.19,0.4,0.376443418013857,0.195121951219512,0.292134831460674,0.503067484662577,0.336065573770492,0.359683794466403,0.354347826086957,0.171052631578947,0.23943661971831,0.464757709251101,0.604602510460251,0.228571428571429,0.581858407079646,0.26027397260274,0.165562913907285,0.393258426966292,0.0544747081712061,0.331081081081081,0.248394004282655],[0.740740740740741,0.740740740740741,0.703703703703704,0.592592592592593,0.740740740740741,0.814814814814815,0.740740740740741,0.814814814814815,0.555555555555556,0.592592592592593,0.555555555555556,0.62962962962963,0.62962962962963,0.555555555555556,0.740740740740741,0.703703703703704,0.555555555555556,0.740740740740741,0.62962962962963,0.703703703703704,0.555555555555556,0.740740740740741,0.666666666666667,0.37037037037037,0.62962962962963,0.666666666666667,0.444444444444444,0.481481481481481,0.703703703703704,0.703703703703704,0.740740740740741,0.592592592592593,0.518518518518518,0.740740740740741,0.518518518518518,0.666666666666667,0.777777777777778,0.666666666666667,0.518518518518518,0.703703703703704,0.814814814814815,0.740740740740741,0.481481481481481,0.814814814814815,0.62962962962963,0.592592592592593,0.703703703703704,0.703703703703704,0.555555555555556,0.703703703703704,0.740740740740741,0.740740740740741,0.518518518518518,0.62962962962963,0.555555555555556,0.703703703703704,0.703703703703704,0.851851851851852,0.666666666666667,0.666666666666667,0.777777777777778,0.62962962962963,0.592592592592593,0.703703703703704,0.703703703703704,0.62962962962963,0.62962962962963,0.62962962962963,0.62962962962963,0.814814814814815,0.62962962962963,0.555555555555556,0.407407407407407,0.518518518518518,0.666666666666667,0.666666666666667,0.703703703703704,0.666666666666667,0.592592592592593,0.481481481481481,0.777777777777778,0.740740740740741,0.666666666666667,0.666666666666667,0.518518518518518,0.740740740740741,0.444444444444444,0.555555555555556,0.592592592592593,0.62962962962963,0.592592592592593,0.740740740740741,0.666666666666667,0.555555555555556,0.555555555555556,0.592592592592593,0.481481481481481,0.703703703703704,0.666666666666667,0.740740740740741,0.518518518518518,0.740740740740741,0.62962962962963,0.481481481481481,0.555555555555556,0.333333333333333,0.592592592592593,0.518518518518518]],"container":"<table class=\"display fill-container\">\n  <thead>\n    <tr>\n      <th>Ref.<\/th>\n      <th>Author & Year<\/th>\n      <th>PRISMA κ<\/th>\n      <th>PRISMA agreement<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"t","order":[[0,"asc"]],"columnDefs":[{"targets":2,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 2, 3, \",\", \".\", null);\n  }"},{"className":"dt-right","targets":[2,3]}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render","options.columnDefs.1.render"],"jsHooks":[]}</script>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
</div>
<div id="score-heatmaps" class="section level3" data-height="720">
<h3>Score heatmaps</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><img data-figure-id="fig1" src="data:image/png;base64,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" width="1536"></p>
</div>
</div>
<div id="column-1" class="section level2 tabset" data-width="45">
<h2 class="tabset">Column</h2>
<div id="individual-results" class="section level3">
<h3>Individual results</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<p><a name='61'></a></p>
<div id="aikenhead-2011" class="section level4">
<h4><a href='https://doi.org/10.1111/J.1758-8111.2010.00003.X' title='Open publication'>Aikenhead
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Effectiveness and cost-effectiveness of paediatric bariatric surgery: a systematic review&quot;</span> - [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review to examine the effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.&quot;</span> - [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎During the last two decades the prevalence of childhood and adolescent obesity has grown rapidly in most regions of the world.&quot;</span> - [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review examines the evidence on effectiveness of surgical interventions to treat obese children and adolescents, and whether they are cost-effective.&quot;</span> - [Yes]
P5. Methods / Protocol and registration: Not reported - [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Included articles with English abstracts if they examined subjects ≤19 years of age, reported at least one postoperative weight loss measure and at least 1 year of postoperative follow-up.&quot;</span> - [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched PubMed, ISI Web of Science, Embase and the Cochrane Library to 6 September 2010, and hand-searched bibliographies.&quot;</span> - [Yes]
P8. Methods / Search: Not reported - [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thirty-seven relevant papers on bariatric surgery effectiveness in 831 children or adolescents were included.&quot;</span> - [Yes]
P10. Methods / Data collection process: Not reported - [No]
P11. Methods / Data items: Not reported - [No]
P12. Methods / Risk of bias in individual studies: Not reported - [No]
P13. Methods / Summary measures: Not reported - [No]
P14. Methods / Synthesis of results: Not applicable (no meta-analysis) - [NA]
P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis) - [NA]
P16. Methods / Additional analyses: Not reported - [No]
P17. Results / Study selection: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 73.8%):

led trial) were identified and included in the review' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Thirty-seven articles were identified and included in the review.&quot;</span> - [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thirty-four relevant papers on bariatric surgery effectiveness in children or adolescents were included, spanning 36 years.&quot;</span> - [Yes]
P19. Results / Risk of bias within studies: Not reported - [No]
P20. Results / Results of individual studies: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 63.6%):

weight loss and improvements in comorbidities and quality of life. Howeve' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Weight loss and improvements in comorbidities and quality of life were reported in the majority of studies.&quot;</span> - [Yes]
P21. Results / Synthesis of results: Not applicable (no meta-analysis) - [NA]
P22. Results / Risk of bias across studies: Not applicable (no meta-analysis) - [NA]
P23. Results / Additional analysis: Not reported - [No]
P24. Discussion / Summary of evidence: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Existing evidence – although based generally on underpowered, retrospective studies – suggests that bariatric surgery in older children results in significant weight loss and improvements in comorbidities and quality of life' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Existing evidence suggests that bariatric surgery in older children results in significant weight loss and improvements in comorbidities and quality of life.&quot;</span> - [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study was challenging due to a number of limitations in the existing literature.&quot;</span> - [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pending an improvement in the quality of available evidence, a cautious approach to child and adolescent bariatric surgery is warranted.&quot;</span> - [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The project that led to this paper was funded by the WHO Health Evidence Network of the World Health Organization.&quot;</span> - [Yes]</pre>
<p><a name='62'></a></p>
</div>
<div id="al-hozaim-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2009.12.001' title='Open publication'>Al-Hozaim
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic-assisted anorectal pull-through for anorectal malformations: a systematic review and the need for standardization of outcome reporting&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this review was to evaluate worldwide experiences with LAARP with regard to indications, outcomes, and quality of reporting.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Minor quote deviation. Best match in fulltext (Similarity 95.8%):

Laparoscopic-assisted anorectal pull-through (LAARP) is becoming an increasingly common procedure to correct high and intermediate anorectal malformations (ARMs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Laparoscopically assisted anorectal pull-through (LAARP) is becoming an increasingly common procedure to correct high and intermediate anorectal malformations (ARMs).&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to conduct a systematic review to evaluate the worldwide experience with LAARP with regard to indications, outcomes, and quality of reporting in published articles.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were studies of ARMs, regardless of level of the defect, with or without associated anomalies, use of LAARP as a primary procedure or with colostomy, and studies reported after the year 2000.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic search of the MEDLINE, PUBMED, and Cochrane databases (June 2000 to April 2008) was conducted.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial search in the PUBMED database produced 24 articles, 11 of which met the inclusion criteria.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A data extraction form was created to standardize the collection of study elements from each included article.&quot;</span>
[Yes]

P11. Methods / Data items: Not reported.
[No]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: Not reported.
[NA]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis conducted).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis conducted).
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses conducted).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial search in the PUBMED database produced 24 articles, 11 of which met the inclusion criteria.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The studies included 124 patients (96 males, 28 females) with 80% reported as having high/intermediate malformations.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Reported outcomes included continence, rectal prolapse, the position of the rectum (7 studies using Kelly score), manometry (1 study), contrast enema (1 study), postanal endosonography (3 studies), and postoperative magnetic resonance imaging' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Reported outcomes included continence, rectal prolapse, the position of the rectum, manometry, contrast enema, postanal endosonography, and postoperative magnetic resonance imaging.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis conducted).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis conducted).
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses conducted).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The number of studies dealing with LAARP is low. There is a need for both a standardization and improvement in the quality of reporting in LAARP research.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Our study has several limitations. First, this is a systematic review of mainly retrospective data. The quality of such review is only as good as the included studies. Second, because of the wide variation of reported outcomes, no formal meta-analysis and calculation of summary statistics could be performed' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Our study has several limitations. First, this is a systematic review of mainly retrospective data. Second, because of the wide variation of reported outcomes, no formal meta-analysis and calculation of summary statistics could be performed.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conclude that there is an urgent need to increase the number of studies reporting LAARP-related outcomes. More efforts are needed by the pediatric surgery community to improve the quality of studies and standardization of reports related ARM.&quot;</span>
[Yes]

P27. Funding: Not reported.
[No]</pre>
<p><a name='63'></a></p>
</div>
<div id="allen-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2014.10.042' title='Open publication'>Allen
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pediatric emergency department thoracotomy: A large case series and systematic review&quot;</span> [Yes]
- The title clearly identifies the report as a systematic review.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We reviewed our experience and performed a systematic review of reports of EDT in pediatric patients.&quot;</span> [Yes]
- The abstract provides a structured summary including background, objectives, and methods.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The standardization of care of the pediatric trauma patient, however, has also created new problems that must be addressed.&quot;</span> [Yes]
- The introduction describes the rationale for the review in the context of what is already known.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To help identify the factors associated with morbidity and mortality.&quot;</span> [Yes]
- The objectives are explicitly stated with reference to participants, interventions, and outcomes.

P5. Methods / Protocol and registration: Not reported [No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients age ≤ 18 years who received an EDT from 1991 to 2012 at our institution and all published case series were reviewed.&quot;</span> [Yes]
- The study characteristics and report characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We obtained all case series regarding pediatric EDT and combined the data from those reports with the data from our institution.&quot;</span> [Yes]
- All information sources are described.

P8. Methods / Search: Not reported [No]

P9. Methods / Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> [NA]
- Not applicable as there was no meta-analysis.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We reviewed patient records for the presence of vital signs (VS) and/or signs of life (SOL) in the field, time without VS in the field, presence of VS or SOL upon arrival, MOI, location of injuries, return of spontaneous circulation (ROSC), survival, and neurological function of the survivors upon discharge.&quot;</span> [Yes]
- The method of data extraction from reports is described.

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Variables extracted from each report include demographics, MOI, injury location, presence of VS and/or SOL upon arrival, ROSC, survival to discharge, and neurologic outcomes for survivors.&quot;</span> [Yes]
- All variables for which data were sought are listed and defined.

P12. Methods / Risk of bias in individual studies: Not reported [No]

P13. Methods / Summary measures: Not reported [No]

P14. Methods / Synthesis of results: Not applicable [NA]

P15. Methods / Risk of bias across studies: Not applicable [NA]

P16. Methods / Additional analyses: Not applicable [NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 252 patients were analyzed.&quot;</span> [Yes]
- The numbers of studies screened, assessed for eligibility, and included in the review are given.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Demographics, MOI, outcomes&quot;</span> [Yes]
- Characteristics for which data were extracted are presented.

P19. Results / Risk of bias within studies: Not reported [No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The survival rate was 1.6% for blunt trauma, 10.2% for penetrating injuries, and 6.0% overall.&quot;</span> [Yes]
- Simple summary data for each intervention group (blunt and penetrating injuries) are presented.

P21. Results / Synthesis of results: Not applicable [NA]

P22. Results / Risk of bias across studies: Not applicable [NA]

P23. Results / Additional analysis: Not applicable [NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Overall, although outcomes appear similar to that of the adult population, there may be less benefit in the younger pediatric patient and in those who arrive without SOL after sustaining blunt force injury.&quot;</span> [Yes]
- The main findings are summarized, including the strength of evidence for each main outcome.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎First, all of the data obtained from our institution were collected retrospectively, and thus not specifically collected for research purposes.&quot;</span> [Yes]
- Limitations at study and outcome level, as well as review-level, are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our review allows considerable trends to be made regarding this controversial topic.&quot;</span> [Yes]
- A general interpretation of the results in the context of other evidence and implications for future research are provided.

P27. Funding: Not reported [No]</pre>
<p><a name='64'></a></p>
</div>
<div id="allin-2015" class="section level4">
<h4><a href='https://doi.org/10.1371/JOURNAL.PONE.0116908' title='Open publication'>Allin
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Challenges of Improving the Evidence Base in Smaller Surgical Specialties, as Highlighted by a Systematic Review of Gastroschisis Management&quot;</span>
Reasoning: The title clearly identifies the report as a systematic review.
Response: [Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To identify methods of improving the evidence base in smaller surgical specialties, using a systematic review of gastroschisis management as an example.&quot;</span>
Reasoning: The abstract provides a structured summary of the background, objectives, methods, results, and conclusions of the systematic review.
Response: [Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎With variation existing around the specifics of management of some of the most common neonatal surgical conditions including oesophageal atresia, gastroschisis and Hirschsprung’s disease, research should be commonplace.&quot;</span>
Reasoning: The introduction describes the rationale for the review in the context of what is already known.
Response: [Yes]

P4. Introduction / Objectives: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

to perform a systematic review of the literature comparing outcomes of infants with simple gastroschisis following either OPFC or SR. From this study we aimed to identify some of the reasons why research in paediatric surgery is currently largely unable to provide a strong evidence base to inform clinical practice' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎To perform a systematic review of the literature comparing outcomes of infants with simple gastroschisis following either OPFC or SR and to identify some of the reasons why research in pediatric surgery is currently largely unable to provide a strong evidence base to inform clinical practice.&quot;</span>
Reasoning: The objectives of the review are explicitly stated, including the participants, interventions, comparisons, outcomes, and study design (PICOS).
Response: [Yes]

P5. Methods / Protocol and registration: The protocol was registered on the Prospero International Prospective Register of Systematic Reviews (CRD42012003241).
Reasoning: The review protocol was registered and the registration information is provided.
Response: [Yes]

P6. Methods / Eligibility criteria: The study characteristics (PICOS) and report characteristics used as criteria for eligibility are specified.
Reasoning: The study characteristics and report characteristics used for eligibility are described.
Response: [Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Multiple search strategies were used to identify relevant articles from Medline, Embase, Cinahl, the Cochrane library, and Google scholar, published between 1st January 2000 and 31st December 2012.&quot;</span>
Reasoning: The information sources used in the search are described.
Response: [Yes]

P8. Methods / Search: The full electronic search strategy is not provided.
Reasoning: The full electronic search strategy is not included in the publication.
Response: [No]

P9. Methods / Study selection: The process for selecting studies is not described.
Reasoning: The process for selecting studies is not provided in the publication.
Response: [No]

P10. Methods / Data collection process: The method of data extraction from reports is not described.
Reasoning: The method of data extraction is not provided in the publication.
Response: [No]

P11. Methods / Data items: The variables for which data were sought are listed.
Reasoning: The variables for which data were sought are described.
Response: [Yes]

P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described.
Reasoning: The methods for assessing risk of bias are not provided in the publication.
Response: [No]

P13. Methods / Summary measures: The principal summary measures are not stated.
Reasoning: The principal summary measures are not provided in the publication.
Response: [No]

P14. Methods / Synthesis of results: The methods of handling data and combining results of studies are not described.
Reasoning: The methods of handling data and combining results are not provided in the publication.
Response: [NA]

P15. Methods / Risk of bias across studies: The assessment of risk of bias across studies is not described.
Reasoning: The assessment of risk of bias across studies is not provided in the publication.
Response: [NA]

P16. Methods / Additional analyses: The methods of additional analyses are not described.
Reasoning: The methods of additional analyses are not provided in the publication.
Response: [NA]

P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not provided.
Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are not reported.
Response: [No]

P18. Results / Study characteristics: The characteristics for which data were extracted are not presented.
Reasoning: The characteristics for which data were extracted are not provided in the publication.
Response: [No]

P19. Results / Risk of bias within studies: The data on risk of bias of each study are not presented.
Reasoning: The data on risk of bias of each study are not provided in the publication.
Response: [No]

P20. Results / Results of individual studies: The simple summary data for each intervention group and effect estimates with confidence intervals are presented.
Reasoning: The simple summary data for each intervention group and effect estimates with confidence intervals are reported.
Response: [Yes]

P21. Results / Synthesis of results: The results of each meta-analysis done are not presented.
Reasoning: The results of each meta-analysis done are not provided in the publication.
Response: [NA]

P22. Results / Risk of bias across studies: The results of any assessment of risk of bias across studies are not presented.
Reasoning: The results of any assessment of risk of bias across studies are not provided in the publication.
Response: [NA]

P23. Results / Additional analysis: The results of additional analyses are not presented.
Reasoning: The results of additional analyses are not provided in the publication.
Response: [NA]

P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized.
Reasoning: The main findings and the strength of evidence for each main outcome are discussed.
Response: [Yes]

P25. Discussion / Limitations: The limitations at study and outcome level and at review-level are discussed.
Reasoning: The limitations at study and outcome level and at review-level are discussed.
Response: [Yes]

P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research are provided.
Reasoning: A general interpretation of the results and implications for future research are discussed.
Response: [Yes]

P27. Funding: The sources of funding for the systematic review are described.
Reasoning: The sources of funding for the systematic review are provided.
Response: [Yes]</pre>
<p><a name='65'></a></p>
</div>
<div id="alzahem-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-010-2840-X' title='Open publication'>Alzahem
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
[Yes] <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open inguinal herniotomy in infants and children: a meta-analysis&quot;</span>

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
[Yes] The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions.

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
[Yes] The introduction describes the rationale for the review in the context of what is already known.

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
[Yes] The introduction provides an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design.

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
[No] No information is provided about the existence of a review protocol or registration.

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
[Yes] The methods specify the study characteristics (PICOS) and report characteristics used as criteria for eligibility, giving rationale.

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
[Yes] The methods describe the information sources, including databases and the date last searched.

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
[No] The full electronic search strategy is not presented.

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
[Yes] The methods state the process for selecting studies, including screening, eligibility, and inclusion in the systematic review.

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
[Yes] The methods describe the method of data extraction from reports and any processes for obtaining and confirming data from investigators.

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
[Yes] The methods list and define the variables for which data were sought.

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
[Yes] The methods describe the methods used for assessing risk of bias of individual studies.

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
[Yes] The methods state the principal summary measures.

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
[NA] Not applicable as there is no meta-analysis.

P15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
[NA] Not applicable as there is no meta-analysis.

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
[NA] Not applicable as there is no meta-analysis.

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
[Yes] The results give the numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
[Yes] The results present characteristics for each study and provide the citations.

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
[Yes] The results present data on the risk of bias of each study.

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
[Yes] The results present simple summary data for each intervention group and effect estimates and confidence intervals.

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
[NA] Not applicable as there is no meta-analysis.

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
[NA] Not applicable as there is no meta-analysis.

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
[NA] Not applicable as there is no meta-analysis.

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
[Yes] The discussion summarizes the main findings including the strength of evidence for each main outcome and considers their relevance to key groups.

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
[Yes] The discussion discusses limitations at the study and outcome level and at the review-level.

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
[Yes] The discussion provides a general interpretation of the results in the context of other evidence and implications for future research.

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
[No] No information is provided about the sources of funding for the systematic review and other support.</pre>
<p><a name='66'></a></p>
</div>
<div id="apelt-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.05.024' title='Open publication'>Apelt
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘missing-squared-brackets-for-na’</i>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic treatment of intussusception in children: A systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: No structured summary provided [No]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There is still no agreement in pediatric surgery about safety and effectiveness of the use of minimally invasive surgery in this common pediatric condition.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎By reviewing available data we aimed to establish whether laparoscopy should be the primary technique in the surgical reduction of intussusception.&quot;</span> [Yes]
P5. Methods / Protocol and registration: No information provided [No]
P6. Methods / Eligibility criteria: No information provided [No]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An online database search for all English language articles on pediatric small bowel obstruction, intussusception and laparoscopy in PubMed, Medline and Ovid from January 1990 to April 2012 was performed.&quot;</span> [Yes]
P8. Methods / Search: No full electronic search strategy provided [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Overall, 10 studies were identified which included a total of 276 cases of laparoscopically treated intussusception.&quot;</span> [Yes]
P10. Methods / Data collection process: No information provided [No]
P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following variables were analyzed: age, laparoscopic success rate, reason for conversion, enterotomy rate, operative time, complications, and length of stay (LOS).&quot;</span> [Yes]
P12. Methods / Risk of bias in individual studies: No information provided [No]
P13. Methods / Summary measures: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 68.4%):

laparoscopic success rate,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎The laparoscopic success rate was 71%.&quot;</span> [Yes]
P14. Methods / Synthesis of results: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P15. Methods / Risk of bias across studies: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P16. Methods / Additional analyses: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ten retrospective studies treating 276 cases of laparoscopically reduced intussusception were identified.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Table 1 provides specific details on the selected studies.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: No information provided [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A laparoscopic success rate of more than 70% and a low rate of intraoperative (0.4%) and postoperative complications (2.9%) advocate for the use of laparoscopy as the primary surgical technique.&quot;</span> [Yes]
P21. Results / Synthesis of results: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P22. Results / Risk of bias across studies: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P23. Results / Additional analysis: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review shows laparoscopy to be safe and effective in the treatment of pediatric intussusception.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main limitation of the present study includes the lack of prospective randomized controlled trials (RCT) comparing laparoscopic vs. open reduction of pediatric intussusception.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We advocate for laparoscopy to be considered the primary interventional technique for intussusception in tertiary centers with advanced pediatric minimally invasive skills.&quot;</span> [Yes]
P27. Funding: No information provided [No]</pre>
<p><a name='67'></a></p>
</div>
<div id="aworanti-2014" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0034-1370780' title='Open publication'>Aworanti
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Management of Recurrent Tracheoesophageal Fistulas: A Systematic Review&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We aim to comparatively review all published treatment options, and outcomes, for managing RTEF.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 61.2%):

 The management of a recurrent tracheoesophageal fistula (RTEF) in' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎The ideal approach to the management of recurrent tracheoesophageal fistulas (RTEF) is still in debate.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We aim to comparatively review all published treatment options, and outcomes, for managing RTEF.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All English language articles published by August 2013, irrespective of design, describing the management of, and outcome after, RTEF in children under 18 years were reviewed.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Medline, Embase, and web of science searches were performed using the keywords recurrent tracheoesophageal fistula.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All English language articles published by August 2013, irrespective of design, describing the management of, and outcome after, RTEF in children under 18 years were reviewed.&quot;</span> [Yes]
P10. Methods / Data collection process: Not reported [No]
P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The data obtained included number of patients treated, treatment modality employed, effectiveness of each treatment modality, and the outcomes after treatment.&quot;</span> [Yes]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: Not reported [NA]
P14. Methods / Synthesis of results: Not reported [NA]
P15. Methods / Risk of bias across studies: Not reported [NA]
P16. Methods / Additional analyses: Not reported [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 23 papers between 1984 and 2012 described 57 patients undergoing some form of endoscopic treatment (ET) while 21 papers between 1955 and 2013 described 108 patients that underwent an open surgical repair.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 165 cases of RTEF are described and there were 44 (26.7%) cases associated with anastomotic leaks while 35 (21.2%) were associated with anastomotic strictures preceding the diagnosis of RTEF.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the 57 ET patients, there was an 84% success rate compared with 93.5% of 108 OS patients.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not reported [NA]
P22. Results / Risk of bias across studies: Not reported [NA]
P23. Results / Additional analysis: Not reported [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎OS for RTEF has a low morbidity and mortality, a higher success rate, and requires fewer treatments than an endoscopic repair.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main limitations of this review include the heterogeneity of the included articles, particularly as case reports would predominantly report positive outcomes.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎OS for the repair of recurrent TEF has a low morbidity, mortality, and re-fistulation rate particularly when an interposition tissue is placed between the trachea and esophagus. We recommend OS as the treatment of choice when faced with a recurrent TEF.&quot;</span> [Yes]
P27. Funding: Not reported [No]</pre>
<p><a name='68'></a></p>
</div>
<div id="baker-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.02.021' title='Open publication'>Baker
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review and meta-analysis of gastrostomy insertion techniques in children&quot;</span> - [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, methods, results, and conclusions of the review. - [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. - [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. - [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. - [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. - [Yes]
P7. Methods / Information sources: The information sources used in the search are described. - [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is presented. - [Yes]
P9. Methods / Study selection: The process for selecting studies is described. - [Yes]
P10. Methods / Data collection process: The method of data extraction from reports is described. - [Yes]
P11. Methods / Data items: The variables for which data were sought are listed and defined. - [Yes]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias in individual studies are described. - [Yes]
P13. Methods / Summary measures: The principal summary measures used are stated. - [Yes]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. - [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. - [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses. - [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage. - [Yes]
P18. Results / Study characteristics: The characteristics of each study for which data were extracted are presented. - [Yes]
P19. Results / Risk of bias within studies: Data on the risk of bias of each study are presented. - [Yes]
P20. Results / Results of individual studies: The results of each study for all outcomes considered are presented. - [Yes]
P21. Results / Synthesis of results: No information is provided about the methods of synthesizing the results. - [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. - [NA]
P23. Results / Additional analysis: No information is provided about additional analyses. - [NA]
P24. Discussion / Summary of evidence: The main findings of the review are summarized, including the strength of evidence for each main outcome. - [Yes]
P25. Discussion / Limitations: The limitations of the review are discussed. - [Yes]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. - [Yes]
P27. Funding: No information is provided about funding sources. - [No]</pre>
<p><a name='69'></a></p>
</div>
<div id="berger-2012" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0032-1311695' title='Open publication'>Berger
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mitomycin C in the Therapy of Recurrent Esophageal Strictures: Hype or Hope?&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS). [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics (PICOS) and report characteristics used as criteria for eligibility. [Yes]
P7. Methods / Information sources: The methods describe the information sources used in the search. [Yes]
P8. Methods / Search: No information is provided about the full electronic search strategy. [No]
P9. Methods / Study selection: The methods state the process for selecting studies. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports. [Yes]
P11. Methods / Data items: No information is provided about the variables for which data were sought. [No]
P12. Methods / Risk of bias in individual studies: No information is provided about the methods used for assessing risk of bias. [No]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The results provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations. [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study. [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no meta-analysis. [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings and their relevance to key groups. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results and implications for future research. [Yes]
P27. Funding: No information is provided about sources of funding for the systematic review. [No]</pre>
<p><a name='70'></a></p>
</div>
<div id="billingham-2010" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0029-1241871' title='Open publication'>Billingham
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pediatric Surgical Technique: Laparoscopic or Open Approach? A systematic Review and Meta-Analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review was conducted to compare the clinical and cost effectiveness of laparoscopic and open surgical approaches for a variety of surgical indications in pediatric populations.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review was conducted to evaluate the clinical and cost-effectiveness of this approach for a variety of different surgical indications in pediatric populations.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Moderate quote deviation. Best match in fulltext (Similarity 85.3%):

are the clinical and cost effectiveness of laparoscopic and open surgical approaches for a variety of surgical indications in pediatric populations' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎To evaluate the clinical and cost-effectiveness of laparoscopic and open techniques in pediatric populations.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Inclusion criteria

    Prospective randomized or prospective non-randomized study format only.

    Operative results reported for a “pediatric population”, using the words “children, infants or neonates” to describe the study group and including infants, neonates or children (or combinations of the three).

    Study subjects under 17 years of age only.

    Comparison of laparoscopic and open techniques.

    Report on at least one of the outcome measures mentioned previously' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Inclusion criteria: Prospective randomized or prospective non-randomized study format only. Operative results reported for a “pediatric population”, using the words “children, infants or neonates” to describe the study group and including infants, neonates or children (or combinations of the three). Study subjects under 17 years of age only. Comparison of laparoscopic and open techniques. Report on at least one of the outcome measures mentioned previously.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All available electronic databases including the British Nursing Index (BNI), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, EMBASE (Excerpta Medica), Intute: Health & Life Sciences, MEDLINE, PubMed, BIOSIS Previews, ISI Web of Knowledge, ISI Web of Science and IgentaConnect, were systematically searched for each procedure, between the period 1992–2009 for all English and non–English language articles.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

Each article was independently assessed for eligibility using the following criteria:
#
Inclusion criteria

    Prospective randomized or prospective non-randomized study format only.

    Operative results reported for a “pediatric population”, using the words “children, infants or neonates” to describe the study group and including infants, neonates or children (or combinations of the three).

    Study subjects under 17 years of age only.

    Comparison of laparoscopic and open techniques.

    Report on at least one of the outcome measures mentioned previously' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Each article was independently assessed for eligibility using the following criteria: Prospective randomized or prospective non-randomized study format only. Operative results reported for a “pediatric population”, using the words “children, infants or neonates” to describe the study group and including infants, neonates or children (or combinations of the three). Study subjects under 17 years of age only. Comparison of laparoscopic and open techniques. Report on at least one of the outcome measures mentioned previously.&quot;</span>
[Yes]

P10. Methods / Data collection process: Not reported.
[No]

P11. Methods / Data items: Not reported.
[No]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: Not reported.
[No]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis).
[NA]

P16. Methods / Additional analyses: Not applicable (no meta-analysis).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 24 articles were identified that met the search and inclusion criteria.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎16 appendectomy, 4 fundoplication and 4 inguinal hernia studies comparing procedural outcomes method were included.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎LOS was found to be significantly reduced in favor of the laparoscopic approach, with a weighted mean difference of −1.44 days, although the OR time was significantly increased, with a weighted mean difference of +12.8 min. Laparoscopic intervention was associated with a significantly reduced complication rate compared to the open approach (10.6 vs. 15.6%). Total hospital costs of the laparoscopic approaches were found to be insignificantly increased compared to the open techniques.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis).
[NA]

P23. Results / Additional analysis: Not applicable (no meta-analysis).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review strengthens the use of MIS in pediatric populations, demonstrating that the three laparoscopic procedures reviewed showed better patient outcomes compared to open procedures in the form of reduced LOS and complication rates.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The validity of the results of this review largely depends on the validity of the included studies. Many of the included studies failed to take all the steps necessary to avoid bias. There may well be an inherent bias in the analyses, which are likely to favor the ‘newer’ MIS/laparoscopic technique.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review further supports the use of minimally invasive surgery (MIS) in pediatric populations, demonstrating that the three types laparoscopic procedures reviewed resulted in better patient outcomes compared to open procedures, in the form of reduced LOS and overall complication rates.&quot;</span>
[Yes]

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Conflict of interest: None&quot;</span>
[Yes]</pre>
<p><a name='71'></a></p>
</div>
<div id="black-2013" class="section level4">
<h4><a href='https://doi.org/10.1111/OBR.12037' title='Open publication'>Black
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis&quot;</span>
2. Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
3. Response: [Yes]

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents; (ii) meta-analyse change in body mass index (BMI) 1-year post-surgery and (iii) report complications, co-morbidity resolution and health-related quality of life (HRQoL).&quot;</span>
2. Reasoning: The abstract provides a structured summary including the background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions.
3. Response: [Yes]

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The global prevalence of obesity is rising in children and adolescents.&quot;</span>
2. Reasoning: The introduction provides the rationale for the review by highlighting the increasing prevalence of obesity in children and adolescents.
3. Response: [Yes]

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents; (ii) meta-analyse change in body mass index (BMI) 1-year post-surgery and (iii) report complications, co-morbidity resolution and health-related quality of life (HRQoL).&quot;</span>
2. Reasoning: The objectives are explicitly stated, including the participants (children and adolescents), interventions (bariatric surgery), outcomes (change in BMI, complications, co-morbidity resolution, HRQoL), and study design (systematic review and meta-analysis).
3. Response: [Yes]

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
1. Quote: No information provided.
2. Reasoning: There is no mention of a review protocol or registration information.
3. Response: [No]

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were included if (i) they assessed BMI before and a minimum of six months after individuals predominately received AGB, RYGB, BPD or SG and (ii) the mean age of the population was between 6 and 18 years at study entry.&quot;</span>
2. Reasoning: The eligibility criteria are specified, including the study characteristics (assessment of BMI before and after surgery) and the report characteristics (age of the population).
3. Response: [Yes]

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The indexed reference libraries EMBASE and Medline were searched between January 1955 and January 2013 using the search terms presented in Table 1, using mapped and exploded terms.&quot;</span>
2. Reasoning: The information sources are described, including the databases used (EMBASE and Medline) and the dates of coverage.
3. Response: [Yes]

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Search terms for EMBASE and Medline via Ovid SP&quot;</span>
2. Reasoning: The search strategy is mentioned, but the full electronic search strategy is not provided.
3. Response: [No]

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors independently screened the abstracts and extraction was verified by a second author (JAB and RKS).&quot;</span>
2. Reasoning: The process for selecting studies is described, including screening the abstracts and verification of extraction by a second author.
3. Response: [Yes]

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used a standard data extraction method to collect the following information on each study: years during which the surgery was performed, authors, country, study design, mean age and variance of study participants, type of surgery, gender distribution, complications, co-morbidities, pre-/post-surgery BMI with variance, number of participants, length of follow-up and loss to follow-up.&quot;</span>
2. Reasoning: The method of data extraction is described, including the information collected from each study.
3. Response: [Yes]

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used a standard data extraction method to collect the following information on each study: years during which the surgery was performed, authors, country, study design, mean age and variance of study participants, type of surgery, gender distribution, complications, co-morbidities, pre-/post-surgery BMI with variance, number of participants, length of follow-up and loss to follow-up.&quot;</span>
2. Reasoning: The variables for which data were sought are listed, including the study characteristics (years during which the surgery was performed, authors, country, study design, mean age and variance of study participants, type of surgery, gender distribution) and the outcomes (complications, co-morbidities, pre-/post-surgery BMI with variance, number of participants, length of follow-up and loss to follow-up).
3. Response: [Yes]

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
1. Quote: No information provided.
2. Reasoning: There is no mention of methods used for assessing risk of bias or how this information is used in data synthesis.
3. Response: [No]

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The summary effect measure of unstandardized change in BMI at the time point closest to 12 months post-surgery was produced using the DerSimonian and Laird random effects method.&quot;</span>
2. Reasoning: The principal summary measure (unstandardized change in BMI) is stated.
3. Response: [Yes]

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
1. Quote: No information provided.
2. Reasoning: There is no mention of the methods of handling data or combining results of studies.
3. Response: [NA]

P15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
1. Quote: No information provided.
2. Reasoning: There is no mention of any assessment of risk of bias across studies.
3. Response: [NA]

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
1. Quote: No information provided.
2. Reasoning: There is no mention of any additional analyses.
3. Response: [NA]

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 2303 unique citations were returned by the search strategy (Fig. 1). Of these, 2185 were excluded based on abstract review.&quot;</span>
2. Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are provided, but there is no mention of reasons for exclusions or a flow diagram.
3. Response: [No]

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 54 papers met the inclusion criteria, representing 23 unique study populations.&quot;</span>
2. Reasoning: The number of papers meeting the inclusion criteria and the number of unique study populations are provided, but there is no mention of the characteristics for which data were extracted or the citations.
3. Response: [No]

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
1. Quote: No information provided.
2. Reasoning: There is no mention of data on risk of bias within studies.
3. Response: [NA]

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mean BMI at baseline ranged from 38.5 to 60.2 kg m−2 (mean 47.9 kg m−2), and at follow-up from 25.2 to 41.5 kg m−2 (mean 34.7 kg m−2). All studies reported decreases in BMI.&quot;</span>
2. Reasoning: The results of individual studies are presented, including the mean BMI at baseline and follow-up, and the fact that all studies reported decreases in BMI.
3. Response: [Yes]

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
1. Quote: No information provided.
2. Reasoning: There is no mention of any meta-analysis done or the results of any meta-analysis.
3. Response: [NA]

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
1. Quote: No information provided.
2. Reasoning: There is no mention of any assessment of risk of bias across studies.
3. Response: [NA]

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
1. Quote: No information provided.
2. Reasoning: There is no mention of any additional analyses.
3. Response: [NA]

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Bariatric surgery in adolescents results in similar short-term weight outcomes to adults, with RYGB producing the greatest weight loss with the most robust evidence base.&quot;</span>
2. Reasoning: The main findings are summarized, including the weight outcomes and the evidence base for each surgery type.
3. Response: [Yes]

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The potential exists that the benefits of bariatric surgery have been inflated in the literature presented in this systematic review, as there were very few fixed study protocols before data collection and only clinics with promising records might have been incentivized to publish their data.&quot;</span>
2. Reasoning: The limitations are discussed, including the potential for inflated benefits due to publication bias.
3. Response: [Yes]

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Current guidelines suggest that paediatric-adolescent bariatric care should be handled within the controlled and restricted setting of a multidisciplinary team.&quot;</span>
2. Reasoning: The general interpretation of the results and implications for future research are provided, including the recommendation for multidisciplinary team care.
3. Response: [Yes]

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
1. Quote: No information provided.
2. Reasoning: There is no mention of funding sources or other support.
3. Response: [No]</pre>
<p><a name='72'></a></p>
</div>
<div id="borruto-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2010.07.007' title='Open publication'>Borruto
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic vs open varicocelectomy in children and adolescents: review of the recent literature and meta-analysis&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic vs open varicocelectomy in children and adolescents: review of the recent literature and meta-analysis&quot;</span>
2. Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
3. Response: [Yes]

P2. Abstract / Structured summary: Not reported
Reasoning: The abstract or structured summary is not provided in the full text.
Response: [No]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Varicocele is generally considered the most common correctable cause of male infertility.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Varicocele is generally considered the most common correctable cause of male infertility.&quot;</span>
2. Reasoning: The introduction provides the rationale for the review by highlighting the importance of varicocele as a cause of male infertility.
3. Response: [Yes]

P4. Introduction / Objectives: Not reported
Reasoning: The explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS) is not provided in the introduction.
Response: [No]

P5. Methods / Protocol and registration: Not reported
Reasoning: The existence of a review protocol and registration information are not mentioned in the methods section.
Response: [No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a Medline search for articles published during the last 10 years, using the key words 'varicocele,' 'treatment,' and 'adolescent.'&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a Medline search for articles published during the last 10 years, using the key words 'varicocele,' 'treatment,' and 'adolescent.'&quot;</span>
2. Reasoning: The study characteristics and report characteristics used as eligibility criteria are specified.
3. Response: [Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A literature search was performed, using Medline and Pubmed database, on all articles published during the last 10 years (2000-2009), reporting on varicocele treatments.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A literature search was performed, using Medline and Pubmed database, on all articles published during the last 10 years (2000-2009), reporting on varicocele treatments.&quot;</span>
2. Reasoning: The information sources, including the databases searched and the time frame, are described.
3. Response: [Yes]

P8. Methods / Search: Not reported
Reasoning: The full electronic search strategy for at least one database is not presented in the methods section.
Response: [No]

P9. Methods / Study selection: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):

ed 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We recorded 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population.&quot;</span>
1. Relevant quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):

ed 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We recorded 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population.&quot;</span>
2. Reasoning: The process for selecting studies, including screening and eligibility criteria, is described.
3. Response: [Yes]

P10. Methods / Data collection process: Not reported
Reasoning: The method of data extraction from reports and any processes for obtaining and confirming data from investigators are not described.
Response: [No]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Articles with data regarding recurrence, complications (hydrocele, hypotrophy, atrophy), and, if available, semen parameters after treatment were analyzed.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Articles with data regarding recurrence, complications (hydrocele, hypotrophy, atrophy), and, if available, semen parameters after treatment were analyzed.&quot;</span>
2. Reasoning: The variables for which data were sought are listed.
3. Response: [Yes]

P12. Methods / Risk of bias in individual studies: Not reported
Reasoning: The methods used for assessing risk of bias of individual studies are not described.
Response: [No]

P13. Methods / Summary measures: Not reported
Reasoning: The principal summary measures are not stated in the methods section.
Response: [No]

P14. Methods / Synthesis of results: NA
Reasoning: This item is not applicable as there is no meta-analysis reported in the study.
Response: [NA]

P15. Methods / Risk of bias across studies: NA
Reasoning: This item is not applicable as there is no assessment of risk of bias across studies reported in the study.
Response: [NA]

P16. Methods / Additional analyses: NA
Reasoning: This item is not applicable as there are no additional analyses reported in the study.
Response: [NA]

P17. Results / Study selection: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):

ed 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We recorded 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population.&quot;</span>
1. Relevant quote: <span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):

ed 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We recorded 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population.&quot;</span>
2. Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions, are provided.
3. Response: [Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the studies analyzed, we found 5 multicentric studies, 4 randomized trials, and 2 clinical trials.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of the studies analyzed, we found 5 multicentric studies, 4 randomized trials, and 2 clinical trials.&quot;</span>
2. Reasoning: The characteristics of the included studies are presented.
3. Response: [Yes]

P19. Results / Risk of bias within studies: Not reported
Reasoning: Data on risk of bias of each study are not presented in the results section.
Response: [No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The results, globally considered, demonstrated a recurrence rate of 4.7% and hydrocele formation in 9.5% of patients.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The results, globally considered, demonstrated a recurrence rate of 4.7% and hydrocele formation in 9.5% of patients.&quot;</span>
2. Reasoning: The results of individual studies, including simple summary data for each intervention group, are provided.
3. Response: [Yes]

P21. Results / Synthesis of results: NA
Reasoning: This item is not applicable as there is no meta-analysis reported in the study.
Response: [NA]

P22. Results / Risk of bias across studies: NA
Reasoning: This item is not applicable as there is no assessment of risk of bias across studies reported in the study.
Response: [NA]

P23. Results / Additional analysis: NA
Reasoning: This item is not applicable as there are no additional analyses reported in the study.
Response: [NA]

P24. Discussion / Summary of evidence: Not reported
Reasoning: A summary of the main findings, including the strength of evidence for each main outcome, is not provided in the discussion section.
Response: [No]

P25. Discussion / Limitations: Not reported
Reasoning: Limitations at study and outcome level, as well as review-level limitations, are not discussed in the discussion section.
Response: [No]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From the analysis performed in our study, results after laparoscopic technique are similar to that after open inguinal approaches.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From the analysis performed in our study, results after laparoscopic technique are similar to that after open inguinal approaches.&quot;</span>
2. Reasoning: A general interpretation of the results in the context of other evidence and implications for future research are provided.
3. Response: [Yes]

P27. Funding: Not reported
Reasoning: Sources of funding for the systematic review and other support are not described.
Response: [No]</pre>
<p><a name='73'></a></p>
</div>
<div id="castagnetti-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JURO.2010.06.044' title='Open publication'>Castagnetti
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘missing-squared-brackets-for-na’</i>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Surgical Management of Primary Severe Hypospadias in Children: Systematic 20-Year Review&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We systematically reviewed the literature published during the last 20 years on the treatment of primary proximal hypospadias associated with severe ventral curvature.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present systematic review shows the weak evidence backing current management of primary severe hypospadias.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of the present review was to assess the results of studies published during the last 20 years on the primary repair of severe hypospadias.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included in this review only series containing detailed results after primary repair of severe hypospadias or after curvature correction in patients with primary severe hypospadias.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We reviewed studies published between 1990 and December 2009, searching for “hypospadias” in MEDLINE®/PubMed®, EMBASE®, Web of Science® and the Cochrane Library.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three doctors reviewed the abstracts. Articles relevant to the topic of the review were selected by consensus.&quot;</span> [Yes]
P10. Methods / Data collection process: Not reported [No]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: Not reported [No]
P14. Methods / Synthesis of results: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P15. Methods / Risk of bias across studies: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P16. Methods / Additional analyses: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We identified 69 studies for review.&quot;</span> [Yes]
P18. Results / Study characteristics: Not reported [No]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We first reviewed the results of the different straightening procedures, then the crude complication rates (overall complication, fistula/dehiscence, stricture/stenosis rates) of the different urethroplasty techniques.&quot;</span> [Yes]
P21. Results / Synthesis of results: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P22. Results / Risk of bias across studies: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P23. Results / Additional analysis: <span style='background-color: #ffe9e2' title='Added squared brackets during extraction'>[NA]</span>
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present review illustrates that there is an extreme paucity of studies to address in an evidence-based manner many of the common issues related to the primary repair of proximal hypospadias.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An important limitation is that this review did not account for some variables such as age at surgery, use of additional coverage of urethroplasty, and type of preoperative and postoperative drainage and care.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review demonstrates the weak evidence supporting current management of primary severe hyposapdias.&quot;</span> [Yes]
P27. Funding: Not reported [No]</pre>
<p><a name='74'></a></p>
</div>
<div id="castagnetti-2016" class="section level4">
<h4><a href='https://doi.org/10.3389/FPED.2016.00041' title='Open publication'>Castagnetti
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Does Preputial Reconstruction Increase Complication Rate of Hypospadias Repair? 20-Year Systematic Review and Meta-Analysis&quot;</span>
[Yes] The report is identified as a systematic review and meta-analysis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review of the literature on preputial reconstruction (PR) during hypospadias repair to determine the cumulative risk of preputial skin complications and the influence of PR on urethroplasty complications, namely, fistula formation and overall reoperation rate of the repair.&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, and key findings.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Preputial asymmetry is one of the components of hypospadias. The prepuce stands like a hood over the glans penis, open ventrally, and redundant dorsally. Preputial reconstruction (PR) is an option during hypospadias repair, but many surgeons favor circumcision for the concern that PR might increase the complication rate of hypospadias repair.&quot;</span>
[Yes] The rationale for the review is described in the context of what is already known.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review of the literature on PR during hypospadias repair to determine the cumulative risk of specific complications related to the procedure. Moreover, we performed a meta-analysis of studies comparing urethroplasty complications and reoperation rates in patients undergoing hypospadias repair associated with PR vs. circumcision.&quot;</span>
[Yes] The objectives of the review are explicitly stated.

P5. Methods / Protocol and registration: Not reported.
[No] There is no mention of a review protocol or registration information.

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only studies on the outcome of PR in children, defined as dehiscence of the reconstructed prepuce or secondary phimosis needing circumcision, were selected.&quot;</span>
[Yes] The study characteristics and report characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic search of the literature published after 06/1995 was performed in 06/2015 using the keyword 'hypospadias.'&quot;</span>
[Yes] The information sources and search strategy are described.

P8. Methods / Search: Not reported.
[No] The full electronic search strategy is not presented.

P9. Methods / Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
[Yes] The process for selecting studies is described.

P10. Methods / Data collection process: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
[Yes] The method of data extraction and any processes for obtaining and confirming data are not described.

P11. Methods / Data items: Not reported.
[NA] There is no specific mention of the data items sought.

P12. Methods / Risk of bias in individual studies: Not reported.
[NA] There is no mention of methods used for assessing risk of bias.

P13. Methods / Summary measures: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
[Yes] The principal summary measures are not stated.

P14. Methods / Synthesis of results: Not reported.
[NA] There is no mention of methods for handling data and combining results.

P15. Methods / Risk of bias across studies: Not reported.
[NA] There is no mention of assessment of risk of bias across studies.

P16. Methods / Additional analyses: Not reported.
[NA] There is no mention of additional analyses.

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Twenty studies were identified.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are provided.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 20 studies included 2215 patients undergoing preputial sparing hypospadias repair.&quot;</span>
[Yes] Characteristics for which data were extracted are presented.

P19. Results / Risk of bias within studies: Not reported.
[NA] There is no presentation of data on risk of bias within studies.

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A meta-analysis of seven studies comparing patients undergoing PR vs. circumcision showed no increased risk of urethral fistula formation associated with PR.&quot;</span>
[Yes] Results of individual studies are presented.

P21. Results / Synthesis of results: Not reported.
[NA] There is no mention of methods for synthesizing results.

P22. Results / Risk of bias across studies: Not reported.
[NA] There is no mention of assessment of risk of bias across studies.

P23. Results / Additional analysis: Not reported.
[NA] There is no mention of additional analyses.

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review shows that according to available evidence PR carries an 8% risk of specific preputial complications, whereas it does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repairs.&quot;</span>
[Yes] The main findings and the strength of evidence are summarized.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Results of systematic reviews are unavoidably dependent on the criteria chosen to select the studies and the quality of the studies included.&quot;</span>
[Yes] Limitations at study and review-level are discussed.

P26. Discussion / Conclusions: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Preputial reconstruction is an option particularly in patients with distal hypospadias without associated penile curvature. It carries an 8% risk of specific complications, the most common being dehiscence of reconstructed prepuce, whereas secondary phimosis needing circumcision seems to be exceptional although we lack long-term follow-up data on these patients. Overall, PR does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Preputial reconstruction is an option particularly in patients with distal hypospadias without associated penile curvature. It carries an 8% risk of specific complications, but does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair.&quot;</span>
[Yes] A general interpretation of the results and implications for future research are provided.

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.&quot;</span>
[Yes] Sources of funding and the role of funders are described.</pre>
<p><a name='75'></a></p>
</div>
<div id="chan-2014-pediatr-surg-int" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-013-3429-Y' title='Open publication'>Chan
2014 (Pediatr Surg Int)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ideal timing of orchiopexy: a systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to determine, based on a systematic review, the most favorable age at which orchiopexy should be performed.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The ideal timing of orchiopexy for cryptorchidism has long been debated.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To assess the ideal timing for orchiopexy with respect to both fertility and malignancy outcomes.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included all studies that examined the effect of age at orchiopexy on fertility or malignancy.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), Embase (1980 onwards), and CINAHL (1982 onwards) to find relevant articles' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and CINAHL to find relevant articles.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two researchers independently performed each level of screening, comparing the selected studies to reach a consensus.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One researcher extracted data from each of the included studies, and a second researcher checked the data for accuracy and completeness.&quot;</span> [Yes]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

We used the MINORS criteria [22] to assess the quality of all relevant non-randomized studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We used the MINORS criteria to assess the quality of all relevant non-randomized studies.&quot;</span> [Yes]
P13. Methods / Summary measures: Not reported [NA]
P14. Methods / Synthesis of results: Not applicable (no meta-analysis) [NA]
P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P16. Methods / Additional analyses: Not applicable (no additional analyses) [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our initial search yielded 198 studies. After screening, we quality assessed the 32 remaining studies that met our criteria.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Publication dates ranged from 1974 to 2011.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

We found one RCT that included fertility potential as an outcome [14] which received a Jadad score of 3' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We found one RCT that included fertility potential as an outcome which received a Jadad score of 3.&quot;</span> [Yes]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Fertility potential was greatest when orchiopexy was performed before 1 year of age.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable (no meta-analysis) [NA]
P22. Results / Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P23. Results / Additional analysis: Not applicable (no additional analyses) [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Orchiopexy between 6 and 12 months of age may optimize fertility potential and help protect against the increased risk of testicular cancer associated with cryptorchidism.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Moderate quote deviation. Best match in fulltext (Similarity 84.5%):

The most direct measurement of male fertility is paternity rate and time until conception of a live born child [4]; however, due to the difficult' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The most direct measurement of male fertility is paternity rate and time until conception of a live born child, but these outcomes are difficult to assess.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study is the first step towards determining the ideal management of undescended testes.&quot;</span> [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This research was carried out as part of the development of the Canadian Association of Pediatric Surgeons (CAPS) Evidence-Based Resource.&quot;</span> [Yes]</pre>
<p><a name='76'></a></p>
</div>
<div id="chan-2014-j-pediatr-surg" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2014.02.049' title='Open publication'>Chan
2014 (J Pediatr Surg)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive versus open repair of Bochdalek hernia: a meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is presented. [Yes]
P9. Methods / Study selection: The process for selecting studies is stated. [Yes]
P10. Methods / Data collection process: The method of data extraction from reports is described. [Yes]
P11. Methods / Data items: The variables for which data were sought are listed and defined. [Yes]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are described. [Yes]
P13. Methods / Summary measures: The principal summary measures are stated. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The characteristics for which data were extracted are presented. [Yes]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are presented. [Yes]
P20. Results / Results of individual studies: Simple summary data for each intervention group and effect estimates with confidence intervals are presented. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no meta-analysis. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized. [Yes]
P25. Discussion / Limitations: Limitations at study and outcome level, as well as at review-level, are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research are provided. [Yes]
P27. Funding: No information is provided about funding sources. [No]</pre>
<p><a name='77'></a></p>
</div>
<div id="chang-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00345-015-1526-3' title='Open publication'>Chang
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparing the efficacy and safety between robotic-assisted versus open pyeloplasty in children: a systemic review and meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This manuscript is mainly to systemically review the published reports that compared the efficacy and safety of robotic-assisted (RP) versus open pyeloplasty (OP) in children with ureteropelvic junction obstruction (UPJO).&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Open dismembered pyeloplasty remained the best standard treating children with ureteropelvic junction obstruction (UPJO) despite the introduction of minimal invasive therapy.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This manuscript is mainly to systemically review the published reports that compared the efficacy and safety of robotic-assisted (RP) versus open pyeloplasty (OP) in children with ureteropelvic junction obstruction (UPJO).&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched PubMed® for comparative studies (from January 1990 to 2014 September) that compared the efficacy and safety of robotic versus open pyeloplasty.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched PubMed® for comparative studies (from January 1990 to 2014 September) that compared the efficacy and safety of robotic versus open pyeloplasty.&quot;</span> [Yes]
P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used the following keywords: robotic, pyeloplasty, ureteropelvic junction obstruction, children, and pediatric.&quot;</span> [Yes]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors (Hsu and Chang) of the current study independently searched and reviewed the articles.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors of this paper, Hsu and Chang, evaluated the quality of the study.&quot;</span> [Yes]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: Not reported [No]
P14. Methods / Synthesis of results: Not applicable [NA]
P15. Methods / Risk of bias across studies: Not applicable [NA]
P16. Methods / Additional analyses: Not applicable [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Initial research yielded 104 abstracts, and a total of 102 abstracts were included for evaluation after duplicates were removed.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Totally, seven retrospective comparative trials [9–15] and three studies [4, 16, 17] using national database were included.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Most studies reported median value of patient age, operative time, and hospital stay.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable [NA]
P22. Results / Risk of bias across studies: Not applicable [NA]
P23. Results / Additional analysis: Not applicable [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The current meta-analysis fails to validate robotic pyeloplasty as a standard of care in managing pediatric UPJO in the current status.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The included studies were all retrospective in origin with lack of prospective data.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We urge the pediatric laparoendoscopists and manufacturer to improve the surgical efficacy and safety of pediatric robotic-assisted pyeloplasty.&quot;</span> [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study is partly funded by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation.&quot;</span> [Yes]</pre>
<p><a name='78'></a></p>
</div>
<div id="chen-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2012.12.036' title='Open publication'>Chen
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Transanal endorectal pull-through versus transabdominal approach for Hirschsprung's disease: A systematic review and meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified [Yes]
P7. Methods / Information sources: The information sources are described [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is presented [Yes]
P9. Methods / Study selection: The process for selecting studies is stated [Yes]
P10. Methods / Data collection process: The method of data extraction from reports is described [Yes]
P11. Methods / Data items: The variables for which data were sought are listed [Yes]
P12. Methods / Risk of bias in individual studies: No information is provided about the methods used for assessing risk of bias [No]
P13. Methods / Summary measures: The principal summary measures are stated [Yes]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage [Yes]
P18. Results / Study characteristics: The characteristics for which data were extracted are presented [Yes]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are not presented [No]
P20. Results / Results of individual studies: Simple summary data for each intervention group and effect estimates are presented [Yes]
P21. Results / Synthesis of results: No information is provided about the methods of combining results [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]
P23. Results / Additional analysis: No information is provided about additional analyses [NA]
P24. Discussion / Summary of evidence: The main findings are summarized, including the strength of evidence for each main outcome [Yes]
P25. Discussion / Limitations: Limitations at study and outcome level, and at review-level, are discussed [Yes]
P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research are provided [Yes]
P27. Funding: No information is provided about the sources of funding for the systematic review [No]</pre>
<p><a name='79'></a></p>
</div>
<div id="corbett-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2015.08.014' title='Open publication'>Corbett
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
[No] The title does not clearly identify the report as a systematic review or meta-analysis.

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
[No] The abstract does not provide a structured summary with all the required information.

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
[Yes] The introduction describes the rationale for the review.

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
[Yes] The introduction provides an explicit statement of the objectives with reference to participants, interventions, comparisons, outcomes, and study design.

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
[No] There is no mention of a review protocol or registration information.

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
[Yes] The methods specify the eligibility criteria used for study and report characteristics.

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
[Yes] The methods describe the information sources used in the search.

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
[No] The full electronic search strategy is not presented.

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
[Yes] The methods state the process for selecting studies.

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
[Yes] The methods describe the method of data extraction and any processes for obtaining and confirming data.

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
[Yes] The methods list and define the variables for which data were sought.

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
[Yes] The methods describe the methods used for assessing risk of bias in individual studies.

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
[Yes] The methods state the principal summary measures.

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
[NA] Not applicable as there is no meta-analysis.

P15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
[NA] Not applicable as there is no assessment of risk of bias across studies.

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
[NA] Not applicable as there are no additional analyses.

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
[No] The results do not provide the numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions.

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
[Yes] The results present characteristics for each study and provide the citations.

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
[Yes] The results present data on risk of bias within studies.

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
[Yes] The results present the results of individual studies.

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
[NA] Not applicable as there is no meta-analysis.

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
[NA] Not applicable as there is no assessment of risk of bias across studies.

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
[NA] Not applicable as there are no additional analyses.

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
[Yes] The discussion summarizes the main findings and their relevance to key groups.

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
[Yes] The discussion discusses the limitations of the study.

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
[Yes] The discussion provides a general interpretation of the results and implications for future research.

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
[No] There is no description of sources of funding or other support for the systematic review.</pre>
<p><a name='80'></a></p>
</div>
<div id="cullis-2016" class="section level4">
<h4><a href='https://doi.org/10.1097/sla.0000000000001563' title='Open publication'>Cullis
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Is Screening of Intestinal Foregut Anatomy in Heterotaxy Patients Really Necessary? A Systematic Review in Search of the Evidence&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Objective: 

(1) Is screening of intestinal rotational anatomy obligatory in “asymptomatic” patients with heterotaxy? (2) Does detection of an anomaly warrant surgical correction' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Objective: (1) Is screening of intestinal rotational anatomy obligatory in “asymptomatic” patients with heterotaxy? (2) Does detection of an anomaly warrant surgical correction?&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Heterotaxy is an abnormal arrangement of thoraco-abdominal viscera across a left-to-right axis. Intestinal rotational anomalies are frequent among patients with heterotaxy, but debate exists as to whether they are benign in nature, requiring careful observation alone, or if surgical correction is warranted to prevent obstruction or midgut volvulus.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎we undertook a systematic review of the available literature to determine (1) whether screening of IRA is obligatory in “asymptomatic” patients with heterotaxy and (2) whether detection of a rotational anomaly warrant(s) surgical correction in such a fragile patient cohort.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: No mention of a review protocol or registration.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria were then applied to remaining studies&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic search of the English language literature was conducted using a keyword algorithm (Supplemental Figure 1, https://links.lww.com/SLA/A928). The search was conducted using the indexed databases: CINAHL, EMBASE, Medline, and Cochrane Databases, from inception to January 11, 2015 (the search was again updated on June 18, 2015). Additional articles were identified through the reference listings of those articles yielded through the initial electronic database search. The conference proceedings of all significant pediatric surgery and cardiology society congresses over the past decade were also searched. Finally, data regarding patients with heterotaxy from our own institution were also obtained.&quot;</span>
[Yes]

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The search was conducted using the indexed databases: CINAHL, EMBASE, Medline, and Cochrane Databases, from inception to January 11, 2015 (the search was again updated on June 18, 2015). Additional articles were identified through the reference listings of those articles yielded through the initial electronic database search. The conference proceedings of all significant pediatric surgery and cardiology society congresses over the past decade were also searched.&quot;</span>
[Yes]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria were then applied to remaining studies&quot;</span>
[Yes]

P10. Methods / Data collection process: No specific mention of data extraction process.
[No]

P11. Methods / Data items: No specific mention of variables sought or assumptions made.
[No]

P12. Methods / Risk of bias in individual studies: No mention of risk of bias assessment.
[No]

P13. Methods / Summary measures: No mention of principal summary measures.
[No]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis conducted).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis conducted).
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses conducted).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Nineteen studies met the eligibility criteria but reporting was adequate for 9.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All studies were retrospective case series&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: No specific mention of risk of bias assessment.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of 414 patients managed expectantly, only a single patient (0.24%) developed symptoms directly attributable to IRA during the total follow-up period.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis conducted).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis conducted).
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses conducted).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review shows that “asymptomatic patients” with heterotaxy are at a low risk of developing IRA-related complications.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We fully acknowledge that there are some limitations with the present study.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review has robustly demonstrated that the evidence base for foregut imaging screening in “asymptomatic patients” with heterotaxy is substantially weak.&quot;</span>
[Yes]

P27. Funding: No mention of funding sources.
[No]</pre>
<p><a name='81'></a></p>
</div>
<div id="cundy-2014-bju-int" class="section level4">
<h4><a href='https://doi.org/10.1111/bju.12683 ' title='Open publication'>Cundy
2014 (BJU Int)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis of robot-assisted vs conventional laparoscopic and open pyeloplasty in children&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To critically analyse outcomes for robot-assisted pyeloplasty (RAP) vs conventional laparoscopic pyeloplasty (LP) or open pyeloplasty (OP) by systematic review and meta-analysis of published data.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎It remains largely unclear how the many technological enhancements offered by robot-assistance might translate into clinically measurable outcome benefits.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):

The aim of thepresent study was therefore to undertake a meta-analysis of RAP vs LP and OP in children' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The aim of the present study was therefore to undertake a meta-analysis of RAP vs LP and OP in children.&quot;</span> [Yes]
P5. Methods / Protocol and registration: No information provided [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only comparative studies investigating RAP vs LP or OP in children were included.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies published up to December 2013 were identified from multiple literature databases.&quot;</span> [Yes]
P8. Methods / Search: No information provided [No]
P9. Methods / Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors independently undertook literature searches, screened abstracts, and assessed eligible articles against inclusion criteria.&quot;</span> [Yes]
P11. Methods / Data items: No information provided [No]
P12. Methods / Risk of bias in individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The methodological quality of studies was appraised using a star-based modified Newcastle-Ottawa Scale (mNOS).&quot;</span> [Yes]
P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Effect sizes were estimated by pooled odds ratios and weighted mean differences.&quot;</span> [Yes]
P14. Methods / Synthesis of results: No meta-analysis performed [NA]
P15. Methods / Risk of bias across studies: No assessment of risk of bias across studies [NA]
P16. Methods / Additional analyses: No additional analyses performed [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In all, 12 studies met the inclusion criteria, involving 384 RAP, 131 LP, and 164 OP procedures.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Characteristics of studies included in the meta-analysis&quot;</span> [Yes]
P19. Results / Risk of bias within studies: No information provided [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pooled analyses determined no significant differences between RAP and LP or OP for all primary outcomes.&quot;</span> [Yes]
P21. Results / Synthesis of results: No meta-analysis performed [NA]
P22. Results / Risk of bias across studies: No assessment of risk of bias across studies [NA]
P23. Results / Additional analysis: No additional analyses performed [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Existing evidence shows largely comparable outcomes amongst surgical techniques available to treat pelvi-ureteric junction obstruction in children.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No randomised controlled trials were identified.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Higher quality evidence from prospective observational studies and clinical trials is required, as well as further cost-effectiveness analyses.&quot;</span> [Yes]
P27. Funding: No information provided [No]</pre>
<p><a name='82'></a></p>
</div>
<div id="cundy-2014-j-pediatr-surg" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.12.014' title='Open publication'>Cundy
2014 (J Pediatr Surg)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta analysis of robot-assisted versus conventional laparoscopic fundoplication in children&quot;</span> - [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions - [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known - [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design - [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration - [No]
P6. Methods / Eligibility criteria: The methods specify study characteristics and report characteristics used as criteria for eligibility - [Yes]
P7. Methods / Information sources: The methods describe all information sources used in the search - [Yes]
P8. Methods / Search: The methods present the full electronic search strategy for at least one database - [Yes]
P9. Methods / Study selection: The methods state the process for selecting studies - [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports - [Yes]
P11. Methods / Data items: The methods list and define all variables for which data were sought - [Yes]
P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing risk of bias of individual studies - [Yes]
P13. Methods / Summary measures: The methods state the principal summary measures - [Yes]
P14. Methods / Synthesis of results - [NA]
P15. Methods / Risk of bias across studies - [NA]
P16. Methods / Additional analyses - [NA]
P17. Results / Study selection: The results give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage - [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations - [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study - [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot - [Yes]
P21. Results / Synthesis of results - [NA]
P22. Results / Risk of bias across studies - [NA]
P23. Results / Additional analysis - [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome - [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level - [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research - [Yes]
P27. Funding: No information is provided about sources of funding for the systematic review - [No]</pre>
<p><a name='83'></a></p>
</div>
<div id="cundy-2014-eur-j-pediatr-surg" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1347297' title='Open publication'>Cundy
2014 (Eur J Pediatr Surg)</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Robot-Assisted Minimally Invasive Surgery for Pediatric Solid Tumors: A Systematic Review of Feasibility and Current Status&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics and report characteristics used as criteria for eligibility. [Yes]
P7. Methods / Information sources: The methods describe the information sources used in the search. [Yes]
P8. Methods / Search: The methods present the full electronic search strategy for at least one database. [Yes]
P9. Methods / Study selection: The methods state the process for selecting studies. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports. [Yes]
P11. Methods / Data items: The methods list and define all variables for which data were sought. [Yes]
P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing risk of bias of individual studies. [Yes]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The results provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations. [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study. [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no meta-analysis. [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]
P27. Funding: No information is provided about funding. [No]</pre>
<p><a name='84'></a></p>
</div>
<div id="ding-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.01.026' title='Open publication'>Ding
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Single-incision versus conventional three-incision laparoscopic appendicectomy for appendicitis: A systematic review and meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified [Yes]
P7. Methods / Information sources: The information sources are described [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not presented [No]
P9. Methods / Study selection: The process for selecting studies is not described [No]
P10. Methods / Data collection process: The method of data extraction from reports is not described [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described [No]
P13. Methods / Summary measures: The principal summary measures are not stated [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results of studies [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not given [No]
P18. Results / Study characteristics: The characteristics of each study are not presented [No]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are not presented [No]
P20. Results / Results of individual studies: The results of each individual study are presented [Yes]
P21. Results / Synthesis of results: No information is provided about the synthesis of results [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]
P23. Results / Additional analysis: No information is provided about additional analyses [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized [Yes]
P25. Discussion / Limitations: The limitations at study and outcome level, and at review-level are not discussed [No]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided [Yes]
P27. Funding: No information is provided about the sources of funding for the systematic review [No]</pre>
<p><a name='85'></a></p>
</div>
<div id="dingemann-2014" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1350060' title='Open publication'>Dingemann
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thoracoscopic Procedures in Pediatric Surgery: What is the Evidence?&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics and report characteristics used as criteria for eligibility. [Yes]
P7. Methods / Information sources: The methods describe the information sources used in the search. [Yes]
P8. Methods / Search: No information is provided about the full electronic search strategy. [No]
P9. Methods / Study selection: The methods state the process for selecting studies. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports. [Yes]
P11. Methods / Data items: The methods list and define the variables for which data were sought. [Yes]
P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing risk of bias of individual studies. [Yes]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The results provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations. [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study. [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no meta-analysis. [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]
P27. Funding: No information is provided about sources of funding for the systematic review. [No]</pre>
<p><a name='86'></a></p>
</div>
<div id="dingemann-2013" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1333639' title='Open publication'>Dingemann
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic Review of Level 1 Evidence for Laparoscopic Pediatric Surgery: Do Our Procedures Comply with the Requirements of Evidence-Based Medicine?&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of our study was to evaluate the availability of Level 1 studies comparing laparoscopic procedures with the corresponding open operation in pediatric surgery.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎However, most studies comparing laparoscopic operations with the corresponding open procedure do not reach a high level of evidence according to the criteria of the Oxford Centre for Evidence-Based Medicine.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of our study was to evaluate the availability of Level 1 studies comparing laparoscopic procedures with the corresponding open operation in pediatric surgery.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only studies comparing pediatric laparoscopic procedures with the corresponding open operation were included.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic review of clinical Level 1 studies using PubMed.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.&quot;</span>
[Yes]

P11. Methods / Data items: Not reported.
[No]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the principal summary measures (e.g., risk ratio, difference in means).&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis).
[NA]

P16. Methods / Additional analyses: Not applicable (no meta-analysis).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 20 manuscripts met the inclusion criteria (9 MA and 11 RCT).&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis).
[NA]

P23. Results / Additional analysis: Not applicable (no meta-analysis).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span>
[Yes]

P27. Funding: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.&quot;</span>
[Yes]</pre>
<p><a name='87'></a></p>
</div>
<div id="ells-2015" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD011740' title='Open publication'>Ells
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Surgery for the treatment of obesity in children and adolescents&quot;</span> - [Yes]

P2. Abstract / Structured summary: No relevant quote found - [No]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Child and adolescent overweight and obesity have increased globally, and are associated with significant short and long term health consequences.&quot;</span> - [Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To assess the effects of surgical interventions for treating obesity in childhood and adolescence.&quot;</span> - [Yes]

P5. Methods / Protocol and registration: No relevant quote found - [No]

P6. Methods / Eligibility criteria: No relevant quote found - [No]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched the Cochrane Library, MEDLINE, PubMed, EMBASE as well as LILACS, ICTRP Search Portal and ClinicalTrials.gov (all from database inception to March 2015). References of identified studies and systematic reviews were checked. No language restrictions were applied.&quot;</span> - [Yes]

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched the following sources on the 30th of March 2015 from inception to the specified database date and placed no restrictions on the language of publication.&quot;</span> - [Yes]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To determine the studies to be assessed further, two review authors (LJE, EM) independently scanned the abstract, title, or both, of every record retrieved by the searches.&quot;</span> - [Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For studies that fulfilled inclusion criteria, two review authors (LJE, KR, or EM) independently extracted key participant and intervention characteristics and reported data on efficacy outcomes and adverse events using a standard data extraction form supplied by the CMED Group.&quot;</span> - [Yes]

P11. Methods / Data items: No relevant quote found - [No]

P12. Methods / Risk of bias in individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two review authors (LJE, KR) independently assessed the risk of bias of each included study.&quot;</span> - [Yes]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For dichotomous outcomes we calculated odds ratio (OR) or risk ratio (RR) and corresponding 95% confidence interval (CI). For continuous outcomes we calculated the mean difference (MD) and corresponding 95% CI.&quot;</span> - [Yes]

P14. Methods / Synthesis of results: No relevant quote found - [No]

P15. Methods / Risk of bias across studies: No relevant quote found - [No]

P16. Methods / Additional analyses: No relevant quote found - [No]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial search on 30 March 2015 identified 2405 records (2290 from database searches and 115 from trial registry searches); from these, 11 full text publications and protocols were identified for further examination and four trials met the inclusion criteria for ongoing studies.&quot;</span> - [Yes]

P18. Results / Study characteristics: No relevant quote found - [No]

P19. Results / Risk of bias within studies: No relevant quote found - [No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study authors reported a mean reduction in weight of 34.6 kg (95% confidence interval (CI) 30.2 to 39.0) at two years, representing a change in body mass index (BMI) of 12.7 (95% CI 11.3 to 14.2) for the surgery intervention; and a mean reduction in weight of 3.0 kg (95% CI 2.1 to 8.1) representing a change in BMI of 1.3 (95% CI 0.4 to 2.9) for the lifestyle intervention.&quot;</span> - [Yes]

P21. Results / Synthesis of results: No relevant quote found - [No]

P22. Results / Risk of bias across studies: No relevant quote found - [No]

P23. Results / Additional analysis: No relevant quote found - [No]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic gastric banding led to greater body weight loss compared to a multi component lifestyle program in one small study with 50 patients.&quot;</span> - [Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The study authors reported a mean reduction in weight of 34.6 kg (95% confidence interval (CI) 30.2 to 39.0) at two years, representing a change in body mass index (BMI) of 12.7 (95% CI 11.3 to 14.2) for the surgery intervention; and a mean reduction in weight of 3.0 kg (95% CI 2.1 to 8.1) representing a change in BMI of 1.3 (95% CI 0.4 to 2.9) for the lifestyle intervention.&quot;</span> - [Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic gastric banding led to greater body weight loss compared to a multi component lifestyle program in one small study with 50 patients.&quot;</span> - [Yes]

P27. Funding: No relevant quote found - [No]</pre>
<p><a name='88'></a></p>
</div>
<div id="elyas-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JURO.2010.01.035' title='Open publication'>Elyas
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Is Staging Beneficial for Fowler-Stephens Orchiopexy? A Systematic Review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified [Yes]
P7. Methods / Information sources: All information sources are described [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not presented [No]
P9. Methods / Study selection: The process for selecting studies is not stated [No]
P10. Methods / Data collection process: The method of data extraction from reports is not described [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described [No]
P13. Methods / Summary measures: The principal summary measures are not stated [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage [Yes]
P18. Results / Study characteristics: The characteristics for which data were extracted are not presented [No]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are not presented [No]
P20. Results / Results of individual studies: Simple summary data for each intervention group and effect estimates with confidence intervals are presented [Yes]
P21. Results / Synthesis of results: No information is provided about the methods of combining results [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]
P23. Results / Additional analysis: No results of additional analyses are presented [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized [Yes]
P25. Discussion / Limitations: Limitations at study and outcome level, and at review-level, are discussed [Yes]
P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research are provided [Yes]
P27. Funding: No information is provided about the sources of funding for the systematic review [No]</pre>
<p><a name='89'></a></p>
</div>
<div id="esposito-2014" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2014.0194' title='Open publication'>Esposito
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic Versus Open Inguinal Hernia Repair in Pediatric Patients: A Systematic Review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions of the review. [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources used in the search are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not provided. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction from reports is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: The methods of handling data and combining results of studies are not described. [NA]
P15. Methods / Risk of bias across studies: The assessment of risk of bias across studies is not specified. [NA]
P16. Methods / Additional analyses: The methods of additional analyses are not described. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not provided. [No]
P18. Results / Study characteristics: The characteristics of each study for which data were extracted are not presented. [No]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are not presented. [No]
P20. Results / Results of individual studies: Simple summary data for each intervention group and effect estimates with confidence intervals are not provided. [No]
P21. Results / Synthesis of results: The results of each meta-analysis done are not presented. [NA]
P22. Results / Risk of bias across studies: The results of any assessment of risk of bias across studies are not presented. [NA]
P23. Results / Additional analysis: The results of additional analyses are not presented. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are not summarized. [No]
P25. Discussion / Limitations: The limitations at study and outcome level, and at review-level are not discussed. [No]
P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research are provided. [Yes]
P27. Funding: No information is provided about the sources of funding for the systematic review. [No]</pre>
<p><a name='90'></a></p>
</div>
<div id="feng-2016" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3845-2' title='Open publication'>Feng
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open splenectomy in children: a systematic review and meta-analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted a systematic review and meta-analysis to compare the clinical outcomes between laparoscopic splenectomy and the traditional open splenectomy in children.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To avoid the potential disadvantages related to open surgery, surgeons are now drawing their attention to the laparoscopic techniques.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Clinical outcomes following LS and OS in children were pooled to provide results for comparison in this systematic review and meta-analysis.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria: (1) clinical trials that compared laparoscopic versus open splenectomy between 1993 and 2015; (2) children under 18 years old who suffered from benign or malignant hematological diseases; exclusion criteria: (1) no open splenectomy as a control; (2) reports fewer than ten cases per group; and (3) studies did not provide available original data or duplicate publications.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Published records were searched using the MEDLINE, EMBASE, and Web of Science from 1993 to 2015.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies comparing LS and OS in children were included regardless of randomization or non-randomization.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Included studies were independently reviewed by two reviewers, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
[Yes]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measures of our analysis was to evaluate the operative time, blood loss, and length of postoperative stay. Secondary outcome measures included an analysis of the removal of accessory spleens and postoperative complications including postoperative high fever, acute chest syndrome (ACS), and ileus.&quot;</span>
[Yes]

P12. Methods / Risk of bias in individual studies: Not reported.
[NA]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For continuous data, we presented mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous data, we calculated odds ratios (ORs).&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not reported.
[NA]

P15. Methods / Risk of bias across studies: Not reported.
[NA]

P16. Methods / Additional analyses: Not reported.
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎21 of the 159 publications identified from the initial literature search were retrieved for full text review and 10 studies with 922 participants (508 received LS and 414 OS) met our total inclusion criteria.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Tables 2 and 3 outlines the primary and secondary outcome results from each study.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[NA]

P20. Results / Results of individual studies: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 74.3%):

Meta-analysis demonstrated that the LS approach had a significantly longer operative time than the OS approach with obvious statistical heterogeneity (I 2 = 99 %, WMD 42.22, 95 % CI 7.69–76.74; P = 0.02; Fig. 2).
Fig. 2
figure 2

Forest plot comparing operative time for children treated with LS versus OS
Full size image
Blood loss

Blood loss was reported in three studies [7, 8, 12]. Meta-analysis demonstrated a statistically significant decrease in blood loss for LS compared with OS while the statistical heterogeneity was evident (I 2 = 98 %, WMD −31.77, 95 % CI −59.74 to −3.8; P = 0.03; Fig. 3).
Fig. 3
figure 3

Forest plot comparing blood loss for children treated with LS versus OS
Full size image
Length of hospital stay

Length of hospital stay was reported in eight studies and six studies were suitable for meta-analysis [7, 8, 10–12, 15]. Meta-analysis revealed a statistically significant decrease in mean length of hospital stay for LS compared with OS (WMD −1.61, 95 % CI −2.19 to −1.02; P = 0.001; Fig. 4). There was obvious statistica' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Meta-analysis demonstrated that the LS approach had a significantly longer operative time than the OS approach with obvious statistical heterogeneity. Meta-analysis demonstrated a statistically significant decrease in blood loss for LS compared with OS while the statistical heterogeneity was evident. Meta-analysis revealed a statistically significant decrease in mean length of hospital stay for LS compared with OS. There was no statistically significant difference between the two groups in the removal of accessory spleens or postoperative complications including postoperative high fever, ACS, and ileus.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not reported.
[NA]

P22. Results / Risk of bias across studies: Not reported.
[NA]

P23. Results / Additional analysis: Not reported.
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study suggests that LS is a feasible, safe, and effective surgical procedure alternative to OS for pediatric patients. LS is associated with shorter hospital stays, less blood loss, and longer operative times compared with OS. Furthermore, LS has a similar rate of the removal of accessory spleens and postoperative complications including postoperative high fever, ACS, and ileus when compared to OS in children.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our systematic review and meta-analysis have several limitations. On one hand, there was no randomized clinical trials available in the literature for our study and the decision to perform LS or OS usually depends on preference and experiences of surgeons. Besides, some of the included studies had rather small sample size. On the other hand, obvious statistical heterogeneity was detected among different trials in terms of operative time, blood loss, and length of hospital stay.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎LS is a feasible, safe, and effective surgical procedure alternative to OS for pediatric patients. LS is associated with shorter hospital stays, less blood loss, and longer operative times compared with OS. Furthermore, LS has a similar rate of the removal of accessory spleens and postoperative complications including postoperative high fever, ACS, and ileus when compared to OS in children.&quot;</span>
[Yes]

P27. Funding: Not reported.
[No]</pre>
<p><a name='91'></a></p>
</div>
<div id="feng-2015" class="section level4">
<h4><a href='https://doi.org/10.1097/SLE.0000000000000161' title='Open publication'>Feng
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):

Open Versus Laparoscopic Inguinal Herniotomy in Children
A Systematic Review and Meta-Analysis Focusing on Postoperative Complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Open Versus Laparoscopic Inguinal Herniotomy in Children: A Systematic Review and Meta-Analysis Focusing on Postoperative Complications&quot;</span>
Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to compare both of the surgical strategies as regards operative time, recurrence rate, postoperative complications by means of a systematic review, and meta-analysis of the available literatures.&quot;</span>
Reasoning: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions.
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There is an ongoing debate about whether laparoscopic or open herniorrhaphy (LH or OH) is the best choice for inguinal hernia in children.&quot;</span>
Reasoning: The introduction describes the rationale for the review in the context of what is already known.
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to compare both of the surgical strategies as regards operative time, recurrence rate, postoperative complications by means of a systematic review, and meta-analysis of the available literatures.&quot;</span>
Reasoning: The objectives are explicitly stated, including the participants (children), interventions (laparoscopic or open herniorrhaphy), comparisons (operative time, recurrence rate, postoperative complications), outcomes, and study design (systematic review and meta-analysis).
[Yes]

P5. Methods / Protocol and registration: Not reported.
Reasoning: There is no mention of a review protocol or registration information.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria included total available studies comparing LH with OH for the repair of PIH. The children were younger than 18 years when they underwent LH or OH.&quot;</span>
Reasoning: The study characteristics (participants, interventions) and report characteristics (comparing LH with OH) used as eligibility criteria are specified.
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We systematically searched PubMed for relevant studies reported from 2005 to 2014 with the keywords 'laparoscopic herniorrhaphy', 'pediatric inguinal hernia,' and 'open herniorrhaphy.' Total reference lists of selected articles were also included.&quot;</span>
Reasoning: The information sources (PubMed and reference lists) and the dates of coverage are described.
[Yes]

P8. Methods / Search: Not reported.
Reasoning: The full electronic search strategy is not presented.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (S.F., Z.L.) screened the citation identified by the search strategy.&quot;</span>
Reasoning: The process for selecting studies is stated, including screening and eligibility.
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The first author independently extracted data from the included studies.&quot;</span>
Reasoning: The method of data extraction is described.
[Yes]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Details of publication (type of repairing the internal ring, trocars, and follow-up duration), inclusion and exclusion criteria, and demographics of the enrolled patients were collected and collated.&quot;</span>
Reasoning: The variables for which data were sought are listed (details of publication, inclusion and exclusion criteria, demographics).
[Yes]

P12. Methods / Risk of bias in individual studies: Not reported.
Reasoning: There is no mention of methods used for assessing risk of bias of individual studies.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Weighted mean differences and odds ratios were used for the analysis of continuous and dichotomous variables, respectively.&quot;</span>
Reasoning: The principal summary measures used in the analysis are stated.
[Yes]

P14. Methods / Synthesis of results: Not applicable.
Reasoning: This item is not applicable since there is no mention of combining results of studies or measures of consistency.
[NA]

P15. Methods / Risk of bias across studies: Not applicable.
Reasoning: This item is not applicable since there is no mention of assessment of risk of bias across studies.
[NA]

P16. Methods / Additional analyses: Not applicable.
Reasoning: This item is not applicable since there is no mention of additional analyses.
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial search strategy identified 249 citations and 14 of them were retrieved for full-text review. Five trials met the total inclusion criteria and had no exclusion criteria.&quot;</span>
Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are provided, along with reasons for exclusions.
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 5 selected trials included 553 participants. Two hundred and seventy-eight patients received OH and 275 received LH.&quot;</span>
Reasoning: Characteristics for which data were extracted (number of participants, interventions) are presented.
[Yes]

P19. Results / Risk of bias within studies: Not reported.
Reasoning: There is no presentation of data on risk of bias of each study.
[No]

P20. Results / Results of individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

Compared with OH, shorter operative time for unilateral hernias was noted in extraperitoneal approaches’ group [95% confidence interval (CI), −6.71 to −3.71; I2=0%] as well as for bilateral hernias (95% CI, −12.18 to −3.79; I2=82%). Besides, less total postoperative complications was found in LH group, especially for major postoperative complications in male children (95% CI, 0.01-0.78; I2=0%). However, no significant difference was observed between LH and OH in patients’ recurrence' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Compared with OH, shorter operative time for unilateral hernias was noted in extraperitoneal approaches’ group as well as for bilateral hernias. Besides, less total postoperative complications was found in LH group, especially for major postoperative complications in male children. However, no significant difference was observed between LH and OH in patients’ recurrence.&quot;</span>
Reasoning: Simple summary data for each intervention group (operative time, postoperative complications) are presented.
[Yes]

P21. Results / Synthesis of results: Not applicable.
Reasoning: This item is not applicable since there is no mention of meta-analysis.
[NA]

P22. Results / Risk of bias across studies: Not applicable.
Reasoning: This item is not applicable since there is no mention of assessment of risk of bias across studies.
[NA]

P23. Results / Additional analysis: Not applicable.
Reasoning: This item is not applicable since there is no mention of additional analyses.
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results show that LH is superior for the inguinal hernia repair in children, with shorter operative time for unilateral hernias in extraperitoneal approaches group as well as for bilateral hernias. Besides, less total postoperative complications was found in the LH group, especially for major postoperative complications in male children.&quot;</span>
Reasoning: The main findings are summarized, including the strength of evidence and their relevance to key groups.
[Yes]

P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

because of the limited number of patients and studies, more RCTs need to be conducted to confirm these findings; on the other hand, the learning curve in the 5 RCTs may play an underestimated role in the study, which may weaken the results of the compariso' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Because of the limited number of patients and studies, more RCTs need to be conducted to confirm these findings; the learning curve in the 5 RCTs may play an underestimated role in the study, which may weaken the results of the comparison.&quot;</span>
Reasoning: Limitations at study and outcome level (limited number of patients and studies, learning curve) and at review-level (weakened results) are discussed.
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎LH can be accepted as the standard of care as long as total postoperative complications was substantially reduced, especially for major postoperative complications in male children.&quot;</span>
Reasoning: A general interpretation of the results in the context of other evidence and implications for future research are provided.
[Yes]

P27. Funding: Not reported.
Reasoning: There is no mention of sources of funding for the systematic review.
[No]</pre>
<p><a name='92'></a></p>
</div>
<div id="friedmacher-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-011-2958-5' title='Open publication'>Friedmacher
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Minor quote deviation. Best match in fulltext (Similarity 95.1%):

Residual aganglionosis after pull-through operation for Hirschsprung’s disease: a systematic review and meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Residual aganglionosis after pull-through operation for Hirschsprung’s disease: a systematic review and meta-analysis&quot;</span>
- The title clearly identifies the report as a systematic review and meta-analysis.

P2. Abstract / Structured summary: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):

Most patients with Hirschsprung’s disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT. Redo PT operation in HD is usually indicated for anastomotic strictures or residual aganglionosis (RA). We designed this meta-analysis to determine the incidence and outcome of RA among patients with HD following PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Most patients with Hirschsprung’s disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT. Redo PT operation in HD is usually indicated for anastomotic strictures or residual aganglionosis (RA). We designed this meta-analysis to determine the incidence and outcome of RA among patients with HD following PT operation.&quot;</span>
- The abstract provides a structured summary including background, objectives, and study eligibility criteria.

P3. Introduction / Rationale: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

n

Pull-through (PT) operations for Hirschsprung’s disease (HD) generally result in a satisfactory outcome [1]. However, some patients after definitive PT operation have disturbances of bowel function such as constipation, enterocolitis and recurrent obstructive symptoms [2–9]. In the majority of these patients, residual bowel problems can be managed by non-surgical treatment such as laxatives, enemas or intrasphincteric botulinum toxin injection [10–12]. In a few patients, persistent abdominal distension, constipation or enterocolitis is due to postoperative stricture or retained aganglionic segment which may require a redo PT operation [13–17]. We designed this meta-analysis to determine the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Pull-through (PT) operations for Hirschsprung’s disease (HD) generally result in a satisfactory outcome. However, some patients after definitive PT operation have disturbances of bowel function such as constipation, enterocolitis and recurrent obstructive symptoms. In a few patients, persistent abdominal distension, constipation or enterocolitis is due to postoperative stricture or retained aganglionic segment which may require a redo PT operation. We designed this meta-analysis to determine the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation.&quot;</span>
- The introduction describes the rationale for the review in the context of what is already known.

P4. Introduction / Objectives: <span title='Minor quote deviation. Best match in fulltext (Similarity 96%):

. We designed this meta-analysis to determine the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] We designed this meta-analysis to determine the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation.&quot;</span>
- The objectives are explicitly stated.

P5. Methods / Protocol and registration: "[No]"
- No information is provided about a review protocol or registration.

P6. Methods / Eligibility criteria: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

ds

PubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] PubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011.&quot;</span>
- The study characteristics and report characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

ds

PubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] PubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011.&quot;</span>
- The information sources are described.

P8. Methods / Search: "[No]"
- The full electronic search strategy is not presented.

P9. Methods / Study selection: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.7%):

s

Between 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Between 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation.&quot;</span>
- The process for selecting studies is stated.

P10. Methods / Data collection process: "[No]"
- No information is provided about the method of data extraction.

P11. Methods / Data items: "[No]"
- No information is provided about the variables for which data were sought.

P12. Methods / Risk of bias in individual studies: "[No]"
- No information is provided about the methods used for assessing risk of bias.

P13. Methods / Summary measures: "[No]"
- No information is provided about the principal summary measures.

P14. Methods / Synthesis of results: "[NA]"
- Not applicable since there is no meta-analysis.

P15. Methods / Risk of bias across studies: "[NA]"
- Not applicable since there is no meta-analysis.

P16. Methods / Additional analyses: "[NA]"
- Not applicable since there is no additional analysis.

P17. Results / Study selection: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.7%):

s

Between 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Between 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation.&quot;</span>
- The numbers of studies screened, assessed for eligibility, and included in the review are given.

P18. Results / Study characteristics: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):

Information about patient’s gender was reported in 135 (69.9%) patients. A male-to-female ratio of 3.5:1 was observed' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Information about patient’s gender was reported in 135 (69.9%) patients. A male-to-female ratio of 3.5:1 was observed.&quot;</span>
- Characteristics for which data were extracted are presented.

P19. Results / Risk of bias within studies: "[No]"
- No information is provided about the risk of bias of each study.

P20. Results / Results of individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 95.8%):

years). Of the 134 patients, 99 (73.9%) patients had normal bowel habits after redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Of the 134 patients, 99 (73.9%) patients had normal bowel habits after redo PT operation.&quot;</span>
- Simple summary data for each intervention group are presented.

P21. Results / Synthesis of results: "[NA]"
- Not applicable since there is no meta-analysis.

P22. Results / Risk of bias across studies: "[NA]"
- Not applicable since there is no meta-analysis.

P23. Results / Additional analysis: "[NA]"
- Not applicable since there is no additional analysis.

P24. Discussion / Summary of evidence: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):

s. Our meta-analysis reveals that RA and TZB are the underlying causes of persistent bowel symptoms in one-third of all patients requiring redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Our meta-analysis reveals that RA and TZB are the underlying causes of persistent bowel symptoms in one-third of all patients requiring redo PT operation.&quot;</span>
- The main findings are summarized.

P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

n

Over the years, various PT operations have been used to treat patients with HD [18–23]. It has been shown in several studies that there is no statistically significant difference in the functional outcome with respect to bowel function between the various PT procedures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Over the years, various PT operations have been used to treat patients with HD. It has been shown in several studies that there is no statistically significant difference in the functional outcome with respect to bowel function between the various PT procedures.&quot;</span>
- Limitations at study and outcome level are discussed.

P26. Discussion / Conclusions: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):

The presence of RA or TZB means that resection of this section of bowel may cure the patients of their recurrent symptoms. Thus, a redo PT is generally recommended for surgical management of RA' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] The presence of RA or TZB means that resection of this section of bowel may cure the patients of their recurrent symptoms. Thus, a redo PT is generally recommended for surgical management of RA.&quot;</span>
- A general interpretation of the results is provided.

P27. Funding: "[No]"
- No information is provided about the sources of funding for the systematic review.</pre>
<p><a name='93'></a></p>
</div>
<div id="friedmacher-2012" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-012-3142-2' title='Open publication'>Friedmacher
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Delayed primary anastomosis for management of long-gap esophageal atresia: a meta-analysis of complications and long-term outcome&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis aimed to investigate the complications and long-term outcome in patients with LGEA managed by DPA.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Management of newborns with long-gap esophageal atresia (LGEA) remains a challenge for pediatric surgeons.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis aimed to investigate the complications and long-term outcome in patients with LGEA managed by DPA.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not applicable (no mention of a protocol or registration)
[NA]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic literature search was conducted for relevant articles published between 1981 and 2011.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic literature search was conducted for relevant articles published between 1981 and 2011.&quot;</span>
[Yes]

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Common electronic databases as MEDLINE®, EMBASE®, ISI Web of ScienceSM and the Cochrane Library were searched in December 2011 using a combination of the following terms: “esophageal atresia”, “long-gap” and “delayed primary anastomosis”.&quot;</span>
[Yes]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Identified articles were reviewed by title, keywords and abstract by one of the authors (F.F.). All articles that did not contain original research data (e.g. letters, editorials, commentaries and reviews) and articles not giving adequate information regarding complication rates and outcome were excluded.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An unblinded, standardized full-text assessment of relevant articles was independently performed by both authors (F.F. and P.P.). The data was extracted into an electronic datasheet in a standardized manner.&quot;</span>
[Yes]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data extracted from each participating article included study characteristics (first author, publication year, sample size, follow-up time and mortality rate) and patient characteristics (gestational age, birth weight, type of LGEA and additional congenital anomalies).&quot;</span>
[Yes]

P12. Methods / Risk of bias in individual studies: Not applicable (no mention of risk of bias assessment)
[NA]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome of this analysis was complication rates.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis conducted)
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis conducted)
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses conducted)
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature search resulted in a total of 223 articles, of which 207 were identified by electronic database search and 16 by cross-referencing.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The overall number of study subjects managed by DPA was 451, ranging from 1 to 74 newborns with LGEA per study.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A cumulative meta-analysis revealed the incidences for each specific complication.&quot;</span>
[Yes]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The incidence for reported mortality rates was 34 out of 332 (95 % CI 7.3–14.1) patients.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis conducted)
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis conducted)
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses conducted)
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis shows that the DPA provides good long-term functional results.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The potential risk of Barrett’s metaplasia highlights the need for continued long-term follow-up with regular endoscopic surveillance protocols.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, this meta-analysis shows that the DPA provides good long-term functional results.&quot;</span>
[Yes]

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors declare that they have no conflict of interests.&quot;</span>
[Yes]</pre>
<p><a name='94'></a></p>
</div>
<div id="frongia-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.05.018' title='Open publication'>Frongia
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparison of LILT and STEP procedures in children with short bowel syndrome — A systematic review of the literature&quot;</span>
Reasoning: The title clearly identifies the report as a systematic review.
Response: [Yes]

P2. Abstract / Structured summary: No relevant quote provided.
Reasoning: No abstract or structured summary is provided in the full text.
Response: [No]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The therapeutic aims of SBS-therapy are to ensure alimentation of the child by parenteral nutrition and also the early detection and therapy of any occurring complications.&quot;</span>
Reasoning: The introduction provides a rationale for the review by discussing the therapeutic aims of SBS therapy.
Response: [Yes]

P4. Introduction / Objectives: No relevant quote provided.
Reasoning: The objectives of the review are not explicitly stated in the full text.
Response: [No]

P5. Methods / Protocol and registration: No relevant quote provided.
Reasoning: No information is provided about a review protocol or registration.
Response: [No]

P6. Methods / Eligibility criteria: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

The articles were included in this review if they met the following criteria:

    Population: Studies of humans aged 0–18 years.

    Intervention: Bianchi and STEP procedure, either alone or in combination.

    Type of study: All study designs were eligible for inclusion. Case series with 1 or more cases were included' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The articles were included in this review if they met the following criteria: Population: Studies of humans aged 0–18 years. Intervention: Bianchi and STEP procedure, either alone or in combination. Type of study: All study designs were eligible for inclusion. Case series with 1 or more cases were included.&quot;</span>
Reasoning: The eligibility criteria for the included studies are clearly described.
Response: [Yes]

P7. Methods / Information sources: No relevant quote provided.
Reasoning: No information is provided about the information sources used in the review.
Response: [No]

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic literature search was carried out using the search terms 'bowel lengthening', 'intestinal lengthening', 'longitudinal intestinal lengthening and tailoring', 'LILT', 'Bianchi procedure', 'serial transverse enteroplasty' and 'step procedure'.&quot;</span>
Reasoning: The full electronic search strategy is provided in the methods section.
Response: [Yes]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One reviewer (GF) screened all titles and abstracts to assess whether each report was potentially eligible for inclusion, and whether or not the full text was available. Then, the relevant full text articles of all studies, which were considered as appropriate ones, were reviewed by one researcher (GF) who evaluated the articles and extracted their data.&quot;</span>
Reasoning: The process for selecting studies is described, including screening of titles and abstracts and full-text review.
Response: [Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One researcher (GF) who evaluated the articles and extracted their data.&quot;</span>
Reasoning: The method of data extraction is described.
Response: [Yes]

P11. Methods / Data items: No relevant quote provided.
Reasoning: No information is provided about the specific data items sought.
Response: [No]

P12. Methods / Risk of bias in individual studies: No relevant quote provided.
Reasoning: No information is provided about the methods used for assessing risk of bias in individual studies.
Response: [No]

P13. Methods / Summary measures: No relevant quote provided.
Reasoning: No information is provided about the principal summary measures used.
Response: [No]

P14. Methods / Synthesis of results: NA
Reasoning: This item is not applicable as there is no meta-analysis in the review.
Response: [NA]

P15. Methods / Risk of bias across studies: NA
Reasoning: This item is not applicable as there is no assessment of risk of bias across studies.
Response: [NA]

P16. Methods / Additional analyses: NA
Reasoning: This item is not applicable as there are no additional analyses reported.
Response: [NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎N = 39 articles with useable information (LILT n = 24 articles, STEP n = 15 articles), including n = 472 patients (LILT n = 363 patients, STEP n = 109 patients) remained to be analyzed and are reviewed here.&quot;</span>
Reasoning: The number of studies screened, assessed for eligibility, and included in the review is provided.
Response: [Yes]

P18. Results / Study characteristics: No relevant quote provided.
Reasoning: No information is provided about the characteristics of the included studies.
Response: [No]

P19. Results / Risk of bias within studies: No relevant quote provided.
Reasoning: No information is provided about the risk of bias within the included studies.
Response: [No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both procedures have a similar extent of intestinal lengthening (approximately 70%) and result in improvement of enteral nutrition and reversal of complications of parenteral nutrition. STEP seems to have a lower mortality and overall progression to transplantation.&quot;</span>
Reasoning: The results of individual studies are summarized, including the extent of intestinal lengthening and the outcomes related to enteral nutrition, mortality, and transplantation.
Response: [Yes]

P21. Results / Synthesis of results: NA
Reasoning: This item is not applicable as there is no meta-analysis in the review.
Response: [NA]

P22. Results / Risk of bias across studies: NA
Reasoning: This item is not applicable as there is no assessment of risk of bias across studies.
Response: [NA]

P23. Results / Additional analysis: NA
Reasoning: This item is not applicable as there are no additional analyses reported.
Response: [NA]

P24. Discussion / Summary of evidence: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):

and LILT are both accepted procedures for non-transplant surgical management of SBS in children. The outcome after STEP seems to be more favourable, but larger series are needed to further assess accurate selection of eligible patients and to estimate effectiveness of procedures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎LILT and STEP are both accepted procedures for non-transplant surgical management of SBS in children. The outcome after STEP seems to be more favourable, but larger series are needed to further assess accurate selection of eligible patients and to estimate effectiveness of procedures.&quot;</span>
Reasoning: The main findings of the review are summarized, including the acceptance of LILT and STEP as procedures for non-transplant surgical management of SBS in children and the need for larger series to assess effectiveness.
Response: [Yes]

P25. Discussion / Limitations: No relevant quote provided.
Reasoning: No limitations of the review are discussed.
Response: [No]

P26. Discussion / Conclusions: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):

and LILT are both accepted procedures for non-transplant surgical management of SBS in children. The outcome after STEP seems to be more favourable, but larger series are needed to further assess accurate selection of eligible patients and to estimate effectiveness of procedures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎LILT and STEP are both accepted procedures for non-transplant surgical management of SBS in children. The outcome after STEP seems to be more favourable, but larger series are needed to further assess accurate selection of eligible patients and to estimate effectiveness of procedures.&quot;</span>
Reasoning: The general interpretation of the results is provided, including the acceptance of LILT and STEP as procedures for non-transplant surgical management of SBS in children and the need for larger series to assess effectiveness.
Response: [Yes]

P27. Funding: No relevant quote provided.
Reasoning: No information is provided about the sources of funding for the review.
Response: [No]</pre>
<p><a name='95'></a></p>
</div>
<div id="gallo-2012" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0032-1331459' title='Open publication'>Gallo
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Long-Gap Esophageal Atresia: a Meta-Analysis of Jejunal Interposition, Colon Interposition, and Gastric Pull-Up&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, methods, results, and conclusions of the study. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are not specified. [No]
P7. Methods / Information sources: The information sources used in the search are not described. [No]
P8. Methods / Search: The full electronic search strategy is not presented. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No information is provided about any additional analyses conducted. [NA]
P17. Results / Study selection: No information is provided about the numbers of studies screened, assessed for eligibility, and included in the review. [No]
P18. Results / Study characteristics: No information is provided about the characteristics of the included studies. [No]
P19. Results / Risk of bias within studies: No information is provided about the risk of bias of each study. [No]
P20. Results / Results of individual studies: No information is provided about the results of each individual study. [No]
P21. Results / Synthesis of results: No information is provided about the methods of combining results. [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P23. Results / Additional analysis: No information is provided about any additional analyses conducted. [NA]
P24. Discussion / Summary of evidence: The main findings and their implications are summarized. [Yes]
P25. Discussion / Limitations: The limitations of the study are discussed. [Yes]
P26. Discussion / Conclusions: The results are interpreted in the context of other evidence and implications for future research are discussed. [Yes]
P27. Funding: No information is provided about the sources of funding for the review. [No]</pre>
<p><a name='96'></a></p>
</div>
<div id="gosemann-2013" class="section level4">
<h4><a href='https://doi.org/10.1055/s-0033-1343085 ' title='Open publication'>Gosemann
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Open Versus Transanal Pull-Through for Hirschsprung Disease: A Systematic Review of Long-Term Outcome&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, methods, results, and conclusion of the review. [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: There is no mention of a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are not specified. [No]
P7. Methods / Information sources: The information sources used in the search are not described. [No]
P8. Methods / Search: The full electronic search strategy is not presented. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: There is no description of the methods used for handling data and combining results. [NA]
P15. Methods / Risk of bias across studies: There is no assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: There is no description of additional analyses. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not provided. [No]
P18. Results / Study characteristics: The characteristics of the included studies are not presented. [No]
P19. Results / Risk of bias within studies: The risk of bias of each study is not presented. [No]
P20. Results / Results of individual studies: The results of each individual study are not presented. [No]
P21. Results / Synthesis of results: There is no synthesis of results. [NA]
P22. Results / Risk of bias across studies: There is no assessment of risk of bias across studies. [NA]
P23. Results / Additional analysis: There is no presentation of additional analyses. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each outcome are summarized. [Yes]
P25. Discussion / Limitations: The limitations of the study are discussed. [Yes]
P26. Discussion / Conclusions: The results are interpreted in the context of other evidence and implications for future research are discussed. [Yes]
P27. Funding: There is no mention of funding sources. [No]</pre>
<p><a name='97'></a></p>
</div>
<div id="graziano-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.06.019' title='Open publication'>Graziano
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Asymptomatic malrotation: Diagnosis and surgical management: An American Pediatric Surgical Association outcomes and evidence based practice committee systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, methods, results, and conclusions of the systematic review. [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are not specified. [No]
P7. Methods / Information sources: The information sources used in the search are not described. [No]
P8. Methods / Search: The full electronic search strategy is not presented. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction and any processes for obtaining and confirming data are not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias in individual studies are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No information is provided about any additional analyses conducted. [NA]
P17. Results / Study selection: No information is provided about the numbers of studies screened, assessed for eligibility, and included in the review. [No]
P18. Results / Study characteristics: No information is provided about the characteristics of the included studies. [No]
P19. Results / Risk of bias within studies: No data on risk of bias of individual studies are presented. [No]
P20. Results / Results of individual studies: No results of individual studies are presented. [No]
P21. Results / Synthesis of results: No information is provided about the methods of combining results. [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P23. Results / Additional analysis: No results of additional analyses are presented. [NA]
P24. Discussion / Summary of evidence: The main findings of the review are summarized. [Yes]
P25. Discussion / Limitations: The limitations of the review are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: No information is provided about the sources of funding for the review. [No]</pre>
<p><a name='98'></a></p>
</div>
<div id="guo-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-011-2889-1' title='Open publication'>Guo
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open orchiopexy for non-palpable undescended testes in children: a systemic review and meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although shorter hospital stay is noted in LO, it does not provide significant advantage over open surgery for treating NPT.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The undescended testes (cryptorchidism) is one of the most common disorders of childhood, affecting 0.8–1.8% of infants at 1 year of age, 3% of full-term newborns, and 21% of premature babies.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

compared the laparoscopic and open approaches, and did not find significant advantages of laparoscopy in the management of children with NPT' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎To compare the laparoscopic and open approaches, and did not find significant advantages of laparoscopy in the management of children with NPT.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria included all available studies comparing LO with OO for the treatment of NPT in children.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Published studies until August 31, 2010 were searched from Medline, Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Out of 226 studies, 2 RCTs and 5 OCSs were eligible for inclusion criteria.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Minor quote deviation. Best match in fulltext (Similarity 99%):

Three reviewers (GJ, LZL and TQS) independently assessed selected studies, extracted and tabulated data from each article' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Three reviewers independently assessed selected studies, extracted and tabulated data from each article.&quot;</span> [Yes]
P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data regarding the following factors were considered: first author, study duration, methodology, participant features, intervention characteristics, and outcome measures.&quot;</span> [Yes]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Weighted mean differences (WMDs) and ORs were used for the analysis of continuous and dichotomous variables, respectively.&quot;</span> [Yes]
P14. Methods / Synthesis of results: Not applicable [NA]
P15. Methods / Risk of bias across studies: Not applicable [NA]
P16. Methods / Additional analyses: Not applicable [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Out of 226 studies, 2 RCTs and 5 OCSs were eligible for inclusion criteria.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A summary of the studies’ methodology, intervention characteristics, and measured outcomes was provided.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The hospital stay of LO was significantly shorter than that of OO.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable [NA]
P22. Results / Risk of bias across studies: Not applicable [NA]
P23. Results / Additional analysis: Not applicable [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although shorter hospital stay is noted in LO, it does not provide significant advantage over open surgery for treating NPT.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Due to the publishing bias, a series of RCTs are still necessary to explore the efficiencies of LO in the management of NPT in children.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopy does not provide significant advantage over open surgery for treating NPT.&quot;</span> [Yes]
P27. Funding: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

This work was supported by the National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 81071997, No. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This work was supported by the National Natural Science Foundation of China, Program for New Century Excellent Talents in University, Scientific Research Foundation for the Returned Overseas Chinese Scholars, and Fundamental Research Funds for the Central Universities.&quot;</span> [Yes]</pre>
<p><a name='99'></a></p>
</div>
<div id="hall-2011" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2011.01.019' title='Open publication'>Hall
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Is interval appendicectomy justified after successful nonoperative treatment of an appendix mass in children? A systematic review&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Is interval appendicectomy justified after successful nonoperative treatment of an appendix mass in children?&quot;</span>
2. Reasoning: The title clearly identifies the report as a systematic review and states the specific topic being addressed.
3. Response: [Yes]

P2. Abstract / Structured summary
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We systematically reviewed the pediatric literature with regard to the justification for this practice.&quot;</span>
2. Reasoning: The abstract provides a summary of the background, objectives, and methods of the systematic review.
3. Response: [Yes]

P3. Introduction / Rationale
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this systematic review was to evaluate the evidence for IA in children after successful nonoperative treatment of an AM based on the current available literature.&quot;</span>
2. Reasoning: The introduction provides the rationale for the review and states the objective of evaluating the evidence for interval appendicectomy in children.
3. Response: [Yes]

P4. Introduction / Objectives
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this systematic review was to evaluate the evidence for IA in children after successful nonoperative treatment of an AM based on the current available literature.&quot;</span>
2. Reasoning: The objectives are explicitly stated as evaluating the evidence for interval appendicectomy in children after successful nonoperative treatment of an appendix mass.
3. Response: [Yes]

P5. Methods / Protocol and registration
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Medline search was performed using the keywords appendix mass, interval appendicectomy, and children from January 1964 to July 2009 to identify reports of successful nonoperative treatment of AM in children (<16 years).&quot;</span>
2. Reasoning: The methods describe the search strategy used to identify relevant studies.
3. Response: [Yes]

P6. Methods / Eligibility criteria
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only reports comparing IA with nonoperative expectant management in children after successful nonoperative treatment of an AM were initially considered.&quot;</span>
2. Reasoning: The eligibility criteria are specified as reports comparing interval appendicectomy with nonoperative expectant management in children after successful nonoperative treatment of an appendix mass.
3. Response: [Yes]

P7. Methods / Information sources
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Medline search was performed using the keywords appendix mass, interval appendicectomy, and children from January 1964 to July 2009 to identify reports of successful nonoperative treatment of AM in children (<16 years).&quot;</span>
2. Reasoning: The information sources are described as the Medline database and specific journals.
3. Response: [Yes]

P8. Methods / Search
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Medline search was performed using the keywords appendix mass, interval appendicectomy, and children from January 1964 to July 2009 to identify reports of successful nonoperative treatment of AM in children (<16 years).&quot;</span>
2. Reasoning: The search strategy is described as using specific keywords and a defined time period.
3. Response: [Yes]

P9. Methods / Study selection
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only reports comparing IA with nonoperative expectant management in children after successful nonoperative treatment of an AM were initially considered.&quot;</span>
2. Reasoning: The process for selecting studies is described as considering reports comparing interval appendicectomy with nonoperative expectant management in children after successful nonoperative treatment of an appendix mass.
3. Response: [Yes]

P10. Methods / Data collection process
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data relating to the risk of recurrence of appendicitis, morbidity of IA, unexpected histopathologic findings after IA, and cost were extracted independently by 2 reviewers.&quot;</span>
2. Reasoning: The method of data extraction is described as independent extraction by two reviewers.
3. Response: [Yes]

P11. Methods / Data items
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data relating to the risk of recurrence of appendicitis, morbidity of IA, unexpected histopathologic findings after IA, and cost were extracted independently by 2 reviewers.&quot;</span>
2. Reasoning: The data items sought are clearly stated as the risk of recurrence of appendicitis, morbidity of interval appendicectomy, unexpected histopathologic findings after interval appendicectomy, and cost.
3. Response: [Yes]

P12. Methods / Risk of bias in individual studies
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No study reported cost of IA, and no study reported a comparison between the 2 approaches after successful conservative treatment of an AM.&quot;</span>
2. Reasoning: The methods do not mention the assessment of risk of bias in individual studies.
3. Response: [NA]

P13. Methods / Summary measures
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis is used to obtain estimates of incidence pooled from comparative studies but cannot be used where there is no comparison group.&quot;</span>
2. Reasoning: The methods mention the use of meta-analysis to obtain estimates of incidence from comparative studies.
3. Response: [Yes]

P14. Methods / Synthesis of results
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This led us to broaden our inclusion criteria as described in the methods.&quot;</span>
2. Reasoning: The methods mention the broadening of inclusion criteria, but do not provide details on the synthesis of results.
3. Response: [NA]

P15. Methods / Risk of bias across studies
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This led us to broaden our inclusion criteria as described in the methods.&quot;</span>
2. Reasoning: The methods do not mention the assessment of risk of bias across studies.
3. Response: [NA]

P16. Methods / Additional analyses
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review goes some way to estimating the risks of each of these 2 approaches by providing the most up-to-date and accurate data currently available.&quot;</span>
2. Reasoning: The methods mention the estimation of risks associated with different approaches, but do not provide details on additional analyses.
3. Response: [NA]

P17. Results / Study selection
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were no studies directly comparing IA with nonoperative expectant management after successful nonoperative treatment of an AM in children.&quot;</span>
2. Reasoning: The results state that there were no studies directly comparing interval appendicectomy with nonoperative expectant management after successful nonoperative treatment of an appendix mass in children.
3. Response: [Yes]

P18. Results / Study characteristics
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Only 1 study reported risk of recurrent appendicitis in a cohort of children who either received IA or did not.&quot;</span>
2. Reasoning: The results mention the characteristics of the included studies, including the number of studies and the specific outcomes reported.
3. Response: [Yes]

P19. Results / Risk of bias within studies
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No study reported cost of IA, and no study reported a comparison between the 2 approaches after successful conservative treatment of an AM.&quot;</span>
2. Reasoning: The results do not mention the assessment of risk of bias within studies.
3. Response: [NA]

P20. Results / Results of individual studies
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Risk of recurrence of acute appendicitis was reported by 3 studies [5], [7], [8] relating to a total of 127 children electively managed without planned IA.&quot;</span>
2. Reasoning: The results present the results of individual studies, including the risk of recurrence of acute appendicitis.
3. Response: [Yes]

P21. Results / Synthesis of results
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review goes some way to estimating the risks of each of these 2 approaches by providing the most up-to-date and accurate data currently available.&quot;</span>
2. Reasoning: The results mention the estimation of risks associated with different approaches, but do not provide details on the synthesis of results.
3. Response: [NA]

P22. Results / Risk of bias across studies
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No study reported cost of IA, and no study reported a comparison between the 2 approaches after successful conservative treatment of an AM.&quot;</span>
2. Reasoning: The results do not mention the assessment of risk of bias across studies.
3. Response: [NA]

P23. Results / Additional analysis
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review goes some way to estimating the risks of each of these 2 approaches by providing the most up-to-date and accurate data currently available.&quot;</span>
2. Reasoning: The results mention the estimation of risks associated with different approaches, but do not provide details on additional analyses.
3. Response: [NA]

P24. Discussion / Summary of evidence
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The most significant finding of this review is that, despite the relative frequency of the condition, we have been unable to identify any data comparing routine IA with a 'watchful waiting' approach nor any prospective data relating to the risk of recurrent appendicitis in children.&quot;</span>
2. Reasoning: The discussion provides a summary of the main findings of the review, including the lack of data comparing routine interval appendicectomy with a watchful waiting approach.
3. Response: [Yes]

P25. Discussion / Limitations
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The retrospective nature of the included studies may limit the strength of this review.&quot;</span>
2. Reasoning: The limitations of the review are mentioned, including the retrospective nature of the included studies.
3. Response: [Yes]

P26. Discussion / Conclusions
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We anticipate that these data will help to inform current practice while we set about the task of obtaining prospective data comparing the 2 approaches in a prospective randomized study.&quot;</span>
2. Reasoning: The conclusions state that the data from the review will help inform current practice and highlight the need for prospective data.
3. Response: [Yes]

P27. Funding
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No reports compared costs.&quot;</span>
2. Reasoning: The funding sources for the systematic review are not mentioned.
3. Response: [No]

Summary: The systematic review reports on the justification for interval appendicectomy after successful nonoperative treatment of an appendix mass in children. It provides a structured summary, describes the rationale and objectives, presents the search strategy and study selection process, reports on the risk of recurrence and complications, and discusses the limitations and implications of the findings. However, it does not mention the assessment of risk of bias in individual studies, synthesis of results, risk of bias across studies, or additional analyses. The funding sources are also not reported.</pre>
<p><a name='100'></a></p>
</div>
<div id="healy-2015" class="section level4">
<h4><a href='https://doi.org/10.1097/MD.0000000000001352' title='Open publication'>Healy
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic Review and Meta-Analysis on the Influence of Surgeon Specialization on Outcomes Following Appendicectomy in Children&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study is to assess the influence of surgeon specialization on outcomes following appendicectomy in children.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

An expanding body of evidence suggests that surgeon subspecialization affects outcomes; studies found that colorectal surgery subspecialization4 and orthopedic surgery subspecialization5 lead to improved results and that outcomes from a variety of cancers are improved with subspecialization' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎An expanding body of evidence suggests that surgeon subspecialization affects outcomes; studies found that colorectal surgery subspecialization and orthopedic surgery subspecialization lead to improved results and that outcomes from a variety of cancers are improved with subspecialization.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review and meta-analysis to determine the influence of surgeon subspecialty on outcomes following appendicectomy in children.&quot;</span> [Yes]
P5. Methods / Protocol and registration: No information provided [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligible studies were comparative and provided data on children who had appendicectomy while under the care of general or pediatric surgical teams.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors searched Medline and Embase to identify relevant studies.&quot;</span> [Yes]
P8. Methods / Search: No information provided [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors initially screened titles and abstracts and then full text manuscripts were evaluated.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

Two authors (DD and DH) independently extracted data from eligible studies using an electronic spreadsheet' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two authors extracted data from eligible studies using an electronic spreadsheet.&quot;</span> [Yes]
P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Extracted data comprised details on the following variables: lead author, publication date, study design, inclusion and exclusion criteria, outcomes reported, whether there was a specified primary endpoint, main results, numbers and characteristics of patients, surgical approach, rate of negative appendiceal histology, wound infections, intra-abdominal collections, readmissions, mortality, and length of stay.&quot;</span> [Yes]
P12. Methods / Risk of bias in individual studies: No information provided [No]
P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pooled risk ratios and pooled mean differences were used to evaluate the effect of treatment by general surgery units or pediatric surgery units on dichotomous and continuous outcomes, respectively.&quot;</span> [Yes]
P14. Methods / Synthesis of results: No meta-analysis performed [NA]
P15. Methods / Risk of bias across studies: No information provided [No]
P16. Methods / Additional analyses: No additional analyses performed [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We identified 9 relevant studies involving 50,963 children who were managed by general surgery teams and 15,032 children who were managed by pediatric surgery teams.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

Characteristics of the 9 included studies8,11–18 are shown in Table 1 and results from the studies are provided in Table 2' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Characteristics of the 9 included studies are shown in Table 1 and results from the studies are provided in Table 2.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: No information provided [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A normal appendix was removed in 4660/48,105 children treated by general surgery units and in 889/14,760 children treated by pediatric units.&quot;</span> [Yes]
P21. Results / Synthesis of results: No meta-analysis performed [NA]
P22. Results / Risk of bias across studies: No information provided [No]
P23. Results / Additional analysis: No additional analyses performed [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We found that children who were managed by specialized pediatric surgery teams had lower rates of negative appendicectomy although mean length of stay was longer.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our article is based upon a group of heterogeneous and mostly retrospective studies, and therefore there is little external validity.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We wish to encourage future research through the use of large-scale prospective multicenter registries.&quot;</span> [Yes]
P27. Funding: No information provided [No]</pre>
<p><a name='101'></a></p>
</div>
<div id="healy-2016" class="section level4">
<h4><a href='https://doi.org/10.1007/s00383-015-3839-0' title='Open publication'>Healy
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pediatric incidental appendectomy: a systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A detailed review was undertaken of the techniques, pathology, risks of appendectomy, utility of the appendix, and incidental appendectomy in the treatment of specific pediatric medical conditions.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The risks and benefits of incidental appendectomy during various operations in children have been debated for over a century, but need to be revisited in light of innovations in medical practice.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To review the available literature for techniques, pathology, risks of appendectomy, utility of the appendix, and IA in the treatment of specific pediatric medical conditions.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A comprehensive literature search was performed, and retrieved results were reviewed for relevance to the topic.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

a comprehensive literature search was performed using Ovid MEDLINE (1946–present) and Embase' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A comprehensive literature search was performed using Ovid MEDLINE and Embase.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The search identified studies comparing the risks of performing an incidental or prophylactic appendectomy versus leaving the appendix in place.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data was collected to index the type of study, specialty, year, location, number of patients, and primary outcomes of each study.&quot;</span> [Yes]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: Not reported [NA]
P14. Methods / Synthesis of results: Not reported [NA]
P15. Methods / Risk of bias across studies: Not reported [NA]
P16. Methods / Additional analyses: Not reported [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From the initial 389 search results, 132 were selected as potentially relevant to our review.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Of these, 24 publications related to adult IA (Table 1), 12 specifically to obstetrics and gynecology in adults (Table 2), and 12 to pediatric surgery' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Of these, 24 publications related to adult IA, 12 specifically to obstetrics and gynecology in adults, and 12 to pediatric surgery.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In pediatric cases, approximately 11.6 % of incidentally removed appendices had abnormal pathologic findings.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not reported [NA]
P22. Results / Risk of bias across studies: Not reported [NA]
P23. Results / Additional analysis: Not reported [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thoughtful consideration should be given to the individual pediatric patient’s co-morbid conditions before performing IA.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94.9%):

The question of whether or not to perform the procedure does not have a single simple answer; rather the answer must consider the global condition of the individual patient' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The decision whether to perform IA does not have a single simple answer and must consider the global condition of the individual patient.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The decision to perform IA needs to be carefully weighed in regards to the procedure to be performed, the patients’ medical history, and the likelihood of requiring the appendix for future use.&quot;</span> [Yes]
P27. Funding: Not reported [No]</pre>
<p><a name='102'></a></p>
</div>
<div id="heloury-2012" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2011.08.003' title='Open publication'>Heloury
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive adrenalectomy in children&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this review was to determine the place of MIA in children.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive adrenalectomy (MIA) is the criterion standard for removal of small adrenal tumors in adults.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

we attempted to answer the following questions:

    -

    Is MIA superior to open adrenalectomy (OA)?
    -

    What is the best approach (transperitoneal or retroperitoneal)?
    -

    What are the pediatric indications for MIA' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎we attempted to answer the following questions: Is MIA superior to open adrenalectomy (OA)? What is the best approach (transperitoneal or retroperitoneal)? What are the pediatric indications for MIA?&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎focusing on the technique and indications&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors conducted a systematic review of the pediatric and adult literature about MIA&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: Not reported [No]
P10. Methods / Data collection process: Not reported [No]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: Not reported [NA]
P14. Methods / Synthesis of results: Not applicable (no meta-analysis) [NA]
P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P16. Methods / Additional analyses: Not applicable (no meta-analysis) [NA]
P17. Results / Study selection: Not reported [No]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors conducted a systematic review of the pediatric and adult literature about MIA&quot;</span> [Yes]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive adrenalectomy appears superior to open adrenalectomy for small tumors.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable (no meta-analysis) [NA]
P22. Results / Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P23. Results / Additional analysis: Not applicable (no meta-analysis) [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive adrenalectomy is promising for removal of small adrenal tumors.&quot;</span> [Yes]
P25. Discussion / Limitations: Not reported [No]
P26. Discussion / Conclusions: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 73.8%):

is potentially superior to OA for the removal of noninvasive tumors with low morbidity rates' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Minimally invasive adrenalectomy is potentially superior to OA for the removal of noninvasive tumors with low morbidity rates.&quot;</span> [Yes]
P27. Funding: Not reported [No]</pre>
<p><a name='103'></a></p>
</div>
<div id="huang-2015" class="section level4">
<h4><a href='https://doi.org/pmid:26131065' title='Open publication'>Huang
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An updated meta-analysis of laparoscopic versus open pyeloplasty for ureteropelvic junction obstruction in children&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS). [Yes]
P5. Methods / Protocol and registration: No information is provided about the existence of a review protocol or registration information. [No]
P6. Methods / Eligibility criteria: The methods specify study characteristics (PICOS, length of follow-up) and report characteristics used as criteria for eligibility, giving rationale. [Yes]
P7. Methods / Information sources: The methods describe all information sources used in the search and the date last searched. [Yes]
P8. Methods / Search: The methods present the full electronic search strategy for at least one database, including any limits used. [No]
P9. Methods / Study selection: The methods state the process for selecting studies. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports and any processes for obtaining and confirming data from investigators. [No]
P11. Methods / Data items: No information is provided about the variables for which data were sought. [No]
P12. Methods / Risk of bias in individual studies: No information is provided about the methods used for assessing risk of bias of individual studies. [No]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The results give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations. [Yes]
P19. Results / Risk of bias within studies: No information is provided about the risk of bias of each study. [No]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no additional analysis. [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]
P27. Funding: The funding sources for the systematic review and other support are described. [Yes]</pre>
<p><a name='104'></a></p>
</div>
<div id="ishii-2014" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2014.08.003' title='Open publication'>Ishii
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Flexible ureteroscopy and lasertripsy (FURSL) for paediatric renal calculi: Results from a systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: No abstract or structured summary provided [No]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To understand the role, safety and efficacy of flexible ureterorenoscopy and lasertripsy (FURSL) for paediatric renal stones.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of the present systematic review of the literature was to investigate the role of flexible ureterorenoscopy and lasertripsy (FURSL) in the management of renal calculi in the paediatric population and to look at its efficacy and safety.&quot;</span> [Yes]
P5. Methods / Protocol and registration: No information provided [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All English language articles reporting on a minimum of five patients ≤18-years old, treated with flexible ureteroscopy and lasertripsy for stone disease were included.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The search involved finding relevant studies from MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, CINAHL, Google Scholar and individual urological journals between January 1990 and March 2014.&quot;</span> [Yes]
P8. Methods / Search: No information provided [No]
P9. Methods / Study selection: No information provided [No]
P10. Methods / Data collection process: No information provided [No]
P11. Methods / Data items: No information provided [No]
P12. Methods / Risk of bias in individual studies: No information provided [No]
P13. Methods / Summary measures: No information provided [No]
P14. Methods / Synthesis of results: [NA]
P15. Methods / Risk of bias across studies: [NA]
P16. Methods / Additional analyses: [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of six studies (282 patients) were reported&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The mean age of all the study populations was 7.3 years (range 0.25–17 years)&quot;</span> [Yes]
P19. Results / Risk of bias within studies: No information provided [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The mean stone-free rate across the three studies was 85.5% (range 58.0–93.0%)&quot;</span> [Yes]
P21. Results / Synthesis of results: [NA]
P22. Results / Risk of bias across studies: [NA]
P23. Results / Additional analysis: [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present systematic review highlights that FURSL can be used even for stones in lower pole locations, for stones up to 30 mm, and in children from the age of three months.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The first limitation is that all of the reviewed studies were retrospective studies and the results were not recorded in a uniform manner to allow the data to be meta-analysed. Second, the numbers involved in these studies were small and this may skew the results, as the authors may be reporting on their initial experiences.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present review shows that, despite the small numbers studied, FURSL in the management of renal calculi in the paediatric population is an effective and safe procedure in high-volume centres.&quot;</span> [Yes]
P27. Funding: No information provided [No]</pre>
<p><a name='105'></a></p>
</div>
<div id="ishii-2015" class="section level4">
<h4><a href='https://doi.org/10.1111/BJU.12927' title='Open publication'>Ishii
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ureteroscopy for stone disease in the paediatric population: a systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives are not explicitly stated in the introduction. [No]
P5. Methods / Protocol and registration: No mention of a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics (PICOS) and report characteristics used as eligibility criteria are not specified. [No]
P7. Methods / Information sources: The information sources are described as databases and individual urological journals. [Yes]
P8. Methods / Search: The full electronic search strategy is not presented. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined. [No]
P12. Methods / Risk of bias in individual studies: No description of methods used for assessing risk of bias. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: No description of methods for handling data and combining results. [NA]
P15. Methods / Risk of bias across studies: No specification of assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No description of methods for additional analyses. [NA]
P17. Results / Study selection: No numbers of studies screened, assessed for eligibility, and included in the review are provided. [No]
P18. Results / Study characteristics: Characteristics for which data were extracted are provided (e.g., study size, stone burden), but not all variables are reported. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]
P19. Results / Risk of bias within studies: No data on risk of bias of each study are presented. [No]
P20. Results / Results of individual studies: Simple summary data for each intervention group are provided, but effect estimates and confidence intervals are not reported. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]
P21. Results / Synthesis of results: No presentation of results of meta-analysis. [NA]
P22. Results / Risk of bias across studies: No presentation of results of risk of bias assessment across studies. [NA]
P23. Results / Additional analysis: No results of additional analyses are reported. [NA]
P24. Discussion / Summary of evidence: The main findings are summarized, but the strength of evidence for each main outcome is not discussed. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]
P25. Discussion / Limitations: Limitations at study and outcome level are not discussed, but limitations at the review-level are mentioned. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: No mention of funding sources or support. [No]</pre>
<p><a name='106'></a></p>
</div>
<div id="ito-2014" class="section level4">
<h4><a href='https://doi.org/10.1111/PED.12429' title='Open publication'>Ito
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Does frenotomy improve breast-feeding difficulties in infants with ankyloglossia?&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS). [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics (PICOS) and report characteristics used as criteria for eligibility, giving rationale. [Yes]
P7. Methods / Information sources: The methods describe all information sources used in the search and the date last searched. [Yes]
P8. Methods / Search: The methods present the full electronic search strategy for at least one database, including any limits used. [Yes]
P9. Methods / Study selection: The methods state the process for selecting studies, including screening, eligibility, and inclusion in the review. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports and any processes for obtaining and confirming data from investigators. [Yes]
P11. Methods / Data items: The methods list and define all variables for which data were sought and any assumptions and simplifications made. [Yes]
P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing risk of bias of individual studies and how this information is to be used in any data synthesis. [Yes]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The results give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations. [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study. [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no meta-analysis. [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings, including the strength of evidence for each main outcome, and considers their relevance to key groups. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]
P27. Funding: No information is provided about sources of funding for the systematic review. [No]</pre>
<p><a name='107'></a></p>
</div>
<div id="jia-2011" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0030-1261926' title='Open publication'>Jia
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Open versus Laparoscopic Pyloromyotomy for Pyloric Stenosis: A Meta-analysis of Randomized Controlled Trials&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics and report characteristics used as criteria for eligibility. [Yes]
P7. Methods / Information sources: The methods describe the information sources used in the search and the date last searched. [Yes]
P8. Methods / Search: No information is provided about the full electronic search strategy. [No]
P9. Methods / Study selection: The methods state the process for selecting studies. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports. [Yes]
P11. Methods / Data items: No information is provided about the variables for which data were sought. [No]
P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing risk of bias of individual studies. [Yes]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The results give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations. [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study. [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no meta-analysis. [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]
P27. Funding: The funding sources for the systematic review are described. [Yes]</pre>
<p><a name='108'></a></p>
</div>
<div id="kapralik-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.11.022' title='Open publication'>Kapralik
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Surgical versus conservative management of congenital pulmonary airway malformation in children: A systematic review and meta-analysis&quot;</span>
[Yes] The report is identified as a systematic review and meta-analysis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review and meta-analysis comparing elective resection versus expectant management.&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, and results.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The ideal management of infants born with asymptomatic congenital pulmonary airway malformation (CPAM) is controversial.&quot;</span>
[Yes] The rationale for the review is described.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our objective was to conduct a systematic review and meta-analysis of all published literature comparing the postoperative outcomes associated with elective surgery (while asymptomatic) versus those following surgery as part of expectant management (i.e., performing surgery only upon the development of symptoms) in children born with asymptomatic CPAM lesions.&quot;</span>
[Yes] The objectives of the review are explicitly stated.

P5. Methods / Protocol and registration: No information provided.
[No] There is no mention of a review protocol or registration.

P6. Methods / Eligibility criteria: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

we conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), EMBASE (1980 onwards), CINAHL (1982 onwards), and PubMed (1966 onwards) in January 2015' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, and PubMed in January 2015.&quot;</span>
[Yes] The study characteristics and report characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

we conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), EMBASE (1980 onwards), CINAHL (1982 onwards), and PubMed (1966 onwards) in January 2015' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, and PubMed in January 2015.&quot;</span>
[Yes] All information sources are described.

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used the search terms (“asymptomatic” AND “congenital” AND “cystic” AND “adenomatoid malformation”) OR (“lung” AND “lesion”) AND (“management” OR “treatment” OR “therapy.”)&quot;</span>
[Yes] The full electronic search strategy for at least one database is presented.

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent reviewers conducted all article screening; where consensus on an article could not be reached, a third reviewer was consulted.&quot;</span>
[Yes] The process for selecting studies is stated.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One reviewer extracted all data from the included studies, and another checked it for accuracy and completeness.&quot;</span>
[Yes] The method of data extraction from reports is described.

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We extracted the following data exclusively on patients who were asymptomatic at birth: number of patients undergoing elective surgery, number undergoing surgery as part of expectant management (after symptom development), age at symptom development if applicable, postoperative complications, mortalities, and total length of postoperative hospital stay, as well as number of patients successfully managed conservatively at the end of follow-up, and length of follow-up for these patients.&quot;</span>
[Yes] The variables for which data were sought are listed and defined.

P12. Methods / Risk of bias in individual studies: No information provided.
[No] There is no mention of methods used for assessing risk of bias in individual studies.

P13. Methods / Summary measures: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

We conducted our meta-analyses using Review Manager 5.3 [20], using random-effects models [21], to produce an odds ratio (OR) for morbidity, as this is a categorical variable, and a mean difference (MD) for length of stay, as this is a continuous variable, along with 95% confidence intervals (CIs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted our meta-analyses using Review Manager 5.3, using random-effects models, to produce an odds ratio (OR) for morbidity, as this is a categorical variable, and a mean difference (MD) for length of stay, as this is a continuous variable, along with 95% confidence intervals (CIs).&quot;</span>
[Yes] The principal summary measures are stated.

P14. Methods / Synthesis of results: Not applicable (no meta-analysis conducted).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis conducted).
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses conducted).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our electronic search yielded 342 studies. After applying our exclusion criteria to titles and abstracts, 63 studies remained. Full-text review resulted in eight of these studies being included, while an additional one was identified from hand-searching the reference sections of included articles; nine studies were ultimately included.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our electronic search yielded 342 studies. After applying our exclusion criteria to titles and abstracts, 63 studies remained. Full-text review resulted in eight of these studies being included, while an additional one was identified from hand-searching the reference sections of included articles; nine studies were ultimately included.&quot;</span>
[Yes] Characteristics for which data were extracted are presented.

P19. Results / Risk of bias within studies: No information provided.
[No] There is no presentation of data on risk of bias of each study.

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Out of 168 patients, 70 underwent surgery before symptoms developed with seven experiencing postoperative complications (10.0%); 63 developed symptoms while being managed expectantly and subsequently underwent surgery with 20 complications (31.8%).&quot;</span>
[Yes] Results of individual studies are presented.

P21. Results / Synthesis of results: Not applicable (no meta-analysis conducted).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis conducted).
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses conducted).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on our results, we recommend elective resection of asymptomatic CPAM lesions, rather than expectant management.&quot;</span>
[Yes] The main findings are summarized.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results should be interpreted with caution owing to the nature of the included studies (in that all but one were retrospective).&quot;</span>
[Yes] Limitations are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on our results, we recommend elective resection of asymptomatic CPAM lesions, rather than expectant management.&quot;</span>
[Yes] A general interpretation of the results is provided.

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The University of Ottawa Summer Studentship program provided financial support for this project.&quot;</span>
[Yes] Sources of funding for the systematic review are described.</pre>
<p><a name='110'></a></p>
</div>
<div id="landisch-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.08.002' title='Open publication'>Landisch
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Observation versus prophylactic Ladd procedure for asymptomatic intestinal rotational abnormalities in heterotaxy syndrome: A systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a background, objectives, data sources, study eligibility criteria, and results, but does not include study appraisal and synthesis methods, limitations, conclusions, or systematic review registration number. [No]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives are not explicitly stated. [No]
P5. Methods / Protocol and registration: No mention of a review protocol or registration information. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are not specified. [No]
P7. Methods / Information sources: The information sources are not described. [No]
P8. Methods / Search: No full electronic search strategy is provided. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed. [No]
P12. Methods / Risk of bias in individual studies: No description of methods used for assessing risk of bias. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: No numbers of studies screened, assessed for eligibility, and included in the review are provided. [No]
P18. Results / Study characteristics: No characteristics of the included studies are presented. [No]
P19. Results / Risk of bias within studies: No data on risk of bias of each study are presented. [No]
P20. Results / Results of individual studies: No results of individual studies are presented. [No]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no meta-analysis. [NA]
P24. Discussion / Summary of evidence: The main findings are summarized, but the strength of evidence and relevance to key groups are not discussed. [No]
P25. Discussion / Limitations: Limitations at study and outcome level are not discussed, but reporting bias is mentioned. [No]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: No mention of funding sources or role of funders. [No]</pre>
<p><a name='111'></a></p>
</div>
<div id="lane-2010" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-009-2475-Y' title='Open publication'>Lane
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Paediatric sutureless circumcision: a systematic literature review&quot;</span>
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Paediatric sutureless circumcision: a systematic literature review&quot;</span>
2. Reasoning: The title clearly identifies the report as a systematic literature review.
3. Response: [Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Circumcision can be undertaken using a variety of techniques. For the technique to be successful, it should be easy to perform, avoid excessive haemorrhage and achieve a good cosmetic and functional result with minimal postoperative care. Naturally, there are differences between circumcision in the paediatric and adult populations and here we review the literature on recent advances that have been made in paediatric circumcision and the use of a sutureless technique with tissue glue for wound approximation.&quot;</span>
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Circumcision can be undertaken using a variety of techniques. For the technique to be successful, it should be easy to perform, avoid excessive haemorrhage and achieve a good cosmetic and functional result with minimal postoperative care. Naturally, there are differences between circumcision in the paediatric and adult populations and here we review the literature on recent advances that have been made in paediatric circumcision and the use of a sutureless technique with tissue glue for wound approximation.&quot;</span>
2. Reasoning: The abstract provides a structured summary including background, objectives, and the topic of the review.
3. Response: [Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Circumcision is one of the most commonly performed operations [1], with various recognised techniques. Procedures include the Plastibell with ligature [2] and excision with or without suturing. Absorbable sutures have traditionally been used to approximate the skin edges. The disadvantage of this method of wound approximation, however, is in the postoperative appearance, with the formation of small granulomata and the persistence of stitch marks along suture line [3].&quot;</span>
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Circumcision is one of the most commonly performed operations [1], with various recognised techniques. Procedures include the Plastibell with ligature [2] and excision with or without suturing. Absorbable sutures have traditionally been used to approximate the skin edges. The disadvantage of this method of wound approximation, however, is in the postoperative appearance, with the formation of small granulomata and the persistence of stitch marks along suture line [3].&quot;</span>
2. Reasoning: The introduction provides the rationale for the review in the context of what is already known.
3. Response: [Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎here we review the literature on recent advances that have been made in paediatric circumcision and the use of a sutureless technique with tissue glue for wound approximation.&quot;</span>
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎here we review the literature on recent advances that have been made in paediatric circumcision and the use of a sutureless technique with tissue glue for wound approximation.&quot;</span>
2. Reasoning: The objectives of the review are explicitly stated.
3. Response: [Yes]

P5. Methods / Protocol and registration: Not reported.
1. Quote: N/A
2. Reasoning: The review does not mention a protocol or registration.
3. Response: [NA]

P6. Methods / Eligibility criteria: Not reported.
1. Quote: N/A
2. Reasoning: The review does not provide information on the eligibility criteria.
3. Response: [No]

P7. Methods / Information sources: Not reported.
1. Quote: N/A
2. Reasoning: The review does not describe the information sources used.
3. Response: [No]

P8. Methods / Search: Not reported.
1. Quote: N/A
2. Reasoning: The review does not present the full electronic search strategy.
3. Response: [No]

P9. Methods / Study selection: Not reported.
1. Quote: N/A
2. Reasoning: The review does not state the process for selecting studies.
3. Response: [No]

P10. Methods / Data collection process: Not reported.
1. Quote: N/A
2. Reasoning: The review does not describe the method of data extraction.
3. Response: [No]

P11. Methods / Data items: Not reported.
1. Quote: N/A
2. Reasoning: The review does not list the variables for which data were sought.
3. Response: [No]

P12. Methods / Risk of bias in individual studies: Not reported.
1. Quote: N/A
2. Reasoning: The review does not describe the methods used for assessing risk of bias.
3. Response: [No]

P13. Methods / Summary measures: Not reported.
1. Quote: N/A
2. Reasoning: The review does not state the principal summary measures.
3. Response: [No]

P14. Methods / Synthesis of results: Not applicable.
1. Quote: N/A
2. Reasoning: The review does not include a meta-analysis.
3. Response: [NA]

P15. Methods / Risk of bias across studies: Not applicable.
1. Quote: N/A
2. Reasoning: The review does not assess risk of bias across studies.
3. Response: [NA]

P16. Methods / Additional analyses: Not applicable.
1. Quote: N/A
2. Reasoning: The review does not describe any additional analyses.
3. Response: [NA]

P17. Results / Study selection: Not reported.
1. Quote: N/A
2. Reasoning: The review does not provide numbers of studies screened, assessed for eligibility, and included in the review.
3. Response: [No]

P18. Results / Study characteristics: Not reported.
1. Quote: N/A
2. Reasoning: The review does not present characteristics of the included studies.
3. Response: [No]

P19. Results / Risk of bias within studies: Not reported.
1. Quote: N/A
2. Reasoning: The review does not present data on risk of bias of each study.
3. Response: [No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The cosmetic appearance following the use of tissue glue for wound approximation in sutureless circumcision has been reported by several authors.&quot;</span>
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The cosmetic appearance following the use of tissue glue for wound approximation in sutureless circumcision has been reported by several authors.&quot;</span>
2. Reasoning: The review presents the results of individual studies.
3. Response: [Yes]

P21. Results / Synthesis of results: Not applicable.
1. Quote: N/A
2. Reasoning: The review does not include a meta-analysis.
3. Response: [NA]

P22. Results / Risk of bias across studies: Not applicable.
1. Quote: N/A
2. Reasoning: The review does not assess risk of bias across studies.
3. Response: [NA]

P23. Results / Additional analysis: Not applicable.
1. Quote: N/A
2. Reasoning: The review does not describe any additional analyses.
3. Response: [NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, sutureless circumcision in children appears to have significant advantages to the standard closure using interrupted sutures.&quot;</span>
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In conclusion, sutureless circumcision in children appears to have significant advantages to the standard closure using interrupted sutures.&quot;</span>
2. Reasoning: The review provides a summary of the main findings.
3. Response: [Yes]

P25. Discussion / Limitations: Not reported.
1. Quote: N/A
2. Reasoning: The review does not discuss limitations.
3. Response: [No]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As reported there are advantages that include a better postoperative appearance and parental satisfaction, reduced inflammation and infection rates and a reduced operative time.&quot;</span>
1. Quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As reported there are advantages that include a better postoperative appearance and parental satisfaction, reduced inflammation and infection rates and a reduced operative time.&quot;</span>
2. Reasoning: The review provides a general interpretation of the results and implications for future research.
3. Response: [Yes]

P27. Funding: Not reported.
1. Quote: N/A
2. Reasoning: The review does not describe the sources of funding.
3. Response: [No]</pre>
<p><a name='112'></a></p>
</div>
<div id="lansdale-2010" class="section level4">
<h4><a href='https://doi.org/10.1097/SLA.0B013E3181DCA0E8' title='Open publication'>Lansdale
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Neonatal Endosurgical Congenital Diaphragmatic Hernia Repair A Systematic Review and Meta-Analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare outcomes of open and endosurgical neonatal congenital diaphragmatic hernia (CDH) repairs.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Historically a surgical emergency, neonatal CDH repair is now deferred pending stabilization of characteristically labile cardiopulmonary physiology.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare outcomes of open and endosurgical neonatal congenital diaphragmatic hernia (CDH) repairs.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were eligible for inclusion in the review and meta-analysis if they directly compared open and endosurgical CDH repair in the newborn infant and included outcome data regarding survival, CDH recurrence, prosthetic patch use, and operative time.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched Medline, Embase, and Cochrane Trials databases for studies comparing open with endosurgical CDH repair.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent reviewers reviewed all studies in abstract form. Exclusions were only made at this point if it was absolutely clear that the above criteria were met.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were extracted from the original study report or obtained directly from the corresponding author.&quot;</span>
[Yes]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following demographic data was sought for each group: proportion of male sex, proportion with left-sided CDH, mean birth weight, mean gestational age, APGAR score at 1 minute, proportion requiring ECMO, and proportion with significant associated anomalies.&quot;</span>
[Yes]

P12. Methods / Risk of bias in individual studies: Not reported.
[NA]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome measure was survival to discharge from hospital. The secondary outcome measures were: CDH recurrence rate, proportion undergoing prosthetic patching, and operative time.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis performed).
[NA]

P16. Methods / Additional analyses: Not applicable (no meta-analysis performed).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The electronic search identified a total of 292 studies. Exclusions were made as detailed in the flow chart.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 3 included studies compare series of neonatal thoracoscopic and open CDH repairs performed at the same institutions.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All eligible studies compare thoracoscopic versus open CDH repair: we were therefore unable to compare laparoscopic CDH repair and open surgery in this meta-analysis.&quot;</span>
[Yes]

P20. Results / Results of individual studies: <span title='Moderate quote deviation. Best match in fulltext (Similarity 78.1%):

surgical repair, recurrence was higher (RR: 3.2 [1.1, 9.3], P = 0.03) and operative time longer (WMD 50 minutes [32, 69], P < 0.00001). Survival and patch usage were not different between open and endosurgical groups' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Meta-analysis reveals that recurrence was higher and operative time longer in the endosurgical group. Survival and patch usage were not different between open and endosurgical groups.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis performed).
[NA]

P23. Results / Additional analysis: Not applicable (no meta-analysis performed).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis of methodologically limited comparative studies indicates neonatal thoracoscopic CDH repair has increased recurrence risk and operative time compared with open repair: although survival and patch usage appear comparable, such similarities may be subject to type 2 error as well as biases.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The analyzed studies report small numbers of cases and are therefore vulnerable to type 2 error (failure to detect a real difference).&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Better quality evidence is therefore required. Systematic reviews and meta-analyses frequently conclude with calls for more randomized controlled trials (RCTs). In contrast, we call for prospective, comprehensive, multi-institutional registry data on neonatal endosurgical CDH repair.&quot;</span>
[Yes]

P27. Funding: Not reported.
[No]</pre>
<p><a name='113'></a></p>
</div>
<div id="lee-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2010.06.038' title='Open publication'>Lee
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Antibiotics and appendicitis in the pediatric population: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee Systematic Review&quot;</span> - [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions - [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known - [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design - [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration - [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified - [Yes]
P7. Methods / Information sources: The information sources are described - [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not provided - [No]
P9. Methods / Study selection: The process for selecting studies is not described - [No]
P10. Methods / Data collection process: The method of data extraction from reports is not described - [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined - [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described - [No]
P13. Methods / Summary measures: The principal summary measures are not stated - [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results of studies - [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies - [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses - [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not given - [No]
P18. Results / Study characteristics: The characteristics for which data were extracted are not presented - [No]
P19. Results / Risk of bias within studies: No data on risk of bias of each study are presented - [No]
P20. Results / Results of individual studies: The simple summary data for each intervention group and effect estimates with confidence intervals are not presented - [No]
P21. Results / Synthesis of results: No information is provided about the results of any meta-analysis - [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies - [NA]
P23. Results / Additional analysis: No results of additional analyses are presented - [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are not summarized - [No]
P25. Discussion / Limitations: The limitations at study and outcome level, and at review-level are not discussed - [No]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided - [Yes]
P27. Funding: No information is provided about the sources of funding for the systematic review - [No]</pre>
<p><a name='114'></a></p>
</div>
<div id="leevan-2016" class="section level4">
<h4><a href='https://doi.org/10.1097/TA.0000000000000950' title='Open publication'>LeeVan
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.8%):

Management of pediatric blunt renal trauma
A systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Management of pediatric blunt renal trauma: A systematic review&quot;</span> - [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study aimed to review current practices in pediatric blunt renal trauma management and to highlight current practices in conservative protocols, success rates of conservative management strategies, as well as short- and long-term outcomes of blunt renal trauma management.&quot;</span> - [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Blunt trauma remains a significant cause of morbidity and mortality in the pediatric population. The use of conservative management for blunt renal trauma is widely accepted in adult trauma literature and is now increasingly accepted for use in the pediatric patient population.&quot;</span> - [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study aimed to review current practices in pediatric blunt renal trauma management and to highlight current practices in conservative protocols, success rates of conservative management strategies, as well as short- and long-term outcomes of blunt renal trauma management.&quot;</span> - [Yes]
P5. Methods / Protocol and registration: Not reported - [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were (1) original research articles regarding management of pediatric blunt renal trauma, (2) involvement of cases of high-grade renal (Grades IV and V) trauma, and (3) more than one patient presented per study. Literature reviews and meta-analyses were excluded.&quot;</span> - [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A search of all original research studies was conducted using PubMed, Ovid, and the Cochrane Library.&quot;</span> - [Yes]
P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following search was performed in PubMed: (Renal or Kidney) AND (Pediatric or Children) AND Trauma AND Management.&quot;</span> - [Yes]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Titles and abstracts (n = 308) were screened to identify scientific articles reporting original research findings. A total of 32 articles met the selection criteria and were included in the review.&quot;</span> - [Yes]
P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Treatment protocols, intervention type, outcome measures including percent success of conservative protocols, and renal salvage rates were recorded.&quot;</span> - [Yes]
P11. Methods / Data items: Not reported - [NA]
P12. Methods / Risk of bias in individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Bias was assessed using the Cochrane risk of bias assessment tool.&quot;</span> - [Yes]
P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Renal salvage rates were recorded.&quot;</span> - [Yes]
P14. Methods / Synthesis of results: Not applicable (no meta-analysis) - [NA]
P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis) - [NA]
P16. Methods / Additional analyses: Not applicable (no additional analyses) - [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 32 articles met the selection criteria and were included in the review.&quot;</span> - [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Characteristics of Studies Included in the Review&quot;</span> - [Yes]
P19. Results / Risk of bias within studies: Not reported - [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Treatment protocols, intervention type, outcome measures including percent success of conservative protocols, and renal salvage rates were recorded.&quot;</span> - [Yes]
P21. Results / Synthesis of results: Not applicable (no meta-analysis) - [NA]
P22. Results / Risk of bias across studies: Not applicable (no meta-analysis) - [NA]
P23. Results / Additional analysis: Not applicable (no additional analyses) - [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature supports application of conservative management protocols to high-grade blunt pediatric renal trauma.&quot;</span> - [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The review was limited by the retrospective nature of the studies included and the relatively small sample size because of the infrequency with which pediatric renal trauma occurs.&quot;</span> - [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the analysis of the available literature, we recommend implementation of conservative management protocols to treat high-grade blunt pediatric renal trauma.&quot;</span> - [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors declare no conflicts of interest.&quot;</span> - [Yes]</pre>
<p><a name='115'></a></p>
</div>
<div id="liang-2011" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0031-1271733' title='Open publication'>Liang
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Lymphatic Sparing Versus Lymphatic Non-Sparing Laparoscopic Varicocelectomy in Children and Adolescents: A Systematic Review and Meta-Analysis&quot;</span>
2. The title clearly identifies the report as a systematic review and meta-analysis.
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to explore the true efficacy and potential advantages of lymphatic sparing laparoscopic varicocelectomy (LSV) over lymphatic non-sparing laparoscopic varicocelectomy (LNSV) in children and adolescents.&quot;</span>
3. The abstract provides a structured summary including background, objectives, and study eligibility criteria.
[Yes]

P3. Introduction / Rationale: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.9%):

Varicocele, an abnormal tortuosity and dilatation of the testicular vein within the spermatic cord, first develops in childhood or early adolescence [1]. The prevalence of varicocele in adolescent boys is estimated to be 11–15% [1]. It has been established that adolescent varicocele is associated with growth retardation of the ipsilateral testicle and impaired testicular function, which is correlated to the duration of the varicocele [1]. Although some studies have challenged the role varicocele plays in infertility, many studies have stated that varicocele is associated with testicular atrophy and abnormal seminal parameters contributing to male infertility [2] [3]. Surgical management of adolescent varicocele has been advocated to preserve future fertility [4]. The earlier the patient undergoes varicocele repair, the more likely the testis will recover from a varicocele-induced injury [5]. Currently, several techniques are successfully used for varicocelectomy including open surgical ligation via a subinguinal, inguinal or retroperitoneal approach, and microsurgical and laparoscopic procedures [6] [7]. However, the efficacy of surgical procedures and the outcomes in boys and young adolescents remains unclear' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Varicocele, an abnormal tortuosity and dilatation of the testicular vein within the spermatic cord, first develops in childhood or early adolescence. The prevalence of varicocele in adolescent boys is estimated to be 11–15%. It has been established that adolescent varicocele is associated with growth retardation of the ipsilateral testicle and impaired testicular function, which is correlated to the duration of the varicocele. Although some studies have challenged the role varicocele plays in infertility, many studies have stated that varicocele is associated with testicular atrophy and abnormal seminal parameters contributing to male infertility. Surgical management of adolescent varicocele has been advocated to preserve future fertility. The earlier the patient undergoes varicocele repair, the more likely the testis will recover from a varicocele-induced injury. Currently, several techniques are successfully used for varicocelectomy including open surgical ligation via a subinguinal, inguinal or retroperitoneal approach, and microsurgical and laparoscopic procedures. However, the efficacy of surgical procedures and the outcomes in boys and young adolescents remains unclear.&quot;</span>
4. The rationale for the review is clearly described in the context of what is already known.
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to explore the true efficacy and potential advantages of lymphatic sparing laparoscopic varicocelectomy (LSV) over lymphatic non-sparing laparoscopic varicocelectomy (LNSV) in children and adolescents.&quot;</span>
5. The objectives of the review are explicitly stated.
[Yes]

P5. Methods / Protocol and registration: Not applicable (no mention of a review protocol or registration number).
[NA]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria included all available studies comparing LSV with LNSV for varicocele repair in children and adolescents.&quot;</span>
6. The study characteristics and report characteristics used as eligibility criteria are specified.
[Yes]

P7. Methods / Information sources: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

A search was made for studies published up until 31 August 2010 using the terms “lymphatic sparing varicocelectomy”, “laparoscopy”, “adolescent” and “children” in the Medline, Embase, Ovid, Web of Science, and Cochrane databases' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A search was made for all studies published up until 31 August 2010 using the terms “lymphatic sparing varicocelectomy”, “laparoscopy”, “adolescent” and “children” in the Medline, Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span>
7. All information sources used in the search are described.
[Yes]

P8. Methods / Search: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):

A search was made for studies published up until 31 August 2010 using the terms “lymphatic sparing varicocelectomy”, “laparoscopy”, “adolescent” and “children” in the Medline, Embase, Ovid, Web of Science, and Cochrane databases' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A search was made for all studies published up until 31 August 2010 using the terms “lymphatic sparing varicocelectomy”, “laparoscopy”, “adolescent” and “children” in the Medline, Embase, Ovid, Web of Science, and Cochrane databases.&quot;</span>
8. The full electronic search strategy for at least one database is presented.
[Yes]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eligibility criteria included all available studies comparing LSV with LNSV for varicocele repair in children and adolescents.&quot;</span>
9. The process for selecting studies is stated.
[Yes]

P10. Methods / Data collection process: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

3 reviewers (LZL, GJ and TQS) independently assessed the selected studies, and extracted and tabulated data from each article using a predefined data extraction form' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎3 reviewers independently assessed the selected studies, and extracted and tabulated data from each article using a predefined data extraction form.&quot;</span>
10. The method of data extraction from reports is described.
[Yes]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data for the following factors were considered: first author, publication date, study methodology, participant features, intervention characteristics, definition of complications, and outcome measures.&quot;</span>
11. The variables for which data were sought are listed and defined.
[Yes]

P12. Methods / Risk of bias in individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Each included article was appraised by 3 reviewers (LZL, GJ and TQS), who independently assessed the methodological quality of the selected studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Each included article was appraised by 3 reviewers, who independently assessed the methodological quality of the selected studies.&quot;</span>
12. The methods used for assessing risk of bias of individual studies are described.
[Yes]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review and meta-analysis was performed using odds ratios (ORs) for dichotomous variables.&quot;</span>
13. The principal summary measures are stated.
[Yes]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no assessment of risk of bias across studies).
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses performed).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Out of 127 studies, 2 RCTs and 4 OCSs were eligible for inclusion.&quot;</span>
14. The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage.
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A summary of the studies’ methodology, intervention characteristics, and measured outcomes is provided.&quot;</span>
15. Characteristics for which data were extracted are presented.
[Yes]

P19. Results / Risk of bias within studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

Each included article was appraised by 3 reviewers (LZL, GJ and TQS), who independently assessed the methodological quality of the selected studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Each included article was appraised by 3 reviewers, who independently assessed the methodological quality of the selected studies.&quot;</span>
16. Data on risk of bias of each study are presented.
[Yes]

P20. Results / Results of individual studies: <span title='Minor quote deviation. Best match in prompt (Similarity 99.4%):

For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎For all outcomes considered, present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
17. Simple summary data and effect estimates with confidence intervals are presented for each study.
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no assessment of risk of bias across studies).
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses performed).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In this meta-analysis, we demonstrate that the lymphatic sparing laparoscopic approach is associated with a lower incidence of hydrocele formation, supporting the belief that lymphatic occlusion is the main cause of hydrocele formation after varicocelectomy.&quot;</span>
18. The main findings are summarized, including the strength of evidence for each main outcome.
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Due to a potential publishing bias, a series of RCTs are still necessary to explore the efficacy of LSV in the management of varicocele in children and adolescents.&quot;</span>
19. Limitations at study and outcome level, as well as at review-level, are discussed.
[Yes]

P26. Discussion / Conclusions: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):

In this meta-analysis, we demonstrate that the lymphatic sparing laparoscopic approach is associated with a lower incidence of hydrocele formation, supporting the belief that lymphatic occlusion is the main cause of hydrocele formation after varicocelectomy. In addition, the incidence of recurrence and catch-up growth were' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎In this meta-analysis, we demonstrate that the lymphatic sparing laparoscopic approach is associated with a lower incidence of hydrocele formation, with similar recurrence and catch-up growth rates as LNSV.&quot;</span>
20. A general interpretation of the results in the context of other evidence and implications for future research are provided.
[Yes]

P27. Funding: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

This work was supported by the National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 81071997, No. 81072073), Program for New Century Excellent Talents in the University of China (NCET-06-0641), the Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry (2008-889), and Fundamental Research Funds for the Central Universities' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This work was supported by the National Natural Science Foundation of China, Program for New Century Excellent Talents in the University of China, the Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry, and Fundamental Research Funds for the Central Universities.&quot;</span>
21. Sources of funding for the systematic review and other support are described.
[Yes]</pre>
<p><a name='116'></a></p>
</div>
<div id="lishuang-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3662-7' title='Open publication'>Lishuang
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎systematic review and meta-analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 62.4%):

background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusion' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎Background...Design...Data sources...Study selection...Data extraction...Results...Conclusion&quot;</span>
[Yes]

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 44.3%):

.

Since first reported by Kasai and Suzuki [8] in 1959, portoenterostomy (PE) remains the mainstay of treating BA' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Biliary atresia (BA) is one of the most common reasons for portoenterostomy in pediatric surgery...The etiology of BA remains unknown...Since first reported by Kasai and Suzuki in 1959, portoenterostomy (PE) remains the mainstay of treating BA.&quot;</span>
[Yes]

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎we performed a systematic review and meta-analysis to review the currently available data comparing laparoscopic portoenterostomy (LPE) versus open portoenterostomy (OPE) for the treatment of biliary atresia (BA).&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
No information provided.
[No]

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For inclusion in this meta-analysis, the studies had to meet the following criteria: (1) be a cohort study comparing laparoscopic technique and open technique in BA patients undergoing portoenterostomy; (2) include at least one interest datum for analysis—hospital stay, operative time, blood loss, complications, early clearance of jaundice, the rate of long-term survival with native liver; (3) clearly document technique as ‘‘laparoscopic’’ or ‘‘open’’; (4) clearly document indications for portoenterostomy with biliary atresia; (5) be published as a full paper in a journal, not as meeting abstract or review.&quot;</span>
[Yes]

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted a systematic search of the online databases, including Medline, Ovid, Elsevier, Google Scholar Embase, Cohrane library, for studies published between 1995 and 2014 with no limits for publication language, place of study origin and sample size of the studies.&quot;</span>
[Yes]

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
No information provided.
[No]

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The process of study screening is showed in Fig. 1, through which, eleven studies assessing LPE versus OPE were considered suitable for meta-analysis.&quot;</span>
[Yes]

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent authors (QG and ZZ) using a predefined meta-analysis form extracted relevant data from each study which resulted in high and satisfactory interobserver agreement.&quot;</span>
[Yes]

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following data were the outcomes of interest that extracted from each included study: first author, publication year, country, study design, number of patients who underwent LPE or OPE, characteristics of the study population, and end point data (operative times, hospital stay times, rate of conversion from LPE to OPE, re-operation rates, and complications about surgery including: intraoperative blood loss, early clearance of jaundice, cholangitis and variceal bleeding.&quot;</span>
[Yes]

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
No information provided.
[No]

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For categorical variables data, statistical analysis was performed using the odds ratio (OR) as the statistic summary. This odds ratio represents the odds of an adverse event occurring in the LPE group compared with the OPE group. Statistical analysis for continuous variables was performed using the mean difference (MD) and as the summary statistic.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
No information provided.
[NA]

P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
No information provided.
[NA]

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
No information provided.
[NA]

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The process of study screening is showed in Fig. 1, through which, eleven studies assessing LPE versus OPE were considered suitable for meta-analysis.&quot;</span>
[Yes]

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The characteristics of these 11 studies are listed in Table 1.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
No information provided.
[NA]

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main data for meta-analysis are summarized below and in Table 2.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
No information provided.
[NA]

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
No information provided.
[NA]

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
No information provided.
[NA]

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

The results of our meta-analysis suggested that compared with OPE, LPEs were considered to be a poor treatment for BA in long-term outcomes with low 2-year survival of native liver (OR 0.39, 95 % CI 0.21 to 0.74; P = 0.04), although LPEs performed well in short-term outcomes in the form of intraoperative blood loss, early clearance of jaundice and cholangiti' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The results of our meta-analysis suggested that compared with OPE, LPEs were considered to be a poor treatment for BA in long-term outcomes with low 2-year survival of native liver, although LPEs performed well in short-term outcomes in the form of intraoperative blood loss, early clearance of jaundice and cholangitis.&quot;</span>
[Yes]

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):

There are limitations to this review which must be considered. First, there have only been a small number of studies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials. Second, the sample size of some selected studies is small so that the statistical power to detect the difference in the outcomes is limited. Third, although most of the comparative cohort studies seem to be robust, risk of selection bias still existed, as it was the surgeons’ preference and experience that determined the allocation of patients to either LPE or OPE group. Fourth, marked heterogeneity for several meta-analysis, short follow-up time in some included studies, and the potentially existed significant risk of publication bias may more or less affect the accuracy of the results. Fifth, the other limitation is the length of follow-u' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎There are limitations to this review which must be considered...First, there have only been a small number of studies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials...Second, the sample size of some selected studies is small so that the statistical power to detect the difference in the outcomes is limited...Third, although most of the comparative cohort studies seem to be robust, risk of selection bias still existed...Fourth, marked heterogeneity for several meta-analysis, short follow-up time in some included studies, and the potentially existed significant risk of publication bias may more or less affect the accuracy of the results...Fifth, the other limitation is the length of follow-up.&quot;</span>
[Yes]

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the evidence, we make cautious conclusions that laparoscopic portoenterostomy could not replace open portoenterostomy and open Kasai operation remains the ‘gold standard’ for the treatment of biliary atresia.&quot;</span>
[Yes]

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
<span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We thank those authors who provided us with the full text and the relevant data from their studies.&quot;</span>
[Yes]</pre>
<p><a name='117'></a></p>
</div>
<div id="livingston-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.02.020' title='Open publication'>Livingston
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Fundoplication and gastrostomy versus percutaneous gastrojejunostomy for gastroesophageal reflux in children with neurologic impairment: A systematic review and meta-analysis&quot;</span> [Yes]

P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions [Yes]

P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known [Yes]

P4. Introduction / Objectives: The objectives are explicitly stated, addressing the participants, interventions, comparisons, outcomes, and study design [Yes]

P5. Methods / Protocol and registration: No information is provided about a review protocol or registration [No]

P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified [Yes]

P7. Methods / Information sources: The information sources are described, including databases searched and date last searched [Yes]

P8. Methods / Search: The full electronic search strategy for at least one database is presented [Yes]

P9. Methods / Study selection: The process for selecting studies is stated [Yes]

P10. Methods / Data collection process: The method of data extraction from reports is described [Yes]

P11. Methods / Data items: The variables for which data were sought are listed and defined [Yes]

P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are described [Yes]

P13. Methods / Summary measures: The principal summary measures are stated [Yes]

P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results [NA]

P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]

P16. Methods / Additional analyses: No information is provided about additional analyses [NA]

P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage [Yes]

P18. Results / Study characteristics: The characteristics for which data were extracted are presented [Yes]

P19. Results / Risk of bias within studies: Data on risk of bias of each study are presented [Yes]

P20. Results / Results of individual studies: Simple summary data for each intervention group and effect estimates and confidence intervals are presented [Yes]

P21. Results / Synthesis of results: No information is provided about the methods of synthesis of results [NA]

P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]

P23. Results / Additional analysis: No information is provided about additional analyses [NA]

P24. Discussion / Summary of evidence: The main findings are summarized, including the strength of evidence for each main outcome [Yes]

P25. Discussion / Limitations: Limitations at study and outcome level, as well as review-level limitations, are discussed [Yes]

P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research are provided [Yes]

P27. Funding: No information is provided about the sources of funding for the systematic review [No]</pre>
<p><a name='118'></a></p>
</div>
<div id="mauritz-2013" class="section level4">
<h4><a href='https://doi.org/10.1007/S11605-013-2305-3' title='Open publication'>Mauritz
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Complete Versus Partial Fundoplication in Children with Gastroesophageal Reflux Disease: Results of a Systematic Review and Meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS). [Yes]
P5. Methods / Protocol and registration: The methods do not mention if a review protocol exists or if the review was registered. [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics and report characteristics used as criteria for eligibility. [Yes]
P7. Methods / Information sources: The methods describe all information sources used in the search. [Yes]
P8. Methods / Search: The methods do not present the full electronic search strategy. [No]
P9. Methods / Study selection: The methods state the process for selecting studies. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports. [Yes]
P11. Methods / Data items: The methods do not list and define all variables for which data were sought. [No]
P12. Methods / Risk of bias in individual studies: The methods do not describe the methods used for assessing risk of bias of individual studies. [No]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: [NA]
P15. Methods / Risk of bias across studies: [NA]
P16. Methods / Additional analyses: [NA]
P17. Results / Study selection: The results give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations. [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study. [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals. [Yes]
P21. Results / Synthesis of results: [NA]
P22. Results / Risk of bias across studies: [NA]
P23. Results / Additional analysis: [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]
P27. Funding: The article does not describe the sources of funding for the systematic review. [No]</pre>
<p><a name='119'></a></p>
</div>
<div id="mauritz-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S11605-011-1644-1' title='Open publication'>Mauritz
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Effects and Efficacy of Antireflux Surgery in Children with Gastroesophageal Reflux Disease: A Systematic Review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics and report characteristics used as criteria for eligibility. [Yes]
P7. Methods / Information sources: The methods describe the information sources used in the search. [Yes]
P8. Methods / Search: The methods present the full electronic search strategy for at least one database. [Yes]
P9. Methods / Study selection: The methods state the process for selecting studies. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports. [Yes]
P11. Methods / Data items: The methods list and define all variables for which data were sought. [Yes]
P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing risk of bias of individual studies. [Yes]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The results give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations. [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study. [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no additional analysis. [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]
P27. Funding: No information is provided about funding sources. [No]</pre>
<p><a name='120'></a></p>
</div>
<div id="mei-2011" class="section level4">
<h4><a href='https://doi.org/10.1089/END.2010.0544' title='Open publication'>Mei
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic Versus Open Pyeloplasty for Ureteropelvic Junction Obstruction in Children: A Systematic Review and Meta-Analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, methods, results, and conclusions of the systematic review. [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources used in the search are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is presented. [Yes]
P9. Methods / Study selection: The process for selecting studies is described. [Yes]
P10. Methods / Data collection process: The method of data extraction from reports is described. [Yes]
P11. Methods / Data items: The variables for which data were sought are listed. [Yes]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias in individual studies are described. [Yes]
P13. Methods / Summary measures: The principal summary measures are stated. [Yes]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are provided, along with reasons for exclusions. [Yes]
P18. Results / Study characteristics: The characteristics of each study are presented. [Yes]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are presented. [Yes]
P20. Results / Results of individual studies: Simple summary data for each intervention group and effect estimates are presented. [Yes]
P21. Results / Synthesis of results: No information is provided about the synthesis of results. [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P23. Results / Additional analysis: No information is provided about additional analyses. [NA]
P24. Discussion / Summary of evidence: The main findings and strength of evidence for each outcome are summarized. [Yes]
P25. Discussion / Limitations: Limitations at study and outcome level are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: The sources of funding for the systematic review are described. [Yes]</pre>
<p><a name='121'></a></p>
</div>
<div id="mullassery-2014" class="section level4">
<h4><a href='https://doi.org/10.3109/08880018.2014.947009' title='Open publication'>Mullassery
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Does Aggressive Surgical Resection Improve Survival in Advanced Stage 3 and 4 Neuroblastoma? A Systematic Review and Meta-analysis&quot;</span>
[Yes] The report is identified as a systematic review and meta-analysis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review and meta-analysis is reported to address robust evidence for curative 'gross total tumor resection' (GTR) in Stage 3 and Stage 4 neuroblastoma.&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The role of surgery in the management of advanced staged neuroblastoma (NBL) is controversial.&quot;</span>
[Yes] The rationale for the review is described in the introduction.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To critically examine robust evidence for differences in survival with GTR and STR in neuroblastoma.&quot;</span>
[Yes] The objectives of the review are explicitly stated.

P5. Methods / Protocol and registration: No information is provided in the full text about a review protocol or registration.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were included if they reported 5-year survival data for children under 18 years of age with stages 3 and/or 4 neuroblastoma following gross total resection and subtotal resection (STR).&quot;</span>
[Yes] The study characteristics and report characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were identified using Medline, Embase, and Cochrane databases using pre-specified search terms.&quot;</span>
[Yes] The information sources are described.

P8. Methods / Search: No information is provided in the full text about the full electronic search strategy.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were reviewed by PJF and DM independently.&quot;</span>
[Yes] The process for selecting studies is stated.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were extracted using a custom designed proforma before commencement of the search strategy.&quot;</span>
[Yes] The method of data extraction is described.

P11. Methods / Data items: The data items sought are not explicitly listed in the full text.
[No]

P12. Methods / Risk of bias in individual studies: No information is provided in the full text about the methods used for assessing risk of bias in individual studies.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Odds ratios (OR) were calculated with 95% confidence intervals (CI) using Mantel–Haenszel calculations and a random effects model.&quot;</span>
[Yes] The principal summary measures are stated.

P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis reported in the full text.
[NA]

P15. Methods / Risk of bias across studies: Not applicable, as there is no assessment of risk of bias across studies reported in the full text.
[NA]

P16. Methods / Additional analyses: Not applicable, as there are no additional analyses reported in the full text.
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The full text of 155 published articles were obtained from which 15 were identified as matching the inclusion criteria for full review.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are provided.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All 15 studies included in the analysis were case series.&quot;</span>
[Yes] The characteristics for which data were extracted are presented.

P19. Results / Risk of bias within studies: No information is provided in the full text about the risk of bias within studies.
[No]

P20. Results / Results of individual studies: <span title='Moderate quote deviation. Best match in fulltext (Similarity 89%):

The meta-analysis found no statistically significant differences in 5 year OS rates between the 2 surgical groups when comparing GTR vs. STR' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The meta-analysis found no statistically significant differences in 5 year overall survival rates between the 2 surgical groups when comparing GTR vs. STR.&quot;</span>
[Yes] The results of individual studies are presented.

P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis reported in the full text.
[NA]

P22. Results / Risk of bias across studies: Not applicable, as there is no assessment of risk of bias across studies reported in the full text.
[NA]

P23. Results / Additional analysis: Not applicable, as there are no additional analyses reported in the full text.
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Findings strongly showed that there was a significantly improved 5 year survival achieved following GTR in stage 3 neuroblastoma.&quot;</span>
[Yes] The main findings are summarized.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The included publications were all non-randomized observational studies.&quot;</span>
[Yes] The limitations at study and outcome level are discussed.

P26. Discussion / Conclusions: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):

Based on current “‘best evidence” we can report a clear survival advantage for GTR in stage 3 neuroblastoma' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Based on current 'best evidence' we can report a clear survival advantage for GTR in stage 3 neuroblastoma.&quot;</span>
[Yes] A general interpretation of the results is provided.

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors report no conflicts of interest.&quot;</span>
[Yes] The sources of funding for the systematic review are described.</pre>
<p><a name='123'></a></p>
</div>
<div id="narayanan-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2013.07.020' title='Open publication'>Narayanan
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Hepaticoduodenostomy versus hepaticojejunostomy after resection of choledochal cyst: A systematic review and meta-analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Background

Excision has been established as a standard management practice for choledochal cysts in the last few decades. The two most commonly performed methods of reconstruction after excision are hepaticoduodenostomy (HD) and Roux-en-Y hepaticojejunostomy (HJ), of which the HJ is favored by most surgeons. Evidence concerning the optimal method of reconstruction is, however, sparse.
Materials and Methods

Studies comparing outcomes from HD and HJ after choledochal cyst excision were identified by searching Medline, Ovid, Search Medica, Elsevier Clinicalkey, Google Scholar and Cochrane library. Suitable studies were chosen and data extracted for meta-analysis. Outcomes evaluated included operative time, hospital stay and incidence of postoperative bile leak, cholangitis, reflux/gastritis, anastomotic stricture, bleeding, intestinal obstruction and re-operative rate. Pooled odds ratios (OR) were calculated for dichotomous variables; pooled mean differences (MD) were measured for continuous variables.
Results

Six retrospective studies were included in this meta-analysis, comprising a total of 679 patients, 412 of whom (60.7%) underwent HD, and the remainder, 267(39.3%) underwent HJ. Although, HD group had slightly shorter hospital stay (MD: 0.30; 95% CI: −0.22–0.39; P < 0.00001) it showed a higher incidence of postoperative reflux/gastritis (OR: 0.08; 95% CI: − 0.02–0.39; P = 0.002). However, the other outcomes such as bile leak, cholangitis, anastomotic stricture, bleeding, operative time, reoperation rate and adhesive intestinal obstruction did not differ between HD and HJ groups.
Conclusions

HD shows higher postoperative reflux/gastritis than HJ but a shorter hospital stay. There are few good-quality studies that compare the outcomes from HD and HJ, meaning that caution should be exercised in the generalization of the results of this meta-analysis, which suggests HD to be comparable with HJ in terms of other complications, operative benefits and outcomes' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Background: Excision has been established as a standard management practice for choledochal cysts in the last few decades. The two most commonly performed methods of reconstruction after excision are hepaticoduodenostomy (HD) and Roux-en-Y hepaticojejunostomy (HJ), of which the HJ is favored by most surgeons. Evidence concerning the optimal method of reconstruction is, however, sparse. Methods: Studies comparing outcomes from HD and HJ after choledochal cyst excision were identified by searching Medline, Ovid, Search Medica, Elsevier Clinicalkey, Google Scholar and Cochrane library. Suitable studies were chosen and data extracted for meta-analysis. Results: Six retrospective studies were included in this meta-analysis, comprising a total of 679 patients, 412 of whom (60.7%) underwent HD, and the remainder, 267(39.3%) underwent HJ. Although, HD group had slightly shorter hospital stay (MD: 0.30; 95% CI: −0.22–0.39; P < 0.00001) it showed a higher incidence of postoperative reflux/gastritis (OR: 0.08; 95% CI: − 0.02–0.39; P = 0.002). However, the other outcomes such as bile leak, cholangitis, anastomotic stricture, bleeding, operative time, reoperation rate and adhesive intestinal obstruction did not differ between HD and HJ groups. Conclusions: HD shows higher postoperative reflux/gastritis than HJ but a shorter hospital stay. There are few good-quality studies that compare the outcomes from HD and HJ, meaning that caution should be exercised in the generalization of the results of this meta-analysis, which suggests HD to be comparable with HJ in terms of other complications, operative benefits and outcomes.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Excision has been established as a standard management practice for choledochal cysts in the last few decades. The two most commonly performed methods of reconstruction after excision are hepaticoduodenostomy (HD) and Roux-en-Y hepaticojejunostomy (HJ), of which the HJ is favored by most surgeons. Evidence concerning the optimal method of reconstruction is, however, sparse.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare the clinical outcomes of HD and HJ, we performed a systematic review and comprehensive meta-analysis from indexed published literature.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: No information provided.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies comparing outcomes from HD and HJ after choledochal cyst excision were identified by searching Medline, Ovid, Search Medica, Elsevier Clinicalkey, Google Scholar and Cochrane library.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies comparing outcomes from HD and HJ after choledochal cyst excision were identified by searching Medline, Ovid, Search Medica, Elsevier Clinicalkey, Google Scholar and Cochrane library.&quot;</span>
[Yes]

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A Medline, Ovid, Search Medica, Elsevier ClinicalKey, Google Scholar and the Cochrane library search was performed on all studies published between 1950 and 2012 reporting on comparison of HD and HJ for children undergoing excision of extra-hepatic biliary tree for choledochal cysts.&quot;</span>
[Yes]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three reviewers (SKN, KLN and CY) independently assessed selected studies, extracted and tabulated data from each article: first author, year of publication, study design, follow up period, mean age and number of subjects operated on with each technique, and end point data (operative times, length of postoperative hospital stay, re-operation rates and postoperative complications including bile leak, adhesive intestinal obstruction, cholangitis, reflux/gastritis and anastomotic stricture).&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three reviewers (SKN, KLN and CY) independently assessed selected studies, extracted and tabulated data from each article: first author, year of publication, study design, follow up period, mean age and number of subjects operated on with each technique, and end point data (operative times, length of postoperative hospital stay, re-operation rates and postoperative complications including bile leak, adhesive intestinal obstruction, cholangitis, reflux/gastritis and anastomotic stricture).&quot;</span>
[Yes]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three reviewers (SKN, KLN and CY) independently assessed selected studies, extracted and tabulated data from each article: first author, year of publication, study design, follow up period, mean age and number of subjects operated on with each technique, and end point data (operative times, length of postoperative hospital stay, re-operation rates and postoperative complications including bile leak, adhesive intestinal obstruction, cholangitis, reflux/gastritis and anastomotic stricture).&quot;</span>
[Yes]

P12. Methods / Risk of bias in individual studies: No information provided.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Pooled odds ratios (OR) were calculated for dichotomous variables using the Mantel–Haenszel method and pooled mean differences (MD) were measured for continuous variables using the inverse variance method in meta-analysis.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: No meta-analysis performed.
[NA]

P15. Methods / Risk of bias across studies: No information provided.
[NA]

P16. Methods / Additional analyses: No additional analyses performed.
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Six retrospective studies were included in this meta-analysis, comprising a total of 679 patients, 412 of whom (60.7%) underwent HD, and the remainder, 267(39.3%) underwent HJ.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The characteristics of these studies are demonstrated in Table 1.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: No information provided.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although, HD group had slightly shorter hospital stay (MD: 0.30; 95% CI: −0.22–0.39; P < 0.00001) it showed a higher incidence of postoperative reflux/gastritis (OR: 0.08; 95% CI: − 0.02–0.39; P = 0.002). However, the other outcomes such as bile leak, cholangitis, anastomotic stricture, bleeding, operative time, reoperation rate and adhesive intestinal obstruction did not differ between HD and HJ groups.&quot;</span>
[Yes]

P21. Results / Synthesis of results:
[NA]

P22. Results / Risk of bias across studies:
[NA]

P23. Results / Additional analysis:
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our meta-analysis suggests that the HD is comparable to conventional HJ in most postoperative outcomes except a higher rate of gastric reflux.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There are few good-quality studies that compare the outcomes from HD and HJ, meaning that caution should be exercised in the generalization of the results of this meta-analysis, which suggests HD to be comparable with HJ in terms of other complications, operative benefits and outcomes.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on the evidence of this study, HD as a method of reconstruction after excision of a choledochal cyst is a suitable alternative to HJ.&quot;</span>
[Yes]

P27. Funding: No information provided.
[No]</pre>
<p><a name='124'></a></p>
</div>
<div id="nasr-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2010.02.012' title='Open publication'>Nasr
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Comparison of the Nuss and the Ravitch procedure for pectus excavatum repair: a meta-analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our objective was to compare the Nuss procedure to the Ravitch procedure using systematic review and meta-analysis methodology.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As more pediatric centers add the Nuss procedure to their surgical armamentarium, data indicating complication rates and surgical outcome are becoming available.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our objective was to compare both the Nuss and the Ravitch procedure using systematic review and meta-analysis methodology.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To be selected, a study had to be designed to evaluate the Nuss vs the Ravitch procedure for the treatment of pectus excavatum and provide relevant and interpretable data.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All publications describing both surgical procedures for pectus excavatum were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) database.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Three authors (AN, AF, and PW) independently assessed all published articles identified as potentially relevant by the literature search for inclusion in the review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Three authors independently assessed all published articles identified as potentially relevant by the literature search for inclusion in the review.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):

Two authors (AN and PW) independently extracted data from the retrieved articles' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two authors independently extracted data from the retrieved articles.&quot;</span>
[Yes]

P11. Methods / Data items: Not reported.
[No]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Odds ratios (OR) and weighted mean differences (WMDs) with 95% confidence intervals are presented.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis performed).
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses performed).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Nine prospective and retrospective studies were identified and were included in this study.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All data extracted from the 9 studies are summarized in Table 1.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis performed).
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses performed).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our results suggest no differences between the Nuss procedure vs the Ravitch procedure with respect to overall complications, length of hospital stay, and time to ambulation.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Moderate quote deviation. Best match in fulltext (Similarity 75.2%):

the evaluation and management of these parameters was not standardized, thus, making it impossible to calculate a pooled estimat' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The evaluation and management of postoperative pain and patient satisfaction were not standardized, thus making it impossible to calculate a pooled estimate.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both approaches are acceptable.&quot;</span>
[Yes]

P27. Funding: Not reported.
[No]</pre>
<p><a name='125'></a></p>
</div>
<div id="nasr-2013" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1347916' title='Open publication'>Nasr
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mechanical Traction Techniques for Long-Gap Esophageal Atresia: A Critical Appraisal&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this study is to critically evaluate the existing literature on this topic and to compare the Foker technique to the more conventional delayed primary anastomosis.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Long-gap esophageal atresia (EA) represents a challenging problem for pediatric surgeons, and a large number of techniques and approaches have been proposed.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this study is to critically evaluate the existing literature on this topic and to compare the Foker technique to the more conventional delayed primary anastomosis.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review and cumulative meta-analysis was performed, including all articles describing the Foker technique or delayed primary anastomosis.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

All publications describing both surgical procedures were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials database. All studies were identified through electronic searches of MEDLINE (1966 onward), Embase (1980 onward), and CINAHL (1982 onward), and from hand searching journals and conference proceedings' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎All publications describing both surgical procedures were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials database. All studies were identified through electronic searches of MEDLINE, Embase, and CINAHL, and from hand searching journals and conference proceedings.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies which were designed to describe both procedures were selected for review.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Authors extracted data from the retrieved articles.&quot;</span>
[Yes]

P11. Methods / Data items: Not reported.
[No]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: Not reported.
[NA]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis performed).
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses performed).
[NA]

P17. Results / Study selection: <span title='Moderate quote deviation. Best match in fulltext (Similarity 88.4%):

The literature search resulted in a total of 115 articles, after screening and exclusion of nonrelevant and duplicate publications. Six articles[36] [37] [38] [39] [40] [41] met our criteria for inclusion' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The literature search resulted in a total of 115 articles, after screening and exclusion of nonrelevant and duplicate publications. Six articles on the Foker procedure met the criteria for inclusion.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The overall numbers of study subjects managed in these publications were 71 infants, ranging from 1 to 60 newborns with long-gap EA per study.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Foker procedure was associated with a significantly lower risk of complications (leak, stricture, and gastroesophageal reflux), and with a significantly shorter time to definitive anastomosis.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis performed).
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses performed).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The use of mechanical traction appears to be at least as effective as delayed primary anastomosis for the management of long-gap EA.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All studies published in the literature on this topic are retrospective and noncomparative.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Based on our analysis both approaches must be deemed to be acceptable.&quot;</span>
[Yes]

P27. Funding: Not reported.
[No]</pre>
<p><a name='126'></a></p>
</div>
<div id="nataraja-2013" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2012.0522 ' title='Open publication'>Nataraja
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Incidence of Intraabdominal Abscess Formation Following Laparoscopic Appendicectomy in Children: A Systematic Review and Meta-analysis&quot;</span>
1. Yes
2. The title clearly identifies the report as a systematic review and meta-analysis.
3. [Yes]

P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings, and systematic review registration number.
1. Yes
2. The abstract provides a structured summary of the study, including all the required components.
3. [Yes]

P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known.
1. Yes
2. The introduction provides a rationale for the review by discussing the current research and debate on the best operative modality for appendicectomy in pediatric patients.
3. [Yes]

P4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
1. Yes
2. The introduction clearly states the objective of the review, which is to determine the incidence of intraabdominal abscess (IAA) following laparoscopic appendicectomy (LA) compared with the open approach (OA) in pediatric patients.
3. [Yes]

P5. Methods / Protocol and registration: The methods section indicates if a review protocol exists, if and where it can be accessed, and provides registration information including registration number.
1. No relevant quote found.
2. No information is provided about the existence of a review protocol or registration information.
3. [No]

P6. Methods / Eligibility criteria: The methods section specifies study characteristics and report characteristics used as criteria for eligibility, giving rationale.
1. Yes
2. The methods section describes the inclusion and exclusion criteria used to identify studies, including the rationale for these criteria.
3. [Yes]

P7. Methods / Information sources: The methods section describes all information sources used in the search and date last searched.
1. Yes
2. The methods section describes the information sources used in the search and states that the search was conducted from January 1990 to January 2012.
3. [Yes]

P8. Methods / Search: The methods section presents the full electronic search strategy for at least one database, including any limits used.
1. Yes
2. The methods section describes the search strategy used, including the databases searched and the search terms used.
3. [Yes]

P9. Methods / Study selection: The methods section states the process for selecting studies.
1. Yes
2. The methods section describes the process for selecting studies, including screening abstracts, retrieving full-text articles, and screening them in detail.
3. [Yes]

P10. Methods / Data collection process: The methods section describes the method of data extraction from reports and any processes for obtaining and confirming data from investigators.
1. Yes
2. The methods section describes the data extraction process and states that authors were contacted for additional information when needed.
3. [Yes]

P11. Methods / Data items: The methods section lists and defines all variables for which data were sought and any assumptions and simplifications made.
1. Yes
2. The methods section describes the data items sought, including the primary outcome measure (IAA formation) and secondary outcomes (WI and SBO).
3. [Yes]

P12. Methods / Risk of bias in individual studies: The methods section describes the methods used for assessing risk of bias of individual studies and how this information is to be used in any data synthesis.
1. Yes
2. The methods section does not explicitly describe the methods used for assessing risk of bias, but it does mention that the majority of the included studies had Level II-1 or II-2 evidence.
3. [Yes]

P13. Methods / Summary measures: The methods section states the principal summary measures.
1. Yes
2. The methods section states the principal summary measures as odds ratios (OR) and 95% confidence intervals (CI).
3. [Yes]

P14. Methods / Synthesis of results: The methods section describes the methods of handling data and combining results of studies, if done, including measures of consistency for each meta-analysis.
1. No relevant quote found.
2. No information is provided about the methods of handling data and combining results of studies.
3. [NA]

P15. Methods / Risk of bias across studies: The methods section specifies any assessment of risk of bias that may affect the cumulative evidence.
1. No relevant quote found.
2. No information is provided about any assessment of risk of bias across studies.
3. [NA]

P16. Methods / Additional analyses: The methods section describes methods of additional analyses, if done, indicating which were pre-specified.
1. No relevant quote found.
2. No information is provided about any additional analyses conducted.
3. [NA]

P17. Results / Study selection: The results section gives numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
1. Yes
2. The results section provides the number of studies screened, assessed for eligibility, and included in the review, but does not provide a flow diagram.
3. [Yes]

P18. Results / Study characteristics: The results section presents characteristics for which data were extracted and provides the citations.
1. Yes
2. The results section presents characteristics of the included studies, including the number of patients and the incidence of IAA, WI, and SBO, and provides the citations.
3. [Yes]

P19. Results / Risk of bias within studies: The results section presents data on risk of bias of each study and any outcome level assessment.
1. No relevant quote found.
2. No information is provided about the risk of bias of each study.
3. [NA]

P20. Results / Results of individual studies: The results section presents simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot.
1. Yes
2. The results section presents the incidence of IAA, WI, and SBO for each intervention group and provides odds ratios and 95% confidence intervals.
3. [Yes]

P21. Results / Synthesis of results: The results section presents the results of each meta-analysis done, including confidence intervals and measures of consistency.
1. No relevant quote found.
2. No information is provided about any meta-analyses conducted.
3. [NA]

P22. Results / Risk of bias across studies: The results section presents the results of any assessment of risk of bias across studies.
1. No relevant quote found.
2. No information is provided about any assessment of risk of bias across studies.
3. [NA]

P23. Results / Additional analysis: The results section gives results of additional analyses, if done, indicating which were pre-specified.
1. No relevant quote found.
2. No information is provided about any additional analyses conducted.
3. [NA]

P24. Discussion / Summary of evidence: The discussion section summarizes the main findings including the strength of evidence for each main outcome and considers their relevance to key groups.
1. Yes
2. The discussion section summarizes the main findings, including the incidence of IAA, WI, and SBO, and discusses their relevance to pediatric patients.
3. [Yes]

P25. Discussion / Limitations: The discussion section discusses limitations at study and outcome level, and at review-level.
1. Yes
2. The discussion section discusses the limitations of the included studies, including the lack of Level I evidence, and the limitations of the review, such as the potential for bias in reporting WI.
3. [Yes]

P26. Discussion / Conclusions: The discussion section provides a general interpretation of the results in the context of other evidence and implications for future research.
1. Yes
2. The discussion section provides a general interpretation of the results and discusses the implications for future research.
3. [Yes]

P27. Funding: The publication describes sources of funding for the systematic review and other support, and the role of funders for the systematic review.
1. No relevant quote found.
2. No information is provided about the sources of funding for the systematic review.
3. [No]</pre>
<p><a name='127'></a></p>
</div>
<div id="nicolau-2011" class="section level4">
<h4><a href='https://doi.org/pmid:21520776' title='Open publication'>Nicolau
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Is laparoscopy still needed in blunt abdominal trauma?&quot;</span> - [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study is to assess the role of laparoscopy in the diagnosis and therapy of BAT.&quot;</span> - [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopy is not as frequently applied as anticipated at the beginning of laparoscopic revolution in the ’90s.&quot;</span> - [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study is to assess the role of laparoscopy in the diagnosis and therapy of BAT.&quot;</span> - [Yes]
P5. Methods / Protocol and registration: Not reported - [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All articles referring to pediatric surgery, penetrating trauma, nontraumatic abdominal emergencies, iatrogenic injury were excluded.&quot;</span> - [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A comprehensive literature search was performed on the U.S. National Library of Medicine site in Medline and PubMed from 1 Ian 2000 to 31 Dec 2007 using keywords such as 'laparoscopy and blunt abdominal trauma'.&quot;</span> - [Yes]
P8. Methods / Search: Not reported - [No]
P9. Methods / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

articles were reviewed, which included 22
case studies, 27 case reports, 17 reviews and 2 guidelines' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎66 articles were reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines.&quot;</span> - [Yes]
P10. Methods / Data collection process: Not reported - [No]
P11. Methods / Data items: Not reported - [No]
P12. Methods / Risk of bias in individual studies: Not reported - [No]
P13. Methods / Summary measures: Not reported - [No]
P14. Methods / Synthesis of results: [NA]
P15. Methods / Risk of bias across studies: [NA]
P16. Methods / Additional analyses: [NA]
P17. Results / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):

articles were reviewed, which included 22
case studies, 27 case reports, 17 reviews and 2 guidelines' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎66 articles were reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines.&quot;</span> - [Yes]
P18. Results / Study characteristics: Not reported - [No]
P19. Results / Risk of bias within studies: Not reported - [No]
P20. Results / Results of individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):

343 patients with BAT were approached using
laparoscopy, with one therapeutic laparoscopy possible in
48,98% patients (168/343),and 14,87% in need of conversion
(51/343' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎343 patients with BAT were approached using laparoscopy, with one therapeutic laparoscopy possible in 48,98% patients (168/343), and 14,87% in need of conversion (51/343).&quot;</span> - [Yes]
P21. Results / Synthesis of results: [NA]
P22. Results / Risk of bias across studies: [NA]
P23. Results / Additional analysis: [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopy is still an effective and safe diagnostic and therapeutic tool, which can significantly reduce the number of unnecessary laparotomies.&quot;</span> - [Yes]
P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):

The main limitations attributed to laparoscopy were the
lack of adequate equipment and trained medical personnel,
the issue of general anesthesia, the fact that it is invasive,
expensive, and does not allow a proper visualization of
hollow organ injuries' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The main limitations attributed to laparoscopy were the lack of adequate equipment and trained medical personnel, the issue of general anesthesia, and the fact that it is invasive, expensive, and does not allow a proper visualization of hollow organ injuries.&quot;</span> - [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In carefully selected cases with BAT, laparoscopy is still an effective and safe diagnostic and therapeutic tool.&quot;</span> - [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The author does not have any conflict of interest.&quot;</span> - [Yes]</pre>
<p><a name='128'></a></p>
</div>
<div id="oliveira-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2015.10.003' title='Open publication'>Oliveira
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Neophalloplasty in boys with aphallia: A systematic review&quot;</span> - [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this systematic review was to assess all available literature on neophalloplasty in infancy with an interest in technical alternatives and clinical outcome.&quot;</span> - [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Aphallia is a rare penile congenital abnormality. The aim of this systematic review was to assess all available literature on neophalloplasty in infancy with an interest in technical alternatives and clinical outcome.&quot;</span> - [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this systematic review was to assess all available literature on neophalloplasty in infancy with an interest in technical alternatives and clinical outcome.&quot;</span> - [Yes]
P5. Methods / Protocol and registration: Not reported - [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a Pubmed search using the terms: neophalloplasty, neophallus, and phalloplasty, and selected articles that presented technical alternatives for penile construction in cases of penile dysgenesis, especially aphallia in children and/or adolescents.&quot;</span> - [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a Pubmed search using the terms: neophalloplasty, neophallus, and phalloplasty, and selected articles that presented technical alternatives for penile construction in cases of penile dysgenesis, especially aphallia in children and/or adolescents.&quot;</span> - [Yes]
P8. Methods / Search: Not reported - [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a Pubmed search using the terms: neophalloplasty, neophallus, and phalloplasty, and selected articles that presented technical alternatives for penile construction in cases of penile dysgenesis, especially aphallia in children and/or adolescents.&quot;</span> - [Yes]
P10. Methods / Data collection process: Not reported - [No]
P11. Methods / Data items: Not reported - [No]
P12. Methods / Risk of bias in individual studies: Not reported - [No]
P13. Methods / Summary measures: Not reported - [NA]
P14. Methods / Synthesis of results: Not applicable (no meta-analysis) - [NA]
P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis) - [NA]
P16. Methods / Additional analyses: Not applicable (no meta-analysis) - [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 319 articles were identified in the initial search. Among the different techniques presented in 19 papers collected, we categorized reconstructive procedures into two groups: microsurgical and non-microsurgical techniques.&quot;</span> - [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Among the different techniques presented in the 19 papers collected initially, we were able to assemble reconstructive procedures into two groups: microsurgical and non-microsurgical techniques.&quot;</span> - [Yes]
P19. Results / Risk of bias within studies: Not reported - [No]
P20. Results / Results of individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):

Among the different techniques presented in 19 papers collected, we categorized reconstructive procedures into two groups: microsurgical and non-microsurgical techniques' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Among the different techniques presented in the 19 papers collected, we categorized reconstructive procedures into two groups: microsurgical and non-microsurgical techniques.&quot;</span> - [Yes]
P21. Results / Synthesis of results: Not applicable (no meta-analysis) - [NA]
P22. Results / Risk of bias across studies: Not applicable (no meta-analysis) - [NA]
P23. Results / Additional analysis: Not applicable (no meta-analysis) - [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Taking recent literature into account, it seems rational that neophalloplasty be regarded as the preferred strategy for boys born with aphallia.&quot;</span> - [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies reporting on late clinical presentation post puberty, specifically in regards to sexual development-pleasure and quality of life, are still lacking.&quot;</span> - [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As a personal input, based on this review and considering our personal experience, we still believe that flap techniques should be the first choice when treating a child with penile agenesis.&quot;</span> - [Yes]
P27. Funding: Not reported - [No]

In summary, out of the 27 PRISMA items:
- 14 items were reported
- 10 items were not reported
- 3 items were not applicable</pre>
<p><a name='129'></a></p>
</div>
<div id="oomen-2012" class="section level4">
<h4><a href='https://doi.org/10.1007/S00464-012-2174-Y' title='Open publication'>Oomen
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Open Versus Laparoscopic Pyloromyotomy for Hypertrophic Pyloric Stenosis: A Systematic Review and Meta-Analysis Focusing on Major Complications&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to compare the results of both surgical strategies by means of a systematic review and meta-analysis of the available literature.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There is an ongoing debate about whether laparoscopic pyloromyotomy (LP) or open pyloromyotomy (OP) is the best option for treating hypertrophic pyloric stenosis (HPS).&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):

the aim of this study was to compare the results of LP and open pyloromyotomy (OP) by means of a systematic review of the available randomized trials while focusing on major complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The aim of this study was to compare the results of LP and OP by means of a systematic review of the available randomized trials while focusing on major complications.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: No information provided.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were included in the review if they were RCTs that compared the results of LP and OP in children with HPS with admission time after pyloromyotomy and postoperative complication rate as outcomes.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic search for RCTs that compared open and LP was conducted. Retrieval of studies was performed through a systematic search of the databases PubMed, Ovid (Ovid Technologies, New York, NY) and Cochrane (Cochrane database of systematic reviews).&quot;</span>
[Yes]

P8. Methods / Search: No information provided.
[No]

P9. Methods / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

Potentially eligible studies were reviewed independently by two authors (MWNO, RB) for inclusion and exclusion criteria' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Potentially eligible studies were reviewed independently by two authors for inclusion and exclusion criteria.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

data on setting, methodological quality [according to the Cochrane handbook for systematic reviews of interventions (http://dcc.cochrane.org/sites/dcc.cochrane.org/files/uploads/RCT)], population, and type of surgery were extracted by two authors independently, as well as data on primary and secondary outcome measures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data on setting, methodological quality, population, and type of surgery were extracted by two authors independently, as well as data on primary and secondary outcome measures.&quot;</span>
[Yes]

P11. Methods / Data items: No information provided.
[No]

P12. Methods / Risk of bias in individual studies: No information provided.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Results for comparisons of dichotomous outcomes (e.g., major postoperative complications) are expressed as risk differences [or absolute risk reduction, ARR) with 95% confidence intervals (CI)].&quot;</span>
[Yes]

P14. Methods / Synthesis of results: [NA]

P15. Methods / Risk of bias across studies: [NA]

P16. Methods / Additional analyses: [NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial search yielded 361 potentially relevant articles, of which 346 articles were excluded because of failure to meet the inclusion criteria.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Four RCTs with a total of 502 patients (OP 255, LP 247) fulfilled the inclusion criteria and were analyzed in this review.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All studies included in this review reported major complications, with a total of 12 (4.9%) major complications in children who underwent LP and 5 (2.0%) in the OP group.&quot;</span>
[Yes]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The forest plot comparing major postoperative complications is shown in Fig. 2.&quot;</span>
[Yes]

P21. Results / Synthesis of results: [NA]

P22. Results / Risk of bias across studies: [NA]

P23. Results / Additional analysis: [NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In our systematic review of high-level evidence, LP was found to be superior to OP with respect to a shorter time to full feed but not regarding (major) postoperative complications or length of hospital stay.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There are still contradictory results in the literature with regard to the benefits and disadvantages of LP compared to the open procedure to treat infants with HPS.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In this systematic review we summarized all RCTs available in the pediatric surgical literature, focusing mainly on major complications that need surgical reintervention in patients with HPS. However, our results show no clear benefit of the laparoscopic procedure over the open operation.&quot;</span>
[Yes]

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Dr. M. W. N. Oomen, Dr. L. T. Hoekstra, Dr. R. Bakx, Dr. D. T. Ubbink, and Prof. Dr. H. A. Heij have no conflicts of interest or financial ties to disclose.&quot;</span>
[Yes]</pre>
<p><a name='130'></a></p>
</div>
<div id="parolini-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.10.043' title='Open publication'>Parolini
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

he management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem&quot;</span>
[Yes] The report is identified as a systematic review.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study provides a systematic review of epidemiology, diagnosis, management and short-term results of children with EA and RAA.&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The management of newborns with esophageal atresia (EA) and right aortic arch (RAA) is still an unsolved problem.&quot;</span>
[Yes] The rationale for the review is described.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study provides a systematic review of epidemiology, diagnosis, management and short-term results of children with EA and RAA.&quot;</span>
[Yes] The objectives of the review are explicitly stated.

P5. Methods / Protocol and registration: Not applicable (no mention of a review protocol or registration number).
[NA]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were English language articles reporting original data on epidemiology, diagnosis and treatment of newborns with EA.&quot;</span>
[Yes] The study characteristics and report characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PubMed database was searched for studies of children with EA and RAA published from January 1990 to December 2014.&quot;</span>
[Yes] The information sources are described.

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PubMed database was searched for studies of children with EA and RAA published from January 1990 to December 2014.&quot;</span>
[Yes] The full electronic search strategy for at least one database is presented.

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Inclusion criteria were English language articles reporting original data on epidemiology, diagnosis and treatment of newborns with EA.&quot;</span>
[Yes] The process for selecting studies is stated.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two independent authors extracted information related to each eligible study.&quot;</span>
[Yes] The method of data extraction is described.

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎For each study, data were extracted for the following outcomes: overall number of patients, associated cardiovascular anomalies, type of surgical repair, morbidity and mortality rate.&quot;</span>
[Yes] The variables for which data were sought are listed.

P12. Methods / Risk of bias in individual studies: Not applicable (no mention of risk of bias assessment).
[NA]

P13. Methods / Summary measures: Not applicable (no mention of summary measures).
[NA]

P14. Methods / Synthesis of results: Not applicable (no mention of data synthesis).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no mention of risk of bias assessment across studies).
[NA]

P16. Methods / Additional analyses: Not applicable (no mention of additional analyses).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eight eligible articles met the inclusion criteria.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are provided.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Eight eligible articles met the inclusion criteria.&quot;</span>
[Yes] The characteristics for which data were extracted are mentioned.

P19. Results / Risk of bias within studies: Not applicable (no mention of risk of bias assessment within studies).
[NA]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎RAA was encountered in 3.6% of infants.&quot;</span>
[Yes] The results of individual studies are presented.

P21. Results / Synthesis of results: Not applicable (no mention of data synthesis).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no mention of risk of bias assessment across studies).
[NA]

P23. Results / Additional analysis: Not applicable (no mention of additional analyses).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The surgical treatment of an infant with EA and RAA is technically challenging and most studies reported some operative difficulties.&quot;</span>
[Yes] The main findings are summarized.

P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 96.8%):

This systematic review had some inherent limitations. Firstly, it includes a relatively small number of patients, and many endpoints of the study could not be compared in a statistically significant way. Secondly, all eligible studies were retrospective case series without a control ar' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This systematic review had some inherent limitations, including a relatively small number of patients and retrospective case series without a control arm.&quot;</span>
[Yes] The limitations of the review are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A multicenter prospective study comparing RT and LT in infants with EA and RAA is strongly required.&quot;</span>
[Yes] The general interpretation of the results and implications for future research are provided.

P27. Funding: Not mentioned.
[NA]</pre>
<p><a name='131'></a></p>
</div>
<div id="parolini-2014" class="section level4">
<h4><a href='https://doi.org/10.1016/J.IJPORL.2014.04.011' title='Open publication'>Parolini
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Cervical/thoracotomic/thoracoscopic approaches for H-type congenital tracheo-esophageal fistula: A systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not provided. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction from reports is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results of studies. [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not given. [No]
P18. Results / Study characteristics: The characteristics of each study are not presented. [No]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are not presented. [No]
P20. Results / Results of individual studies: The results of individual studies are not presented. [No]
P21. Results / Synthesis of results: No information is provided about the synthesis of results. [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P23. Results / Additional analysis: No information is provided about additional analyses. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized. [Yes]
P25. Discussion / Limitations: The limitations at study and outcome level, as well as at review-level, are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: No information is provided about the sources of funding for the systematic review. [No]</pre>
<p><a name='132'></a></p>
</div>
<div id="peters-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2012.11.049' title='Open publication'>Peters
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Morbidity and mortality in total esophagogastric dissociation: A systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: No abstract or structured summary provided [No]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Total esophagogastric dissociation has been described as both a primary and a rescue procedure for patients with severe gastroesophageal reflux.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main objective of this study was to determine morbidity and mortality for this procedure.&quot;</span> [Yes]
P5. Methods / Protocol and registration: No information provided about a review protocol or registration [No]
P6. Methods / Eligibility criteria: No information provided about study or report characteristics used as eligibility criteria [No]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Medline, PubMed, National Library of Health and Google Scholarly articles from year 1997 to August 2011 were searched.&quot;</span> [Yes]
P8. Methods / Search: No full electronic search strategy provided [No]
P9. Methods / Study selection: No information provided about the process for selecting studies [No]
P10. Methods / Data collection process: No information provided about the method of data extraction [No]
P11. Methods / Data items: No information provided about the variables for which data were sought [No]
P12. Methods / Risk of bias in individual studies: No information provided about methods used for assessing risk of bias [No]
P13. Methods / Summary measures: No information provided about the principal summary measures [No]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis [NA]
P17. Results / Study selection: No information provided about the numbers of studies screened, assessed for eligibility, and included in the review [No]
P18. Results / Study characteristics: No information provided about the characteristics of the included studies [No]
P19. Results / Risk of bias within studies: No information provided about the risk of bias of each study [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎One hundred eighty-one cases were identified.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis [NA]
P23. Results / Additional analysis: Not applicable, as there is no additional analysis [NA]
P24. Discussion / Summary of evidence: No summary of evidence provided [No]
P25. Discussion / Limitations: No discussion of limitations provided [No]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Esophagogastric dissociation has an acceptable morbidity and mortality. It is useful as both a primary and a rescue procedure.&quot;</span> [Yes]
P27. Funding: No information provided about funding sources [No]</pre>
<p><a name='133'></a></p>
</div>
<div id="peycelon-2014" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0034-1396419' title='Open publication'>Peycelon
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally Invasive Surgery in Childhood Cancer: A Challenging Future&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this review is to update the use of MIS in pediatric oncological surgery over the past five years.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive surgery (MIS) has emerged as an alternative to open approach for cancer diagnosis in children ∼20 years ago, but only recently for tumor resection.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this review is to update the use of MIS in pediatric oncological surgery over the past five years.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: Not reported [No]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our review focuses on the data from the past five years from 2009 to 2014 to try to delineate the new upcoming events in the field of MIS in childhood cancer.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors conducted a systematic review of papers published between 2009 and 2014 focusing on indications and results of the technique.&quot;</span> [Yes]
P10. Methods / Data collection process: Not reported [No]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: Not applicable [NA]
P13. Methods / Summary measures: Not reported [No]
P14. Methods / Synthesis of results: Not applicable [NA]
P15. Methods / Risk of bias across studies: Not applicable [NA]
P16. Methods / Additional analyses: Not applicable [NA]
P17. Results / Study selection: Not reported [No]
P18. Results / Study characteristics: Not reported [No]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎New indications in Wilms tumor, pheochromocytoma, and lung nodules have emerged, thanks to the growing use of MIS in benign urological and thoracic surgery with satisfactory results.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable [NA]
P22. Results / Risk of bias across studies: Not applicable [NA]
P23. Results / Additional analysis: Not applicable [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MIS is a promising method for removal of thoracic and abdominal malignancies as long as oncological principles are strictly followed.&quot;</span> [Yes]
P25. Discussion / Limitations: Not reported [No]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MIS, regardless of the approach—thoracoscopy, laparoscopy, retroperitoneoscopy, robot-assisted—is a new field in pediatric solid tumors with no randomized trials to date.&quot;</span> [Yes]
P27. Funding: Not reported [No]</pre>
<p><a name='134'></a></p>
</div>
<div id="pfistermuller-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2014.12.006' title='Open publication'>Pfistermuller
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Meta-analysis of complication rates of the tubularized incised plate (TIP) repair&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To determine overall complication rates of the tubularized incised plate (TIP) repair and assess the effects of technical modifications, length of follow-up and geographical location of reported results.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

There is a wide discrepancy between published complication rates for different repair types [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16] and a poor evidence base for the current management of hypospadias' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎There is a wide discrepancy between published complication rates for different repair types and a poor evidence base for the current management of hypospadias.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

Assessing the appropriateness of its application to all degrees of hypospadias.
    2.

    Evaluating the long-term results by analysing the pooled complication rates to accurately determine representative complication rates for this technique.
    3.

    Reviewing the effects of technical modifications, length of follow-up and geographical location of these complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Assessing the appropriateness of its application to all degrees of hypospadias; Evaluating the long-term results by analyzing the pooled complication rates to accurately determine representative complication rates for this technique; Reviewing the effects of technical modifications, length of follow-up and geographical location of these complications.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):

Paediatric populations solely
    2.

    TIP technique used
    3.

    Complications given for at least one of those under consideration
    4.

    Population previously unreported
    5.

    Article in English
    6.

    No foreskin reconstruction
    7.

    Results separated by meatal location and primary or secondary repair' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Paediatric populations solely; TIP technique used; Complications given for at least one of those under consideration; Population previously unreported; Article in English; No foreskin reconstruction; Results separated by meatal location and primary or secondary repair.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Medline and Pubmed were searched in order to identify articles published between 1994 and 2012.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎49 studies (4675 patients) were included in the analysis.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

The following data were extracted independently from each article by two reviewers (K.P and P.C): study size; degree of hypospadias (classified by meatal location: distal – midshaft distally, proximal – proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The following data were extracted independently from each article by two reviewers: study size; degree of hypospadias; primary or secondary repair; repair type; modification; mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.&quot;</span> [Yes]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: Not reported [NA]
P14. Methods / Synthesis of results: Not applicable (no meta-analysis) [NA]
P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P16. Methods / Additional analyses: Not applicable (no additional analyses) [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎49 studies (4675 patients) were included in the analysis.&quot;</span> [Yes]
P18. Results / Study characteristics: Not reported [No]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):

Fistula and re-operation rates were significantly higher in secondary repairs (15.5% and 23.3%) compared to primary proximal (10.3% and 12.2%) and primary distal' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Fistula and re-operation rates were significantly higher in secondary repairs compared to primary proximal and primary distal repairs.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable (no meta-analysis) [NA]
P22. Results / Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P23. Results / Additional analysis: Not applicable (no additional analyses) [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The present meta-analysis has shown that the lowest complication rates for the TIP repair are when it is applied to primary distal hypospadias.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Documentation of follow-up duration was limited, making assessment of the impact of length of follow-up difficult.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The TIP repair has evolved to incorporate modifications that have significantly lowered complications.&quot;</span> [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎None of the authors have any conflicts of interest or funding to declare.&quot;</span> [Yes]</pre>
<p><a name='136'></a></p>
</div>
<div id="reddy-2010" class="section level4">
<h4><a href='https://doi.org/10.4103/0970-1591.74459' title='Open publication'>Reddy
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Ureteroscopy: The standard of care in the management of upper tract urolithiasis in children&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this review article is to demonstrate that ureteroscopic lithotripsy is now to be considered the standard of care in the management of upper tract urolithiasis in the pediatric patient, replacing shockwave lithotripsy (ESWL) as the first line of therapy.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this study is to determine whether the safety and efficacy of URS now warrant it being considered the standard of care and the first line of therapy in the management of pediatric urolithiasis.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this review article is to demonstrate that ureteroscopic lithotripsy is now to be considered the standard of care in the management of upper tract urolithiasis in the pediatric patient, replacing shockwave lithotripsy (ESWL) as the first line of therapy.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not applicable (no mention of a protocol or registration)
[NA]

P6. Methods / Eligibility criteria: Not applicable (no mention of study or report characteristics used as eligibility criteria)
[NA]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review of articles written about ureteroscopy (URS) in the contemporary urological literature (1990-2009) on PubMed was undertaken.&quot;</span>
[Yes]

P8. Methods / Search: Not reported
[No]

P9. Methods / Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review of the contemporary urological citations was conducted using the National Library of Medicine (PubMed) search engine. We included only those papers that discussed original series of patients in this review.&quot;</span>
[Yes]

P11. Methods / Data items: Not reported
[No]

P12. Methods / Risk of bias in individual studies: Not reported
[No]

P13. Methods / Summary measures: Not reported
[No]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis conducted)
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis conducted)
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses conducted)
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 27 papers that met the inclusion criteria for this review were identified and the data were abstracted.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Over the past 20 years, the results of 832 pediatric patients (mean age, 9.4 years) managed with URS to treat stones have been published in the urological literature.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The success rate of URS is 93.4% (compared with 80.3% for ESWL). The complication rate associated with the URS procedures is 5.9% (compared with 8.4% for ESWL).&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis conducted)
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis conducted)
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses conducted)
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎URS is safe and efficacious in the management of pediatric urolithiasis. URS should be considered an essential part of the armamentarium of any urologist involved in the care of children and is now considered the standard of care for the management of pediatric urolithiasis.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎URS is shown to be safer and more efficacious than ESWL in the management of pediatric urolithiasis.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎URS is safe and efficacious in the management of pediatric urolithiasis. URS should be considered an essential part of the armamentarium of any urologist involved in the care of children and is now considered the standard of care for the management of pediatric urolithiasis.&quot;</span>
[Yes]

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Source of Support: Nil&quot;</span>
[Yes]</pre>
<p><a name='137'></a></p>
</div>
<div id="romao-2012" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2012.01.009' title='Open publication'>Romao
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎What is the best prosthetic material for patch repair of congenital diaphragmatic hernia? Comparison and meta-analysis of porcine small intestinal submucosa and polytetrafluoroethylene&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎What is the best prosthetic material for patch repair of congenital diaphragmatic hernia?&quot;</span>
2. Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.
3. Response: [Yes]

P2. Abstract / Structured summary: Not reported
Response: [No]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recurrence rates for patch CDH repair can be as high as 50% [5], [6], and so far, the ideal material for diaphragmatic replacement has yet to be found.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Recurrence rates for patch CDH repair can be as high as 50% [5], [6], and so far, the ideal material for diaphragmatic replacement has yet to be found.&quot;</span>
2. Reasoning: The introduction provides the rationale for the review in the context of what is already known.
3. Response: [Yes]

P4. Introduction / Objectives: Not reported
Response: [No]

P5. Methods / Protocol and registration: Not reported
Response: [No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To be selected, a study had to evaluate an absorbable (SIS) and a nonabsorbable (PTFE) material for CDH patch repair and provide relevant and interpretable data.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To be selected, a study had to evaluate an absorbable (SIS) and a nonabsorbable (PTFE) material for CDH patch repair and provide relevant and interpretable data.&quot;</span>
2. Reasoning: The eligibility criteria for the included studies are clearly described.
3. Response: [Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All publications describing both absorbable (SIS) and nonabsorbable (PTFE) material for treatment of CDH were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) database.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All publications describing both absorbable (SIS) and nonabsorbable (PTFE) material for treatment of CDH were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials (CENTRAL) database.&quot;</span>
2. Reasoning: The information sources for the literature search are clearly described.
3. Response: [Yes]

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The terms CDH, patch, Surgisis, and PTFE were mapped to their MeSH terms and then combined.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The terms CDH, patch, Surgisis, and PTFE were mapped to their MeSH terms and then combined.&quot;</span>
2. Reasoning: The full electronic search strategy is provided.
3. Response: [Yes]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three authors (RR, AN, and JL) independently assessed all published articles and identified as potentially relevant by the literature search for inclusion in the review.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Three authors (RR, AN, and JL) independently assessed all published articles and identified as potentially relevant by the literature search for inclusion in the review.&quot;</span>
2. Reasoning: The process for selecting studies is clearly described.
3. Response: [Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors (RR and AN) independently extracted data from the retrieved articles.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors (RR and AN) independently extracted data from the retrieved articles.&quot;</span>
2. Reasoning: The method of data extraction is clearly described.
3. Response: [Yes]

P11. Methods / Data items: Not reported
Response: [No]

P12. Methods / Risk of bias in individual studies: Not reported
Response: [No]

P13. Methods / Summary measures: Not reported
Response: [No]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis performed)
Response: [NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis performed)
Response: [NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses performed)
Response: [NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the study period, 84 patients underwent CDH repair. Of these, 22 (26%) required a patch (13 SIS and 9 PTFE).&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the study period, 84 patients underwent CDH repair. Of these, 22 (26%) required a patch (13 SIS and 9 PTFE).&quot;</span>
2. Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are provided.
3. Response: [Yes]

P18. Results / Study characteristics: Not reported
Response: [No]

P19. Results / Risk of bias within studies: Not reported
Response: [No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary patch (13 SIS, 9 PTFE) repair was performed in 22 (26%) of 84 patients with CDH.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary patch (13 SIS, 9 PTFE) repair was performed in 22 (26%) of 84 patients with CDH.&quot;</span>
2. Reasoning: The results of individual studies are presented.
3. Response: [Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis performed)
Response: [NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis performed)
Response: [NA]

P23. Results / Additional analysis: Not applicable (no additional analyses performed)
Response: [NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We found no difference in complication rates between SIS and PTFE patch repairs for patients with CDH.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We found no difference in complication rates between SIS and PTFE patch repairs for patients with CDH.&quot;</span>
2. Reasoning: The main findings are summarized, including the strength of evidence.
3. Response: [Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Retrospective cohort studies are particularly susceptible to bias, especially patient selection.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Retrospective cohort studies are particularly susceptible to bias, especially patient selection.&quot;</span>
2. Reasoning: The limitations of the study are discussed.
3. Response: [Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both patch materials resulted in a similarly high incidence and pattern of CDH recurrence and risk of SBO.&quot;</span>
1. Relevant quote: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Both patch materials resulted in a similarly high incidence and pattern of CDH recurrence and risk of SBO.&quot;</span>
2. Reasoning: A general interpretation of the results is provided in the context of other evidence.
3. Response: [Yes]

P27. Funding: Not reported
Response: [No]</pre>
<p><a name='138'></a></p>
</div>
<div id="ross-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3691-2' title='Open publication'>Ross
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The role of preformed silos in the management of infants with gastroschisis: a systematic review and meta-analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review and meta-analysis of the literature comparing use of a PFS with alternate treatment strategies.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The optimum surgical treatment of infants born with gastroschisis remains unclear.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.1%):

to evaluate current evidence comparing the use of a PFS with alternate treatment strategies in infants with gastroschisis' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We aimed to evaluate current evidence comparing the use of a PFS with alternate treatment strategies in infants with gastroschisis.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were selected for inclusion in the review if they reported comparative outcomes between infants treated with a PFS and infants treated with an alternate treatment strategy.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched Medline, Embase and the Cochrane controlled trials register from inception to July 2014 using the terms 'gastroschisis', 'gastroschisis and silo', 'preformed silo' and 'silastic silo'.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were selected for inclusion in the review if they reported comparative outcomes between infants treated with a PFS and infants treated with an alternate treatment strategy.&quot;</span>
[Yes]

P10. Methods / Data collection process: Not reported.
[No]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All outcomes were selected a priori. The primary outcome measure was time on a ventilator. Secondary outcomes were number of infants never ventilated, time on parenteral nutrition (PN), time to achieve full enteral feeds, length of hospital stay, incidence of necrotising enterocolitis, number of unplanned re-operations, infectious complications, mortality and occurrence of ventral hernia following repair.&quot;</span>
[Yes]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mean difference (MD) between continuous variables and 95 % confidence intervals were calculated. Risk difference and 95 % CI were determined for dichotomous data.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not applicable.
[NA]

P15. Methods / Risk of bias across studies: Not applicable.
[NA]

P16. Methods / Additional analyses: Not applicable.
[NA]

P17. Results / Study selection: <span title='Moderate quote deviation. Best match in fulltext (Similarity 91.3%):

One-thousand five-hundred and sixty-seven articles were identified using the specified search criteria and their abstracts reviewed. Following application against our inclusion criteria, 1440 were excluded on the basis of their abstract alone and the full text of 127 publications was scrutinised. One hundred and seven of these were subsequently excluded as they did not report a comparative group, did not use a PFS, or did not report outcomes from a group all treated with a PFS. Two further reports were excluded' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎One-thousand five-hundred and sixty-seven articles were identified using the specified search criteria and their abstracts reviewed. Following application against our inclusion criteria, 1440 were excluded on the basis of their abstract alone and the full text of 127 publications was scrutinised. One hundred and seven of these were subsequently excluded as they did not report a comparative group, did not use a PFS, or did not report outcomes from a group all treated with a PFS. The remaining 18 publications were included in this systematic review.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of these 18, four met the criteria for inclusion in the subgroup analysis.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome of number of days of ventilation was reported in 8 studies (641 patients). In the overall analysis there was no statistically significant difference in number of days of ventilation between infants treated with a PFS and alternate techniques.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable.
[NA]

P22. Results / Risk of bias across studies: Not applicable.
[NA]

P23. Results / Additional analysis: Not applicable.
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review demonstrates that use of a PFS results in largely equivalent outcomes compared to alternate treatment approaches for infants with gastroschisis.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The quality of evidence comparing PFS with alternate treatment strategies for gastroschisis is poor.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Further investigation is required to identify not only the optimal treatment pathway for infants with gastroschisis which will likely include a case by case decision algorithm, but also the tools by which to measure success.&quot;</span>
[Yes]

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study highlights the lack of high-quality evidence regarding the optimum treatment strategy for infants with gastroschisis.&quot;</span>
[Yes]</pre>
<p><a name='139'></a></p>
</div>
<div id="ruttenstock-2010" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-010-2695-1' title='Open publication'>Ruttenstock
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprung’s disease&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not provided. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction from reports is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results of studies. [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses. [NA]
P17. Results / Study selection: No numbers of studies screened, assessed for eligibility, and included in the review are given. [No]
P18. Results / Study characteristics: No characteristics for which data were extracted are presented. [No]
P19. Results / Risk of bias within studies: No data on risk of bias of each study are presented. [No]
P20. Results / Results of individual studies: No simple summary data or effect estimates are presented for each study. [No]
P21. Results / Synthesis of results: No results of meta-analyses are presented. [NA]
P22. Results / Risk of bias across studies: No results of assessment of risk of bias across studies are presented. [NA]
P23. Results / Additional analysis: No results of additional analyses are presented. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized. [Yes]
P25. Discussion / Limitations: Limitations at study and outcome level, and at review-level are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research are provided. [Yes]
P27. Funding: No information is provided about sources of funding for the systematic review. [No]</pre>
<p><a name='140'></a></p>
</div>
<div id="rynja-2011" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2011.02.008' title='Open publication'>Rynja
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Functional, cosmetic and psychosexual results in adult men who underwent hypospadias correction in childhood&quot;</span> - [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, methods, results, and conclusions of the study. - [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. - [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. - [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. - [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. - [Yes]
P7. Methods / Information sources: The information sources used in the search are described. - [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is presented. - [No]
P9. Methods / Study selection: The process for selecting studies is described. - [Yes]
P10. Methods / Data collection process: The method of data extraction from reports is described. - [Yes]
P11. Methods / Data items: The variables for which data were sought are listed and defined. - [Yes]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias in individual studies are described. - [No]
P13. Methods / Summary measures: The principal summary measures are stated. - [Yes]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. - [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. - [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses. - [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage. - [Yes]
P18. Results / Study characteristics: The characteristics of each study are presented. - [Yes]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are presented. - [No]
P20. Results / Results of individual studies: The results of each study are presented. - [Yes]
P21. Results / Synthesis of results: No information is provided about the synthesis of results. - [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. - [NA]
P23. Results / Additional analysis: No information is provided about additional analyses. - [NA]
P24. Discussion / Summary of evidence: The main findings are summarized, including the strength of evidence for each main outcome. - [Yes]
P25. Discussion / Limitations: The limitations of the study are discussed. - [Yes]
P26. Discussion / Conclusions: A general interpretation of the results is provided in the context of other evidence, and implications for future research are discussed. - [Yes]
P27. Funding: No information is provided about funding. - [No]</pre>
<p><a name='141'></a></p>
</div>
<div id="saldaña-2013" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2012.0467' title='Open publication'>Saldaña
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Single-Incision Pediatric Endosurgery: A Systematic Review&quot;</span> [Yes]
P2. Abstract: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Several publications exist, but no previous systematic review has been made to evaluate the real benefits of this approach in terms of feasibility and clinical outcomes.&quot;</span> [Yes]
P3. Introduction: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the search for less invasive procedures, ever since the development of laparoscopic surgery and with the limitations and equipment dependence of Natural Orifice Translumenal endoscopic surgery (NOTES®; American Society for Gastrointestinal Endoscopy [Oak Brook, IL] and Society of American Gastrointestinal and Endoscopic Surgeons [Los Angeles, CA]), this new approach through the umbilicus, a natural embrionary orifice,1 was first reported in 1992 by Pelosi and Pelosi.2 Quickly, the literature showed that SIES was a feasible and excellent cosmetic procedure pending the demonstration of its clinical and economic benefits with objective evidence.&quot;</span> [Yes]
P4. Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of this review is to show the initial published experience about SIPES to evaluate its real benefits in terms of feasibility and clinical outcomes.&quot;</span> [Yes]
P5. Protocol and registration: Not mentioned [No]
P6. Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review of the literature to find out the current state of SIPES procedures, including age, technical aspects, and operative outcomes.&quot;</span> [Yes]
P7. Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed an electronic search in PubMed up to March 2012 with the terms 'single AND incision OR site OR port OR trocar AND children' including related articles and obtained 197 articles.&quot;</span> [Yes]
P8. Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed an electronic search in PubMed up to March 2012 with the terms 'single AND incision OR site OR port OR trocar AND children' including related articles and obtained 197 articles.&quot;</span> [Yes]
P9. Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):

After applying our eligibility criteria, we selected 78 articles6–83 to be included in this systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎After applying our eligibility criteria, we selected 78 articles to be included in this systematic review.&quot;</span> [Yes]
P10. Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data extracted from these articles were further analyzed for (1) technical aspects (port and instrumentation type) and (2) operative outcomes (operative time, conversion rate, length of stay, pain assessment, and complications).&quot;</span> [Yes]
P11. Data items: Not mentioned [No]
P12. Risk of bias in individual studies: Not mentioned [No]
P13. Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Operative times, length of stay, and complications similar to standard laparoscopic surgery were described.&quot;</span> [Yes]
P14. Synthesis of results: Not applicable (no meta-analysis) [NA]
P15. Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P16. Additional analyses: Not mentioned [No]
P17. Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.&quot;</span> [Yes]
P18. Study characteristics: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> [Yes]
P19. Risk of bias within studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment.&quot;</span> [Yes]
P20. Results of individual studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> [Yes]
P21. Synthesis of results: Not applicable (no meta-analysis) [NA]
P22. Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P23. Additional analysis: Not mentioned [No]
P24. Summary of evidence: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).&quot;</span> [Yes]
P25. Limitations: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> [Yes]
P26. Conclusions: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> [Yes]
P27. Funding: Not mentioned [No]</pre>
<p><a name='142'></a></p>
</div>
<div id="sauerland-2010" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD001546.PUB3' title='Open publication'>Sauerland
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open surgery for suspected appendicitis&quot;</span> [Yes]
- The title clearly identifies the report as a systematic review comparing laparoscopic and open surgery for suspected appendicitis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare the diagnostic and therapeutic effects of laparoscopic and conventional 'open' surgery.&quot;</span> [Yes]
- The abstract provides a structured summary that includes the background, objectives, and key findings of the review.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic surgery for acute appendicitis has been proposed to have advantages over conventional surgery.&quot;</span> [Yes]
- The introduction provides the rationale for the review by stating that laparoscopic surgery has been proposed to have advantages over conventional surgery for acute appendicitis.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare the diagnostic and therapeutic effects of laparoscopic and conventional 'open' surgery.&quot;</span> [Yes]
- The objectives of the review are clearly stated as comparing the diagnostic and therapeutic effects of laparoscopic and open surgery.

P5. Methods / Protocol and registration: Not reported [No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included randomized clinical trials comparing laparoscopic (LA) versus open appendectomy (OA) in adults or children.&quot;</span> [Yes]
- The eligibility criteria are clearly stated as including randomized clinical trials comparing laparoscopic and open appendectomy in adults or children.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched the Cochrane Library, MEDLINE, EMBASE, LILACS, CNKI, SciSearch, study registries, and the congress proceedings of endoscopic surgical societies.&quot;</span> [Yes]
- The information sources used for the search are clearly described.

P8. Methods / Search: Not reported [No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers independently assessed trial quality. Missing information or data was requested from the authors.&quot;</span> [Yes]
- The process for selecting studies is described, including the assessment of trial quality and the request for missing information or data from authors.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two observers independently extracted the results of each paper on a data sheet; disagreements were resolved by discussion.&quot;</span> [Yes]
- The method of data extraction is described, including the resolution of disagreements through discussion.

P11. Methods / Data items: Not reported [No]

P12. Methods / Risk of bias in individual studies: Not reported [No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We used odds ratios (OR), relative risks (RR), and 95% confidence intervals (CI) for analysis.&quot;</span> [Yes]
- The principal summary measures used for analysis are clearly stated.

P14. Methods / Synthesis of results: Not applicable [NA]

P15. Methods / Risk of bias across studies: Not applicable [NA]

P16. Methods / Additional analyses: Not applicable [NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We included 67 studies...&quot;</span> [Yes]
- The number of studies screened, assessed for eligibility, and included in the review is clearly reported.

P18. Results / Study characteristics: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> [Yes]
- The characteristics of each study, including study size and PICOS, are reported.

P19. Results / Risk of bias within studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The quality of all included studies was moderate to poor.&quot;</span> [Yes]
- The quality of the included studies is described as moderate to poor.

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Wound infections were less likely after LA than after OA (OR 0.43; CI 0.34 to 0.54), but the incidence of intraabdominal abscesses was increased (OR 1.87; CI 1.19 to 2.93).&quot;</span> [Yes]
- The results of individual studies are reported, including the odds ratios and confidence intervals for wound infections and intraabdominal abscesses.

P21. Results / Synthesis of results: Not applicable [NA]

P22. Results / Risk of bias across studies: Not applicable [NA]

P23. Results / Additional analysis: Not applicable [NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopy can serve as a diagnostic and therapeutic tool in patients with suspected appendicitis.&quot;</span> [Yes]
- The main findings of the review, including the diagnostic and therapeutic advantages of laparoscopy, are summarized.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The quality of all included studies was moderate to poor.&quot;</span> [Yes]
- The limitations of the review, including the moderate to poor quality of the included studies, are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We would generally recommend to use laparoscopy and LA in patients with suspected appendicitis unless laparoscopy itself is contraindicated or not feasible.&quot;</span> [Yes]
- The general interpretation of the results is provided, including the recommendation to use laparoscopy and laparoscopic appendectomy in patients with suspected appendicitis.

P27. Funding: Not reported [No]

Overall, 19 out of 27 PRISMA items were reported in the full text.</pre>
<p><a name='143'></a></p>
</div>
<div id="scholfield-2016" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2015.0121' title='Open publication'>Scholfield
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic Duhamel Procedure for Hirschsprung's Disease: Systematic Review and Meta-analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study compared long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study is the first systematic review and meta-analysis comparing the two approaches.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This study compared long-term outcomes for open Duhamel (OD) and laparoscopic Duhamel (LD) procedures for HD, to identify any added advantage of the laparoscopic technique.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All studies between January 1994 and December 2014 were included in the search, as the first LD pull-through was described in 1994.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic PubMed search was performed to identify publications that analyzed outcomes for LD or OD pull-through procedures for HD.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All studies assessing functional outcome for OD and/or LD procedures were analyzed for eligibility, including randomized control trials and observational studies.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data collected included study characteristics (author, journal, publication year, sample size, length of follow-up, and operative technique) and patient demographics (sex and age at surgery).&quot;</span>
[Yes]

P11. Methods / Data items: Not reported.
[No]

P12. Methods / Risk of bias in individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Their risk of bias was assessed and summarized.&quot;</span>
[Yes]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Odds ratios (ORs) were calculated for dichotomous variables using the Mantel–Haenszel method, and mean differences (MDs) were measured for continuous variables using the inverse variance method.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not applicable.
[NA]

P15. Methods / Risk of bias across studies: Not applicable.
[NA]

P16. Methods / Additional analyses: Not applicable.
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎From 11 articles 456 patients were included (253 OD, 203 LD), with no significant difference in age at surgery and length of follow-up (P > .05).&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Four hundred fifty-six patients with HD were included in this review (range, 20–76 patients per study).&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The open group had a significantly greater incidence of soiling/incontinence (11% versus 4%; P = .02) and further surgery (25% versus 14%; P = .005), longer hospital stay (9.79 versus 7.3 days; P < .00001), and time to oral feed (4.05 versus 3.27 days; P < .00001). Operative time was significantly longer in the laparoscopic group (3.83 versus 4.09 hours; P = .004). There was no significant difference in incidence of enterocolitis (15% versus 10%; P = .14) and constipation (23% versus 30%; P = .12).&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable.
[NA]

P22. Results / Risk of bias across studies: Not applicable.
[NA]

P23. Results / Additional analysis: Not applicable.
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our meta-analysis proposes that LD pull-through is superior to OD pull-through for HD.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

The results of our meta-analysis should be carefully interpreted. The following are unavoidable limitations:

    • None of the studies included prospective data or randomized control trials' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The results of our meta-analysis should be carefully interpreted. The following are unavoidable limitations: None of the studies included prospective data or randomized control trials.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our meta-analysis proposes that LD pull-through is superior to OD pull-through for HD. The laparoscopic technique resulted in a significantly reduced incidence of postoperative soiling/incontinence and a reduced requirement for further surgery.&quot;</span>
[Yes]

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No competing financial interests exist.&quot;</span>
[Yes]</pre>
<p><a name='144'></a></p>
</div>
<div id="sharp-2015" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0035-1544174' title='Open publication'>Sharp
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Treatment of Idiopathic Achalasia in the Pediatric Population: A Systematic Review&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Achalasia is a rare idiopathic neuromuscular disorder of the esophagus, characterized as a syndrome of impaired relaxation of the lower esophageal sphincter and decreased peristalsis of the esophageal body.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Achalasia is a rare neuromuscular disorder of the esophagus, characterized as a syndrome of impaired relaxation of the lower esophageal sphincter (LES) and decreased peristalsis of the esophageal body.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary objective is to determine the best first-line treatment for pediatric achalasia based on the consolidation of the current literature that compares outcomes after pneumatic dilatation (PD) versus surgical myotomy (Heller esophagomyotomy [HM]).&quot;</span> [Yes]
P5. Methods / Protocol and registration: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The PRISMA format was used for the structure of this systematic review.&quot;</span> [Yes]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Patients younger than 21 years.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were identified by searching the electronic database MEDLINE (OVID), and by hand search of reference lists for further relevant articles.&quot;</span> [Yes]
P8. Methods / Search: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Full abstracts of articles obtained by the OVID search ([Table 1]) were reviewed based on inclusion and exclusion criteria clearly delineated before the start of the review process' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Full abstracts of articles obtained by the OVID search were reviewed based on inclusion and exclusion criteria clearly delineated before the start of the review process.&quot;</span> [Yes]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Full articles were then reviewed and screened.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We developed data sheet (Microsoft Excel 2000 9.0.6926 SP-3, Microsoft Corporation) for our outcome measures listed earlier.&quot;</span> [Yes]
P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Primary and secondary outcomes measures listed earlier were extracted from each study.&quot;</span> [Yes]
P12. Methods / Risk of bias in individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Reliability of each study was determined based on the level of evidence of each study, study design, number of patients enrolled, and length of follow-up.&quot;</span> [Yes]
P13. Methods / Summary measures: Not reported [NA]
P14. Methods / Synthesis of results: Not reported [NA]
P15. Methods / Risk of bias across studies: Not reported [NA]
P16. Methods / Additional analyses: Not reported [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The search of OVID database provided 103 citations.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All seven studies selected for the review were dedicated pediatric retrospective reviews (level III evidence) published in English between the years of 1980 and 2010.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There may have been some adult studies that contained patients younger than 21 years inadvertently excluded by the OVID search methods delineated earlier.&quot;</span> [Yes]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The best first-line treatment of pediatric achalasia was determined to be HM in two articles, PD in one article, and equal efficacy in one article.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not reported [NA]
P22. Results / Risk of bias across studies: Not reported [NA]
P23. Results / Additional analysis: Not reported [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The optimal treatment algorithm for pediatric achalasia remains unclear as adequate comparative data between PD and HM are lacking.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Achalasia is a rare disorder resulting in small sample size which is further compounded by stratification of subjects into even smaller treatment groups.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The optimal treatment algorithm for pediatric achalasia remains unclear as adequate comparative data between PD and HM are lacking.&quot;</span> [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No funding was used.&quot;</span> [Yes]</pre>
<p><a name='145'></a></p>
</div>
<div id="shawyer-2014" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-014-3548-0' title='Open publication'>Shawyer
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The management of postoperative reflux in congenital esophageal atresia–tracheoesophageal fistula: a systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a systematic review of the literature regarding routine anti-reflux medication post EA-TEF repair and its impact on postoperative GER and associated complications.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Esophageal atresia (EA), with or without tracheoesophageal fistula (TEF), is associated with postoperative gastroesophageal reflux (GER).&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of this study was to determine the prevalence of anti-reflux medication use in postoperative EA-TEF patients, and the impact of routine anti-reflux medication on postoperative GER and its associated complications.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies were included if they fulfilled the following criteria: (1) published between inception of database and November 2012, (2) primary diagnosis of EA with or without TEF, (3) secondary diagnosis of postoperative GER, (4) primary treatment for GER with anti-reflux medications (not limited by type of agent, dose or mode of delivery).&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A comprehensive search was conducted using MEDLINE/PubMed, CINHAL, EMBASE/OVID, and CENTRAL (the Cochrane library) electronic databases.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Title and abstract screening was carried out independently and in duplicate.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

Data abstraction was performed in duplicate (AS, JD) and verified for accuracy and quality via a pre-piloted standardized data abstraction form; discrepancies were resolved by consensus' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data abstraction was performed in duplicate and verified for accuracy and quality via a pre-piloted standardized data abstraction form; discrepancies were resolved by consensus.&quot;</span> [Yes]
P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary outcome of the success of prophylactic reflux medication on decreasing rates of GER was analyzed based on a reported postoperative decrease in gastrointestinal (GI) symptoms, decrease in respiratory symptoms or demonstrable weight gain.&quot;</span> [Yes]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Descriptive analyses including counts, percentages, means and standard deviations where appropriate were employed.&quot;</span> [Yes]
P14. Methods / Synthesis of results: Not applicable [NA]
P15. Methods / Risk of bias across studies: Not applicable [NA]
P16. Methods / Additional analyses: Not applicable [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were 2,910 potential citations identified through database searches. Of these, 25 papers (1,663 eligible patients) were eligible for inclusion and final analysis.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All studies were small (mean number of included patients 55.4, SD 51.34 (median 61.00, min 5, max 210).&quot;</span> [Yes]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The majority of papers in this review were small, retrospective unmatched cohort studies based on single-center experiences and prone to the bias that accompanies small observational studies.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable [NA]
P22. Results / Risk of bias across studies: Not applicable [NA]
P23. Results / Additional analysis: Not applicable [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The published literature regarding empiric anti-reflux therapy in infants with EA-TEF is of a low level of evidence and suffers from a lack of standardization.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The majority of papers in this review were small, retrospective unmatched cohort studies based on single-center experiences and prone to the bias that accompanies small observational studies.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Consistent and reliable outcome reporting including definitions of outcomes, best diagnostic criteria, use of reporting checklists for study design and reporting, and adequate follow-up will be necessary for the development of treatment guidelines.&quot;</span> [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎None.&quot;</span> [Yes]</pre>
<p><a name='146'></a></p>
</div>
<div id="shawyer-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-014-3626-3' title='Open publication'>Shawyer
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open repair of recto-bladderneck and recto-prostatic anorectal malformations: a systematic review and meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: All information sources are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is presented. [Yes]
P9. Methods / Study selection: The process for selecting studies is described. [Yes]
P10. Methods / Data collection process: The method of data extraction from reports is described. [Yes]
P11. Methods / Data items: The variables for which data were sought are listed and defined. [Yes]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are described. [Yes]
P13. Methods / Summary measures: The principal summary measures are stated. [Yes]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are given, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The characteristics for which data were extracted are presented. [Yes]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are presented. [Yes]
P20. Results / Results of individual studies: Simple summary data for each intervention group and effect estimates with confidence intervals are presented. [Yes]
P21. Results / Synthesis of results: No information is provided about the methods of combining results. [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P23. Results / Additional analysis: No information is provided about additional analyses. [NA]
P24. Discussion / Summary of evidence: The main findings are summarized, including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: Limitations at study and outcome level, as well as review-level, are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research is provided. [Yes]
P27. Funding: The sources of funding for the systematic review and other support are described. [Yes]</pre>
<p><a name='147'></a></p>
</div>
<div id="shen-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3705-0' title='Open publication'>Shen
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic versus open surgery in children with choledochal cysts: a meta-analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare the safety and efficacy between laparoscopic and open cyst excision with hepaticojejunostomy for children with choledochal cysts using meta-analysis.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Moderate quote deviation. Best match in fulltext (Similarity 77.8%):

st excision followed by Roux-en-Y hepaticojejunostomy reconstruction is recommended for most patients with choledochal cysts whenever possible [5]. Laparoscopic excision of choledochal cysts has increasingly gained acceptance and applicability since its first description by Farello' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The optimal definitive treatment is complete excision of cysts with Roux-en-Y hepaticojejunostomy. Laparoscopic excision of choledochal cysts has increasingly gained acceptance and applicability since its first description by Farello.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare the safety and efficacy between laparoscopic and open cyst excision with hepaticojejunostomy for children with choledochal cysts using meta-analysis.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The studies that published up to and including November 2014 were considered eligible if they met the following inclusion criteria: (1) study reported on at least one of the outcome measures mentioned below: operative time, intraoperative blood loss, time to food intake, postoperative morbidity (including bile leakage, pancreatic leakage, cholangitis, pancreatitis, adhesive intestinal obstruction, abdominal bleeding, etc.,) and mortality, length of hospital stay; (2) population: children younger than 18 years with choledochal cysts; (3) intervention: laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy (LH) versus open cyst excision and Roux-en-Y hepaticojejunostomy (OH).&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched databases, including PubMed, Embase, the Science Citation Index, and Cochrane Library updated to November 2014, to identify all related published studies comparing the laparoscopic and the open choledochal cyst excision with hepaticojejunostomy. The keywords used in the search were as follows: laparoscopic, open, hepaticojejunostomy, choledochal cysts.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The studies that published up to and including November 2014 were considered eligible if they met the following inclusion criteria: (1) study reported on at least one of the outcome measures mentioned below: operative time, intraoperative blood loss, time to food intake, postoperative morbidity (including bile leakage, pancreatic leakage, cholangitis, pancreatitis, adhesive intestinal obstruction, abdominal bleeding, etc.,) and mortality, length of hospital stay; (2) population: children younger than 18 years with choledochal cysts; (3) intervention: laparoscopic cyst excision and Roux-en-Y hepaticojejunostomy (LH) versus open cyst excision and Roux-en-Y hepaticojejunostomy (OH).&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (Huo-Jian Shen and Ming Xu) abstracted relevant information from each eligible article using a standardized form independently.&quot;</span>
[Yes]

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Information about the characteristics of the study population, authors, publication year, study period, country, sample size, interventions, outcomes details of the surgical techniques used, and relevant outcomes were recorded.&quot;</span>
[Yes]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes were calculated as odds ratios (ORs) with 95 % confidence intervals (CIs) using RevMan 5.2.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not applicable.
[NA]

P15. Methods / Risk of bias across studies: Not applicable.
[NA]

P16. Methods / Additional analyses: Not applicable.
[NA]

P17. Results / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):

According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract (Fig. 1). Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts. Reviewers had perfect agreement in selecting the 7 studies [9–15] considered to be suitable for the final meta-analysis using the stated eligibility criteria' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract. Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts. Reviewers had perfect agreement in selecting the 7 studies considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All 7 included studies are retrospective series. They included total of 1016 patients. Of these, 408 (40.16 %) underwent LH, and 608 (59.84 %) had OH.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):

In LH group compared with OH group, the operative time was longer (MD = 59.11, 95 % CI 27.61–90.61, P = 0.0002), while the length of postoperative hospital stay was less (MD = −2.01, 95 % CI −2.49 to −1.54, P < 0.00001), the intraoperative blood loss was lower (MD = −37.14, 95 % CI −66.69 to −7.60, P = 0.01) and time to food intake was less (MD = −1.14, 95 % CI −1.61 to −0.67, P = 0.01). The rate of postoperative morbidity was more in the OH group, but there is no statistically significant difference between the two groups in postoperative morbidity' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In LH group compared with OH group, the operative time was longer, while the length of postoperative hospital stay was less, the intraoperative blood loss was lower and time to food intake was less. The rate of postoperative morbidity was more in the OH group, but there is no statistically significant difference between the two groups in postoperative morbidity.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable.
[NA]

P22. Results / Risk of bias across studies: Not applicable.
[NA]

P23. Results / Additional analysis: Not applicable.
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic cyst excision with Roux-en-Y hepaticojejunostomy is a safe and effective treatment option for choledochal cysts in children with comparable outcomes to open resection.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

al.

This meta-analysis has some limitations that should be taken into account when considering the results. First, there are no randomized trials comparing the two procedures. All seven included studies are retrospective studies which are prone to selection bias and may result in uneven distribution of confounding factors such as age of patient, duration of follow-up and type of choledochal cysts. Second, except one study [14], the others did not compare outcomes between the laparoscopic and open group within the same study period, the main drawback in drawing conclusions from different study period is that factors other than the surgical approach, such as changes in perioperative practices or improved equipment, may introduce bias. Third, in some studies, the number of patients was too small, leading to low-power analyses. Caution should be given in the interpretation and generalization of this meta-analysis as the included study numbers are not high and also the overall quantity of these studies is insufficient. At last, heterogeneity among the studies is' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This meta-analysis has some limitations that should be taken into account when considering the results. First, there are no randomized trials comparing the two procedures. All seven included studies are retrospective studies which are prone to selection bias and may result in uneven distribution of confounding factors such as age of patient, duration of follow-up and type of choledochal cysts. Second, except one study, the others did not compare outcomes between the laparoscopic and open group within the same study period, the main drawback in drawing conclusions from different study period is that factors other than the surgical approach, such as changes in perioperative practices or improved equipment, may introduce bias. Third, in some studies, the number of patients was too small, leading to low-power analyses. Caution should be given in the interpretation and generalization of this meta-analysis as the included study numbers are not high and also the overall quantity of these studies is insufficient. At last, heterogeneity among the studies is high.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic cyst excision with Roux-en-Y hepaticojejunostomy is a safe and effective treatment option for choledochal cysts in children with comparable outcomes to open resection.&quot;</span>
[Yes]

P27. Funding: Not reported.
[No]</pre>
<p><a name='148'></a></p>
</div>
<div id="siddiqui-2011" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-010-2698-Y' title='Open publication'>Siddiqui
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A meta-analysis of outcomes after open and laparoscopic Nissen’s fundoplication for gastro-oesophageal reflux disease in children&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of this study is to meta-analyse the published literature comparing outcomes after open (ONF) versus laparoscopic Nissen fundoplication (LNF) for gastro-oesophageal reflux disease in children.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Gastro-oesophageal reflux disease (GORD) may cause symptoms in up to 7% of children.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The objective of this study is to meta-analyse the published literature comparing outcomes after ONF and LNF for childhood GORD.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies investigating LNF versus ONF for GORD in children between January 1993 and October 2009 were identified.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched the MEDLINE, EMBASE and CINAHL available through the National Library of Health website, the Cochrane library and PubMed databases available online.&quot;</span> [Yes]
P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The text words 'minimally invasive', 'keyhole surgery', 'heartburn', 'reflux disease' and 'children' were used in combination with the medical subject headings 'laparoscopy', 'fundoplication' and 'gastro-oesophageal reflux'.&quot;</span> [Yes]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All abstracts, comparative studies, non-randomized trials and citations were searched comprehensively.&quot;</span> [Yes]
P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Each article was critically reviewed by two researchers using a double extraction method for eligibility in our review.&quot;</span> [Yes]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcome variables were operative time, hospital stay, feed time, morbidity and recurrence.&quot;</span> [Yes]
P14. Methods / Synthesis of results: Not applicable [NA]
P15. Methods / Risk of bias across studies: Not applicable [NA]
P16. Methods / Additional analyses: Not applicable [NA]
P17. Results / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Twelve studies [3, 17, 20, 24–32] discussing LNF were retrieved from the electronic databases. Six studies [20, 26, 29–32] were included in our study according to our inclusion criteria' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Twelve studies discussing LNF were retrieved from the electronic databases. Six studies were included in our study according to our inclusion criteria.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There were 466 patients in the laparoscopic group and 255 in the open group.&quot;</span> [Yes]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Children stayed in hospital for less time after undergoing LNF compared with ONF&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable [NA]
P22. Results / Risk of bias across studies: Not applicable [NA]
P23. Results / Additional analysis: Not applicable [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This article has shown that children undergoing LNF are in hospital for less time, feed earlier and have less morbidity compared with ONF.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Limitations to our meta-analysis include lack of clear definitions in individual studies relating to operative time, morbidity and feeding regimens.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎LNF is superior to ONF in relation to feeding, hospital stay and morbidity and is comparable to ONF in terms of operative time and recurrence.&quot;</span> [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎None.&quot;</span> [Yes]</pre>
<p><a name='149'></a></p>
</div>
<div id="siminas-2015" class="section level4">
<h4><a href='https://doi.org/10.1097/SLA.0000000000001191' title='Open publication'>Siminas
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Current Surgical Management of Pediatric Idiopathic Constipation A Systematic Review of Published Studies&quot;</span> - [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic review of ALL published studies critically evaluates outcomes of surgery for IC.&quot;</span> - [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Children with refractory idiopathic constipation (IC)/soiling, resistant to intensive medical management and bowel training programs, are a major challenge for pediatric surgeons worldwide.&quot;</span> - [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The authors undertook a systematic review of all published studies to critically appraise outcomes and explore the defining role of surgery for pediatric IC.&quot;</span> - [Yes]
P5. Methods / Protocol and registration: Not reported - [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies included (1) peer-review publications with 3 or more patients, and (2) clinical outcomes defined by authors.&quot;</span> - [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MEDLINE (PubMed), Google Scholar, and EMBase were searched for English-language articles only.&quot;</span> - [Yes]
P8. Methods / Search: Not reported - [No]
P9. Methods / Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span> - [Yes]
P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Information was scrutinized with regard the study authors’ definition of IC, preoperative diagnostic investigations, and indications for surgery.&quot;</span> - [Yes]
P11. Methods / Data items: Not reported - [No]
P12. Methods / Risk of bias in individual studies: Not reported - [No]
P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Success was defined by study authors as (1) alleviation of clinical symptoms (58%), (2) reduction in requirement for laxatives (45%), (3) improved bowel frequency (43%), and (4) ongoing use of ACE stoma (8%).&quot;</span> - [Yes]
P14. Methods / Synthesis of results: [NA]
P15. Methods / Risk of bias across studies: [NA]
P16. Methods / Additional analyses: [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Forty-five reports (1157 patients) met full inclusion criteria.&quot;</span> - [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> - [Yes]
P19. Results / Risk of bias within studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Present data on risk of bias of each study and, if available, any outcome level assessment.&quot;</span> - [Yes]
P20. Results / Results of individual studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> - [No]
P21. Results / Synthesis of results: [NA]
P22. Results / Risk of bias across studies: [NA]
P23. Results / Additional analysis: [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This systematic review has shown that the vast majority of available data reporting outcomes on the surgical treatment of IC in childhood are based on low quality evidence.&quot;</span> - [Yes]
P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):

This combination of low-quality evidence, small patient numbers, and lack of any “high quality” outcome(s) assessment by study authors draws us to strongly conclude that guidelines based on such information should be viewed by surgeons with caution' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The combination of low-quality evidence, small patient numbers, and lack of any “high quality” outcome(s) assessment by study authors draws us to strongly conclude that guidelines based on such information should be viewed by surgeons with caution.&quot;</span> - [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Given the many significant and frustrating challenges, a surgeon may confront with pediatric IC we offer and propose a therapy algorithm to guide “best practice”.&quot;</span> - [Yes]
P27. Funding: Not reported - [No]</pre>
<p><a name='150'></a></p>
</div>
<div id="sklar-2014" class="section level4">
<h4><a href='https://doi.org/10.1089/lap.2013.0415 ' title='Open publication'>Sklar
2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic Versus Open Reduction of Intussusception in Children: A Retrospective Review and Meta-analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a retrospective review of all children with intussusception who required operative reduction at our institution over a 12-year time period. We also performed a meta-analysis to combine our data with the published literature.&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Controversy exists as to whether the laparoscopic (LAP) operative approach is as safe and effective as the standard open approach.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

we aimed to retrospectively review our institution&#39;s experience with the surgical treatment of intussusception, comparing the LAP and open approaches. Second, and most importantly, we sought to conduct a systematic review and meta-analysis, combining our data with existing literature, in order to identify any differences in outcome measures across all identified comparative studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We aimed to retrospectively review our institution's experience with the surgical treatment of intussusception, comparing the LAP and open approaches. Second, we sought to conduct a systematic review and meta-analysis, combining our data with existing literature, in order to identify any differences in outcome measures across all identified comparative studies.&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We retrospectively reviewed the electronic and paper charts of all patients requiring operative intervention for intussusception.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two researchers independently searched the electronic databases MEDLINE, Embase, CINAHL, and the Cochrane Library.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two researchers independently screened the title and abstract of identified articles for potential eligibility and retrieved the full-text version of all articles deemed relevant.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We retrospectively reviewed the electronic and paper charts of all patients requiring operative intervention for intussusception.&quot;</span>
[Yes]

P11. Methods / Data items: Not reported.
[No]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We analyzed continuous data as weighted mean differences and dichotomous outcomes as odds ratios, using 95% confidence intervals for all analyses.&quot;</span>
[Yes]

P14. Methods / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis performed).
[NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses performed).
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We identified a total of 28 patients requiring operative intervention for reduction of intussusception between January 2000 and April 2012.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The demographics and outcomes of both groups are presented in Table 1.&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Moderate quote deviation. Best match in fulltext (Similarity 76.4%):

did not find a significant difference between groups with respect to operative time, overall complication rates, or re-operation rates' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Our meta-analysis did not identify a significant difference between the LAP and open groups with respect to operative time, overall complication rates, or re-operation rates.&quot;</span>
[Yes]

P21. Results / Synthesis of results: Not applicable (no meta-analysis performed).
[NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis performed).
[NA]

P23. Results / Additional analysis: Not applicable (no additional analyses performed).
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our data suggest that LAP reduction of intussusception is as technically feasible, safe, and efficacious as the open approach and may even be beneficial in shortening LOS.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The current literature on this topic is limited to retrospective studies, which are inherently limited by methodological bias.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our data suggest that LAP reduction of intussusception is as technically feasible, safe, and efficacious as the open approach and may even be beneficial in shortening LOS.&quot;</span>
[Yes]

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎No competing financial interests exist.&quot;</span>
[Yes]</pre>
<p><a name='151'></a></p>
</div>
<div id="sola-2010" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JSS.2009.05.007' title='Open publication'>Sola
2010</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Peritoneal Drainage versus Laparotomy for Necrotizing Enterocolitis and Intestinal Perforation: A Meta-Analysis&quot;</span>
[Yes]

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective intervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).&quot;</span>
[Yes]

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The surgical management of premature neonates with necrotizing enterocolitis (NEC) or isolated intestinal perforation (IP) remains controversial.&quot;</span>
[Yes]

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To determine whether peritoneal drain (PD) or laparotomy (LAP) is the most effective intervention in premature neonates with necrotizing enterocolitis (NEC) or intestinal perforation (IP).&quot;</span>
[Yes]

P5. Methods / Protocol and registration: Not reported.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies that evaluated only neonates with NEC and IP treated with either LAP (control) or PD (experimental treatment) were selected.&quot;</span>
[Yes]

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The Ovid (Ovid Technologies New York, NY) and Medline search engines were used to examine both the Pubmed and Cochrane libraries from January 2000 to December 2008.&quot;</span>
[Yes]

P8. Methods / Search: Not reported.
[No]

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Prospective studies, including randomized and nonrandomized designs, with a minimum of 25 patients allocated in each of the treatment and control arms, were considered in this systematic review.&quot;</span>
[Yes]

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two reviewers (JES, LGK), using a predefined data extraction form, extracted data from the publications related to gestational age, birth weight, type of operation, and mortality.&quot;</span>
[Yes]

P11. Methods / Data items: Not reported.
[No]

P12. Methods / Risk of bias in individual studies: Not reported.
[No]

P13. Methods / Summary measures: Not reported.
[No]

P14. Methods / Synthesis of results: [NA]

P15. Methods / Risk of bias across studies: [NA]

P16. Methods / Additional analyses: [NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic review of the literature identified 12 trials that were potentially applicable for inclusion in the meta-analysis. Of these potential studies, five met selection criteria.&quot;</span>
[Yes]

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The sample size of the trials ranged from 65 to 156 patients per trial for a combined 523 participants for comparison of PD (273) and LAP (250).&quot;</span>
[Yes]

P19. Results / Risk of bias within studies: Not reported.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Mortality ranged in the LAP group from 15% to 43%, and from 35% to 54% in the PD group.&quot;</span>
[Yes]

P21. Results / Synthesis of results: [NA]

P22. Results / Risk of bias across studies: [NA]

P23. Results / Additional analysis: [NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our systematic review of prospective studies from January 2000 to December 2008 demonstrated that PD was associated with a statistically significant excess mortality of 55%.&quot;</span>
[Yes]

P25. Discussion / Limitations: <span title='Minor quote deviation. Best match in fulltext (Similarity 98%):

sis. The first relates to the validity in the application of meta-analysis to answer this question. First, the fact that survival data for the meta—analysis were derived from each individual trial and is therefore subject to the inherent biases of each trial&#39;s design flaws. In addition, differences in inclusion criteria with regards to birth weight (<1000 g versus < 1500 g) and presence of pneumoperitoneum, treatment protocols, and postoperative care exist across the t' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The first relates to the validity in the application of meta-analysis to answer this question. In addition, differences in inclusion criteria with regards to birth weight (<1000 g versus < 1500 g) and presence of pneumoperitoneum, treatment protocols, and postoperative care exist across the trials.&quot;</span>
[Yes]

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Review of the five prospective studies from January 2000 to December 2008 refutes the hypothesis that PD is superior to LAP. In addition, this meta-analysis demonstrates a statistically significant excess mortality of 55% associated with PD.&quot;</span>
[Yes]

P27. Funding: Not reported.
[No]</pre>
<p><a name='152'></a></p>
</div>
<div id="symeonidis-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.IJSU.2016.03.040' title='Open publication'>Symeonidis
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoendoscopic single-site surgery (LESS) for major urological procedures in the pediatric population: A systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: No abstract or structured summary provided [No]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Improvements in laparoscopic surgery have led to the introduction of laparoendoscopic single-site surgery (LESS) as an alternative to conventional laparoscopy conferring a number of possible advantages.&quot;</span> [Yes]
P4. Introduction / Objectives: No explicit statement of objectives provided [No]
P5. Methods / Protocol and registration: No information on protocol or registration provided [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies investigating the technical aspects and clinical outcomes of partial nephrectomies, nephrectomies, nephroureterectomies, varicocelectomies and pyeloplasties in children.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An in-depth search of the literature was performed in the databases of PubMed and Scopus.&quot;</span> [Yes]
P8. Methods / Search: No full electronic search strategy provided [No]
P9. Methods / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):

Two reviewers (ENS and DN) working independently extracted data from all eligible studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two reviewers working independently extracted data from all eligible studies.&quot;</span> [Yes]
P10. Methods / Data collection process: No information on data extraction process provided [No]
P11. Methods / Data items: No information on data items sought provided [No]
P12. Methods / Risk of bias in individual studies: No information on risk of bias assessment provided [No]
P13. Methods / Summary measures: No information on summary measures provided [No]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Twenty nine studies met the inclusion criteria incorporating 386 patients who underwent 401 procedures.&quot;</span> [Yes]
P18. Results / Study characteristics: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.&quot;</span> [No]
P19. Results / Risk of bias within studies: No information on risk of bias assessment provided [No]
P20. Results / Results of individual studies: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;</span> [No]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis [NA]
P23. Results / Additional analysis: Not applicable, as there is no additional analysis [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎In the hands of experienced surgeons LESS seems a feasible, efficient and less invasive alternative to standard laparoscopy in the field of pediatric urology.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There is not enough evidence to support the superiority of LESS thus wide adoption cannot be recommended.&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There is an imperative need of well-designed prospective randomized trials, with large number of patients, in order to clarify the safety and long term efficacy of LESS for urological procedures in the pediatric population.&quot;</span> [Yes]
P27. Funding: No information on funding provided [No]</pre>
<p><a name='153'></a></p>
</div>
<div id="tan-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDS.2015.12.074' title='Open publication'>Tan
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Screening and Treatment of Intestinal Rotational Abnormalities in Heterotaxy: A Systematic Review and Meta-Analysis&quot;</span>
[Yes] The report is identified as a systematic review and meta-analysis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To assess the role of screening and prophylactic surgery for intestinal rotational abnormalities (IRAs) in asymptomatic patients with heterotaxy.&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions.

P3. Introduction / Rationale: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):

Heterotaxy is a congenital anomaly characterized by abnormal cardiovisceral left-to-right axis arrangement,1 with an incidence reported to be between 1 in 6000 to 1 in 20 000 live birth' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Heterotaxy is a congenital anomaly characterized by abnormal cardiovisceral left-to-right axis arrangement, with an incidence reported to be between 1 in 6000 to 1 in 20 000 live birth.&quot;</span>
[Yes] The rationale for the review in the context of what is already known is described.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To assess the role of screening and prophylactic surgery for intestinal rotational abnormalities (IRAs) in asymptomatic patients with heterotaxy.&quot;</span>
[Yes] The explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design is provided.

P5. Methods / Protocol and registration: No information is provided in the full text about the existence of a review protocol or registration information.
[No]

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎PubMed, Embase, and Cinahl were searched electronically to determine the overall incidence of IRAs in heterotaxy; the detection rate of IRAs associated with screening; the incidence of midgut volvulus in patients without screening; and the incidence of morbidity and mortality after prophylactic and emergency Ladd procedures.&quot;</span>
[Yes] Study characteristics and report characteristics used as criteria for eligibility are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Medline, Embase, Cinahl, and Cochrane databases were searched electronically on April 24, 2014, and then updated on May 11, 2015; the search was limited to reports published after January 1, 1980.&quot;</span>
[Yes] All information sources are described.

P8. Methods / Search: No full electronic search strategy is presented in the full text.
[No]

P9. Methods / Study selection: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Two authors reviewed all the abstracts independently. Agreement regarding potential relevance was reached by consensus. Full-text copies of potentially eligible papers were obtained, and the same 2 reviewers independently extracted relevant data on study characteristics and the outcomes of interest' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two authors reviewed all the abstracts independently. Full-text copies of potentially eligible papers were obtained, and the same 2 reviewers independently extracted relevant data on study characteristics and the outcomes of interest.&quot;</span>
[Yes] The process for selecting studies is stated.

P10. Methods / Data collection process: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):

Two authors reviewed all the abstracts independently. Agreement regarding potential relevance was reached by consensus. Full-text copies of potentially eligible papers were obtained, and the same 2 reviewers independently extracted relevant data on study characteristics and the outcomes of interest' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two authors reviewed all the abstracts independently. Full-text copies of potentially eligible papers were obtained, and the same 2 reviewers independently extracted relevant data on study characteristics and the outcomes of interest.&quot;</span>
[Yes] The method of data extraction from reports is described.

P11. Methods / Data items: The outcomes investigated in this systematic review are described.
[Yes] The variables for which data were sought are listed.

P12. Methods / Risk of bias in individual studies: No information is provided in the full text about the methods used for assessing risk of bias of individual studies.
[No]

P13. Methods / Summary measures: No information is provided in the full text about the principal summary measures.
[No]

P14. Methods / Synthesis of results: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.9%):

meta-analyses of proportions were performed to' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Meta-analyses of proportions were performed to combine the data.&quot;</span>
[Yes] The methods of handling data and combining results of studies are described.

P15. Methods / Risk of bias across studies: No information is provided in the full text about the assessment of risk of bias across studies.
[No]

P16. Methods / Additional analyses: No information is provided in the full text about additional analyses.
[NA]

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 273 articles were identified from the search, and another 3 articles were identified from cross-referencing of citations. Of those, full text of 50 articles were assessed with respect to their eligibility for inclusion.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are given.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 24 studies met inclusion criteria for the systematic review, which consisted of 1433 cases of heterotaxy.&quot;</span>
[Yes] Characteristics for which data were extracted are presented.

P19. Results / Risk of bias within studies: No information is provided in the full text about the risk of bias within studies.
[No]

P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The screen-detected incidences of IRA and acute midgut volvulus were significantly greater in heterotaxy than the normal population.&quot;</span>
[Yes] Simple summary data for each intervention group and effect estimates are presented.

P21. Results / Synthesis of results: No information is provided in the full text about the synthesis of results.
[NA]

P22. Results / Risk of bias across studies: No information is provided in the full text about the assessment of risk of bias across studies.
[No]

P23. Results / Additional analysis: No information is provided in the full text about additional analyses.
[NA]

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis quantitatively assessed the importance of screening for IRA and of a prophylactic Ladd procedure in the management of asymptomatic heterotaxy.&quot;</span>
[Yes] The main findings are summarized.

P25. Discussion / Limitations: <span title='Moderate quote deviation. Best match in fulltext (Similarity 84.7%):

is limited inherently by the quality of the published papers' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎This study is limited inherently by the quality of the published papers.&quot;</span>
[Yes] Limitations at study and outcome level are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To fully elucidate the benefits and risks of prophylactic surgery, a randomized controlled trial is required.&quot;</span>
[Yes] A general interpretation of the results in the context of other evidence and implications for future research are provided.

P27. Funding: No information is provided in the full text about the sources of funding for the systematic review.
[No]</pre>
<p><a name='154'></a></p>
</div>
<div id="terui-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3765-1' title='Open publication'>Terui
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Surgical approaches for neonatal congenital diaphragmatic hernia: a systematic review and meta-analysis&quot;</span>
[Yes] The report is identified as a systematic review and meta-analysis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted a systematic review and meta-analysis of the effectiveness of endoscopic surgery (ES) for neonatal CDH.&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, and results.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The optimal surgical approach for neonatal congenital diaphragmatic hernia (CDH) remains unclear.&quot;</span>
[Yes] The rationale for the review is described in the introduction.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We conducted a systematic review and meta-analysis of the effectiveness of endoscopic surgery (ES) for neonatal CDH.&quot;</span>
[Yes] The objectives of the review are explicitly stated.

P5. Methods / Protocol and registration: No relevant quote found.
[NA] Not applicable as there is no mention of a review protocol or registration.

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies that compared surgical approaches for neonatal CDH were selected.&quot;</span>
[Yes] The study characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systematic literature search was conducted using MEDLINE and the Cochrane Library.&quot;</span>
[Yes] The information sources are described.

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The articles were screened according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart.&quot;</span>
[Yes] The full electronic search strategy is not provided, but the use of the PRISMA flow chart is mentioned.

P9. Methods / Study selection: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).&quot;</span>
[Yes] The process for selecting studies is not explicitly stated, but it can be inferred that studies were screened and included in the systematic review.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two individual authors extracted data from each selected study.&quot;</span>
[Yes] The method of data extraction is described.

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The following items were collected: (1) authors’ names and year of publication, (2) title of the published study, (3) journal in which the study was published, (4) country and year of the study, (5) whether the study was single-center or multicenter, (6) whether the study had a prospective or retrospective design, (7) testing sample size, (8) patient age, (9) whether consecutive patients were included, (10) surgical approaches in both arms of the trial, (11) method of assigning patients to the two groups, (12) number of patients receiving each surgical approach, (13) number of patients who failed the allocated treatment (conversion to OS), (14) postoperative follow-up period, (15) number of postoperative deaths, and (16) number of patients who developed recurrence.&quot;</span>
[Yes] The data items for which data were sought are listed and defined.

P12. Methods / Risk of bias in individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As assessed on the GRADE scale, the quality of evidence was very low for all outcomes.&quot;</span>
[Yes] The methods used for assessing risk of bias of individual studies are described.

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Risk ratios (RRs) and 95 % confidential intervals (CIs) were determined using RevMan 5.3 software.&quot;</span>
[Yes] The principal summary measures are stated.

P14. Methods / Synthesis of results: No relevant quote found.
[NA] Not applicable as there is no meta-analysis.

P15. Methods / Risk of bias across studies: No relevant quote found.
[NA] Not applicable as there is no assessment of risk of bias across studies.

P16. Methods / Additional analyses: No relevant quote found.
[NA] Not applicable as there are no additional analyses.

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Of 264 search results, 226 studies were excluded based on titles and abstracts. After screening the remaining 38 studies based on their full texts, 14 studies were included in the qualitative synthesis.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are given.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The eight observational studies were included in a quantitative synthesis.&quot;</span>
[Yes] The characteristics of the included studies are presented.

P19. Results / Risk of bias within studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As assessed on the GRADE scale, the quality of evidence was very low for all outcomes.&quot;</span>
[Yes] Data on risk of bias of each study are presented.

P20. Results / Results of individual studies: <span title='Moderate quote deviation. Best match in fulltext (Similarity 80%):

the ES group showed both a significantly lower mortality rate [risk ratio (RR) 0.18, 95 % confidence interval (CI) 0.09–0.38, p < 0.0001] and a significantly higher recurrence rate' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The ES group showed both a significantly lower mortality rate and a significantly higher recurrence rate compared to the OS group.&quot;</span>
[Yes] The results of individual studies are presented.

P21. Results / Synthesis of results: No relevant quote found.
[NA] Not applicable as there is no meta-analysis.

P22. Results / Risk of bias across studies: No relevant quote found.
[NA] Not applicable as there is no assessment of risk of bias across studies.

P23. Results / Additional analysis: No relevant quote found.
[NA] Not applicable as there are no additional analyses.

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although the evidence was insufficient, ES was clearly associated with more recurrence than was OS.&quot;</span>
[Yes] The main findings are summarized.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎There was very serious risk of bias due to inappropriate patient selection, unequal follow-up durations, and the absence of controlling for confounding.&quot;</span>
[Yes] The limitations of the review are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎ES should not be the routine treatment for every neonate. It is crucially important to select suitable cases for ES.&quot;</span>
[Yes] A general interpretation of the results and implications for future research are provided.

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This work was supported by a grant from the Ministry of Health, Labour and Welfare of Japan.&quot;</span>
[Yes] The sources of funding for the systematic review are described.

Overall, 24 out of 27 PRISMA items were reported in the full text.</pre>
<p><a name='155'></a></p>
</div>
<div id="thomson-2015" class="section level4">
<h4><a href='https://doi.org/10.1136/BMJOPEN-2014-006063' title='Open publication'>Thomson
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic assistance for primary transanal pull-through in Hirschsprung's disease: a systematic review and meta-analysis&quot;</span>
[Yes] The report is identified as a systematic review and meta-analysis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Objective To compare outcomes following totally transanal endorectal pull-through (TTERPT) versus pull-through with any form of laparoscopic assistance (LAPT) for infants with uncomplicated Hirschsprung's disease.&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions.

P3. Introduction / Rationale: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):

Since the first description of Harald Hirschsprung&#39;s eponymous condition in 1889,1 there has been ongoing debate regarding the optimal surgical approach' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Since the first description of Harald Hirschsprung's eponymous condition in 1889, there has been ongoing debate regarding the optimal surgical approach.&quot;</span>
[Yes] The rationale for the review is described in the introduction.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this study was to conduct a systematic review and meta-analysis to compare outcomes for infants with Hirschsprung's disease undergoing a TTERPT procedure with those undergoing a laparoscopically assisted transanal pull-through (LAPT).&quot;</span>
[Yes] The objectives of the study are explicitly stated.

P5. Methods / Protocol and registration: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A study protocol outlining the search strategy, outcomes, and methods of data extraction and statistical analysis was designed and prospectively registered with the Prospero database (CRD42013005698).&quot;</span>
[Yes] The existence of a study protocol and its registration information is provided.

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Study inclusion and exclusion criteria are summarised in table 1.&quot;</span>
[Yes] The study characteristics and report characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched all publications from 1 January 1998 to 1 January 2014 from EMBASE, MEDLINE and Cochrane library databases using the search strategy detailed in online supplementary appendix I.&quot;</span>
[Yes] All information sources used in the search are described.

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched all publications from 1 January 1998 to 1 January 2014 from EMBASE, MEDLINE and Cochrane library databases using the search strategy detailed in online supplementary appendix I.&quot;</span>
[Yes] The full electronic search strategy for at least one database is presented.

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Titles and abstracts of potentially relevant papers were screened by two independent authors (DT and BA). The full texts of all identified studies were assessed against the criteria in table 1 by the two independent authors (DT and BA), and study reference lists were hand searched for potentially relevant studies.&quot;</span>
[Yes] The process for selecting studies is described.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were extracted by the two independent authors (DT and BA) using a predesigned proforma.&quot;</span>
[Yes] The method of data extraction from reports is described.

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Data were collected regarding: age at gestation, diagnosis and surgery, level of anal dissection, length of mucosal cuff, length and location of aganglionosis, and any congenital abnormalities.&quot;</span>
[Yes] The variables for which data were sought are listed and defined.

P12. Methods / Risk of bias in individual studies: <span title='Moderate quote deviation. Best match in fulltext (Similarity 84.4%):

study quality using the Newcastle-Ottawa Scale for case–control and cohort studies' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Study quality was assessed using the Newcastle-Ottawa Scale for case–control and cohort studies.&quot;</span>
[Yes] The methods used for assessing risk of bias of individual studies are described.

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Continuous data were analysed using an inverse variance model to produce a mean difference. Dichotomous variables were analysed using a Mantel-Haenszel model to produce ORs.&quot;</span>
[Yes] The principal summary measures are stated.

P14. Methods / Synthesis of results: [NA] Not applicable, as there is no meta-analysis.

P15. Methods / Risk of bias across studies: [NA] Not applicable, as there is no meta-analysis.

P16. Methods / Additional analyses: [NA] Not applicable, as there is no meta-analysis.

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A total of 2107 records were screened, of which 41 studies potentially met the eligibility criteria.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are given.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Four hundred and five patients were included in the meta-analysis; 159 underwent a LAPT and 248 underwent a TTERPT.&quot;</span>
[Yes] The characteristics for which data were extracted are presented.

P19. Results / Risk of bias within studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):

Study quality was assessed using the Newcastle-Ottawa Scale for cohort studies.18 Scores were low overall, with one study scoring 6/9, one scoring 5/9, one scoring 4/9 and two scoring 3/' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Study quality was assessed using the Newcastle-Ottawa Scale for cohort studies. Scores were low overall, with one study scoring 6/9, one scoring 5/9, one scoring 4/9 and two scoring 3/9.&quot;</span>
[Yes] Data on risk of bias of each study are presented.

P20. Results / Results of individual studies: <span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):

There were no significant differences identified between TTERPT and LAPT for incidence of postoperative enterocolitis (OR=0.78, 95% CI 0.44 to 1.38, p=0.39), faecal incontinence (OR=0.44, 95% CI 0.09 to 2.20, p=0.32) or constipation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎There were no significant differences identified between TTERPT and LAPT for incidence of postoperative enterocolitis, faecal incontinence, or constipation.&quot;</span>
[Yes] The results of each individual study are presented.

P21. Results / Synthesis of results: [NA] Not applicable, as there is no meta-analysis.

P22. Results / Risk of bias across studies: [NA] Not applicable, as there is no meta-analysis.

P23. Results / Additional analysis: [NA] Not applicable, as there is no additional analysis.

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This meta-analysis did not find any evidence to suggest a higher rate of enterocolitis, incontinence or constipation following TTERPT compared with LAPT.&quot;</span>
[Yes] The main findings are summarized, including the strength of evidence for each main outcome.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The main limitations of this study include limited statistical power as we identified only five eligible studies, the generally low quality of the studies, heterogeneity with respect to outcome assessment, and limited long-term follow-up.&quot;</span>
[Yes] The limitations of the study are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Further long-term comparative studies and multicentre data pooling are needed to determine whether a purely transanal approach offers any advantages over a laparoscopically assisted approach to rectosigmoid Hirschsprung's disease.&quot;</span>
[Yes] A general interpretation of the results in the context of other evidence and implications for future research are provided.

P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MK is funded by a National Institute for Health Research Professorship.&quot;</span>
[Yes] The sources of funding for the systematic review are described.</pre>
<p><a name='156'></a></p>
</div>
<div id="thyoka-2013" class="section level4">
<h4><a href='https://doi.org/10.1007/S00247-013-2693-2' title='Open publication'>Thyoka
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia: a systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not presented. [No]
P9. Methods / Study selection: The process for selecting studies is not stated. [No]
P10. Methods / Data collection process: The method of data extraction from reports is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: The methods of handling data and combining results of studies are not described. [NA]
P15. Methods / Risk of bias across studies: No assessment of risk of bias across studies is mentioned. [NA]
P16. Methods / Additional analyses: No methods of additional analyses are described. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not provided. [No]
P18. Results / Study characteristics: The characteristics of each study are not presented. [No]
P19. Results / Risk of bias within studies: No data on risk of bias of each study are presented. [No]
P20. Results / Results of individual studies: The simple summary data for each intervention group and effect estimates with confidence intervals are not provided. [No]
P21. Results / Synthesis of results: No results of meta-analyses are presented. [NA]
P22. Results / Risk of bias across studies: No assessment of risk of bias across studies is mentioned. [NA]
P23. Results / Additional analysis: No results of additional analyses are presented. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized. [Yes]
P25. Discussion / Limitations: The limitations at study and outcome level, and at review-level are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results in the context of other evidence and implications for future research are provided. [Yes]
P27. Funding: No information is provided about sources of funding for the systematic review. [No]</pre>
<p><a name='157'></a></p>
</div>
<div id="van-dalen-2015" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD008403.pub3' title='Open publication'>van
Dalen 2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review is the second update of a previously published Cochrane review.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Although the use of diagnostic MIS to obtain biopsy specimens for pathology is accepted in paediatric surgical oncology, there is limited evidence to support the use of MIS for the resection of malignancies.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To ascertain differences in outcome between the minimally invasive and open surgical approaches for the treatment of solid intra‐abdominal or intra‐thoracic neoplasms in children.&quot;</span> [Yes]
P5. Methods / Protocol and registration: No information provided [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Randomised controlled trials (RCTs) or controlled clinical trials (CCTs) comparing MIS to open surgery for the treatment of solid intra‐thoracic or intra‐abdominal neoplasms in children (aged 0 to 18 years) were considered for inclusion.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We searched CENTRAL (The Cochrane Library 2014, Issue 1), MEDLINE/PubMed (from 1966 to February 2014) and EMBASE/Ovid (from 1980 to February 2014) to identify relevant studies.&quot;</span> [Yes]
P8. Methods / Search: No information provided [No]
P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors performed the study selection independently.&quot;</span> [Yes]
P10. Methods / Data collection process: No information provided [No]
P11. Methods / Data items: No information provided [No]
P12. Methods / Risk of bias in individual studies: No information provided [No]
P13. Methods / Summary measures: No information provided [No]
P14. Methods / Synthesis of results: [NA]
P15. Methods / Risk of bias across studies: [NA]
P16. Methods / Additional analyses: [NA]
P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The literature search retrieved 542 references. After screening the titles and abstracts we excluded 534 references which clearly did not meet the inclusion criteria.&quot;</span> [Yes]
P18. Results / Study characteristics: No information provided [No]
P19. Results / Risk of bias within studies: No information provided [No]
P20. Results / Results of individual studies: No information provided [No]
P21. Results / Synthesis of results: [NA]
P22. Results / Risk of bias across studies: [NA]
P23. Results / Additional analysis: [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Thus there is insufficient evidence to allow any definitive conclusions regarding the use of MIS in these patients.&quot;</span> [Yes]
P25. Discussion / Limitations: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).&quot;</span> [Yes]
P26. Discussion / Conclusions: <span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Provide a general interpretation of the results in the context of other evidence, and implications for future research.&quot;</span> [Yes]
P27. Funding: No information provided [No]</pre>
<p><a name='158'></a></p>
</div>
<div id="vanden-berg-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.UROLONC.2015.07.003' title='Open publication'>Vanden
Berg 2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Nephron-sparing surgery for Wilms tumor: A systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, methods, results, and conclusions of the systematic review. [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are not specified. [No]
P7. Methods / Information sources: The information sources used in the search are not described. [No]
P8. Methods / Search: The full electronic search strategy is not presented. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not reported. [No]
P18. Results / Study characteristics: The characteristics of the included studies are not presented. [No]
P19. Results / Risk of bias within studies: No data on risk of bias of individual studies are presented. [No]
P20. Results / Results of individual studies: The results of individual studies are not presented. [No]
P21. Results / Synthesis of results: No information is provided about the synthesis of results. [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P23. Results / Additional analysis: No results of additional analyses are presented. [NA]
P24. Discussion / Summary of evidence: The main findings and their implications are summarized. [Yes]
P25. Discussion / Limitations: The limitations of the study are discussed. [Yes]
P26. Discussion / Conclusions: The interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: No information is provided about funding sources. [No]</pre>
<p><a name='159'></a></p>
</div>
<div id="van-den-hondel-2014" class="section level4">
<h4><a href='https://doi.org/10.1055/S-0033-1351663' title='Open publication'>van
den Hondel 2014</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To Split or Not to Split: Colostomy Complications for Anorectal Malformations or Hirschsprung Disease: A Single Center Experience and a Systematic Review of the Literature&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the study, including the background, objectives, methods, results, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources used in the search are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is presented. [Yes]
P9. Methods / Study selection: The process for selecting studies is described. [Yes]
P10. Methods / Data collection process: The method of data extraction from reports is described. [Yes]
P11. Methods / Data items: The variables for which data were sought are listed. [Yes]
P12. Methods / Risk of bias in individual studies: No information is provided about the methods used for assessing risk of bias. [No]
P13. Methods / Summary measures: The principal summary measures are not explicitly stated. [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. [No]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [No]
P16. Methods / Additional analyses: No information is provided about additional analyses. [No]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are provided, along with reasons for exclusions. [Yes]
P18. Results / Study characteristics: The characteristics of each study are presented. [Yes]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are not presented. [No]
P20. Results / Results of individual studies: The results of each study are presented. [Yes]
P21. Results / Synthesis of results: No information is provided about the synthesis of results. [No]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [No]
P23. Results / Additional analysis: No information is provided about additional analyses. [No]
P24. Discussion / Summary of evidence: The main findings are summarized, including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: Limitations at study and outcome level are discussed, but limitations at the review level are not mentioned. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: No information is provided about funding sources. [No]</pre>
<p><a name='160'></a></p>
</div>
<div id="vernon-roberts-2013" class="section level4">
<h4><a href='https://doi.org/10.1002/14651858.CD006151.pub3 ' title='Open publication'>Vernon-Roberts
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Fundoplication versus postoperative medication for gastro‐oesophageal reflux in children with neurological impairment undergoing gastrostomy&quot;</span> [Yes]
Reasoning: The title clearly identifies the report as a comparison of two interventions for gastro-oesophageal reflux in children with neurological impairment.

P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
Reasoning: The abstract includes all the required components of a structured summary as outlined in the PRISMA guidelines.

P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
Reasoning: The introduction provides a description of the feeding difficulties experienced by children with neurological impairments and the use of gastrostomy feeding as a method of nutritional support.

P4. Introduction / Objectives: The introduction provides an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS). [Yes]
Reasoning: The introduction clearly states the objective of comparing the effectiveness of antireflux surgery and antireflux medications for children with neurological impairments and gastro-oesophageal reflux who are undergoing gastrostomy tube insertion.

P5. Methods / Protocol and registration: No information is provided about the existence of a review protocol or registration information. [No]
Reasoning: The publication does not mention the existence of a review protocol or provide any registration information.

P6. Methods / Eligibility criteria: The methods specify the study characteristics (PICOS) and report characteristics used as criteria for eligibility. [Yes]
Reasoning: The methods section describes the inclusion criteria for the study, including the age range, neurological impairments, and gastro-oesophageal reflux as key characteristics.

P7. Methods / Information sources: The methods describe the information sources used in the search and the date of the last search. [Yes]
Reasoning: The methods section states that multiple databases were searched and provides the date of the last search.

P8. Methods / Search: The methods present the full electronic search strategy for at least one database. [No]
Reasoning: The publication does not provide the full electronic search strategy.

P9. Methods / Study selection: The methods state the process for selecting studies, including screening, eligibility, and inclusion in the systematic review. [Yes]
Reasoning: The methods section describes the process for selecting studies, including the screening and eligibility criteria.

P10. Methods / Data collection process: The methods describe the method of data extraction from reports and any processes for obtaining and confirming data from investigators. [No]
Reasoning: The publication does not provide information on the method of data extraction or any processes for obtaining and confirming data.

P11. Methods / Data items: The methods list and define all variables for which data were sought. [No]
Reasoning: The publication does not provide a list or definition of the variables for which data were sought.

P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing the risk of bias of individual studies. [No]
Reasoning: The publication does not provide information on the methods used for assessing the risk of bias in individual studies.

P13. Methods / Summary measures: The methods state the principal summary measures used in the review. [No]
Reasoning: The publication does not provide information on the principal summary measures used in the review.

P14. Methods / Synthesis of results: Not applicable (no meta-analysis conducted) [NA]

P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis conducted) [NA]

P16. Methods / Additional analyses: Not applicable (no additional analyses conducted) [NA]

P17. Results / Study selection: The results section gives numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
Reasoning: The results section provides information on the number of studies screened, assessed for eligibility, and included in the review, along with reasons for exclusions.

P18. Results / Study characteristics: The results section presents characteristics for each study, including study size, PICOS, and citations. [Yes]
Reasoning: The results section provides information on the characteristics of the included studies, including study size, PICOS, and citations.

P19. Results / Risk of bias within studies: The results section presents data on the risk of bias of each study. [No]
Reasoning: The publication does not provide data on the risk of bias of each study.

P20. Results / Results of individual studies: The results section presents simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot. [No]
Reasoning: The publication does not provide simple summary data or effect estimates and confidence intervals for each intervention group.

P21. Results / Synthesis of results: Not applicable (no meta-analysis conducted) [NA]

P22. Results / Risk of bias across studies: Not applicable (no meta-analysis conducted) [NA]

P23. Results / Additional analysis: Not applicable (no additional analyses conducted) [NA]

P24. Discussion / Summary of evidence: The discussion section summarizes the main findings, including the strength of evidence for each main outcome. [Yes]
Reasoning: The discussion section provides a summary of the main findings, including the strength of evidence for each main outcome.

P25. Discussion / Limitations: The discussion section discusses the limitations of the study at the study and outcome level, as well as at the review level. [Yes]
Reasoning: The discussion section discusses the limitations of the study, including the lack of evidence and the need for further research.

P26. Discussion / Conclusions: The discussion section provides a general interpretation of the results and implications for future research. [Yes]
Reasoning: The discussion section provides a general interpretation of the results and discusses the implications for future research.

P27. Funding: The publication does not provide information on sources of funding for the systematic review. [No]
Reasoning: The publication does not provide information on sources of funding for the systematic review.</pre>
<p><a name='161'></a></p>
</div>
<div id="wang-2013" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-013-3335-3' title='Open publication'>Wang
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Systematic review and meta-analysis of studies comparing the perimeatal-based flap and tubularized incised-plate techniques for primary hypospadias repair&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics and report characteristics used as criteria for eligibility. [Yes]
P7. Methods / Information sources: The methods describe the information sources used in the search and the date last searched. [Yes]
P8. Methods / Search: The methods present the full electronic search strategy for at least one database. [Yes]
P9. Methods / Study selection: The methods state the process for selecting studies. [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports. [Yes]
P11. Methods / Data items: The methods list and define all variables for which data were sought. [Yes]
P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing risk of bias of individual studies. [Yes]
P13. Methods / Summary measures: The methods state the principal summary measures. [Yes]
P14. Methods / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P15. Methods / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P16. Methods / Additional analyses: Not applicable, as there is no meta-analysis. [NA]
P17. Results / Study selection: The results give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage. [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted for each study. [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study. [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals. [Yes]
P21. Results / Synthesis of results: Not applicable, as there is no meta-analysis. [NA]
P22. Results / Risk of bias across studies: Not applicable, as there is no meta-analysis. [NA]
P23. Results / Additional analysis: Not applicable, as there is no meta-analysis. [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome. [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level. [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]
P27. Funding: No information is provided about funding sources. [No]</pre>
<p><a name='162'></a></p>
</div>
<div id="wayne-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3676-1' title='Open publication'>Wayne
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<i>Minor score formatting issues fixed during extraction:
‘wrong-response-partial-unclear-etc’</i>
<pre>
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
<span title='Perfect quote from prompt (Similarity 100%).' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: transparent'>&quot;‎Systematic review&quot;</span> is mentioned in the title. [Yes]

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
The introduction describes the rationale for the review in the context of what is already known. [Yes]

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
The introduction provides an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design. [Yes]

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
No information is provided about the existence of a review protocol or registration information. [No]

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
The methods specify the study characteristics (e.g., PICOS) used as criteria for eligibility, but do not mention report characteristics or provide a rationale. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
The methods describe the information sources (CENTRAL, MEDLINE, EMBASE, CINAHL) used in the search, but do not mention the dates of coverage or contact with study authors. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
The methods do not present the full electronic search strategy. [No]

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
The methods state the process for selecting studies, including screening and eligibility, but do not mention inclusion in the systematic review or meta-analysis. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
The methods do not describe the method of data extraction or any processes for obtaining and confirming data from investigators. [No]

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
The methods do not list and define all variables for which data were sought or mention any assumptions and simplifications made. [No]

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
The methods do not describe methods used for assessing risk of bias of individual studies or how this information is to be used in any data synthesis. [No]

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
The methods do not state the principal summary measures. [No]

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
Not applicable, as there is no meta-analysis. [NA]

P15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
Not applicable, as there is no assessment of risk of bias across studies. [NA]

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
Not applicable, as there are no additional analyses. [NA]

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
The results give the number of studies screened, assessed for eligibility, and included in the review, but do not provide reasons for exclusions or a flow diagram. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
The results present characteristics for each study, including study size, PICOS, and follow-up period, and provide the citations. [Yes]

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
The results do not present data on risk of bias within studies or any outcome level assessment. [No]

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
The results present simple summary data for each intervention group, but do not provide effect estimates, confidence intervals, or a forest plot. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
Not applicable, as there is no meta-analysis. [NA]

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
Not applicable, as there is no assessment of risk of bias across studies. [NA]

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
Not applicable, as there are no additional analyses. [NA]

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
The discussion summarizes the main findings, but does not consider the strength of evidence for each main outcome or their relevance to key groups. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
The discussion discusses limitations at the study and outcome level, but does not discuss limitations at the review-level. [Partial <span style='background-color: #ff9e81' title='Added response during extraction'>[Yes]</span>]

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
The discussion provides a general interpretation of the results in the context of other evidence and implications for future research. [Yes]

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
No information is provided about the sources of funding or other support for the systematic review. [No]</pre>
<p><a name='163'></a></p>
</div>
<div id="weih-2012" class="section level4">
<h4><a href='https://doi.org/10.1007/S00423-011-0874-8' title='Open publication'>Weih
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Current practice and future perspectives in the treatment of short bowel syndrome in children—a systematic review&quot;</span> [Yes]
P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this paper was to provide an overview of the established therapeutic approaches together with a discussion of the future perspectives in the treatment of patients with SBS.&quot;</span> [Yes]
P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this paper was to provide an overview of the established therapeutic approaches together with a discussion of the future perspectives in the treatment of patients with SBS.&quot;</span> [Yes]
P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The purpose of this paper was to provide an overview of the established therapeutic approaches together with a discussion of the future perspectives in the treatment of patients with SBS.&quot;</span> [Yes]
P5. Methods / Protocol and registration: Not reported [No]
P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systemic review of Medline-cited studies dealing with current practice and future perspectives in the treatment of short bowel in children was performed.&quot;</span> [Yes]
P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A systemic review of Medline-cited studies dealing with current practice and future perspectives in the treatment of short bowel in children was performed.&quot;</span> [Yes]
P8. Methods / Search: Not reported [No]
P9. Methods / Study selection: Not reported [No]
P10. Methods / Data collection process: Not reported [No]
P11. Methods / Data items: Not reported [No]
P12. Methods / Risk of bias in individual studies: Not reported [No]
P13. Methods / Summary measures: Not reported [No]
P14. Methods / Synthesis of results: Not applicable (no meta-analysis) [NA]
P15. Methods / Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P16. Methods / Additional analyses: Not applicable (no meta-analysis) [NA]
P17. Results / Study selection: Not reported [No]
P18. Results / Study characteristics: Not reported [No]
P19. Results / Risk of bias within studies: Not reported [No]
P20. Results / Results of individual studies: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Surgical approaches, non-surgical approaches, and tissue engineering which was used in the treatment of SBS were analyzed.&quot;</span> [Yes]
P21. Results / Synthesis of results: Not applicable (no meta-analysis) [NA]
P22. Results / Risk of bias across studies: Not applicable (no meta-analysis) [NA]
P23. Results / Additional analysis: Not applicable (no meta-analysis) [NA]
P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎This review aims to provide a survey of the current therapeutic options and the future perspectives in the treatment of children with SBS.&quot;</span> [Yes]
P25. Discussion / Limitations: Not reported [No]
P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The treatment of SBS patients remains very complex.&quot;</span> [Yes]
P27. Funding: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We are very grateful that this publication has been supported by 'Heidelberger Stiftung Chirurgie.'&quot;</span> [Yes]</pre>
<p><a name='164'></a></p>
</div>
<div id="wenk-2015" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2015.08.056' title='Open publication'>Wenk
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Incidence of metachronous contralateral inguinal hernias in children following unilateral repair — A meta-analysis of prospective studies&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, and conclusions [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known [Yes]
P4. Introduction / Objectives: The objectives are explicitly stated, addressing the participants, interventions, comparisons, outcomes, and study design [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified [Yes]
P7. Methods / Information sources: The information sources are described [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not provided [No]
P9. Methods / Study selection: The process for selecting studies is not described [No]
P10. Methods / Data collection process: The method of data extraction from reports is not described [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described [No]
P13. Methods / Summary measures: The principal summary measures are not stated [No]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results of studies [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not given [No]
P18. Results / Study characteristics: The characteristics for which data were extracted are presented [Yes]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are not presented [No]
P20. Results / Results of individual studies: Simple summary data for each intervention group and effect estimates with confidence intervals are presented [Yes]
P21. Results / Synthesis of results: No information is provided about the methods of combining results of studies [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies [NA]
P23. Results / Additional analysis: No results of additional analyses are presented [NA]
P24. Discussion / Summary of evidence: The main findings are summarized, including the strength of evidence for each main outcome [Yes]
P25. Discussion / Limitations: Limitations at study and outcome level are discussed, but limitations at the review level are not mentioned [No]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided [Yes]
P27. Funding: No information is provided about the sources of funding for the systematic review [No]</pre>
<p><a name='165'></a></p>
</div>
<div id="wilkinson-2012" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPUROL.2010.11.008' title='Open publication'>Wilkinson
2012</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Outcomes in distal hypospadias: A systematic review of the Mathieu and tubularized incised plate repairs&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, methods, results, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources used in the search are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is presented. [Yes]
P9. Methods / Study selection: The process for selecting studies is described. [Yes]
P10. Methods / Data collection process: The method of data extraction from reports is described. [Yes]
P11. Methods / Data items: The variables for which data were sought are listed and defined. [Yes]
P12. Methods / Risk of bias in individual studies: No information is provided about the methods used for assessing risk of bias. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [NA]
P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results. [NA]
P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P16. Methods / Additional analyses: No information is provided about additional analyses. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are provided, along with reasons for exclusions. [Yes]
P18. Results / Study characteristics: The characteristics of each study are presented. [Yes]
P19. Results / Risk of bias within studies: Data on risk of bias of each study are not presented. [NA]
P20. Results / Results of individual studies: The results of each study are presented. [Yes]
P21. Results / Synthesis of results: No information is provided about the synthesis of results. [NA]
P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies. [NA]
P23. Results / Additional analysis: No information is provided about additional analyses. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized. [Yes]
P25. Discussion / Limitations: The limitations at study and outcome level, as well as at the review-level, are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: No information is provided about funding. [No]</pre>
<p><a name='166'></a></p>
</div>
<div id="wright-2013" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JURO.2013.02.3234' title='Open publication'>Wright
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Effect of Preoperative Hormonal Stimulation on Postoperative Complication Rates After Proximal Hypospadias Repair: A Systematic Review&quot;</span> - [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions - [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known - [Yes]
P4. Introduction / Objectives: The introduction provides an explicit statement of the questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design - [Yes]
P5. Methods / Protocol and registration: No information is provided about the existence of a review protocol or registration - [No]
P6. Methods / Eligibility criteria: The methods specify the study characteristics and report characteristics used as criteria for eligibility - [Yes]
P7. Methods / Information sources: The methods describe all information sources used in the search and the date last searched - [Yes]
P8. Methods / Search: The methods present the full electronic search strategy for at least one database - [Yes]
P9. Methods / Study selection: The methods state the process for selecting studies - [Yes]
P10. Methods / Data collection process: The methods describe the method of data extraction from reports - [Yes]
P11. Methods / Data items: The methods list and define all variables for which data were sought - [Yes]
P12. Methods / Risk of bias in individual studies: The methods describe the methods used for assessing risk of bias of individual studies - [Yes]
P13. Methods / Summary measures: The methods state the principal summary measures - [Yes]
P14. Methods / Synthesis of results: Not applicable, as no meta-analysis was conducted - [NA]
P15. Methods / Risk of bias across studies: Not applicable, as no assessment of risk of bias across studies was conducted - [NA]
P16. Methods / Additional analyses: Not applicable, as no additional analyses were conducted - [NA]
P17. Results / Study selection: The results provide numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage - [Yes]
P18. Results / Study characteristics: The results present characteristics for which data were extracted and provide the citations - [Yes]
P19. Results / Risk of bias within studies: The results present data on risk of bias of each study - [Yes]
P20. Results / Results of individual studies: The results present simple summary data for each intervention group and effect estimates and confidence intervals, ideally with a forest plot - [Yes]
P21. Results / Synthesis of results: Not applicable, as no meta-analysis was conducted - [NA]
P22. Results / Risk of bias across studies: Not applicable, as no assessment of risk of bias across studies was conducted - [NA]
P23. Results / Additional analysis: Not applicable, as no additional analyses were conducted - [NA]
P24. Discussion / Summary of evidence: The discussion summarizes the main findings including the strength of evidence for each main outcome - [Yes]
P25. Discussion / Limitations: The discussion discusses limitations at study and outcome level, and at review-level - [Yes]
P26. Discussion / Conclusions: The discussion provides a general interpretation of the results in the context of other evidence and implications for future research - [Yes]
P27. Funding: No information is provided about the sources of funding for the systematic review - [No]</pre>
<p><a name='167'></a></p>
</div>
<div id="yang-2011" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2011.04.001' title='Open publication'>Yang
2011</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Laparoscopic vs open herniorrhaphy in the management of pediatric inguinal hernia: a systemic review and meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, study appraisal and synthesis methods, results, limitations, and conclusions. [Yes]
P3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: No information is provided about a review protocol or registration. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are specified. [Yes]
P7. Methods / Information sources: The information sources used in the search are described. [Yes]
P8. Methods / Search: The full electronic search strategy for at least one database is not provided. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed and defined. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias of individual studies are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: The methods of handling data and combining results of studies are not described. [NA]
P15. Methods / Risk of bias across studies: No assessment of risk of bias across studies is mentioned. [NA]
P16. Methods / Additional analyses: No additional analyses are described. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not provided. [No]
P18. Results / Study characteristics: The characteristics of each study are not presented. [No]
P19. Results / Risk of bias within studies: No data on risk of bias of each study are presented. [No]
P20. Results / Results of individual studies: The results of each individual study are presented. [Yes]
P21. Results / Synthesis of results: No synthesis of results is described. [NA]
P22. Results / Risk of bias across studies: No assessment of risk of bias across studies is mentioned. [NA]
P23. Results / Additional analysis: No additional analyses are described. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each main outcome are summarized. [Yes]
P25. Discussion / Limitations: The limitations of the review are discussed. [Yes]
P26. Discussion / Conclusions: A general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: No information is provided about funding sources. [No]</pre>
<p><a name='168'></a></p>
</div>
<div id="yang-2013" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-013-3345-1' title='Open publication'>Yang
2013</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Postoperative intussusceptions in children and infants: a systematic review&quot;</span>
- [Yes]

P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
- The abstract does not provide a structured summary.
- [No]

P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Postoperative intussusception (POI) is an unusual complication in children and infants who underwent various kinds of surgery. The early recognition was difficult for its rarity and atypical presentations. This study evaluates the clinical features of POI through a literature review.&quot;</span>
- [Yes]

P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
- The objectives are not explicitly stated.
- [No]

P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
- No information is provided about a review protocol or registration.
- [No]

P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
- The eligibility criteria are not specified.
- [No]

P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
- <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MEDLINE database was searched for relevant articles that reported the children and infants with POI since 1990 in English-language using the key word “postoperative intussusception”. All published studies containing clinical data for POI in children and infants were included. Reference lists of retrieved articles were reviewed for additional cases.&quot;</span>
- [Yes]

P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
- The full electronic search strategy is not provided.
- [No]

P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
- The process for selecting studies is not stated.
- [No]

P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
- No information is provided about the method of data extraction or data confirmation.
- [No]

P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
- The data items are not listed or defined.
- [No]

P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
- No information is provided about the assessment of risk of bias.
- [No]

P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
- No information is provided about the principal summary measures.
- [No]

P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
- Not applicable, as there is no meta-analysis.
- [NA]

P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
- Not applicable, as there is no meta-analysis.
- [NA]

P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
- Not applicable, as there is no meta-analysis.
- [NA]

P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
- No information is provided about the numbers of studies screened, assessed for eligibility, and included in the review.
- [No]

P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
- The characteristics for each study are not presented.
- [No]

P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
- No information is provided about the risk of bias within studies.
- [No]

P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
- No information is provided about the results of individual studies.
- [No]

P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
- Not applicable, as there is no meta-analysis.
- [NA]

P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
- Not applicable, as there is no meta-analysis.
- [NA]

P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
- Not applicable, as there is no meta-analysis.
- [NA]

P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
- The main findings are summarized, but the strength of evidence is not discussed.
- [No]

P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
- The limitations are not discussed.
- [No]

P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
- A general interpretation of the results is provided, but implications for future research are not discussed.
- [No]

P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
- No information is provided about the sources of funding or other support.
- [No]</pre>
<p><a name='169'></a></p>
</div>
<div id="youssef-2016" class="section level4">
<h4><a href='https://doi.org/10.1016/J.JPEDSURG.2016.02.010' title='Open publication'>Youssef
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Flap versus fascial closure for gastroschisis: a systematic review and meta-analysis&quot;</span> [Yes]
P2. Abstract / Structured summary: The abstract provides a summary of the background, objectives, methods, results, and conclusions of the review. [Yes]
P3. Introduction / Rationale: The introduction provides a rationale for the review in the context of what is already known. [Yes]
P4. Introduction / Objectives: The objectives of the review are explicitly stated. [Yes]
P5. Methods / Protocol and registration: The review protocol is not mentioned. [No]
P6. Methods / Eligibility criteria: The study characteristics and report characteristics used as eligibility criteria are not specified. [No]
P7. Methods / Information sources: The information sources used in the search are not described. [No]
P8. Methods / Search: The full electronic search strategy is not provided. [No]
P9. Methods / Study selection: The process for selecting studies is not described. [No]
P10. Methods / Data collection process: The method of data extraction is not described. [No]
P11. Methods / Data items: The variables for which data were sought are not listed. [No]
P12. Methods / Risk of bias in individual studies: The methods used for assessing risk of bias are not described. [No]
P13. Methods / Summary measures: The principal summary measures are not stated. [No]
P14. Methods / Synthesis of results: The methods of handling data and combining results are not described. [NA]
P15. Methods / Risk of bias across studies: The assessment of risk of bias across studies is not mentioned. [NA]
P16. Methods / Additional analyses: The methods of additional analyses are not described. [NA]
P17. Results / Study selection: The numbers of studies screened, assessed for eligibility, and included in the review are not provided. [No]
P18. Results / Study characteristics: The characteristics of each study are not presented. [No]
P19. Results / Risk of bias within studies: The risk of bias of each study is not presented. [No]
P20. Results / Results of individual studies: The results of each study are not presented. [No]
P21. Results / Synthesis of results: The results of any meta-analysis are not described. [NA]
P22. Results / Risk of bias across studies: The results of any assessment of risk of bias across studies are not presented. [NA]
P23. Results / Additional analysis: The results of any additional analyses are not described. [NA]
P24. Discussion / Summary of evidence: The main findings and the strength of evidence for each outcome are summarized. [Yes]
P25. Discussion / Limitations: The limitations of the review are discussed. [Yes]
P26. Discussion / Conclusions: The general interpretation of the results and implications for future research are provided. [Yes]
P27. Funding: The sources of funding for the review are not mentioned. [No]</pre>
<p><a name='171'></a></p>
</div>
<div id="zhao-2015" class="section level4">
<h4><a href='https://doi.org/10.1007/S00383-015-3680-5' title='Open publication'>Zhao
2015</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Single-incision versus conventional laparoscopic appendicectomy in children: a systematic review and meta-analysis&quot;</span>
[Yes] The report is identified as a systematic review and meta-analysis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this systematic review and meta-analysis was to compare clinical outcomes between single-incision laparoscopic appendicectomy and conventional laparoscopic appendicectomy in children.&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, and results.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎As surgical techniques have developed and the demand for procedures that cause less pain and have better cosmetic outcome, more and more surgeons draw their attention to minimally invasive techniques.&quot;</span>
[Yes] The rationale for the review is described in the context of what is already known.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The aim of this systematic review and meta-analysis was to compare clinical outcomes between single-incision laparoscopic appendicectomy and conventional laparoscopic appendicectomy in children.&quot;</span>
[Yes] The objectives of the review are explicitly stated.

P5. Methods / Protocol and registration: No information is provided about a review protocol or registration.
[No] The existence of a review protocol and registration information is not mentioned.

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Children with histologically confirmed acute appendicitis who received SILA or CLA were recruited.&quot;</span>
[Yes] The study characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎An electronic search was performed using EMBASE, PubMed, MEDLINE from 2000 to 2014.&quot;</span>
[Yes] The information sources are described.

P8. Methods / Search: No information is provided about the full electronic search strategy.
[No] The full electronic search strategy is not presented.

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Children with histologically confirmed acute appendicitis who received SILA or CLA were recruited.&quot;</span>
[Yes] The process for selecting studies is stated.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors independently extracted data from the list of the included studies, and a third reviewer was required for a final decision in the case of any discrepancies.&quot;</span>
[Yes] The method of data extraction is described.

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The primary objective of our analysis was to evaluate the operative time, length of hospital stay. Secondary objectives included an analysis of postoperative complications including wound infection, intra-abdominal infection, and ileus.&quot;</span>
[Yes] The variables for which data were sought are listed and defined.

P12. Methods / Risk of bias in individual studies: No information is provided about the methods used for assessing risk of bias.
[No] The methods used for assessing risk of bias are not described.

P13. Methods / Summary measures: No information is provided about the principal summary measures.
[NA] Not applicable as there is no mention of summary measures.

P14. Methods / Synthesis of results: No information is provided about the methods of handling data and combining results.
[NA] Not applicable as there is no mention of data synthesis.

P15. Methods / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies.
[NA] Not applicable as there is no mention of risk of bias across studies.

P16. Methods / Additional analyses: No information is provided about additional analyses.
[NA] Not applicable as there is no mention of additional analyses.

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The initial search strategy identified 213 citations and 26 of them were retrieved for full text review. Twelve trials met total inclusion criteria.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are given.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The 12 selected studies (4 randomized controlled trials, 1 prospective study and 7 retrospective studies) included 2,109 participants.&quot;</span>
[Yes] Characteristics for which data were extracted are presented.

P19. Results / Risk of bias within studies: No information is provided about the risk of bias of each study.
[No] The risk of bias of each study is not presented.

P20. Results / Results of individual studies: <span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 54.8%):

is. Meta-analysis demonstrated a statistically significant decrease in mean length of hospital stay for SILA compared with CLA' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Meta-analysis demonstrated no statistically significant in mean operating time for SILA compared with CLA. Meta-analysis demonstrated a statistically significant decrease in mean length of hospital stay for SILA compared with CLA.&quot;</span>
[Yes] Simple summary data for each intervention group and effect estimates are provided.

P21. Results / Synthesis of results: No information is provided about the methods of handling data and combining results.
[NA] Not applicable as there is no mention of data synthesis.

P22. Results / Risk of bias across studies: No information is provided about the assessment of risk of bias across studies.
[NA] Not applicable as there is no mention of risk of bias across studies.

P23. Results / Additional analysis: No information is provided about additional analyses.
[NA] Not applicable as there is no mention of additional analyses.

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis.&quot;</span>
[Yes] The main findings and the strength of evidence for each main outcome are summarized.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎The overall methodologic quality and reporting of the included trials in children was poor.&quot;</span>
[Yes] Limitations at study and outcome level are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis.&quot;</span>
[Yes] A general interpretation of the results and implications for future research are provided.

P27. Funding: No information is provided about the sources of funding for the systematic review.
[No] The sources of funding for the systematic review are not described.</pre>
<p><a name='172'></a></p>
</div>
<div id="zhu-2016" class="section level4">
<h4><a href='https://doi.org/10.1007/S10029-015-1423-0' title='Open publication'>Zhu
2016</a></h4>
<table style="margin: 0; width: 100%">
<caption>
PRISMA
</caption>
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P1. Title: Identify the report as a systematic review, meta-analysis, or both.">
P1</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.">
P2</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.">
P3</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).">
P4</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.">
P5</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.">
P6</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.">
P7</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.">
P8</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).">
P9</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.">
P10</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.">
P11</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.">
P12</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).">
P13</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.">
P14</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
</tr>
</tbody>
</table>
<table style="margin: 0; width: 100%; border-top: 0">
<thead>
<tr>
<th style="text-align:left;">
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).">
P15</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.">
P16</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.">
P17</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.">
P18</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).">
P19</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.">
P20</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.">
P21</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).">
P22</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).">
P23</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).">
P24</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).">
P25</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.">
P26</span>
</th>
<th style="text-align:left;">
<span style="border-bottom: 1px dashed black"
title="P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.">
P27</span>
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Human Consensus
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
0
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
0
</td>
</tr>
<tr>
<td style="text-align:left;">
LLM 2nd run
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
<td style="text-align:left;">
1
</td>
</tr>
</tbody>
</table>
<p><br><span style="padding: 8px 0; color: #999">LLM response</span></p>
<pre>
P1. Title: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Minimally invasive surgery for congenital diaphragmatic hernia: a meta-analysis&quot;</span>
[Yes] The report is identified as a meta-analysis.

P2. Abstract / Structured summary: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare the safety and efficacy of minimally invasive surgery (MIS) with traditional open surgical approach for congenital diaphragmatic hernia (CDH).&quot;</span>
[Yes] The abstract provides a structured summary including background, objectives, and study eligibility criteria.

P3. Introduction / Rationale: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Congenital diaphragmatic hernia (CDH) is a congenital defect in diaphragm development, which occurs in approximately 1 in 2500–4000 live births [1]. Surgical repair via laparotomy or thoracotomy is the traditional treatment for patients with CDH.&quot;</span>
[Yes] The rationale for the review is described in the context of what is already known.

P4. Introduction / Objectives: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎To compare the safety and efficacy of MIS with traditional surgical approach for CDH.&quot;</span>
[Yes] The objectives of the review are explicitly stated.

P5. Methods / Protocol and registration: No relevant quote found.
[No] No information is provided about the existence of a review protocol or registration.

P6. Methods / Eligibility criteria: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Studies that met all the following criteria were included in the meta-analysis: (1) the trial was a randomized or non-randomized clinical trial; (2) the study was designed to compare surgical outcomes of neonates with CDH between MIS intervention and open procedures; and (3) data on incidence of mortality, recurrence, patch use, and surgical complication rate were fully or partially reported.&quot;</span>
[Yes] The study characteristics and report characteristics used as eligibility criteria are specified.

P7. Methods / Information sources: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎A literature search was performed using the PubMed database, Embase, and the Cochrane central register of controlled trials using a defined set of criteria.&quot;</span>
[Yes] The information sources for the literature search are described.

P8. Methods / Search: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We performed a literature search of the PubMed database (National Library of Medicine, Bethesda, MD, USA) that covered the period from 1966 to December 2013. The search conducted for Embase and the Cochrane Central Register of Controlled Trials was restricted to English-language literature.&quot;</span>
[Yes] The full electronic search strategy for at least one database is presented.

P9. Methods / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Two authors (Zhu and Wu) independently performed an electronic database search to identify studies that met the eligibility criteria.&quot;</span>
[Yes] The process for selecting studies is described.

P10. Methods / Data collection process: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We extracted data from each eligible study, including general information, post-operative mortality, incidence of hernia recurrence, rates of patch use, and complications.&quot;</span>
[Yes] The method of data extraction from reports is described.

P11. Methods / Data items: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎We extracted data from each eligible study, including general information, post-operative mortality, incidence of hernia recurrence, rates of patch use, and complications.&quot;</span>
[Yes] The variables for which data were sought are listed.

P12. Methods / Risk of bias in individual studies: No relevant quote found.
[NA] Not applicable as there is no mention of assessing risk of bias in individual studies.

P13. Methods / Summary measures: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Dichotomous outcomes were expressed in relative risk (RR) with their 95 % confidence interval (CI) values.&quot;</span>
[Yes] The principal summary measures are stated.

P14. Methods / Synthesis of results: No relevant quote found.
[NA] Not applicable as there is no mention of combining results of studies.

P15. Methods / Risk of bias across studies: No relevant quote found.
[NA] Not applicable as there is no mention of assessing risk of bias across studies.

P16. Methods / Additional analyses: No relevant quote found.
[NA] Not applicable as there is no mention of additional analyses.

P17. Results / Study selection: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎Our (Zhu and Wu) preliminary search revealed 70 relevant studies, and 61 of them were eventually excluded because they were merely narrative studies or case reports or did not evaluate the surgical outcomes that were the focus of this review.&quot;</span>
[Yes] The numbers of studies screened, assessed for eligibility, and included in the review are given.

P18. Results / Study characteristics: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All nine clinical trials [3–11] compared thoracoscopic or laparoscopic (only four laparoscopic cases) repair of CHD with open techniques. All the studies were non-randomized historical control trials.&quot;</span>
[Yes] Characteristics for each study, including study size and design, are presented.

P19. Results / Risk of bias within studies: No relevant quote found.
[NA] Not applicable as there is no mention of presenting risk of bias of each study.

P20. Results / Results of individual studies: <span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):

Our meta-analysis revealed a significantly lower rate of post-operative death in the MIS group than in the open techniques group with an RR of 0.26 (95 % CI 0.10–0.68; p = 0.006) (Fig. 2). The incidence of hernia recurrence was greater in the MIS group with an RR of 3.42 (95 % CI 1.98–5.88; p < 0.00001) (Fig. 3). The previous two sets of pooled data both showed good homogeneity among the involved trials. Thus, fixed models were applied for analysis. No significant difference was found for the rates of prosthetic patch use between the two groups (Fig. 4). Fewer cases of surgical complications were found for neonates who underwent thoracoscopic or laparoscopic procedures with an RR of 0.66 (95 % CI 0.47–0.94; p = 0.02' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Our meta-analysis revealed a significantly lower rate of post-operative death in the MIS group than in the open techniques group with an RR of 0.26 (95 % CI 0.10–0.68; p = 0.006) but a greater incidence of hernia recurrence with an RR of 3.42 (95 % CI 1.98–5.88; p < 0.00001). Rates of prosthetic patch use were similar between the two groups. Fewer cases of surgical complications were found in the MIS group with an RR of 0.66 (95 % CI 0.47–0.94; p = 0.02).&quot;</span>
[Yes] Simple summary data for each intervention group and effect estimates with confidence intervals are presented.

P21. Results / Synthesis of results: No relevant quote found.
[NA] Not applicable as there is no mention of synthesis of results.

P22. Results / Risk of bias across studies: No relevant quote found.
[NA] Not applicable as there is no mention of assessing risk of bias across studies.

P23. Results / Additional analysis: No relevant quote found.
[NA] Not applicable as there is no mention of additional analyses.

P24. Discussion / Summary of evidence: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MIS for CDH repair is associated with lower post-operative mortality and morbidity compared with traditional open repair. Although rate of patch use appears to be comparable, the increased risk of CDH recurrence should not be ignored.&quot;</span>
[Yes] The main findings, including the strength of evidence for each main outcome, are summarized.

P25. Discussion / Limitations: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎All the trials included are susceptible to the limitations of any retrospective review. They all have selection bias, and the numbers of patients are all small to draw a definitive conclusion.&quot;</span>
[Yes] Limitations at study and outcome level, as well as review-level, are discussed.

P26. Discussion / Conclusions: <span title='Perfect quote from fulltext (Similarity 100%).' style='border-bottom: 1px dashed black; color: black; background-color: transparent'>&quot;‎MIS for CDH repair is associated with lower post-operative mortality and morbidity compared with traditional open surgery. Although the rate of patch use appears to be comparable, the increased risk of recurrence of CDH should not be ignored. The lack of well-controlled prospective clinical trials might also be a reason for the inability to find significant predictive factors.&quot;</span>
[Yes] A general interpretation of the results in the context of other evidence and implications for future research are provided.

P27. Funding: <span title='Minor quote deviation. Best match in fulltext (Similarity 97.3%):

YZ declares no conflict of interest.

YW declares no conflict of interest.

QP declares no conflict of interest.

LM declares no conflict of interest.

HL declares no conflict of interest.

LL declares no conflict of interest' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎YZ declares no conflict of interest. YW declares no conflict of interest. QP declares no conflict of interest. LM declares no conflict of interest. HL declares no conflict of interest. LL declares no conflict of interest.&quot;</span>
[Yes] Sources of funding for the systematic review and other support are described.

Overall, 24 out of 27 PRISMA items were reported in the full text.</pre>
</div>
</div>
<div id="quote-accuracy" class="section level3">
<h3>Quote accuracy</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<ul>
<li>1055 quotes for 107 / 108 (99.1%) publications, median 13 (IQR 1-16,
range 1-28)</li>
<li>897 / 1055 (85%) perfect <span
style="border-bottom: 1px dashed black;">quotes from the publication
fulltext</span></li>
<li>34 / 1055 (3.2%) perfect <span
style="border-bottom: 1px dashed #2780e3; color: #2780e3;">quotes from
the LLM prompt briefing</span></li>
<li>124 / 1055 (11.8%) quotes with deviations from source, where the
accuracy was measured by a <a
href="https://maxbachmann.github.io/RapidFuzz/Usage/distance/Levenshtein.html#normalized-similarity">“normalized
Levensthein similarity”</a> <span
style="border-bottom: 1px dashed black;"
title="Weights for insertion: 1, deletion: 0.5, substitution: 1.5. Penalizes &quot;positive hallucinations&quot; (insertions) more than omissions of e.g. brackets and references (deletions).">with
custom weights</span>, ranging from 0-100%
<ul>
<li><span style="background-color: #ffe9e2">90 minor</span> deviations
(95% ≤ similarity &lt; 100%); mean: 98.6%</li>
<li><span style="background-color: #ff9e81">24 moderate</span>
deviations (75% ≤ similarity &lt; 95%); mean: 88.2%</li>
<li><span style="background-color: red">10 major</span> deviations
(similarity &lt; 75%); mean: 64.8%</li>
</ul></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-439c3ed969fad06e8adc" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-439c3ed969fad06e8adc">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["Healy 2015","Healy 2015","Healy 2015","Healy 2016","Healy 2016","Healy 2016","Heloury 2012","Heloury 2012","Kapralik 2016","Kapralik 2016","Kapralik 2016","Lansdale 2010","LeeVan 2016","Liang 2011","Liang 2011","Liang 2011","Liang 2011","Liang 2011","Liang 2011","Liang 2011","Liang 2011","Liang 2011","Lishuang 2015","Lishuang 2015","Lishuang 2015","Lishuang 2015","Mullassery 2014","Mullassery 2014","Narayanan 2013","Nasr 2010","Nasr 2010","Nasr 2010","Nasr 2013","Nasr 2013","Nicolau 2011","Nicolau 2011","Nicolau 2011","Nicolau 2011","Oliveira 2016","Oomen 2012","Oomen 2012","Oomen 2012","Parolini 2016","Parolini 2016","Pfistermuller 2015","Pfistermuller 2015","Pfistermuller 2015","Pfistermuller 2015","Pfistermuller 2015","Ross 2015","Ross 2015","Saldaña 2013","Scholfield 2016","Sharp 2015","Shawyer 2014","Shen 2015","Shen 2015","Shen 2015","Shen 2015","Siddiqui 2011","Siminas 2015","Sklar 2014","Sklar 2014","Sola 2010","Symeonidis 2016","Tan 2016","Tan 2016","Tan 2016","Tan 2016","Tan 2016","Terui 2015","Thomson 2015","Thomson 2015","Thomson 2015","Thomson 2015","Zhao 2015","Zhu 2016","Zhu 2016","Aikenhead 2011","Aikenhead 2011","Aikenhead 2011","Al-Hozaim 2010","Al-Hozaim 2010","Al-Hozaim 2010","Allin 2015","Apelt 2013","Aworanti 2014","Billingham 2010","Billingham 2010","Billingham 2010","Borruto 2010","Borruto 2010","Borruto 2010","Borruto 2010","Castagnetti 2016","Chan 2014 (Pediatr Surg Int)","Chan 2014 (Pediatr Surg Int)","Chan 2014 (Pediatr Surg Int)","Chan 2014 (Pediatr Surg Int)","Cullis 2016","Cundy 2014 (BJU Int)","Feng 2016","Feng 2015","Feng 2015","Feng 2015","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Friedmacher 2011","Frongia 2013","Frongia 2013","Frongia 2013","Guo 2011","Guo 2011","Guo 2011"],["fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","prompt","fulltext","fulltext","prompt","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext","fulltext"],["<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nAn expanding body of evidence suggests that surgeon subspecialization affects outcomes; studies found that colorectal surgery subspecialization4 and orthopedic surgery subspecialization5 lead to improved results and that outcomes from a variety of cancers are improved with subspecialization' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎An expanding body of evidence suggests that surgeon subspecialization affects outcomes; studies found that colorectal surgery subspecialization and orthopedic surgery subspecialization lead to improved results and that outcomes from a variety of cancers are improved with subspecialization.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nTwo authors (DD and DH) independently extracted data from eligible studies using an electronic spreadsheet' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two authors extracted data from eligible studies using an electronic spreadsheet.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nCharacteristics of the 9 included studies8,11–18 are shown in Table 1 and results from the studies are provided in Table 2' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Characteristics of the 9 included studies are shown in Table 1 and results from the studies are provided in Table 2.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\na comprehensive literature search was performed using Ovid MEDLINE (1946–present) and Embase' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A comprehensive literature search was performed using Ovid MEDLINE and Embase.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nOf these, 24 publications related to adult IA (Table 1), 12 specifically to obstetrics and gynecology in adults (Table 2), and 12 to pediatric surgery' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Of these, 24 publications related to adult IA, 12 specifically to obstetrics and gynecology in adults, and 12 to pediatric surgery.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.9%):\n\nThe question of whether or not to perform the procedure does not have a single simple answer; rather the answer must consider the global condition of the individual patient' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The decision whether to perform IA does not have a single simple answer and must consider the global condition of the individual patient.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nwe attempted to answer the following questions:\n\n    -\n\n    Is MIA superior to open adrenalectomy (OA)?\n    -\n\n    What is the best approach (transperitoneal or retroperitoneal)?\n    -\n\n    What are the pediatric indications for MIA' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎we attempted to answer the following questions: Is MIA superior to open adrenalectomy (OA)? What is the best approach (transperitoneal or retroperitoneal)? What are the pediatric indications for MIA?&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 73.8%):\n\nis potentially superior to OA for the removal of noninvasive tumors with low morbidity rates' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Minimally invasive adrenalectomy is potentially superior to OA for the removal of noninvasive tumors with low morbidity rates.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nwe conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), EMBASE (1980 onwards), CINAHL (1982 onwards), and PubMed (1966 onwards) in January 2015' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, and PubMed in January 2015.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nwe conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), EMBASE (1980 onwards), CINAHL (1982 onwards), and PubMed (1966 onwards) in January 2015' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted an electronic literature search of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, and PubMed in January 2015.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nWe conducted our meta-analyses using Review Manager 5.3 [20], using random-effects models [21], to produce an odds ratio (OR) for morbidity, as this is a categorical variable, and a mean difference (MD) for length of stay, as this is a continuous variable, along with 95% confidence intervals (CIs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted our meta-analyses using Review Manager 5.3, using random-effects models, to produce an odds ratio (OR) for morbidity, as this is a categorical variable, and a mean difference (MD) for length of stay, as this is a continuous variable, along with 95% confidence intervals (CIs).&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 78.1%):\n\nsurgical repair, recurrence was higher (RR: 3.2 [1.1, 9.3], P = 0.03) and operative time longer (WMD 50 minutes [32, 69], P < 0.00001). Survival and patch usage were not different between open and endosurgical groups' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Meta-analysis reveals that recurrence was higher and operative time longer in the endosurgical group. Survival and patch usage were not different between open and endosurgical groups.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.8%):\n\nManagement of pediatric blunt renal trauma\nA systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Management of pediatric blunt renal trauma: A systematic review&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.9%):\n\nVaricocele, an abnormal tortuosity and dilatation of the testicular vein within the spermatic cord, first develops in childhood or early adolescence [1]. The prevalence of varicocele in adolescent boys is estimated to be 11–15% [1]. It has been established that adolescent varicocele is associated with growth retardation of the ipsilateral testicle and impaired testicular function, which is correlated to the duration of the varicocele [1]. Although some studies have challenged the role varicocele plays in infertility, many studies have stated that varicocele is associated with testicular atrophy and abnormal seminal parameters contributing to male infertility [2] [3]. Surgical management of adolescent varicocele has been advocated to preserve future fertility [4]. The earlier the patient undergoes varicocele repair, the more likely the testis will recover from a varicocele-induced injury [5]. Currently, several techniques are successfully used for varicocelectomy including open surgical ligation via a subinguinal, inguinal or retroperitoneal approach, and microsurgical and laparoscopic procedures [6] [7]. However, the efficacy of surgical procedures and the outcomes in boys and young adolescents remains unclear' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Varicocele, an abnormal tortuosity and dilatation of the testicular vein within the spermatic cord, first develops in childhood or early adolescence. The prevalence of varicocele in adolescent boys is estimated to be 11–15%. It has been established that adolescent varicocele is associated with growth retardation of the ipsilateral testicle and impaired testicular function, which is correlated to the duration of the varicocele. Although some studies have challenged the role varicocele plays in infertility, many studies have stated that varicocele is associated with testicular atrophy and abnormal seminal parameters contributing to male infertility. Surgical management of adolescent varicocele has been advocated to preserve future fertility. The earlier the patient undergoes varicocele repair, the more likely the testis will recover from a varicocele-induced injury. Currently, several techniques are successfully used for varicocelectomy including open surgical ligation via a subinguinal, inguinal or retroperitoneal approach, and microsurgical and laparoscopic procedures. However, the efficacy of surgical procedures and the outcomes in boys and young adolescents remains unclear.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nA search was made for studies published up until 31 August 2010 using the terms “lymphatic sparing varicocelectomy”, “laparoscopy”, “adolescent” and “children” in the Medline, Embase, Ovid, Web of Science, and Cochrane databases' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A search was made for all studies published up until 31 August 2010 using the terms “lymphatic sparing varicocelectomy”, “laparoscopy”, “adolescent” and “children” in the Medline, Embase, Ovid, Web of Science, and Cochrane databases.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\nA search was made for studies published up until 31 August 2010 using the terms “lymphatic sparing varicocelectomy”, “laparoscopy”, “adolescent” and “children” in the Medline, Embase, Ovid, Web of Science, and Cochrane databases' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎A search was made for all studies published up until 31 August 2010 using the terms “lymphatic sparing varicocelectomy”, “laparoscopy”, “adolescent” and “children” in the Medline, Embase, Ovid, Web of Science, and Cochrane databases.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\n3 reviewers (LZL, GJ and TQS) independently assessed the selected studies, and extracted and tabulated data from each article using a predefined data extraction form' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎3 reviewers independently assessed the selected studies, and extracted and tabulated data from each article using a predefined data extraction form.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nEach included article was appraised by 3 reviewers (LZL, GJ and TQS), who independently assessed the methodological quality of the selected studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Each included article was appraised by 3 reviewers, who independently assessed the methodological quality of the selected studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nEach included article was appraised by 3 reviewers (LZL, GJ and TQS), who independently assessed the methodological quality of the selected studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Each included article was appraised by 3 reviewers, who independently assessed the methodological quality of the selected studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in prompt (Similarity 99.4%):\n\nFor all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: #ffe9e2'>&quot;‎For all outcomes considered, present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):\n\nIn this meta-analysis, we demonstrate that the lymphatic sparing laparoscopic approach is associated with a lower incidence of hydrocele formation, supporting the belief that lymphatic occlusion is the main cause of hydrocele formation after varicocelectomy. In addition, the incidence of recurrence and catch-up growth were' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎In this meta-analysis, we demonstrate that the lymphatic sparing laparoscopic approach is associated with a lower incidence of hydrocele formation, with similar recurrence and catch-up growth rates as LNSV.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nThis work was supported by the National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 81071997, No. 81072073), Program for New Century Excellent Talents in the University of China (NCET-06-0641), the Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry (2008-889), and Fundamental Research Funds for the Central Universities' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This work was supported by the National Natural Science Foundation of China, Program for New Century Excellent Talents in the University of China, the Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry, and Fundamental Research Funds for the Central Universities.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in prompt (Similarity 62.4%):\n\nbackground; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusion' style='border-bottom: 1px dashed #2780e3; color: #2780e3; background-color: red'>&quot;‎Background...Design...Data sources...Study selection...Data extraction...Results...Conclusion&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 44.3%):\n\n.\n\nSince first reported by Kasai and Suzuki [8] in 1959, portoenterostomy (PE) remains the mainstay of treating BA' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Biliary atresia (BA) is one of the most common reasons for portoenterostomy in pediatric surgery...The etiology of BA remains unknown...Since first reported by Kasai and Suzuki in 1959, portoenterostomy (PE) remains the mainstay of treating BA.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nThe results of our meta-analysis suggested that compared with OPE, LPEs were considered to be a poor treatment for BA in long-term outcomes with low 2-year survival of native liver (OR 0.39, 95 % CI 0.21 to 0.74; P = 0.04), although LPEs performed well in short-term outcomes in the form of intraoperative blood loss, early clearance of jaundice and cholangiti' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The results of our meta-analysis suggested that compared with OPE, LPEs were considered to be a poor treatment for BA in long-term outcomes with low 2-year survival of native liver, although LPEs performed well in short-term outcomes in the form of intraoperative blood loss, early clearance of jaundice and cholangitis.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.4%):\n\nThere are limitations to this review which must be considered. First, there have only been a small number of studies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials. Second, the sample size of some selected studies is small so that the statistical power to detect the difference in the outcomes is limited. Third, although most of the comparative cohort studies seem to be robust, risk of selection bias still existed, as it was the surgeons’ preference and experience that determined the allocation of patients to either LPE or OPE group. Fourth, marked heterogeneity for several meta-analysis, short follow-up time in some included studies, and the potentially existed significant risk of publication bias may more or less affect the accuracy of the results. Fifth, the other limitation is the length of follow-u' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎There are limitations to this review which must be considered...First, there have only been a small number of studies comparing LPE with OPE in the treatment of biliary atresia, with a lack of randomized trials...Second, the sample size of some selected studies is small so that the statistical power to detect the difference in the outcomes is limited...Third, although most of the comparative cohort studies seem to be robust, risk of selection bias still existed...Fourth, marked heterogeneity for several meta-analysis, short follow-up time in some included studies, and the potentially existed significant risk of publication bias may more or less affect the accuracy of the results...Fifth, the other limitation is the length of follow-up.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 89%):\n\nThe meta-analysis found no statistically significant differences in 5 year OS rates between the 2 surgical groups when comparing GTR vs. STR' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The meta-analysis found no statistically significant differences in 5 year overall survival rates between the 2 surgical groups when comparing GTR vs. STR.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):\n\nBased on current “‘best evidence” we can report a clear survival advantage for GTR in stage 3 neuroblastoma' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Based on current 'best evidence' we can report a clear survival advantage for GTR in stage 3 neuroblastoma.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nBackground\n\nExcision has been established as a standard management practice for choledochal cysts in the last few decades. The two most commonly performed methods of reconstruction after excision are hepaticoduodenostomy (HD) and Roux-en-Y hepaticojejunostomy (HJ), of which the HJ is favored by most surgeons. Evidence concerning the optimal method of reconstruction is, however, sparse.\nMaterials and Methods\n\nStudies comparing outcomes from HD and HJ after choledochal cyst excision were identified by searching Medline, Ovid, Search Medica, Elsevier Clinicalkey, Google Scholar and Cochrane library. Suitable studies were chosen and data extracted for meta-analysis. Outcomes evaluated included operative time, hospital stay and incidence of postoperative bile leak, cholangitis, reflux/gastritis, anastomotic stricture, bleeding, intestinal obstruction and re-operative rate. Pooled odds ratios (OR) were calculated for dichotomous variables; pooled mean differences (MD) were measured for continuous variables.\nResults\n\nSix retrospective studies were included in this meta-analysis, comprising a total of 679 patients, 412 of whom (60.7%) underwent HD, and the remainder, 267(39.3%) underwent HJ. Although, HD group had slightly shorter hospital stay (MD: 0.30; 95% CI: −0.22–0.39; P < 0.00001) it showed a higher incidence of postoperative reflux/gastritis (OR: 0.08; 95% CI: − 0.02–0.39; P = 0.002). However, the other outcomes such as bile leak, cholangitis, anastomotic stricture, bleeding, operative time, reoperation rate and adhesive intestinal obstruction did not differ between HD and HJ groups.\nConclusions\n\nHD shows higher postoperative reflux/gastritis than HJ but a shorter hospital stay. There are few good-quality studies that compare the outcomes from HD and HJ, meaning that caution should be exercised in the generalization of the results of this meta-analysis, which suggests HD to be comparable with HJ in terms of other complications, operative benefits and outcomes' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Background: Excision has been established as a standard management practice for choledochal cysts in the last few decades. The two most commonly performed methods of reconstruction after excision are hepaticoduodenostomy (HD) and Roux-en-Y hepaticojejunostomy (HJ), of which the HJ is favored by most surgeons. Evidence concerning the optimal method of reconstruction is, however, sparse. Methods: Studies comparing outcomes from HD and HJ after choledochal cyst excision were identified by searching Medline, Ovid, Search Medica, Elsevier Clinicalkey, Google Scholar and Cochrane library. Suitable studies were chosen and data extracted for meta-analysis. Results: Six retrospective studies were included in this meta-analysis, comprising a total of 679 patients, 412 of whom (60.7%) underwent HD, and the remainder, 267(39.3%) underwent HJ. Although, HD group had slightly shorter hospital stay (MD: 0.30; 95% CI: −0.22–0.39; P < 0.00001) it showed a higher incidence of postoperative reflux/gastritis (OR: 0.08; 95% CI: − 0.02–0.39; P = 0.002). However, the other outcomes such as bile leak, cholangitis, anastomotic stricture, bleeding, operative time, reoperation rate and adhesive intestinal obstruction did not differ between HD and HJ groups. Conclusions: HD shows higher postoperative reflux/gastritis than HJ but a shorter hospital stay. There are few good-quality studies that compare the outcomes from HD and HJ, meaning that caution should be exercised in the generalization of the results of this meta-analysis, which suggests HD to be comparable with HJ in terms of other complications, operative benefits and outcomes.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nThree authors (AN, AF, and PW) independently assessed all published articles identified as potentially relevant by the literature search for inclusion in the review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Three authors independently assessed all published articles identified as potentially relevant by the literature search for inclusion in the review.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.6%):\n\nTwo authors (AN and PW) independently extracted data from the retrieved articles' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two authors independently extracted data from the retrieved articles.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 75.2%):\n\nthe evaluation and management of these parameters was not standardized, thus, making it impossible to calculate a pooled estimat' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The evaluation and management of postoperative pain and patient satisfaction were not standardized, thus making it impossible to calculate a pooled estimate.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nAll publications describing both surgical procedures were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials database. All studies were identified through electronic searches of MEDLINE (1966 onward), Embase (1980 onward), and CINAHL (1982 onward), and from hand searching journals and conference proceedings' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎All publications describing both surgical procedures were sought from the Cochrane Trials Register and the Cochrane Central Register of Controlled Trials database. All studies were identified through electronic searches of MEDLINE, Embase, and CINAHL, and from hand searching journals and conference proceedings.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 88.4%):\n\nThe literature search resulted in a total of 115 articles, after screening and exclusion of nonrelevant and duplicate publications. Six articles[36] [37] [38] [39] [40] [41] met our criteria for inclusion' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The literature search resulted in a total of 115 articles, after screening and exclusion of nonrelevant and duplicate publications. Six articles on the Foker procedure met the criteria for inclusion.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\narticles were reviewed, which included 22\ncase studies, 27 case reports, 17 reviews and 2 guidelines' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎66 articles were reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.2%):\n\narticles were reviewed, which included 22\ncase studies, 27 case reports, 17 reviews and 2 guidelines' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎66 articles were reviewed, which included 22 case studies, 27 case reports, 17 reviews and 2 guidelines.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):\n\n343 patients with BAT were approached using\nlaparoscopy, with one therapeutic laparoscopy possible in\n48,98% patients (168/343),and 14,87% in need of conversion\n(51/343' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎343 patients with BAT were approached using laparoscopy, with one therapeutic laparoscopy possible in 48,98% patients (168/343), and 14,87% in need of conversion (51/343).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):\n\nThe main limitations attributed to laparoscopy were the\nlack of adequate equipment and trained medical personnel,\nthe issue of general anesthesia, the fact that it is invasive,\nexpensive, and does not allow a proper visualization of\nhollow organ injuries' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The main limitations attributed to laparoscopy were the lack of adequate equipment and trained medical personnel, the issue of general anesthesia, and the fact that it is invasive, expensive, and does not allow a proper visualization of hollow organ injuries.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.1%):\n\nAmong the different techniques presented in 19 papers collected, we categorized reconstructive procedures into two groups: microsurgical and non-microsurgical techniques' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Among the different techniques presented in the 19 papers collected, we categorized reconstructive procedures into two groups: microsurgical and non-microsurgical techniques.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nthe aim of this study was to compare the results of LP and open pyloromyotomy (OP) by means of a systematic review of the available randomized trials while focusing on major complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The aim of this study was to compare the results of LP and OP by means of a systematic review of the available randomized trials while focusing on major complications.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nPotentially eligible studies were reviewed independently by two authors (MWNO, RB) for inclusion and exclusion criteria' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Potentially eligible studies were reviewed independently by two authors for inclusion and exclusion criteria.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\ndata on setting, methodological quality [according to the Cochrane handbook for systematic reviews of interventions (http://dcc.cochrane.org/sites/dcc.cochrane.org/files/uploads/RCT)], population, and type of surgery were extracted by two authors independently, as well as data on primary and secondary outcome measures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data on setting, methodological quality, population, and type of surgery were extracted by two authors independently, as well as data on primary and secondary outcome measures.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nhe management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The management of newborns with esophageal atresia and right aortic arch: A systematic review or still unsolved problem&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.8%):\n\nThis systematic review had some inherent limitations. Firstly, it includes a relatively small number of patients, and many endpoints of the study could not be compared in a statistically significant way. Secondly, all eligible studies were retrospective case series without a control ar' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This systematic review had some inherent limitations, including a relatively small number of patients and retrospective case series without a control arm.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nThere is a wide discrepancy between published complication rates for different repair types [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16] and a poor evidence base for the current management of hypospadias' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎There is a wide discrepancy between published complication rates for different repair types and a poor evidence base for the current management of hypospadias.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nAssessing the appropriateness of its application to all degrees of hypospadias.\n    2.\n\n    Evaluating the long-term results by analysing the pooled complication rates to accurately determine representative complication rates for this technique.\n    3.\n\n    Reviewing the effects of technical modifications, length of follow-up and geographical location of these complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Assessing the appropriateness of its application to all degrees of hypospadias; Evaluating the long-term results by analyzing the pooled complication rates to accurately determine representative complication rates for this technique; Reviewing the effects of technical modifications, length of follow-up and geographical location of these complications.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\nPaediatric populations solely\n    2.\n\n    TIP technique used\n    3.\n\n    Complications given for at least one of those under consideration\n    4.\n\n    Population previously unreported\n    5.\n\n    Article in English\n    6.\n\n    No foreskin reconstruction\n    7.\n\n    Results separated by meatal location and primary or secondary repair' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Paediatric populations solely; TIP technique used; Complications given for at least one of those under consideration; Population previously unreported; Article in English; No foreskin reconstruction; Results separated by meatal location and primary or secondary repair.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nThe following data were extracted independently from each article by two reviewers (K.P and P.C): study size; degree of hypospadias (classified by meatal location: distal – midshaft distally, proximal – proximal shaft proximally); primary or secondary repair; repair type (standard vs modified TIP); modification (if used); mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The following data were extracted independently from each article by two reviewers: study size; degree of hypospadias; primary or secondary repair; repair type; modification; mean length of follow-up; study duration; geographical location; and rates of meatal stenosis, fistula, urethral stricture and unplanned re-operation to treat complications.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94%):\n\nFistula and re-operation rates were significantly higher in secondary repairs (15.5% and 23.3%) compared to primary proximal (10.3% and 12.2%) and primary distal' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Fistula and re-operation rates were significantly higher in secondary repairs compared to primary proximal and primary distal repairs.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.1%):\n\nto evaluate current evidence comparing the use of a PFS with alternate treatment strategies in infants with gastroschisis' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We aimed to evaluate current evidence comparing the use of a PFS with alternate treatment strategies in infants with gastroschisis.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 91.3%):\n\nOne-thousand five-hundred and sixty-seven articles were identified using the specified search criteria and their abstracts reviewed. Following application against our inclusion criteria, 1440 were excluded on the basis of their abstract alone and the full text of 127 publications was scrutinised. One hundred and seven of these were subsequently excluded as they did not report a comparative group, did not use a PFS, or did not report outcomes from a group all treated with a PFS. Two further reports were excluded' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎One-thousand five-hundred and sixty-seven articles were identified using the specified search criteria and their abstracts reviewed. Following application against our inclusion criteria, 1440 were excluded on the basis of their abstract alone and the full text of 127 publications was scrutinised. One hundred and seven of these were subsequently excluded as they did not report a comparative group, did not use a PFS, or did not report outcomes from a group all treated with a PFS. The remaining 18 publications were included in this systematic review.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.1%):\n\nAfter applying our eligibility criteria, we selected 78 articles6–83 to be included in this systematic review' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎After applying our eligibility criteria, we selected 78 articles to be included in this systematic review.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nThe results of our meta-analysis should be carefully interpreted. The following are unavoidable limitations:\n\n    • None of the studies included prospective data or randomized control trials' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The results of our meta-analysis should be carefully interpreted. The following are unavoidable limitations: None of the studies included prospective data or randomized control trials.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nFull abstracts of articles obtained by the OVID search ([Table 1]) were reviewed based on inclusion and exclusion criteria clearly delineated before the start of the review process' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Full abstracts of articles obtained by the OVID search were reviewed based on inclusion and exclusion criteria clearly delineated before the start of the review process.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nData abstraction was performed in duplicate (AS, JD) and verified for accuracy and quality via a pre-piloted standardized data abstraction form; discrepancies were resolved by consensus' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Data abstraction was performed in duplicate and verified for accuracy and quality via a pre-piloted standardized data abstraction form; discrepancies were resolved by consensus.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 77.8%):\n\nst excision followed by Roux-en-Y hepaticojejunostomy reconstruction is recommended for most patients with choledochal cysts whenever possible [5]. Laparoscopic excision of choledochal cysts has increasingly gained acceptance and applicability since its first description by Farello' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The optimal definitive treatment is complete excision of cysts with Roux-en-Y hepaticojejunostomy. Laparoscopic excision of choledochal cysts has increasingly gained acceptance and applicability since its first description by Farello.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nAccording to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract (Fig. 1). Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts. Reviewers had perfect agreement in selecting the 7 studies [9–15] considered to be suitable for the final meta-analysis using the stated eligibility criteria' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎According to the search strategy described previously, a total of 162 citations were obtained for review of title and abstract. Of the 162 citations, 14 duplicates were removed by the Endnote X5 software, and 131 irrelevant studies were excluded through scanning titles and abstracts. Reviewers had perfect agreement in selecting the 7 studies considered to be suitable for the final meta-analysis using the stated eligibility criteria.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nIn LH group compared with OH group, the operative time was longer (MD = 59.11, 95 % CI 27.61–90.61, P = 0.0002), while the length of postoperative hospital stay was less (MD = −2.01, 95 % CI −2.49 to −1.54, P < 0.00001), the intraoperative blood loss was lower (MD = −37.14, 95 % CI −66.69 to −7.60, P = 0.01) and time to food intake was less (MD = −1.14, 95 % CI −1.61 to −0.67, P = 0.01). The rate of postoperative morbidity was more in the OH group, but there is no statistically significant difference between the two groups in postoperative morbidity' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎In LH group compared with OH group, the operative time was longer, while the length of postoperative hospital stay was less, the intraoperative blood loss was lower and time to food intake was less. The rate of postoperative morbidity was more in the OH group, but there is no statistically significant difference between the two groups in postoperative morbidity.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nal.\n\nThis meta-analysis has some limitations that should be taken into account when considering the results. First, there are no randomized trials comparing the two procedures. All seven included studies are retrospective studies which are prone to selection bias and may result in uneven distribution of confounding factors such as age of patient, duration of follow-up and type of choledochal cysts. Second, except one study [14], the others did not compare outcomes between the laparoscopic and open group within the same study period, the main drawback in drawing conclusions from different study period is that factors other than the surgical approach, such as changes in perioperative practices or improved equipment, may introduce bias. Third, in some studies, the number of patients was too small, leading to low-power analyses. Caution should be given in the interpretation and generalization of this meta-analysis as the included study numbers are not high and also the overall quantity of these studies is insufficient. At last, heterogeneity among the studies is' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This meta-analysis has some limitations that should be taken into account when considering the results. First, there are no randomized trials comparing the two procedures. All seven included studies are retrospective studies which are prone to selection bias and may result in uneven distribution of confounding factors such as age of patient, duration of follow-up and type of choledochal cysts. Second, except one study, the others did not compare outcomes between the laparoscopic and open group within the same study period, the main drawback in drawing conclusions from different study period is that factors other than the surgical approach, such as changes in perioperative practices or improved equipment, may introduce bias. Third, in some studies, the number of patients was too small, leading to low-power analyses. Caution should be given in the interpretation and generalization of this meta-analysis as the included study numbers are not high and also the overall quantity of these studies is insufficient. At last, heterogeneity among the studies is high.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nTwelve studies [3, 17, 20, 24–32] discussing LNF were retrieved from the electronic databases. Six studies [20, 26, 29–32] were included in our study according to our inclusion criteria' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Twelve studies discussing LNF were retrieved from the electronic databases. Six studies were included in our study according to our inclusion criteria.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.2%):\n\nThis combination of low-quality evidence, small patient numbers, and lack of any “high quality” outcome(s) assessment by study authors draws us to strongly conclude that guidelines based on such information should be viewed by surgeons with caution' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The combination of low-quality evidence, small patient numbers, and lack of any “high quality” outcome(s) assessment by study authors draws us to strongly conclude that guidelines based on such information should be viewed by surgeons with caution.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nwe aimed to retrospectively review our institution&#39;s experience with the surgical treatment of intussusception, comparing the LAP and open approaches. Second, and most importantly, we sought to conduct a systematic review and meta-analysis, combining our data with existing literature, in order to identify any differences in outcome measures across all identified comparative studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We aimed to retrospectively review our institution's experience with the surgical treatment of intussusception, comparing the LAP and open approaches. Second, we sought to conduct a systematic review and meta-analysis, combining our data with existing literature, in order to identify any differences in outcome measures across all identified comparative studies.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 76.4%):\n\ndid not find a significant difference between groups with respect to operative time, overall complication rates, or re-operation rates' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Our meta-analysis did not identify a significant difference between the LAP and open groups with respect to operative time, overall complication rates, or re-operation rates.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98%):\n\nsis. The first relates to the validity in the application of meta-analysis to answer this question. First, the fact that survival data for the meta—analysis were derived from each individual trial and is therefore subject to the inherent biases of each trial&#39;s design flaws. In addition, differences in inclusion criteria with regards to birth weight (<1000 g versus < 1500 g) and presence of pneumoperitoneum, treatment protocols, and postoperative care exist across the t' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The first relates to the validity in the application of meta-analysis to answer this question. In addition, differences in inclusion criteria with regards to birth weight (<1000 g versus < 1500 g) and presence of pneumoperitoneum, treatment protocols, and postoperative care exist across the trials.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nTwo reviewers (ENS and DN) working independently extracted data from all eligible studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two reviewers working independently extracted data from all eligible studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.5%):\n\nHeterotaxy is a congenital anomaly characterized by abnormal cardiovisceral left-to-right axis arrangement,1 with an incidence reported to be between 1 in 6000 to 1 in 20 000 live birth' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Heterotaxy is a congenital anomaly characterized by abnormal cardiovisceral left-to-right axis arrangement, with an incidence reported to be between 1 in 6000 to 1 in 20 000 live birth.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nTwo authors reviewed all the abstracts independently. Agreement regarding potential relevance was reached by consensus. Full-text copies of potentially eligible papers were obtained, and the same 2 reviewers independently extracted relevant data on study characteristics and the outcomes of interest' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two authors reviewed all the abstracts independently. Full-text copies of potentially eligible papers were obtained, and the same 2 reviewers independently extracted relevant data on study characteristics and the outcomes of interest.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nTwo authors reviewed all the abstracts independently. Agreement regarding potential relevance was reached by consensus. Full-text copies of potentially eligible papers were obtained, and the same 2 reviewers independently extracted relevant data on study characteristics and the outcomes of interest' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Two authors reviewed all the abstracts independently. Full-text copies of potentially eligible papers were obtained, and the same 2 reviewers independently extracted relevant data on study characteristics and the outcomes of interest.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 71.9%):\n\nmeta-analyses of proportions were performed to' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Meta-analyses of proportions were performed to combine the data.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.7%):\n\nis limited inherently by the quality of the published papers' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎This study is limited inherently by the quality of the published papers.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 80%):\n\nthe ES group showed both a significantly lower mortality rate [risk ratio (RR) 0.18, 95 % confidence interval (CI) 0.09–0.38, p < 0.0001] and a significantly higher recurrence rate' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The ES group showed both a significantly lower mortality rate and a significantly higher recurrence rate compared to the OS group.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nSince the first description of Harald Hirschsprung&#39;s eponymous condition in 1889,1 there has been ongoing debate regarding the optimal surgical approach' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Since the first description of Harald Hirschsprung's eponymous condition in 1889, there has been ongoing debate regarding the optimal surgical approach.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.4%):\n\nstudy quality using the Newcastle-Ottawa Scale for case–control and cohort studies' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Study quality was assessed using the Newcastle-Ottawa Scale for case–control and cohort studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nStudy quality was assessed using the Newcastle-Ottawa Scale for cohort studies.18 Scores were low overall, with one study scoring 6/9, one scoring 5/9, one scoring 4/9 and two scoring 3/' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Study quality was assessed using the Newcastle-Ottawa Scale for cohort studies. Scores were low overall, with one study scoring 6/9, one scoring 5/9, one scoring 4/9 and two scoring 3/9.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nThere were no significant differences identified between TTERPT and LAPT for incidence of postoperative enterocolitis (OR=0.78, 95% CI 0.44 to 1.38, p=0.39), faecal incontinence (OR=0.44, 95% CI 0.09 to 2.20, p=0.32) or constipation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎There were no significant differences identified between TTERPT and LAPT for incidence of postoperative enterocolitis, faecal incontinence, or constipation.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 54.8%):\n\nis. Meta-analysis demonstrated a statistically significant decrease in mean length of hospital stay for SILA compared with CLA' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Meta-analysis demonstrated no statistically significant in mean operating time for SILA compared with CLA. Meta-analysis demonstrated a statistically significant decrease in mean length of hospital stay for SILA compared with CLA.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 93.7%):\n\nOur meta-analysis revealed a significantly lower rate of post-operative death in the MIS group than in the open techniques group with an RR of 0.26 (95 % CI 0.10–0.68; p = 0.006) (Fig. 2). The incidence of hernia recurrence was greater in the MIS group with an RR of 3.42 (95 % CI 1.98–5.88; p < 0.00001) (Fig. 3). The previous two sets of pooled data both showed good homogeneity among the involved trials. Thus, fixed models were applied for analysis. No significant difference was found for the rates of prosthetic patch use between the two groups (Fig. 4). Fewer cases of surgical complications were found for neonates who underwent thoracoscopic or laparoscopic procedures with an RR of 0.66 (95 % CI 0.47–0.94; p = 0.02' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎Our meta-analysis revealed a significantly lower rate of post-operative death in the MIS group than in the open techniques group with an RR of 0.26 (95 % CI 0.10–0.68; p = 0.006) but a greater incidence of hernia recurrence with an RR of 3.42 (95 % CI 1.98–5.88; p < 0.00001). Rates of prosthetic patch use were similar between the two groups. Fewer cases of surgical complications were found in the MIS group with an RR of 0.66 (95 % CI 0.47–0.94; p = 0.02).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.3%):\n\nYZ declares no conflict of interest.\n\nYW declares no conflict of interest.\n\nQP declares no conflict of interest.\n\nLM declares no conflict of interest.\n\nHL declares no conflict of interest.\n\nLL declares no conflict of interest' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎YZ declares no conflict of interest. YW declares no conflict of interest. QP declares no conflict of interest. LM declares no conflict of interest. HL declares no conflict of interest. LL declares no conflict of interest.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 73.8%):\n\nled trial) were identified and included in the review' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Thirty-seven articles were identified and included in the review.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 63.6%):\n\nweight loss and improvements in comorbidities and quality of life. Howeve' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Weight loss and improvements in comorbidities and quality of life were reported in the majority of studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nExisting evidence – although based generally on underpowered, retrospective studies – suggests that bariatric surgery in older children results in significant weight loss and improvements in comorbidities and quality of life' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Existing evidence suggests that bariatric surgery in older children results in significant weight loss and improvements in comorbidities and quality of life.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.8%):\n\nLaparoscopic-assisted anorectal pull-through (LAARP) is becoming an increasingly common procedure to correct high and intermediate anorectal malformations (ARMs' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Laparoscopically assisted anorectal pull-through (LAARP) is becoming an increasingly common procedure to correct high and intermediate anorectal malformations (ARMs).&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nReported outcomes included continence, rectal prolapse, the position of the rectum (7 studies using Kelly score), manometry (1 study), contrast enema (1 study), postanal endosonography (3 studies), and postoperative magnetic resonance imaging' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Reported outcomes included continence, rectal prolapse, the position of the rectum, manometry, contrast enema, postanal endosonography, and postoperative magnetic resonance imaging.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nOur study has several limitations. First, this is a systematic review of mainly retrospective data. The quality of such review is only as good as the included studies. Second, because of the wide variation of reported outcomes, no formal meta-analysis and calculation of summary statistics could be performed' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Our study has several limitations. First, this is a systematic review of mainly retrospective data. Second, because of the wide variation of reported outcomes, no formal meta-analysis and calculation of summary statistics could be performed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nto perform a systematic review of the literature comparing outcomes of infants with simple gastroschisis following either OPFC or SR. From this study we aimed to identify some of the reasons why research in paediatric surgery is currently largely unable to provide a strong evidence base to inform clinical practice' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎To perform a systematic review of the literature comparing outcomes of infants with simple gastroschisis following either OPFC or SR and to identify some of the reasons why research in pediatric surgery is currently largely unable to provide a strong evidence base to inform clinical practice.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 68.4%):\n\nlaparoscopic success rate,' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎The laparoscopic success rate was 71%.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 61.2%):\n\n The management of a recurrent tracheoesophageal fistula (RTEF) in' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎The ideal approach to the management of recurrent tracheoesophageal fistulas (RTEF) is still in debate.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 85.3%):\n\nare the clinical and cost effectiveness of laparoscopic and open surgical approaches for a variety of surgical indications in pediatric populations' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎To evaluate the clinical and cost-effectiveness of laparoscopic and open techniques in pediatric populations.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nInclusion criteria\n\n    Prospective randomized or prospective non-randomized study format only.\n\n    Operative results reported for a “pediatric population”, using the words “children, infants or neonates” to describe the study group and including infants, neonates or children (or combinations of the three).\n\n    Study subjects under 17 years of age only.\n\n    Comparison of laparoscopic and open techniques.\n\n    Report on at least one of the outcome measures mentioned previously' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Inclusion criteria: Prospective randomized or prospective non-randomized study format only. Operative results reported for a “pediatric population”, using the words “children, infants or neonates” to describe the study group and including infants, neonates or children (or combinations of the three). Study subjects under 17 years of age only. Comparison of laparoscopic and open techniques. Report on at least one of the outcome measures mentioned previously.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.8%):\n\nEach article was independently assessed for eligibility using the following criteria:\n#\nInclusion criteria\n\n    Prospective randomized or prospective non-randomized study format only.\n\n    Operative results reported for a “pediatric population”, using the words “children, infants or neonates” to describe the study group and including infants, neonates or children (or combinations of the three).\n\n    Study subjects under 17 years of age only.\n\n    Comparison of laparoscopic and open techniques.\n\n    Report on at least one of the outcome measures mentioned previously' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Each article was independently assessed for eligibility using the following criteria: Prospective randomized or prospective non-randomized study format only. Operative results reported for a “pediatric population”, using the words “children, infants or neonates” to describe the study group and including infants, neonates or children (or combinations of the three). Study subjects under 17 years of age only. Comparison of laparoscopic and open techniques. Report on at least one of the outcome measures mentioned previously.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):\n\ned 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We recorded 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):\n\ned 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We recorded 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):\n\ned 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We recorded 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 92.2%):\n\ned 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎We recorded 37 studies, but 26 of these were excluded because they were neither relevant nor concerned an adolescent population.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nPreputial reconstruction is an option particularly in patients with distal hypospadias without associated penile curvature. It carries an 8% risk of specific complications, the most common being dehiscence of reconstructed prepuce, whereas secondary phimosis needing circumcision seems to be exceptional although we lack long-term follow-up data on these patients. Overall, PR does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Preputial reconstruction is an option particularly in patients with distal hypospadias without associated penile curvature. It carries an 8% risk of specific complications, but does not seem to increase the risk of urethroplasty complications and the overall reoperation rate of hypospadias repair.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.3%):\n\nWe conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 onwards), Embase (1980 onwards), and CINAHL (1982 onwards) to find relevant articles' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We conducted electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and CINAHL to find relevant articles.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.9%):\n\nWe used the MINORS criteria [22] to assess the quality of all relevant non-randomized studies' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We used the MINORS criteria to assess the quality of all relevant non-randomized studies.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nWe found one RCT that included fertility potential as an outcome [14] which received a Jadad score of 3' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎We found one RCT that included fertility potential as an outcome which received a Jadad score of 3.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 84.5%):\n\nThe most direct measurement of male fertility is paternity rate and time until conception of a live born child [4]; however, due to the difficult' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎The most direct measurement of male fertility is paternity rate and time until conception of a live born child, but these outcomes are difficult to assess.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.4%):\n\nObjective: \n\n(1) Is screening of intestinal rotational anatomy obligatory in “asymptomatic” patients with heterotaxy? (2) Does detection of an anomaly warrant surgical correction' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Objective: (1) Is screening of intestinal rotational anatomy obligatory in “asymptomatic” patients with heterotaxy? (2) Does detection of an anomaly warrant surgical correction?&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.1%):\n\nThe aim of thepresent study was therefore to undertake a meta-analysis of RAP vs LP and OP in children' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The aim of the present study was therefore to undertake a meta-analysis of RAP vs LP and OP in children.&quot;<\/span>","<span title='Major quote deviation, possible hallucination. Best match in fulltext (Similarity 74.3%):\n\nMeta-analysis demonstrated that the LS approach had a significantly longer operative time than the OS approach with obvious statistical heterogeneity (I 2 = 99 %, WMD 42.22, 95 % CI 7.69–76.74; P = 0.02; Fig. 2).\nFig. 2\nfigure 2\n\nForest plot comparing operative time for children treated with LS versus OS\nFull size image\nBlood loss\n\nBlood loss was reported in three studies [7, 8, 12]. Meta-analysis demonstrated a statistically significant decrease in blood loss for LS compared with OS while the statistical heterogeneity was evident (I 2 = 98 %, WMD −31.77, 95 % CI −59.74 to −3.8; P = 0.03; Fig. 3).\nFig. 3\nfigure 3\n\nForest plot comparing blood loss for children treated with LS versus OS\nFull size image\nLength of hospital stay\n\nLength of hospital stay was reported in eight studies and six studies were suitable for meta-analysis [7, 8, 10–12, 15]. Meta-analysis revealed a statistically significant decrease in mean length of hospital stay for LS compared with OS (WMD −1.61, 95 % CI −2.19 to −1.02; P = 0.001; Fig. 4). There was obvious statistica' style='border-bottom: 1px dashed black; color: black; background-color: red'>&quot;‎Meta-analysis demonstrated that the LS approach had a significantly longer operative time than the OS approach with obvious statistical heterogeneity. Meta-analysis demonstrated a statistically significant decrease in blood loss for LS compared with OS while the statistical heterogeneity was evident. Meta-analysis revealed a statistically significant decrease in mean length of hospital stay for LS compared with OS. There was no statistically significant difference between the two groups in the removal of accessory spleens or postoperative complications including postoperative high fever, ACS, and ileus.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):\n\nOpen Versus Laparoscopic Inguinal Herniotomy in Children\nA Systematic Review and Meta-Analysis Focusing on Postoperative Complications' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Open Versus Laparoscopic Inguinal Herniotomy in Children: A Systematic Review and Meta-Analysis Focusing on Postoperative Complications&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nCompared with OH, shorter operative time for unilateral hernias was noted in extraperitoneal approaches’ group [95% confidence interval (CI), −6.71 to −3.71; I2=0%] as well as for bilateral hernias (95% CI, −12.18 to −3.79; I2=82%). Besides, less total postoperative complications was found in LH group, especially for major postoperative complications in male children (95% CI, 0.01-0.78; I2=0%). However, no significant difference was observed between LH and OH in patients’ recurrence' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Compared with OH, shorter operative time for unilateral hernias was noted in extraperitoneal approaches’ group as well as for bilateral hernias. Besides, less total postoperative complications was found in LH group, especially for major postoperative complications in male children. However, no significant difference was observed between LH and OH in patients’ recurrence.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.7%):\n\nbecause of the limited number of patients and studies, more RCTs need to be conducted to confirm these findings; on the other hand, the learning curve in the 5 RCTs may play an underestimated role in the study, which may weaken the results of the compariso' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Because of the limited number of patients and studies, more RCTs need to be conducted to confirm these findings; the learning curve in the 5 RCTs may play an underestimated role in the study, which may weaken the results of the comparison.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.1%):\n\nResidual aganglionosis after pull-through operation for Hirschsprung’s disease: a systematic review and meta-analysis' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Residual aganglionosis after pull-through operation for Hirschsprung’s disease: a systematic review and meta-analysis&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.5%):\n\nMost patients with Hirschsprung’s disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT. Redo PT operation in HD is usually indicated for anastomotic strictures or residual aganglionosis (RA). We designed this meta-analysis to determine the incidence and outcome of RA among patients with HD following PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Most patients with Hirschsprung’s disease (HD) have a satisfactory outcome after pull-through (PT) operation. However, some children continue to have persistent bowel symptoms after the initial operation and may require redo PT. Redo PT operation in HD is usually indicated for anastomotic strictures or residual aganglionosis (RA). We designed this meta-analysis to determine the incidence and outcome of RA among patients with HD following PT operation.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 98.8%):\n\nn\n\nPull-through (PT) operations for Hirschsprung’s disease (HD) generally result in a satisfactory outcome [1]. However, some patients after definitive PT operation have disturbances of bowel function such as constipation, enterocolitis and recurrent obstructive symptoms [2–9]. In the majority of these patients, residual bowel problems can be managed by non-surgical treatment such as laxatives, enemas or intrasphincteric botulinum toxin injection [10–12]. In a few patients, persistent abdominal distension, constipation or enterocolitis is due to postoperative stricture or retained aganglionic segment which may require a redo PT operation [13–17]. We designed this meta-analysis to determine the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Pull-through (PT) operations for Hirschsprung’s disease (HD) generally result in a satisfactory outcome. However, some patients after definitive PT operation have disturbances of bowel function such as constipation, enterocolitis and recurrent obstructive symptoms. In a few patients, persistent abdominal distension, constipation or enterocolitis is due to postoperative stricture or retained aganglionic segment which may require a redo PT operation. We designed this meta-analysis to determine the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96%):\n\n. We designed this meta-analysis to determine the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] We designed this meta-analysis to determine the incidence and outcome of residual aganglionosis (RA) in patients with HD following PT operation.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\nds\n\nPubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] PubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\nds\n\nPubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] PubMed® and MEDLINE® databases were searched for all studies that reported cases of patients with HD who had undergone redo PT operations for RA or transition-zone bowel (TZB) after initial operation between 1985 and 2011.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.7%):\n\ns\n\nBetween 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Between 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.7%):\n\ns\n\nBetween 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Between 1985 and 2011, 29 published articles reported 555 patients with HD who underwent redo PT operation.&quot;<\/span>","<span title='Moderate quote deviation. Best match in fulltext (Similarity 94.4%):\n\nInformation about patient’s gender was reported in 135 (69.9%) patients. A male-to-female ratio of 3.5:1 was observed' style='border-bottom: 1px dashed black; color: black; background-color: #ff9e81'>&quot;‎[Yes] Information about patient’s gender was reported in 135 (69.9%) patients. A male-to-female ratio of 3.5:1 was observed.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 95.8%):\n\nyears). Of the 134 patients, 99 (73.9%) patients had normal bowel habits after redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Of the 134 patients, 99 (73.9%) patients had normal bowel habits after redo PT operation.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.9%):\n\ns. Our meta-analysis reveals that RA and TZB are the underlying causes of persistent bowel symptoms in one-third of all patients requiring redo PT operation' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Our meta-analysis reveals that RA and TZB are the underlying causes of persistent bowel symptoms in one-third of all patients requiring redo PT operation.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.4%):\n\nn\n\nOver the years, various PT operations have been used to treat patients with HD [18–23]. It has been shown in several studies that there is no statistically significant difference in the functional outcome with respect to bowel function between the various PT procedures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] Over the years, various PT operations have been used to treat patients with HD. It has been shown in several studies that there is no statistically significant difference in the functional outcome with respect to bowel function between the various PT procedures.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 96.5%):\n\nThe presence of RA or TZB means that resection of this section of bowel may cure the patients of their recurrent symptoms. Thus, a redo PT is generally recommended for surgical management of RA' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎[Yes] The presence of RA or TZB means that resection of this section of bowel may cure the patients of their recurrent symptoms. Thus, a redo PT is generally recommended for surgical management of RA.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.7%):\n\nThe articles were included in this review if they met the following criteria:\n\n    Population: Studies of humans aged 0–18 years.\n\n    Intervention: Bianchi and STEP procedure, either alone or in combination.\n\n    Type of study: All study designs were eligible for inclusion. Case series with 1 or more cases were included' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎The articles were included in this review if they met the following criteria: Population: Studies of humans aged 0–18 years. Intervention: Bianchi and STEP procedure, either alone or in combination. Type of study: All study designs were eligible for inclusion. Case series with 1 or more cases were included.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):\n\nand LILT are both accepted procedures for non-transplant surgical management of SBS in children. The outcome after STEP seems to be more favourable, but larger series are needed to further assess accurate selection of eligible patients and to estimate effectiveness of procedures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎LILT and STEP are both accepted procedures for non-transplant surgical management of SBS in children. The outcome after STEP seems to be more favourable, but larger series are needed to further assess accurate selection of eligible patients and to estimate effectiveness of procedures.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.2%):\n\nand LILT are both accepted procedures for non-transplant surgical management of SBS in children. The outcome after STEP seems to be more favourable, but larger series are needed to further assess accurate selection of eligible patients and to estimate effectiveness of procedures' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎LILT and STEP are both accepted procedures for non-transplant surgical management of SBS in children. The outcome after STEP seems to be more favourable, but larger series are needed to further assess accurate selection of eligible patients and to estimate effectiveness of procedures.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 97.9%):\n\ncompared the laparoscopic and open approaches, and did not find significant advantages of laparoscopy in the management of children with NPT' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎To compare the laparoscopic and open approaches, and did not find significant advantages of laparoscopy in the management of children with NPT.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99%):\n\nThree reviewers (GJ, LZL and TQS) independently assessed selected studies, extracted and tabulated data from each article' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎Three reviewers independently assessed selected studies, extracted and tabulated data from each article.&quot;<\/span>","<span title='Minor quote deviation. Best match in fulltext (Similarity 99.6%):\n\nThis work was supported by the National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 81071997, No. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities' style='border-bottom: 1px dashed black; color: black; background-color: #ffe9e2'>&quot;‎This work was supported by the National Natural Science Foundation of China, Program for New Century Excellent Talents in University, Scientific Research Foundation for the Returned Overseas Chinese Scholars, and Fundamental Research Funds for the Central Universities.&quot;<\/span>"],[99.6551724137931,98.7654320987654,99.1379310344828,97.4358974358974,99.236641221374,94.8905109489051,99.4974874371859,73.8095238095238,98.7654320987654,98.7654320987654,99.3079584775086,78.1420765027322,96.8253968253968,99.9162479061977,97.8540772532189,97.8540772532189,99.3243243243243,99.2307692307692,99.2307692307692,99.4444444444444,93.6893203883495,99.6753246753247,62.3655913978495,44.2622950819672,99.375,98.3892617449664,89.0322580645161,97.196261682243,99.3880048959608,99.3243243243243,98.5507246376812,75.1592356687898,99.6794871794872,88.4422110552764,96.1538461538462,96.1538461538462,96.4912280701754,96.5250965250965,97.1264367816092,98.8023952095808,99.0825688073395,98.8636363636364,99.1596638655462,96.7532467532468,99.3710691823899,98.8668555240793,97.3977695167286,99.7126436781609,94.0298507462687,93.1297709923664,91.3200723327306,99.0566037735849,99.4565217391304,99.4082840236686,99.4350282485876,77.7777777777778,99.7706422018349,99.7252747252747,99.4392523364486,99.3377483443709,99.1935483870968,99.4490358126722,76.4367816091954,97.9933110367893,98.7012987012987,99.4594594594595,99.5726495726496,99.5726495726496,71.875,84.7222222222222,80,99.3421052631579,84.375,98.9247311827957,99.3589743589744,54.7826086956522,93.681917211329,97.2850678733032,73.8461538461539,63.5514018691589,99.3630573248408,95.7831325301205,99.4475138121547,99.5850622406639,98.9761092150171,68.4210526315789,61.1650485436893,85.3211009174312,99.5652173913043,99.8098859315589,92.1875,92.1875,92.1875,92.1875,99.6644295302013,99.3421052631579,98.876404494382,98.989898989899,84.5161290322581,99.4350282485876,98.0769230769231,74.2622950819672,98.5185185185185,99.7319034852547,98.744769874477,95.1219512195122,98.4815618221258,98.8391376451078,96,97.3684210526316,97.3684210526316,94.6902654867257,94.6902654867257,94.3548387096774,95.7894736842105,96.875,97.3880597014925,96.5,99.6753246753247,97.1929824561404,97.1929824561404,97.9020979020979,99.0384615384615,99.6282527881041]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>Author & Year<\/th>\n      <th>Source<\/th>\n      <th>Quote with deviation<\/th>\n      <th>Similarity<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","order":[[3,"desc"]],"columnDefs":[{"targets":3,"render":"function(data, type, row, meta) {\n    return type !== 'display' ? data : DTWidget.formatRound(data, 1, 3, \",\", \".\", null);\n  }"},{"visible":false,"targets":1},{"className":"dt-right","targets":3}],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
</div>
<div id="formatting-accuracy" class="section level3">
<h3>Formatting accuracy</h3>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<ul>
<li>108 / 118 (91.5%) responses were usable
<ul>
<li>103 / 108 (95.4%) usable responses with correctly formatted
scores</li>
<li>5 / 108 (4.6%) usable responses with minor fixable score formatting
issues
<ul>
<li>3 with ‘wrong-response-partial-unclear-etc’</li>
<li>2 with ‘missing-squared-brackets-for-na’</li>
</ul></li>
</ul></li>
<li>10 / 118 (8.5%) responses were unusable (‘failed’), affecting 6
publications (3 of which were ultimately successful because a repeated
response was usable)
<ul>
<li>4 with failure reason ‘too-short’</li>
<li>3 with failure reason ‘exceeded-max-tokens-2500’</li>
<li>2 with failure reason ‘score-p1-missing’</li>
<li>1 with failure reason ‘scores-missing’</li>
</ul></li>
<li>No results could be obtained for: <a
href="https://doi.org/10.1016/J.JPEDSURG.2013.01.020">Kunz 2013</a>, <a
href="https://doi.org/10.1002/14651858.CD001532.pub4">Nagler 2011</a>,
<a href="https://doi.org/10.1016/J.JPEDSURG.2015.09.010">Puligandla
2015</a></li>
</ul>
<div class="datatables html-widget html-fill-item-overflow-hidden html-fill-item" id="htmlwidget-fa8fa08a2458d7cf2b90" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-fa8fa08a2458d7cf2b90">{"x":{"filter":"none","vertical":false,"fillContainer":false,"data":[["8","9","10","1","2","3","4","5","6","7"],["Black 2013","Borruto 2010","Borruto 2010","Kunz 2013","Kunz 2013","Nagler 2011","Nagler 2011","Nagler 2011","Puligandla 2015","Zhao 2015"],["exceeded-max-tokens-2500","score-p1-missing","score-p1-missing","exceeded-max-tokens-2500","scores-missing","too-short","too-short","too-short","too-short","exceeded-max-tokens-2500"],[true,true,true,false,false,false,false,false,false,true],["P1. Title: Identify the report as a systematic review, meta-analysis, or both.\n1. Quote: 'Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis'\n2. Reasoning: The title clearly identifies the report as a systematic review and meta-analysis.\n3. Response: [Yes]\n\nP2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.\n1. Quote: 'We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents; (ii) meta-analyse change in body mass index (BMI) 1-year post-surgery and (iii) report complications, co-morbidity resolution and health-related quality of life (HRQoL).'\n2. Reasoning: The abstract provides a structured summary including the background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, and conclusions.\n3. Response: [Yes]\n\nP3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.\n1. Quote: 'The global prevalence of obesity is rising in children and adolescents.'\n2. Reasoning: The introduction provides the rationale for the review by highlighting the increasing prevalence of obesity in children and adolescents.\n3. Response: [Yes]\n\nP4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\n1. Quote: 'We aimed to (i) systematically review the literature on bariatric surgery in children and adolescents; (ii) meta-analyse change in body mass index (BMI) 1-year post-surgery and (iii) report complications, co-morbidity resolution and health-related quality of life (HRQoL).'\n2. Reasoning: The objectives are explicitly stated, including the participants (children and adolescents), interventions (bariatric surgery), outcomes (change in BMI, complications, co-morbidity resolution, HRQoL), and study design (systematic review and meta-analysis).\n3. Response: [Yes]\n\nP5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.\n1. Quote: No information provided.\n2. Reasoning: There is no mention of a review protocol or registration information.\n3. Response: [No]\n\nP6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.\n1. Quote: 'Studies were included if (i) they assessed BMI before and a minimum of six months after individuals predominately received AGB, RYGB, BPD or SG and (ii) the mean age of the population was between 6 and 18 years at study entry.'\n2. Reasoning: The eligibility criteria are specified, including the study characteristics (assessment of BMI before and after surgery) and report characteristics (age range of the population).\n3. Response: [Yes]\n\nP7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.\n1. Quote: 'The indexed reference libraries EMBASE and Medline were searched between January 1955 and January 2013 using the search terms presented in Table 1, using mapped and exploded terms.'\n2. Reasoning: The information sources are described, including the databases searched (EMBASE and Medline) and the dates of coverage.\n3. Response: [Yes]\n\nP8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.\n1. Quote: 'Search terms for EMBASE and Medline via Ovid SP'\n2. Reasoning: The search strategy is mentioned, but the full electronic search strategy is not provided.\n3. Response: [No]\n\nP9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).\n1. Quote: 'Two authors independently screened the abstracts and extraction was verified by a second author (JAB and RKS).'\n2. Reasoning: The process for selecting studies is described, including screening the abstracts and verification of extraction by a second author.\n3. Response: [Yes]\n\nP10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.\n1. Quote: 'We used a standard data extraction method to collect the following information on each study: years during which the surgery was performed, authors, country, study design, mean age and variance of study participants, type of surgery, gender distribution, complications, co-morbidities, pre-/post-surgery BMI with variance, number of participants, length of follow-up and loss to follow-up.'\n2. Reasoning: The method of data extraction is described, including the information collected from each study.\n3. Response: [Yes]\n\nP11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.\n1. Quote: 'We used a standard data extraction method to collect the following information on each study: years during which the surgery was performed, authors, country, study design, mean age and variance of study participants, type of surgery, gender distribution, complications, co-morbidities, pre-/post-surgery BMI with variance, number of participants, length of follow-up and loss to follow-up.'\n2. Reasoning: The variables for which data were sought are listed, including the study characteristics (years during which the surgery was performed, authors, country, study design, mean age and variance of study participants, type of surgery, gender distribution) and outcomes (complications, co-morbidities, pre-/post-surgery BMI with variance, number of participants, length of follow-up and loss to follow-up).\n3. Response: [Yes]\n\nP12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.\n1. Quote: No information provided.\n2. Reasoning: There is no mention of methods used for assessing risk of bias or how this information is used in data synthesis.\n3. Response: [No]\n\nP13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).\n1. Quote: 'The summary effect measure of unstandardized change in BMI at the time point closest to 12 months post-surgery was produced using the DerSimonian and Laird random effects method.'\n2. Reasoning: The principal summary measure (unstandardized change in BMI) is stated.\n3. Response: [Yes]\n\nP14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.\n1. Quote: No information provided.\n2. Reasoning: There is no mention of the methods of handling data and combining results of studies or measures of consistency.\n3. Response: [NA]\n\nP15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).\n1. Quote: No information provided.\n2. Reasoning: There is no mention of any assessment of risk of bias across studies.\n3. Response: [NA]\n\nP16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.\n1. Quote: No information provided.\n2. Reasoning: There is no mention of any additional analyses.\n3. Response: [NA]\n\nP17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.\n1. Quote: 'A total of 2303 unique citations were returned by the search strategy (Fig. 1). Of these, 2185 were excluded based on abstract review.'\n2. Reasoning: The numbers of studies screened, assessed for eligibility, and included in the review are provided, along with the reasons for exclusions at each stage.\n3. Response: [Yes]\n\nP18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.\n1. Quote: 'A total of 54 papers met the inclusion criteria, representing 23 unique study populations.'\n2. Reasoning: The number of papers meeting the inclusion criteria and the number of unique study populations are provided.\n3. Response: [Yes]\n\nP19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).\n1. Quote: No information provided.\n2. Reasoning: There is no mention of data on risk of bias within studies.\n3. Response: [NA]\n\nP20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.\n1. Quote: 'Mean BMI at baseline ranged from 38.5 to 60.2 kg m−2 (mean 47.9 kg m−2), and at follow-up from 25.2 to 41.5 kg m−2 (mean 34.7 kg m−2). All studies reported decreases in BMI.'\n2. Reasoning: The results of individual studies are presented, including the mean BMI at baseline and follow-up, and the fact that all studies reported decreases in BMI.\n3. Response: [Yes]\n\nP21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.\n1. Quote: No information provided.\n2. Reasoning: There is no mention of any meta-analysis done or the presentation of results.\n3. Response: [NA]\n\nP22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).\n1. Quote: No information provided.\n2. Reasoning: There is no mention of any assessment of risk of bias across studies.\n3. Response: [NA]\n\nP23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).\n1. Quote: No information provided.\n2. Reasoning: There is no mention of any additional analyses.\n3. Response: [NA]\n\nP24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).\n1. Quote: 'Bariatric surgery in adolescents results in similar short-term weight outcomes to adults, with RYGB producing the greatest weight loss with the most robust evidence base.'\n2. Reasoning: The main findings are summarized, including the strength","P1. Title: 'Laparoscopic vs open varicocelectomy in children and adolescents: review of the recent literature and meta-analysis'\n1. Relevant quote: 'Laparoscopic varicocelectomy has gained popularity in recent years.'\n2. Reasoning: The title clearly identifies the report as a systematic review and meta-analysis by mentioning 'review of the recent literature' and 'meta-analysis.'\n\nP2. Abstract / Structured summary: [Yes]\nReasoning: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions.\n\nP3. Introduction / Rationale: [Yes]\nReasoning: The introduction describes the rationale for the review by stating that varicocele is a common cause of male infertility and that the ideal method for varicocele treatment is still controversial.\n\nP4. Introduction / Objectives: [Yes]\nReasoning: The introduction provides an explicit statement of the questions being addressed, including the comparison of laparoscopic varicocelectomy with open techniques and the outcomes of recurrence rate and hydrocele formation.\n\nP5. Methods / Protocol and registration: [No]\nReasoning: There is no mention of a review protocol or registration information.\n\nP6. Methods / Eligibility criteria: [Yes]\nReasoning: The methods specify the study characteristics (adolescent population) and report characteristics (last 10 years, clinical trials, randomized controlled trials, meta-analysis, multicenter retrospective and prospective studies) used as eligibility criteria.\n\nP7. Methods / Information sources: [No]\nReasoning: There is no description of the information sources used in the search.\n\nP8. Methods / Search: [No]\nReasoning: There is no presentation of the full electronic search strategy.\n\nP9. Methods / Study selection: [Yes]\nReasoning: The methods state that 37 studies were initially pooled, but 26 were excluded based on relevance and not concerning an adolescent population. The process for selecting studies is described.\n\nP10. Methods / Data collection process: [No]\nReasoning: There is no description of the method of data extraction or any processes for obtaining and confirming data from investigators.\n\nP11. Methods / Data items: [No]\nReasoning: There is no list and definition of all variables for which data were sought.\n\nP12. Methods / Risk of bias in individual studies: [No]\nReasoning: There is no description of the methods used for assessing risk of bias in individual studies.\n\nP13. Methods / Summary measures: [No]\nReasoning: There is no statement of the principal summary measures.\n\nP14. Methods / Synthesis of results: [NA]\nReasoning: Not applicable since this is not a meta-analysis.\n\nP15. Methods / Risk of bias across studies: [NA]\nReasoning: Not applicable since this is not a meta-analysis.\n\nP16. Methods / Additional analyses: [NA]\nReasoning: Not applicable since this is not a meta-analysis.\n\nP17. Results / Study selection: [Yes]\nReasoning: The results section provides the numbers of studies screened, assessed for eligibility, and included in the review, along with reasons for exclusions.\n\nP18. Results / Study characteristics: [No]\nReasoning: There is no presentation of the characteristics for which data were extracted from each study.\n\nP19. Results / Risk of bias within studies: [No]\nReasoning: There is no presentation of data on risk of bias of each study.\n\nP20. Results / Results of individual studies: [Yes]\nReasoning: The results present the results of each individual study, including simple summary data for each intervention group and effect estimates.\n\nP21. Results / Synthesis of results: [NA]\nReasoning: Not applicable since this is not a meta-analysis.\n\nP22. Results / Risk of bias across studies: [NA]\nReasoning: Not applicable since this is not a meta-analysis.\n\nP23. Results / Additional analysis: [NA]\nReasoning: Not applicable since this is not a meta-analysis.\n\nP24. Discussion / Summary of evidence: [Yes]\nReasoning: The discussion section summarizes the main findings, including the strength of evidence for each main outcome.\n\nP25. Discussion / Limitations: [Yes]\nReasoning: The discussion section discusses the limitations at the study and outcome level, as well as at the review-level.\n\nP26. Discussion / Conclusions: [Yes]\nReasoning: The discussion section provides a general interpretation of the results in the context of other evidence and implications for future research.\n\nP27. Funding: [No]\nReasoning: There is no description of the sources of funding for the systematic review and other support.","P1. Title: 'Laparoscopic vs open varicocelectomy in children and adolescents: review of the recent literature and meta-analysis'\n1. Relevant quote: 'Laparoscopic varicocelectomy has gained popularity in recent years.'\n2. Reasoning: The title clearly identifies the report as a systematic review and meta-analysis by mentioning 'review of the recent literature' and 'meta-analysis.'\n\nP2. Abstract / Structured summary: [Yes]\nReasoning: The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants and interventions, study appraisal and synthesis methods, results, limitations, and conclusions.\n\nP3. Introduction / Rationale: [Yes]\nReasoning: The introduction describes the rationale for the review by stating that varicocele is a common cause of male infertility and that the ideal method for varicocele treatment is still controversial.\n\nP4. Introduction / Objectives: [Yes]\nReasoning: The introduction provides an explicit statement of the questions being addressed with reference to participants (children and adolescents), interventions (laparoscopic vs open varicocelectomy), comparisons, outcomes (recurrence rate and hydrocele formation), and study design (meta-analysis).\n\nP5. Methods / Protocol and registration: [No]\nReasoning: There is no mention of a review protocol or registration information.\n\nP6. Methods / Eligibility criteria: [Yes]\nReasoning: The methods section specifies the study characteristics (adolescent population) and report characteristics (recurrence, complications, semen parameters) used as criteria for eligibility.\n\nP7. Methods / Information sources: [Yes]\nReasoning: The methods section describes the information sources used, including a Medline search for articles published during the last 10 years.\n\nP8. Methods / Search: [No]\nReasoning: The full electronic search strategy is not presented.\n\nP9. Methods / Study selection: [Yes]\nReasoning: The methods section states the process for selecting studies, including screening, eligibility, and inclusion in the systematic review.\n\nP10. Methods / Data collection process: [No]\nReasoning: There is no description of the method of data extraction from reports.\n\nP11. Methods / Data items: [No]\nReasoning: There is no list and definition of all variables for which data were sought.\n\nP12. Methods / Risk of bias in individual studies: [No]\nReasoning: There is no description of the methods used for assessing risk of bias in individual studies.\n\nP13. Methods / Summary measures: [No]\nReasoning: There is no statement of the principal summary measures.\n\nP14. Methods / Synthesis of results: [NA]\nReasoning: Not applicable as this is not a meta-analysis.\n\nP15. Methods / Risk of bias across studies: [NA]\nReasoning: Not applicable as this is not a meta-analysis.\n\nP16. Methods / Additional analyses: [NA]\nReasoning: Not applicable as this is not a meta-analysis.\n\nP17. Results / Study selection: [No]\nReasoning: There is no presentation of the numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage.\n\nP18. Results / Study characteristics: [No]\nReasoning: There is no presentation of characteristics for each study.\n\nP19. Results / Risk of bias within studies: [No]\nReasoning: There is no presentation of data on risk of bias of each study.\n\nP20. Results / Results of individual studies: [Yes]\nReasoning: The results section presents the results of individual studies, including simple summary data for each intervention group and effect estimates.\n\nP21. Results / Synthesis of results: [NA]\nReasoning: Not applicable as this is not a meta-analysis.\n\nP22. Results / Risk of bias across studies: [NA]\nReasoning: Not applicable as this is not a meta-analysis.\n\nP23. Results / Additional analysis: [NA]\nReasoning: Not applicable as this is not a meta-analysis.\n\nP24. Discussion / Summary of evidence: [Yes]\nReasoning: The discussion section summarizes the main findings, including the strength of evidence for each main outcome.\n\nP25. Discussion / Limitations: [Yes]\nReasoning: The discussion section discusses limitations at the study and outcome level, as well as at the review-level.\n\nP26. Discussion / Conclusions: [Yes]\nReasoning: The discussion section provides a general interpretation of the results in the context of other evidence and implications for future research.\n\nP27. Funding: [No]\nReasoning: There is no description of the sources of funding for the systematic review and other support.","P1. Title: Identify the report as a systematic review, meta-analysis, or both.\nExtracted quote: 'Primary Fascial Closure versus Staged Closure with Silo in Patients with Gastroschisis: A Meta-Analysis'\nReasoning: The title clearly identifies the report as a meta-analysis.\n\nP2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.\nExtracted quote: 'Background/Purpose: Gastroschisis is the most common congenital abdominal wall defect. Despite advances in the surgical closure of gastroschisis, consensus is lacking as to which method results in the best patient outcomes. The purpose of this meta-analysis was to compare short-term outcomes associated with primary fascial closure and staged repair with a silo in patients with gastroschisis.'\nReasoning: The abstract provides a structured summary including background, objectives, and study methods.\n\nP3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.\nExtracted quote: 'Gastroschisis is the most common abdominal wall defect in the newborn, and incidence is increasing worldwide, affecting 4–5/10,000 newborns (1, 2). Survival has dramatically improved to greater than 90% over the past 6 decades, due to improved techniques to close the abdominal wall defect and advances in neonatal care (3, 4, 5). Despite these advances, post-surgical care for gastroschisis remains challenging, and gastroschisis is the congenital defect with the longest ICU length of stay (LOS)(6).'\nReasoning: The introduction provides the rationale for the review by discussing the prevalence of gastroschisis and the need for improved post-surgical care.\n\nP4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\nExtracted quote: 'This meta-analysis sought to identify the best closure method for newborns with gastroschisis by comparing hospital outcomes in patients receiving either primary fascial closure or staged repair with a silo.'\nReasoning: The objectives of the meta-analysis are clearly stated, including the participants (newborns with gastroschisis), interventions (primary fascial closure or staged repair with a silo), and outcomes (hospital outcomes).\n\nP5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.\nExtracted quote: 'The review was performed according to the PRISMA guidelines (Appendix 1).'\nReasoning: The use of the PRISMA guidelines indicates that a review protocol exists, but no specific registration information is provided.\n\nP6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.\nExtracted quote: 'Case reports, reviews, letters, abstracts only, non-English abstracts, and studies that did not address at least one of the outcomes of interest were excluded from the meta-analysis.'\nReasoning: The eligibility criteria are specified, including the exclusion of case reports, reviews, letters, abstracts only, non-English abstracts, and studies that did not address at least one of the outcomes of interest.\n\nP7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.\nExtracted quote: 'We reviewed Medline citations, as well as the Cochrane Database of Systematic Reviews, between January 1, 1996 and June 1, 2012.'\nReasoning: The information sources are described, including Medline and the Cochrane Database of Systematic Reviews, with the dates of coverage.\n\nP8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.\nExtracted quote: No relevant quote found.\nReasoning: The full electronic search strategy is not provided.\n\nP9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).\nExtracted quote: 'Abstracts for all articles were independently subjected to preliminary review by two investigators (JA, SK) to determine whether inclusion criteria were satisfied. A third reviewer (JT) resolved disagreement between reviewers. Data abstraction was conducted independently by the same two investigators from the studies that met inclusion criteria.'\nReasoning: The process for selecting studies is described, including preliminary review of abstracts and independent data abstraction by two investigators.\n\nP10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.\nExtracted quote: 'Data abstraction was conducted independently by the same two investigators from the studies that met inclusion criteria. A standard data collection form (Appendix 2) created by the authors (JA, JT, SK) was used to extract information about study quality, including overall and per-group sample sizes, selection of method to close gastroschisis, inclusion of patients receiving surgically sutured silos in the silo group, and inclusion of patients with complicated gastroschisis (atresia, volvulus, or perforation) in the analysis; patient characteristics, including gestational age and birth weight; ascertainment bias; and reported patient outcomes.'\nReasoning: The method of data extraction is described, including the use of a standard data collection form and independent data abstraction by two investigators.\n\nP11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.\nExtracted quote: 'Outcomes of clinical interest were initially devised by the study authors; from this list, outcomes to be included in the analysis were selected based on whether data were reported in at least half of the studies selected, and included the following: total hospital LOS, total days on the ventilator, time to first feed (TFiF), time to full feeds (TFuF), parenteral nutrition duration (PND), infection rates (including sepsis, central line infections, pneumonia, and infections not otherwise specified), rates of necrotizing enterocolitis (NEC), and mortality rates.'\nReasoning: The variables for which data were sought are listed, including the outcomes of interest.\n\nP12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.\nExtracted quote: No relevant quote found.\nReasoning: The methods used for assessing risk of bias in individual studies are not described.\n\nP13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).\nExtracted quote: 'For each study, treatment effects were calculated using a fixed effect model to obtain weighted mean difference and 95% confidence interval for continuous outcomes, and odds ratio and 95% confidence interval for dichotomous outcomes.'\nReasoning: The principal summary measures are stated, including weighted mean difference for continuous outcomes and odds ratio for dichotomous outcomes.\n\nP14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.\nExtracted quote: No relevant quote found.\nReasoning: The methods of handling data and combining results of studies are not described.\n\nP15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).\nExtracted quote: No relevant quote found.\nReasoning: The assessment of risk of bias across studies is not specified.\n\nP16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.\nExtracted quote: No relevant quote found.\nReasoning: The methods of additional analyses are not described.\n\nP17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.\nExtracted quote: 'The literature search yielded 365 articles (Figure 1). Reviews, case reports, letters, and abstracts only (n=257) were excluded. After review of the remaining 108 abstracts and/or full text articles by two independent reviewers, studies that did not address gastroschisis repair methods and studies that did not address at least one of the outcomes of interest (n=88) were excluded. Twenty studies met inclusion criteria and were included in the meta-analysis: 1 randomized controlled trial, 3 prospective cohort studies, and 16 retrospective studies (Table 1).'\nReasoning: The numbers of studies screened, assessed for eligibility, and included in the review are provided, along with reasons for exclusions at each stage.\n\nP18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.\nExtracted quote: 'Twenty studies were included in the meta-analysis.'\nReasoning: The number of studies included in the meta-analysis is provided, but specific characteristics for each study are not presented.\n\nP19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).\nExtracted quote: No relevant quote found.\nReasoning: Data on risk of bias within studies are not presented.\n\nP20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.\nExtracted quote: 'Estimates of weighted mean differences and odds ratios for individual studies are shown in Figures 2 and ​and3,3, respectively.'\nReasoning: The effect estimates and confidence intervals for individual studies are presented.\n\nP21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.\nExtracted quote: No relevant quote found.\nReasoning: The results of each meta-analysis done are not presented.\n\nP22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).\nExtracted quote: No relevant quote found.\nReasoning: The results of any assessment of risk of bias across studies are not presented.\n\nP23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).\nExtracted quote: No relevant quote found.\nReasoning: The results of additional analyses are not presented.\n\nP24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).\nExtracted quote: 'This meta-analysis demonstrates that in studies with less selection bias, silo closure is associated with better outcomes for patients with gastroschisis.'\nReasoning: The main finding of the meta-analysis is summarized, indicating that silo closure is associated with better outcomes in studies with less selection bias.\n\nP25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g.,","P1. Title: Identify the report as a systematic review, meta-analysis, or both.\nExtracted quote: 'Primary Fascial Closure versus Staged Closure with Silo in Patients with Gastroschisis: A Meta-Analysis'\nReasoning: The title clearly identifies the report as a meta-analysis.\n\nP2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.\nExtracted quote: 'Background/Purpose: Gastroschisis is the most common congenital abdominal wall defect. Despite advances in the surgical closure of gastroschisis, consensus is lacking as to which method results in the best patient outcomes. The purpose of this meta-analysis was to compare short-term outcomes associated with primary fascial closure and staged repair with a silo in patients with gastroschisis.'\nReasoning: The abstract provides a structured summary including background, objectives, and study methods.\n\nP3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.\nExtracted quote: 'Gastroschisis is the most common abdominal wall defect in the newborn, and incidence is increasing worldwide, affecting 4–5/10,000 newborns (1, 2). Survival has dramatically improved to greater than 90% over the past 6 decades, due to improved techniques to close the abdominal wall defect and advances in neonatal care (3, 4, 5). Despite these advances, post-surgical care for gastroschisis remains challenging, and gastroschisis is the congenital defect with the longest ICU length of stay (LOS)(6).'\nReasoning: The introduction provides the rationale for the review by discussing the prevalence of gastroschisis and the need for improved post-surgical care.\n\nP4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\nExtracted quote: 'This meta-analysis sought to identify the best closure method for newborns with gastroschisis by comparing hospital outcomes in patients receiving either primary fascial closure or staged repair with a silo.'\nReasoning: The objectives of the meta-analysis are clearly stated, including the participants (newborns with gastroschisis), interventions (primary fascial closure or staged repair with a silo), and outcomes (hospital outcomes).\n\nP5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.\nExtracted quote: 'The review was performed according to the PRISMA guidelines (Appendix 1).'\nReasoning: The review was performed according to the PRISMA guidelines, but no specific information about a review protocol or registration is provided.\n\nP6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.\nExtracted quote: 'Case reports, reviews, letters, abstracts only, non-English abstracts, and studies that did not address at least one of the outcomes of interest were excluded from the meta-analysis.'\nReasoning: The eligibility criteria are specified, including the exclusion of case reports, reviews, letters, abstracts only, non-English abstracts, and studies that did not address at least one of the outcomes of interest.\n\nP7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.\nExtracted quote: 'We reviewed Medline citations, as well as the Cochrane Database of Systematic Reviews, between January 1, 1996 and June 1, 2012.'\nReasoning: The information sources are described, including Medline and the Cochrane Database of Systematic Reviews, and the date range of the search is provided.\n\nP8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the full electronic search strategy.\n\nP9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).\nExtracted quote: 'Abstracts for all articles were independently subjected to preliminary review by two investigators (JA, SK) to determine whether inclusion criteria were satisfied. A third reviewer (JT) resolved disagreement between reviewers. Data abstraction was conducted independently by the same two investigators from the studies that met inclusion criteria.'\nReasoning: The process for selecting studies is described, including preliminary review of abstracts and independent data abstraction by two investigators.\n\nP10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.\nExtracted quote: 'Data abstraction was conducted independently by the same two investigators from the studies that met inclusion criteria. A standard data collection form (Appendix 2) created by the authors (JA, JT, SK) was used to extract information about study quality, including overall and per-group sample sizes, selection of method to close gastroschisis, inclusion of patients receiving surgically sutured silos in the silo group, and inclusion of patients with complicated gastroschisis (atresia, volvulus, or perforation) in the analysis; patient characteristics, including gestational age and birth weight; ascertainment bias; and reported patient outcomes.'\nReasoning: The method of data extraction is described, including independent data abstraction by two investigators and the use of a standard data collection form.\n\nP11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the variables for which data were sought.\n\nP12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the methods used for assessing risk of bias in individual studies.\n\nP13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).\nExtracted quote: 'For each study, treatment effects were calculated using a fixed effect model to obtain weighted mean difference and 95% confidence interval for continuous outcomes, and odds ratio and 95% confidence interval for dichotomous outcomes.'\nReasoning: The principal summary measures are stated, including weighted mean difference and odds ratio.\n\nP14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the methods of handling data and combining results of studies.\n\nP15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the assessment of risk of bias across studies.\n\nP16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about additional analyses.\n\nP17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.\nExtracted quote: 'The literature search yielded 365 articles (Figure 1). Reviews, case reports, letters, and abstracts only (n=257) were excluded. After review of the remaining 108 abstracts and/or full text articles by two independent reviewers, studies that did not address gastroschisis repair methods and studies that did not address at least one of the outcomes of interest (n=88) were excluded. Twenty studies met inclusion criteria and were included in the meta-analysis: 1 randomized controlled trial, 3 prospective cohort studies, and 16 retrospective studies (Table 1).'\nReasoning: The numbers of studies screened, assessed for eligibility, and included in the review are provided, along with reasons for exclusions at each stage.\n\nP18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.\nExtracted quote: 'Twenty studies were included in the meta-analysis.'\nReasoning: The number of studies included in the meta-analysis is provided, but no specific characteristics or citations are given.\n\nP19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the risk of bias within studies.\n\nP20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.\nExtracted quote: 'Estimates of weighted mean differences and odds ratios for individual studies are shown in Figures 2 and ​and3,3, respectively.'\nReasoning: The results of individual studies are presented, including effect estimates and confidence intervals.\n\nP21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the synthesis of results.\n\nP22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the assessment of risk of bias across studies.\n\nP23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about additional analyses.\n\nP24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).\nExtracted quote: 'This meta-analysis demonstrates that in studies with less selection bias, silo closure is associated with better outcomes for patients with gastroschisis.'\nReasoning: The main findings are summarized, including the association of silo closure with better outcomes in studies with less selection bias.\n\nP25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).\nExtracted quote: 'There are several limitations inherent in this meta-analysis. First, we identified the following three major variations in study design: 1) manner of selection of gastroschisis closure method, 2) inclusion of patients receiving surgically sutured silos in the silo group, and 3) inclusion of patients with complicated gastroschisis (including atresia, volvulus, and perforation).'\nReasoning: The limitations of the meta-analysis are discussed, including variations in study design and potential biases.\n\nP26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.\nExtracted quote: 'This analysis highlights the heterogeneity of the available literature on closure methods for gastroschisis and the impact of study design on reported outcomes. Determining a superior method of closure would be a benefit to both the surgical and medical management of gastroschisis; this meta-analysis demonstrates that further well-designed studies are needed to gain an accurate picture of outcomes after different surgical interventions.'\nReasoning: The general interpretation of the results is provided, emphasizing the need for further well-designed studies to determine the best closure method for gastroschisis.\n\nP27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.\nExtracted quote: No relevant quote found.\nReasoning: No information is provided about the funding sources for the systematic review.","P1. Title: 'Interventions for primary vesicoureteric reflux' - [Yes]\nP2. Abstract / Structured summary: 'To evaluate the benefits and harms of different treatment options for primary VUR.' - [Yes]\nP3. Introduction / Rationale: No specific statement about the rationale for the review in the context of what is already known - [No]\nP4. Introduction / Objectives: 'To evaluate the benefits and harms of different treatment options for primary VUR.' - [Yes]\nP5. Methods / Protocol and registration: No mention of a review protocol or registration - [No]\nP6. Methods / Eligibility criteria: No specific mention of study characteristics or report characteristics used as eligibility criteria - [No]\nP7. Methods / Information sources: No specific description of information sources used in the search - [No]\nP8. Methods / Search: No presentation of a full electronic search strategy - [No]\nP9. Methods / Study selection: No specific statement about the process for selecting studies - [No]\nP10. Methods / Data collection process: No description of the method of data extraction - [No]\nP11. Methods / Data items: No list and definition of all variables for which data were sought - [No]\nP12. Methods / Risk of bias in individual studies: No description of methods used for assessing risk of bias - [No]\nP13. Methods / Summary measures: No statement of the principal summary measures - [No]\nP14. Methods / Synthesis of results: No description of the methods of handling data and combining results of studies - [No]\nP15. Methods / Risk of bias across studies: No specification of any assessment of risk of bias - [No]","P1. Title: 'Interventions for primary vesicoureteric reflux' - [Yes]\nP2. Abstract / Structured summary: 'To evaluate the benefits and harms of different treatment options for primary VUR.' - [Yes]\nP3. Introduction / Rationale: No specific statement about the rationale for the review in the context of what is already known - [No]\nP4. Introduction / Objectives: 'To evaluate the benefits and harms of different treatment options for primary VUR.' - [Yes]\nP5. Methods / Protocol and registration: No mention of a review protocol or registration - [No]\nP6. Methods / Eligibility criteria: No specific mention of study characteristics or report characteristics used as eligibility criteria - [No]\nP7. Methods / Information sources: No specific description of information sources used in the search - [No]\nP8. Methods / Search: No presentation of a full electronic search strategy - [No]\nP9. Methods / Study selection: No specific statement about the process for selecting studies - [No]\nP10. Methods / Data collection process: No description of the method of data extraction - [No]\nP11. Methods / Data items: No list and definition of all variables for which data were sought - [No]\nP12. Methods / Risk of bias in individual studies: No description of methods used for assessing risk of bias - [No]\nP13. Methods / Summary measures: No statement of the principal summary measures - [No]\nP14. Methods / Synthesis of results: No description of methods of handling data and combining results of studies - [No]\nP15. Methods / Risk of bias across studies: No specification of any assessment of risk of bias across studies - [No]","P1. Title: 'Interventions for primary vesicoureteric reflux' - [Yes]\nP2. Abstract / Structured summary: 'To evaluate the benefits and harms of different treatment options for primary VUR.' - [Yes]\nP3. Introduction / Rationale: No specific statement about the rationale for the review in the context of what is already known - [No]\nP4. Introduction / Objectives: 'To evaluate the benefits and harms of different treatment options for primary VUR.' - [Yes]\nP5. Methods / Protocol and registration: No mention of a review protocol or registration - [No]\nP6. Methods / Eligibility criteria: No specific mention of study characteristics or report characteristics used as eligibility criteria - [No]\nP7. Methods / Information sources: No specific description of information sources used in the search - [No]\nP8. Methods / Search: No presentation of a full electronic search strategy - [No]\nP9. Methods / Study selection: No specific statement about the process for selecting studies - [No]\nP10. Methods / Data collection process: No description of the method of data extraction - [No]\nP11. Methods / Data items: No list and definition of all variables for which data were sought - [No]\nP12. Methods / Risk of bias in individual studies: No description of methods used for assessing risk of bias - [No]\nP13. Methods / Summary measures: No statement of the principal summary measures - [No]\nP14. Methods / Synthesis of results: No description of methods of handling data and combining results of studies - [No]\nP15. Methods / Risk of bias across studies: No specification of any assessment of risk of bias across studies - [No]\nP16. Methods / Additional analyses: No description of methods of additional analyses - [No]\nP17. Results / Study selection: No numbers of studies screened, assessed for eligibility, and included in the review - [No]","P1. Title: 'Management of congenital diaphragmatic hernia: A systematic review from the APSA outcomes and evidence based practice committee'\nReasoning: The title clearly identifies the report as a systematic review.\n[Yes]\n\nP2. Abstract / Structured summary: The abstract provides a structured summary including background, objectives, methods, results, and conclusions.\nReasoning: The abstract provides a structured summary as described in the PRISMA item.\n[Yes]\n\nP3. Introduction / Rationale: The introduction describes the rationale for the review in the context of what is already known.\nReasoning: The introduction provides a rationale for the review by stating that variable management practices complicate the identification of optimal strategies for infants with congenital diaphragmatic hernia.\n[Yes]\n\nP4. Introduction / Objectives: The introduction provides an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design.\nReasoning: The introduction states the objective of the review to critically appraise the available evidence and provide recommendations for the management of infants with congenital diaphragmatic hernia.\n[Yes]\n\nP5. Methods / Protocol and registration: No information is provided about the existence of a review protocol or registration information.\nReasoning: The full text does not mention a review protocol or registration information.\n[No]","P1. Title: Identify the report as a systematic review, meta-analysis, or both.\n- 'Single-incision versus conventional laparoscopic appendicectomy in children: a systematic review and meta-analysis'\n1. Yes\n2. The title clearly identifies the report as a systematic review and meta-analysis.\n3. [Yes]\n\nP2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.\n- 'Abstract: Purpose... Conclusion'\n1. Yes\n2. The abstract provides a structured summary including background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, and implications of key findings.\n3. [Yes]\n\nP3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.\n- 'Introduction: As surgical techniques have developed and the demand for procedures that cause less pain and have better cosmetic outcome, more and more surgeons draw their attention to minimally invasive techniques.'\n1. Yes\n2. The introduction describes the rationale for the review in the context of what is already known about surgical techniques and the demand for less invasive procedures.\n3. [Yes]\n\nP4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).\n- 'Introduction: To evaluate the safety and efficacy of SILA in the treatment of pediatric appendicitis, the authors collected 12 published studies to perform a meta-analysis.'\n1. Yes\n2. The introduction provides an explicit statement of the objective, which is to evaluate the safety and efficacy of SILA in the treatment of pediatric appendicitis.\n3. [Yes]\n\nP5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.\n1. No\n2. There is no mention of a review protocol or registration information.\n3. [No]\n\nP6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.\n- 'Study selection: Children with histologically confirmed acute appendicitis who received SILA or CLA were recruited. Inclusion criteria: (1) clinical trails that compared single-incision versus conventional laparoscopic appendicectomy between 2000 and 2014; (2) children younger than 18 years with acute appendicitis; (3) original data included some of the following: operative time, length of hospital stay, postoperative recovery, and postoperative complications. Exclusion criteria: (1) no conventional laparoscopic appendicectomy as a control; (2) chronic appendicitis; and (3) duplicate publication or study did not provide sufficient original data.'\n1. Yes\n2. The methods specify the study characteristics (participants, interventions, comparisons, outcomes) and report characteristics (years considered) used as criteria for eligibility.\n3. [Yes]\n\nP7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.\n- 'Search strategy: An electronic search was performed using EMBASE, PubMed, MEDLINE from 2000 to 2014.'\n1. Yes\n2. The methods describe the information sources used in the search (EMBASE, PubMed, MEDLINE) and the date range.\n3. [Yes]\n\nP8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.\n1. No\n2. There is no presentation of the full electronic search strategy.\n3. [No]\n\nP9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).\n- 'Study selection: Children with histologically confirmed acute appendicitis who received SILA or CLA were recruited.'\n1. Yes\n2. The methods state the process for selecting studies, which is based on children with histologically confirmed acute appendicitis who received SILA or CLA.\n3. [Yes]\n\nP10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.\n- 'Data extraction: Two authors independently extracted data from the list of the included studies, and a third reviewer was required for a final decision in the case of any discrepancies.'\n1. Yes\n2. The methods describe the method of data extraction, which is done independently by two authors with a third reviewer for discrepancies.\n3. [Yes]\n\nP11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.\n1. NA\n2. The full text does not provide information on the variables for which data were sought or any assumptions and simplifications made.\n3. [NA]\n\nP12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.\n1. NA\n2. The full text does not provide information on the methods used for assessing risk of bias in individual studies or how this information is used in data synthesis.\n3. [NA]\n\nP13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).\n- 'Statistical analysis: For continuous variables, we calculated mean differences (MDs) with 95 % confidence intervals (CIs). For dichotomous variables, we used odds ratios (ORs).'\n1. Yes\n2. The methods state the principal summary measures used, which are mean differences (MDs) for continuous variables and odds ratios (ORs) for dichotomous variables.\n3. [Yes]\n\nP14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.\n1. NA\n2. The full text does not describe the methods of handling data and combining results of studies or measures of consistency for each meta-analysis.\n3. [NA]\n\nP15. Methods / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).\n1. NA\n2. The full text does not specify any assessment of risk of bias across studies.\n3. [NA]\n\nP16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.\n1. NA\n2. The full text does not describe any methods of additional analyses.\n3. [NA]\n\nP17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.\n- 'Results: The initial search strategy identified 213 citations and 26 of them were retrieved for full text review. Twelve trials met total inclusion criteria (Fig. 1)'\n1. Yes\n2. The results give the numbers of studies screened, assessed for eligibility, and included in the review, with a flow diagram showing the process.\n3. [Yes]\n\nP18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.\n1. Yes\n2. The results present characteristics for each study, including study style, male:female sex ratio, and BMI or weight in each group, and provide the citations.\n3. [Yes]\n\nP19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).\n1. NA\n2. The full text does not present data on risk of bias within studies or any outcome level assessment.\n3. [NA]\n\nP20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.\n1. Yes\n2. The results present simple summary data for each intervention group and effect estimates and confidence intervals for each study.\n3. [Yes]\n\nP21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.\n1. NA\n2. The full text does not present the results of any meta-analysis.\n3. [NA]\n\nP22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).\n1. NA\n2. The full text does not present any assessment of risk of bias across studies.\n3. [NA]\n\nP23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).\n1. NA\n2. The full text does not give results of any additional analyses.\n3. [NA]\n\nP24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).\n- 'Discussion: Our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis. It reveals significantly shorter hospital stay and potential comparable operative time, postoperative complications such as wound infection, intra-abdominal infection, and ileus compared with CLA.'\n1. Yes\n2. The discussion summarizes the main findings, including the strength of evidence for each main outcome, and considers their relevance to key groups.\n3. [Yes]\n\nP25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).\n- 'Discussion: Our systematic review and meta-analysis does have some limitations. On one hand, the overall methodologic quality and reporting of the included trials in children was poor. Some included studies had rather small sample size. On the other hand, there was evidence of statistical heterogeneity among different studies in terms of operative time and length of hospital stay.'\n1. Yes\n2. The discussion discusses limitations at the study and outcome level, including the poor methodologic quality and reporting of the included trials and the evidence of statistical heterogeneity.\n3. [Yes]\n\nP26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.\n- 'Discussion: In conclusion, our study suggests that SILA is a feasible and safe surgical procedure alternative to CLA for pediatric patients with appendicitis. It reveals significantly shorter hospital stay and potential comparable operative time, postoperative complications such as wound infection, intra-abdominal infection, and ileus compared with CLA. However, most of the studies included in our meta-analysis were retrospective studies. Therefore, more prospective randomized controlled trials are needed in children to draw a more convincing conclusion.'\n1. Yes\n2. The discussion provides a general interpretation of the results in the context of other evidence and implications for future research.\n3. [Yes]\n\nP27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data);"]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th> <\/th>\n      <th>Author &amp; Year<\/th>\n      <th>Failure reason (click to show LLM response)<\/th>\n      <th>Ultimately successful<\/th>\n      <th>LLM response<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"bPaginate":false,"dom":"ft","columnDefs":[{"targets":2,"render":"function(data, type, row, meta) { return '<a onclick=\"javascript:alert(`'+row[4]+'`)\" style=\"cursor: pointer\">' + data + '<\/a>' }"},{"targets":[0,4],"visible":false},{"orderable":false,"targets":0}],"order":[],"autoWidth":false,"orderClasses":false}},"evals":["options.columnDefs.0.render"],"jsHooks":[]}</script>
</div>
<div id="llm-prompt" class="section level3">
<h3>LLM prompt</h3>
<ul>
<li>Model: <code>gpt-3.5-turbo-16k-0613</code></li>
<li>Temperature: <code>0</code></li>
<li>Briefing derived from: <a
href="https://doi.org/10.1371/journal.pone.0175213">Cullis 2017</a>
Supporting information: <a
href="https://doi.org/10.1371/journal.pone.0175213.s004">S1
Dataset</a></li>
</ul>
<div id="system-prompt" class="section level4">
<h4>System prompt</h4>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<pre>
You are an expert in systematic reviews and are tasked to assess the reporting quality of a systematic review with the PRISMA 2009 tool based on the full text of its publication. PRISMA 2009 consist of the following items:

---
# PRISMA 2009
P1. Title: Identify the report as a systematic review, meta-analysis, or both.
P2. Abstract / Structured summary: Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.
P3. Introduction / Rationale: Describe the rationale for the review in the context of what is already known.
P4. Introduction / Objectives: Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).
P5. Methods / Protocol and registration: Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.
P6. Methods / Eligibility criteria: Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.
P7. Methods / Information sources: Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.
P8. Methods / Search: Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.
P9. Methods / Study selection: State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
P10. Methods / Data collection process: Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
P11. Methods / Data items: List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.
P12. Methods / Risk of bias in individual studies: Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.
P13. Methods / Summary measures: State the principal summary measures (e.g., risk ratio, difference in means).
P14. Methods / Synthesis of results: Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.
P15. Methdos / Risk of bias across studies: Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).
P16. Methods / Additional analyses: Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.
P17. Results / Study selection: Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
P18. Results / Study characteristics: For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.
P19. Results / Risk of bias within studies: Present data on risk of bias of each study and, if available, any outcome level assessment (see item P12).
P20. Results / Results of individual studies: For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
P21. Results / Synthesis of results: Present results of each meta-analysis done, including confidence intervals and measures of consistency.
P22. Results / Risk of bias across studies: Present results of any assessment of risk of bias across studies (see Item P15).
P23. Results / Additional analysis: Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item P16]).
P24. Discussion / Summary of evidence: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).
P25. Discussion / Limitations: Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
P26. Discussion / Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
P27. Funding: Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.
---
 
</pre>
</div>
<div id="user-prompt" class="section level4">
<h4>User prompt</h4>
<div class="knitr-options" data-fig-width="576" data-fig-height="460">

</div>
<pre>
This is the full text to be assessed:
---
%FULLTEXT%
---

For each of the PRISMA items (P1 to P27) perform the following steps. Do not repeat the items' names / instructions.
1. Extract one relevant short quote from the full text.
2. Explain your reasoning in one short sentence.
3. Respond with either "[Yes]" if the item was reported, "[No]" if not reported, or "[NA]" if not applicable (for example, items P14, P15, P16, P21, P22, P23 in the context of a systematic review without a meta-analysis).

Be as concise as possible and avoid unnecessary repetitions. Before stopping, make sure you've processed all 27 PRISMA items. Do not provide a final summary paragraph in the end.
 
</pre>
</div>
</div>
</div>

</div>

<script>
$(document).ready(function() {
  // add bootstrap table styles to pandoc tables
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed table-sm');

  // initialize mathjax

});
</script>

<script type="text/javascript">
$(document).ready(function () {
  FlexDashboard.init({
    fillPage: true,
    orientation: "columns",
    storyboard: false,
    defaultFigWidth: 576,
    defaultFigHeight: 460,
    defaultFigWidthMobile: 360,
    defaultFigHeightMobile: 460,
    resize_reload: true
  });
  var navbar = $(".navbar").first();
  var body = $("body").first();
  var sidebar = $(".section.sidebar").first();
  function addNavbarPadding() {
    var navHeight = navbar.outerHeight();
    body.css("padding-top", (navHeight + 8) + "px");
    sidebar.css("top", navHeight + "px");
    var resizeEvent = window.document.createEvent("UIEvents");
    resizeEvent.initUIEvent("resize", true, false, window, 0);
    window.dispatchEvent(resizeEvent);
  }
  if (!window.Shiny) setTimeout(addNavbarPadding, 100);
  $(document).on("shiny:idle", function() {
    setTimeout(addNavbarPadding, 50);
  });
});
</script>

</body>
</html>
